data_2jov_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jov _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.3 145.43 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.746 0.308 . . . . 0.0 110.563 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.38 119.73 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.923 0.392 . . . . 0.0 110.277 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 77.0 t80 -60.11 125.71 24.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.155 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.8 m -145.15 120.39 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 178.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.58 120.97 66.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.3 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.74 150.58 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.805 0.336 . . . . 0.0 110.333 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HA ' HG11 ' A' ' 20' ' ' VAL . 91.0 mtt180 -77.22 134.45 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.577 ' CG1' ' HE3' ' A' ' 16' ' ' LYS . 12.0 t -112.85 111.6 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -90.84 100.91 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.448 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.5 14.0 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 t -85.03 99.84 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.577 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -149.58 39.77 0.81 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.356 -175.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.6 tttm 70.74 -66.07 0.31 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.568 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -73.79 -179.06 3.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 111.363 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.0 -36.43 1.98 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.653 0.263 . . . . 0.0 111.245 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' A' ' 11' ' ' ARG . 17.0 m -129.03 158.99 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.218 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.2 p -128.67 133.4 25.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.93 118.8 5.72 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.529 2.152 . . . . 0.0 111.717 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.473 HG12 ' SG ' ' A' ' 69' ' ' CYS . 28.9 m -112.5 150.54 14.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 70' ' ' THR . 18.3 ptpt -136.66 170.56 15.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.969 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 17.0 t -109.45 155.71 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.441 ' ND2' ' HE2' ' A' ' 27' ' ' LYS . 21.1 p-10 -78.04 -32.86 51.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.176 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HE2' ' ND2' ' A' ' 26' ' ' ASN . 51.1 mtmt -122.58 150.86 58.97 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.975 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 23.3 Cg_exo -64.38 136.9 53.06 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.137 2.558 . . . . 0.0 112.971 -176.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.438 HG11 ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -124.57 150.19 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.824 -177.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -69.52 145.7 52.45 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.866 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tt -60.35 -27.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.987 0.422 . . . . 0.0 111.546 -174.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.45 -28.0 68.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 111.059 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.13 -20.73 22.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.711 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -57.55 -43.33 84.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -67.37 -45.59 85.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.135 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.96 -45.8 89.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.449 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.438 ' CE2' HG11 ' A' ' 29' ' ' VAL . 22.1 m-30 -67.51 -37.44 82.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.602 0.239 . . . . 0.0 110.877 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 m -64.44 -33.7 76.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.21 -40.2 95.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.22 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 50.7 t -64.98 -44.3 96.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.338 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.91 -21.92 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.443 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -73.5 -13.59 61.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.381 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 10.3 ptt180 -111.65 1.26 16.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.366 0.603 . . . . 0.0 109.43 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 tt -108.73 133.02 53.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.683 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.96 110.24 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.642 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 43.2 t -78.01 126.72 38.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.96 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.773 -1.203 . . . . 0.0 112.589 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.8 112.14 20.52 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.535 0.207 . . . . 0.0 110.913 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 6.1 Cg_exo -75.44 102.95 1.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.774 2.316 . . . . 0.0 110.786 170.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.61 -178.57 4.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.302 0.572 . . . . 0.0 112.352 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.91 -178.23 5.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.367 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 p -74.85 140.13 43.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.462 . . . . 0.0 111.181 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 32.16 16.95 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.712 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.731 HD22 ' HB2' ' A' ' 69' ' ' CYS . 10.4 p30 -96.58 128.4 43.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.313 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.41 HG21 HG21 ' A' ' 68' ' ' ILE . 47.7 t -83.15 120.53 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.917 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.99 -61.26 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.509 0.671 . . . . 0.0 109.798 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.69 121.38 25.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.286 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -91.81 136.5 33.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.26 56.52 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.452 0.47 . . . . 0.0 110.236 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.37 125.57 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.254 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 96.9 mmm 64.46 23.85 13.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.564 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.5 t30 51.26 69.5 0.64 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.793 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 p -114.49 -35.01 5.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.845 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.67 9.95 34.13 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.454 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 27' ' ' LYS . 1.7 p -104.04 157.28 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -109.29 137.97 46.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mm -111.52 117.19 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 34.3 pt -123.78 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 111.793 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.731 ' HB2' HD22 ' A' ' 54' ' ' ASN . 2.7 m -82.72 134.59 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.5 HG21 ' HE3' ' A' ' 24' ' ' LYS . 12.7 t -109.77 3.9 21.27 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.246 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HB3' HG23 ' A' ' 21' ' ' VAL . 55.7 tptt -96.68 143.6 27.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -90.93 121.12 32.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.8 mm? -98.35 112.27 61.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.91 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 8.6 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 123.145 2.564 . . . . 0.0 111.719 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.488 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 99.4 mttt . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.42 148.65 50.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.03 0.443 . . . . 0.0 111.377 -176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.47 HG21 ' O ' ' A' ' 25' ' ' SER . 47.2 mm -61.77 110.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.309 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.93 110.9 3.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -123.89 127.93 48.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.878 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.4 m -154.72 173.85 15.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.2 t -117.26 125.04 73.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.6 156.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.808 0.337 . . . . 0.0 110.664 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -90.24 116.9 28.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.124 0.488 . . . . 0.0 109.788 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 t -108.45 140.76 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.875 -172.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 65.9 mtt-85 -97.53 158.41 15.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.62 157.74 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.05 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -81.55 45.37 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.461 0.648 . . . . 0.0 111.013 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 33.58 2.32 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.087 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 tptt 69.74 -59.27 0.5 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 0.0 112.056 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -80.91 -177.46 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -143.5 11.4 1.68 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.294 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.5 m -146.31 147.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.024 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 71' ' ' LYS . 9.5 p -137.66 133.71 18.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.562 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -70.47 116.0 4.44 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.804 2.336 . . . . 0.0 112.269 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.555 HG11 ' SG ' ' A' ' 69' ' ' CYS . 34.9 m -105.44 151.33 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.954 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' HB2' ' HZ1' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -136.28 163.27 30.8 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.363 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.47 ' O ' HG21 ' A' ' 5' ' ' ILE . 19.5 m -109.27 131.82 54.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -75.61 -12.68 60.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HB2' HG23 ' A' ' 65' ' ' VAL . 75.0 mmtt -115.98 143.16 30.33 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 17.1 Cg_exo -67.59 120.25 7.27 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.316 2.011 . . . . 0.0 110.923 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.73 148.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.677 -172.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 54.1 mt-10 -64.0 119.53 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -61.32 -22.31 27.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -70.03 -16.54 63.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.996 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -98.8 11.7 37.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -62.95 -35.07 78.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.685 0.279 . . . . 0.0 110.8 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.58 -39.94 85.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.519 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 40' ' ' VAL . 37.2 t70 -61.77 -48.03 82.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.75 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.43 -40.77 89.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.9 m -60.91 -38.94 87.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.934 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.27 -43.47 98.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 36' ' ' ASP . 47.8 t -65.38 -45.1 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.533 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.19 -27.34 69.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.567 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 m -73.73 -5.01 38.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.29 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -113.6 5.08 16.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.239 0.543 . . . . 0.0 109.679 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.8 tp -109.05 42.14 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.022 -172.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -70.19 94.61 0.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.397 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.59 154.23 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.26 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -124.59 98.42 0.56 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.299 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 7.3 p -168.5 126.14 0.89 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.783 0.325 . . . . 0.0 110.763 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 8.5 Cg_exo -72.49 120.99 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.743 2.295 . . . . 0.0 111.373 174.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -122.11 -179.23 4.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.82 173.13 6.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 p -69.84 126.13 28.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 110.83 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 30.05 13.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.759 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.83 HD22 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -88.85 128.04 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 68' ' ' ILE . 22.1 t -88.19 112.83 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.376 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -76.46 -62.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 44.3 t -130.64 108.81 10.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.253 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.9 138.76 32.33 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.55 43.23 16.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 6.2 tt -50.44 -39.11 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.339 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.86 39.48 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.87 18.82 11.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.11 0.957 . . . . 0.0 109.71 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 65' ' ' VAL . 20.5 p -82.51 -25.4 33.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.164 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.19 15.28 69.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.281 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.55 HG22 ' HB ' ' A' ' 63' ' ' THR . 48.7 t -92.26 139.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.85 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.61 101.01 12.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.81 102.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.8 pt -115.35 136.58 51.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.83 ' HB2' HD22 ' A' ' 54' ' ' ASN . 2.3 m -87.77 135.9 33.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -108.39 0.26 21.01 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.126 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' HG22 ' A' ' 21' ' ' VAL . 66.4 tttp -102.47 140.12 37.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.576 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -89.28 132.31 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.4 mm? -95.64 122.98 57.64 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.257 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 37.6 Cg_exo . . . . . 0 C--O 1.233 0.26 0 C-N-CA 123.007 2.472 . . . . 0.0 112.484 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 60.0 mttm . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.678 0.275 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -140.6 179.64 6.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.0 mm -89.61 101.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.452 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.421 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 75.7 t80 -59.56 107.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.503 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -118.71 127.41 53.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 t -152.99 -171.89 4.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.08 140.74 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -120.72 154.19 24.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.897 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 11' ' ' ARG . 18.7 mtp-105 -82.4 128.73 34.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.402 0.62 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.752 HG11 ' HZ1' ' A' ' 16' ' ' LYS . 15.6 t -97.25 141.95 14.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.326 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -137.29 100.68 4.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 0.0 110.679 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.55 -175.47 47.25 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 t -86.45 78.99 9.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.458 0.646 . . . . 0.0 110.309 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -160.9 148.68 15.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.432 177.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -83.74 37.7 0.6 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.483 ' HB2' HD13 ' A' ' 73' ' ' LEU . 29.4 m-85 -151.75 109.06 3.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -89.52 7.99 33.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.64 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -141.57 132.29 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 71' ' ' LYS . 13.1 p -133.29 131.56 21.67 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.959 0.409 . . . . 0.0 110.896 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.33 124.64 10.09 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.718 2.279 . . . . 0.0 112.396 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -115.79 155.36 17.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.475 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -138.71 171.29 14.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.499 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 18.6 m -109.29 129.28 55.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.257 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -72.92 -21.99 60.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.072 0.463 . . . . 0.0 110.636 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -116.04 135.82 22.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 37.0 Cg_endo -66.13 116.54 4.07 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.449 2.1 . . . . 0.0 112.56 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 6' ' ' PHE . 3.8 m -105.82 148.49 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.983 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 32' ' ' SER . 2.0 mp0 -64.93 141.63 58.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 111.086 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -77.05 22.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.424 0.631 . . . . 0.0 111.279 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' GLU . 25.6 m -114.4 4.15 15.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.347 0.594 . . . . 0.0 109.703 173.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -106.33 16.3 24.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.414 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -52.44 -49.07 65.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.967 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 tt -53.99 -50.77 51.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.071 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 40' ' ' VAL . 45.0 m-20 -65.05 -48.08 75.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.246 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -67.38 -36.46 81.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.294 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -62.86 -41.14 99.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.572 0.225 . . . . 0.0 110.738 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.4 -42.49 98.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.817 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 36' ' ' ASP . 58.7 t -67.51 -49.21 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.137 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.54 -29.68 69.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 111.178 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -72.56 -20.51 61.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 110.481 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 43' ' ' ARG . 12.8 mtp180 -103.51 -1.75 27.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.184 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -107.2 93.46 4.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.124 0.488 . . . . 0.0 110.704 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -96.25 91.29 5.81 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.19 139.26 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.65 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.24 -130.78 5.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.128 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 49' ' ' PRO . 94.0 t 70.41 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 112.081 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 48' ' ' VAL . 61.0 Cg_endo -74.74 98.11 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.478 2.119 . . . . 0.0 111.764 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -108.49 163.78 12.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.67 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.9 mtmt -115.93 177.08 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.536 ' HB2' HD22 ' A' ' 72' ' ' ASN . 34.3 t -61.86 131.84 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.914 0.387 . . . . 0.0 111.149 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.18 25.28 19.81 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.054 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.705 HD22 ' HB2' ' A' ' 69' ' ' CYS . 9.3 p30 -95.0 125.19 39.5 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.413 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 68' ' ' ILE . 17.0 t -86.44 109.25 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.69 -40.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.915 0.388 . . . . 0.0 110.169 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.2 t -130.48 105.37 7.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' HZ3' ' CG ' ' A' ' 66' ' ' ASP . 9.5 tmtm? -90.7 129.56 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 60.71 47.93 7.62 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.392 0.433 . . . . 0.0 111.078 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG21 ' O ' ' A' ' 65' ' ' VAL . 12.7 tt -60.98 135.8 25.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.197 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.405 ' HE1' ' HB3' ' A' ' 36' ' ' ASP . 13.5 mmt 64.33 11.5 6.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.226 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 57.94 28.72 16.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.802 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.44 HG23 HG21 ' A' ' 65' ' ' VAL . 9.0 t -101.95 -7.69 22.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.341 0.591 . . . . 0.0 110.345 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.46 5.53 57.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.903 176.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.543 ' O ' HG21 ' A' ' 60' ' ' ILE . 94.8 t -85.01 130.99 35.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.007 0.432 . . . . 0.0 109.958 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.504 ' CG ' ' HZ3' ' A' ' 58' ' ' LYS . 66.4 m-20 -107.08 110.48 22.6 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.287 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -76.97 108.6 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.539 HG21 HG21 ' A' ' 55' ' ' VAL . 25.8 pt -114.7 136.59 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.249 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.7 m -92.02 136.15 33.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -108.86 8.54 26.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 0.0 111.641 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' ' 21' ' ' VAL . 45.1 tttp -102.2 148.31 25.59 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.76 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.582 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -99.87 124.04 44.76 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.753 ' HG ' ' HZ3' ' A' ' 16' ' ' LYS . 2.5 mm? -108.09 120.3 47.28 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.528 -174.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.237 0.443 0 C-N-CA 122.942 2.428 . . . . 0.0 111.943 175.453 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.1 136.6 54.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.6 mt -74.05 126.15 34.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.611 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -63.88 117.01 6.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.62 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 m -134.62 120.54 19.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -149.96 -169.55 3.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 20' ' ' VAL . 7.2 p -132.44 127.72 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.25 153.33 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.678 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 11' ' ' ARG . 57.6 mtt180 -75.32 128.9 36.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 21' ' ' VAL . 19.5 t -86.56 125.36 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -110.27 123.0 48.99 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.04 -174.61 24.31 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.704 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 m -72.09 95.39 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.467 ' HZ2' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -139.02 176.97 8.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.392 -175.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.653 ' HB3' ' HB2' ' A' ' 74' ' ' PRO . 51.7 tptt -110.66 -30.6 7.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.252 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.42 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -96.29 138.3 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.467 ' HA ' ' HZ2' ' A' ' 16' ' ' LYS . 56.3 t30 -77.83 -45.42 24.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.767 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 9' ' ' VAL . 18.4 m -128.17 147.63 32.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.397 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 12' ' ' VAL . 9.5 p -128.27 121.4 21.53 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 121.246 0.546 . . . . 0.0 111.406 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 32.4 Cg_exo -59.9 125.45 17.74 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.86 2.373 . . . . 0.0 112.636 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.545 HG13 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -117.86 155.48 19.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.839 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -143.64 177.33 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.038 0.447 . . . . 0.0 111.092 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.529 ' HB3' HG23 ' A' ' 5' ' ' ILE . 40.4 t -109.2 147.08 33.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.734 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -84.04 -8.34 59.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 110.716 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HE2' HG21 ' A' ' 65' ' ' VAL . 37.2 mtmm -139.3 144.48 40.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.582 ' HA ' HG12 ' A' ' 5' ' ' ILE . 23.1 Cg_exo -63.61 129.92 26.53 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.155 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 175.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.029 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 124.02 21.94 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.22 -24.11 35.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.107 0.48 . . . . 0.0 110.993 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -83.69 1.79 40.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.596 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -95.05 7.28 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.8 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -59.07 -30.57 68.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.615 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.588 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 9.1 pt -66.49 -38.65 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.554 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 11.4 m-20 -76.8 -40.12 49.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.561 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -66.03 -51.41 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.745 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 m -63.56 -25.75 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.565 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 9.3 t-20 -59.57 -50.78 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.783 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.22 -40.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.26 -32.02 71.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.358 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.6 t -64.96 -21.14 66.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.828 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 21.2 tpt180 -109.59 1.98 20.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.335 0.588 . . . . 0.0 109.883 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' HG ' HG22 ' A' ' 46' ' ' VAL . 44.5 tp -108.26 92.01 3.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.597 -176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.54 95.71 7.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.304 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.426 HG22 ' HG ' ' A' ' 44' ' ' LEU . 15.7 m -141.75 -157.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.916 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . 137.44 -88.08 0.22 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.297 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t 68.28 117.86 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.215 0 O-C-N 123.919 0.423 . . . . 0.0 110.552 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.843 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 80.6 Cg_exo -43.29 105.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.519 2.813 . . . . 0.0 113.455 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -131.93 -163.89 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.195 -176.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' H ' ' HB ' ' A' ' 50' ' ' THR . 55.1 mtpt -120.88 -175.91 3.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.64 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.772 -175.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.32 22.41 24.73 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.408 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.77 HD22 ' HB2' ' A' ' 69' ' ' CYS . 11.0 p30 -85.32 133.45 34.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.195 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 66' ' ' ASP . 61.4 t -90.92 120.48 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.656 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.26 -52.56 9.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.581 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.4 m -130.9 117.3 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.481 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 1.016 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 49.9 tttp -99.49 132.81 44.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.787 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.7 t30 67.11 39.2 3.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.431 0.634 . . . . 0.0 110.161 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.39 128.46 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.916 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.42 ' HE1' ' HB3' ' A' ' 36' ' ' ASP . 57.1 mtt 66.14 16.36 10.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 0.0 111.444 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.34 36.59 20.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.287 0.565 . . . . 0.0 110.848 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.6 p -82.58 -26.06 32.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.415 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.93 10.19 65.0 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.298 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG21 ' HE2' ' A' ' 27' ' ' LYS . 68.8 t -108.59 131.67 58.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.51 0.195 . . . . 0.0 111.022 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 1.016 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.0 p-10 -99.79 124.89 45.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 109.849 170.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.38 121.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.403 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.5 pt -121.11 138.3 51.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.0 111.687 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.77 ' HB2' HD22 ' A' ' 54' ' ' ASN . 2.9 m -91.09 141.93 28.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -111.68 2.17 17.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 111.072 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.1 tmtt? -96.19 131.91 42.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -83.78 113.38 20.87 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.843 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 73.8 mt -97.4 125.93 43.49 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.653 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 33.2 Cg_exo . . . . . 0 C--N 1.348 0.527 0 C-N-CA 122.956 2.438 . . . . 0.0 111.677 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 82.2 mttt . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.658 0.266 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -123.23 158.63 30.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.82 0.343 . . . . 0.0 110.726 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.31 112.39 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.801 0.334 . . . . 0.0 110.735 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 86.2 t80 -63.66 104.21 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 m -115.81 122.67 46.11 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.2 m -148.42 -169.8 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.606 0.241 . . . . 0.0 110.515 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.8 t -123.19 132.03 72.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.4 155.72 11.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -91.63 129.47 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.062 0.458 . . . . 0.0 110.648 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 21' ' ' VAL . 2.6 t -97.67 146.99 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -169.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.493 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 68.9 ttt180 -119.95 147.28 44.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.585 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.16 -168.55 21.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.828 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 p -75.3 99.9 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -157.87 168.82 26.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.233 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.77 -54.28 4.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.83 0.348 . . . . 0.0 111.561 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 70.1 m-85 -86.69 127.12 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.873 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.549 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 16.6 m120 -79.69 -13.72 59.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.173 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.6 m -135.47 139.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.722 HG22 HG23 ' A' ' 12' ' ' VAL . 17.7 m -134.48 134.65 22.63 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.612 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.19 132.47 22.7 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.672 2.248 . . . . 0.0 112.908 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 69' ' ' CYS . 30.7 m -121.66 165.74 17.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.233 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.2 ptpt -148.18 178.99 8.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.086 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.43 ' HB2' HG11 ' A' ' 65' ' ' VAL . 78.9 p -108.97 131.13 55.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.036 0.446 . . . . 0.0 111.131 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -53.4 -41.44 65.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.524 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HB2' HG21 ' A' ' 65' ' ' VAL . 7.1 mtmp? -126.28 151.49 72.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 18.0 Cg_endo -58.0 126.6 22.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.767 2.311 . . . . 0.0 111.969 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.92 157.18 22.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.114 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -73.8 141.72 46.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.717 0.294 . . . . 0.0 110.208 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.6 pt -69.87 -8.1 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 111.16 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -66.06 -25.81 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.454 . . . . 0.0 110.403 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.11 2.48 46.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.914 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -56.01 -52.79 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.1 pt -68.93 -26.66 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.711 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' HE2' ' A' ' 61' ' ' MET . 29.3 t70 -78.24 -46.88 19.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 0.0 110.642 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -61.2 -41.38 96.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 p -66.89 -35.97 81.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.57 -45.55 81.26 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 110.508 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.94 -48.03 87.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.17 -28.78 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.761 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -73.87 -8.82 57.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 43' ' ' ARG . 60.9 mtt180 -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.215 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.419 HD22 ' HG ' ' A' ' 57' ' ' CYS . 45.0 tp -112.43 99.78 8.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.847 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.493 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 17.3 m-85 -88.95 109.48 20.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.636 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.3 120.77 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -120.82 41.23 1.96 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.566 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.42 86.66 56.83 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 71.5 Cg_exo -50.79 118.12 3.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.707 2.271 . . . . 0.0 111.967 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.37 -171.05 2.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.235 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 9.4 mmpt? -95.11 -172.46 2.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.268 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -72.55 136.59 45.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.892 0.377 . . . . 0.0 111.282 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.84 30.14 8.64 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.132 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.482 HD22 ' HB3' ' A' ' 69' ' ' CYS . 10.9 p30 -93.15 133.44 36.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.43 HG12 ' HB3' ' A' ' 66' ' ' ASP . 44.7 t -89.27 105.95 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.692 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.3 -48.19 37.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.153 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.419 ' HG ' HD22 ' A' ' 44' ' ' LEU . 3.2 m -120.33 99.83 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.228 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HG2' HG11 ' A' ' 55' ' ' VAL . 57.0 mttp -76.24 102.73 5.95 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.3 m120 55.04 77.68 0.2 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.3 tt -47.26 -51.83 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 123.695 0.622 . . . . 0.0 112.326 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.478 ' HE2' ' OD2' ' A' ' 36' ' ' ASP . 63.3 mtm -141.99 54.59 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.856 0.36 . . . . 0.0 110.445 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 59.83 28.33 17.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.453 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.7 p -83.62 -20.19 34.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.742 -175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.93 80.46 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.34 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 HG21 ' HB2' ' A' ' 27' ' ' LYS . 71.2 t -112.73 129.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.839 0.352 . . . . 0.0 110.302 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.43 ' HB3' HG12 ' A' ' 55' ' ' VAL . 28.6 m-20 -95.63 134.04 38.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.9 mm -93.2 108.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 22.0 pt -109.43 142.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.482 ' HB3' HD22 ' A' ' 54' ' ' ASN . 53.3 t -92.5 142.0 27.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -113.47 4.74 16.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 111.047 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.59 141.51 29.76 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.895 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.542 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -94.09 112.97 24.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.747 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.421 HD12 HG13 ' A' ' 21' ' ' VAL . 5.9 mp -88.07 127.24 58.24 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 111.524 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.454 -0.841 0 C-N-CA 122.895 2.397 . . . . 0.0 111.154 171.482 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 49.0 mttp . . . . . 0 C--O 1.235 0.329 0 CA-C-O 120.718 0.294 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.35 -179.94 3.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.48 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 28' ' ' PRO . 29.6 mm -101.84 115.28 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.005 0.431 . . . . 0.0 110.19 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -78.11 122.75 26.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.196 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -141.41 137.44 32.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.962 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -153.44 178.51 9.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.449 HG22 ' HB ' ' A' ' 20' ' ' VAL . 10.4 p -110.91 130.31 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.874 0.369 . . . . 0.0 110.121 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.37 157.57 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.149 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -81.23 127.54 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.324 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' HB ' ' HE2' ' A' ' 16' ' ' LYS . 3.7 t -84.28 130.73 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.96 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 61.8 ttp85 -107.0 155.33 19.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.445 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.15 175.7 22.74 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.87 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 p -79.79 105.17 10.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 0.0 111.007 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HD3' ' H ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -162.68 -175.37 4.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.808 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -119.07 40.12 3.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.428 0.633 . . . . 0.0 110.824 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.514 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 4.2 m-85 -129.72 154.02 47.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.448 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -114.92 -46.45 2.92 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.435 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 9' ' ' VAL . 17.8 m -134.26 142.24 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.009 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG22 ' SG ' ' A' ' 69' ' ' CYS . 15.0 p -129.54 136.66 29.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.428 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.72 124.99 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.62 2.214 . . . . 0.0 112.69 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -113.99 164.5 10.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.977 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -145.36 179.06 7.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -109.16 134.66 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.67 -37.73 73.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.275 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -118.43 150.76 48.54 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.252 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 48.6 Cg_endo -67.3 139.6 50.43 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.499 2.132 . . . . 0.0 113.048 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG11 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -113.56 173.5 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.405 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.513 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 79.9 mt-10 -98.67 135.8 39.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.101 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.85 ' HA ' ' HD1' ' A' ' 34' ' ' TRP . 14.6 tt -55.67 -21.52 10.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.781 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.2 m -57.15 -31.81 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.374 . . . . 0.0 111.562 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -102.87 14.79 31.09 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.85 ' HD1' ' HA ' ' A' ' 31' ' ' ILE . 1.2 m95 -60.05 -44.5 94.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.75 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -67.95 -35.08 70.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' O ' HG21 ' A' ' 40' ' ' VAL . 34.8 t70 -67.78 -43.68 79.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.9 m-30 -69.86 -39.95 76.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.975 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.43 -35.85 78.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.481 . . . . 0.0 109.821 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -58.47 -45.44 88.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.861 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 36' ' ' ASP . 43.7 t -69.09 -48.2 70.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.417 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.0 mt -66.63 -33.2 75.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.5 p -71.55 -11.77 61.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.772 0.32 . . . . 0.0 111.559 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -119.08 10.1 12.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.996 0.427 . . . . 0.0 110.499 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 46' ' ' VAL . 31.5 tp -104.71 127.2 52.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 43.9 m-85 -119.45 97.12 5.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.494 HG23 ' HG ' ' A' ' 44' ' ' LEU . 61.4 t -111.29 140.41 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -124.08 -134.75 4.33 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.992 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t 60.08 79.95 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.205 0.526 . . . . 0.0 109.994 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.47 118.41 5.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.652 2.235 . . . . 0.0 111.691 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -174.27 3.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.884 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -87.79 -177.19 5.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.0 t -67.45 134.1 50.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.761 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.32 25.78 11.96 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.987 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 11.0 p30 -94.03 143.06 26.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.38 115.99 28.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.266 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.29 -56.56 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.972 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.0 t -130.72 118.01 20.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 31.0 tttm -97.71 129.88 44.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.736 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.416 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 14.1 m120 54.98 47.21 22.65 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 123.501 0.501 . . . . 0.0 109.955 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.0 tt -53.95 110.04 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.6 mmt 66.68 31.45 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.246 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 71.34 4.22 4.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -57.59 -42.53 83.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.416 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 111.21 -9.37 28.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.646 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.96 137.46 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 110.231 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 7.0 m-20 -102.18 107.31 18.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -75.3 103.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.3 pt -108.05 146.07 14.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.296 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.454 ' SG ' HG22 ' A' ' 21' ' ' VAL . 2.4 t -90.51 142.32 27.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.475 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -119.22 13.97 12.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.399 0.618 . . . . 0.0 110.63 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -96.58 142.05 29.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.97 98.14 11.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 96.6 mt -99.56 117.41 63.81 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.873 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 5.0 Cg_exo . . . . . 0 N--CA 1.457 -0.648 0 C-N-CA 122.661 2.24 . . . . 0.0 112.699 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.264 0.554 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -140.65 154.44 46.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 28' ' ' PRO . 45.9 mm -69.97 117.13 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.96 0.41 . . . . 0.0 110.741 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.487 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 78.2 t80 -78.53 109.67 12.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 109.827 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -123.53 132.21 53.84 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.564 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -152.77 -165.1 2.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.123 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.622 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 42.7 t -128.31 134.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.541 0.21 . . . . 0.0 110.453 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -119.0 148.64 21.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.39 135.23 40.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.275 0.559 . . . . 0.0 111.53 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.34 141.54 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.577 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -127.13 173.87 9.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.278 . . . . 0.0 110.325 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -177.48 31.0 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.864 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 m -76.12 96.47 3.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.254 0.549 . . . . 0.0 110.674 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.9 -173.44 4.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.649 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -100.73 -52.43 3.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.833 0.349 . . . . 0.0 110.742 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -75.2 124.3 26.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.975 0.417 . . . . 0.0 111.956 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.84 -15.92 56.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.622 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.3 m -142.03 146.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.518 ' HB ' HD13 ' A' ' 73' ' ' LEU . 13.0 p -124.38 134.28 25.39 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.92 126.02 13.33 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.515 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -114.33 162.34 12.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.576 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -144.73 178.93 7.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.914 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 69.1 m -109.12 133.55 52.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.202 0.525 . . . . 0.0 111.306 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -59.52 -44.65 93.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.591 174.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 65' ' ' VAL . 67.1 mttm -121.0 152.45 56.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HA ' HD13 ' A' ' 5' ' ' ILE . 31.6 Cg_exo -61.49 139.52 82.37 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.653 2.236 . . . . 0.0 111.88 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.403 HG22 HG23 ' A' ' 65' ' ' VAL . 5.8 t -112.57 136.11 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.97 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.31 118.8 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.5 tt -55.16 -28.1 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 m -65.33 -18.39 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -100.72 17.51 21.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.487 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -57.39 -40.66 78.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 0.0 109.942 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -62.33 -45.43 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.981 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.589 ' HB3' ' HG3' ' A' ' 61' ' ' MET . 1.8 m-20 -53.48 -54.61 34.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.592 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -63.07 -41.1 99.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -61.23 -47.25 86.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -67.06 -27.26 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.572 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 36' ' ' ASP . 99.1 t -77.35 -46.53 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.636 0.255 . . . . 0.0 110.937 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.32 -30.36 66.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 p -69.69 -22.31 63.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -107.19 10.87 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.166 0.507 . . . . 0.0 110.283 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -114.11 143.33 44.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.912 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -130.96 142.12 50.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.145 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 p -119.49 143.83 29.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 48' ' ' VAL . . . -121.7 163.82 15.02 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.055 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 92.1 t 75.82 128.27 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 123.179 0.592 . . . . 0.0 111.262 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.13 110.76 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.155 2.57 . . . . 0.0 111.499 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.452 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 p -99.17 -164.16 1.1 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.713 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.425 ' H ' ' HB ' ' A' ' 50' ' ' THR . 19.6 ptmt -127.16 -152.88 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.434 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 32.6 m -98.96 135.63 40.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.73 24.04 11.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.877 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.813 HD21 ' HB2' ' A' ' 69' ' ' CYS . 40.8 m-20 -78.97 99.1 6.69 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG23 HG21 ' A' ' 68' ' ' ILE . 17.9 t -77.79 92.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 m -74.09 -45.52 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.541 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 8.5 t -130.96 120.16 23.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -104.33 144.06 32.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 44.72 39.82 3.71 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.671 0.748 . . . . 0.0 110.847 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.541 ' HB ' ' SG ' ' A' ' 57' ' ' CYS . 5.3 tt -56.0 127.18 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.277 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.589 ' HG3' ' HB3' ' A' ' 36' ' ' ASP . 93.8 mmm 63.59 29.89 15.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 70.2 17.76 7.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.906 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.3 p -78.44 -61.58 1.96 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.86 0.362 . . . . 0.0 111.777 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.31 1.31 9.35 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 27' ' ' LYS . 96.8 t -88.15 139.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 0.0 110.664 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.68 114.65 26.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.231 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -83.13 106.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.8 pt -119.4 133.5 66.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.259 0.552 . . . . 0.0 112.297 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.813 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.9 m -78.4 147.64 33.99 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 10.9 t -132.38 13.82 4.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -112.93 122.34 47.35 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.481 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -67.8 109.96 3.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.518 HD13 ' HB ' ' A' ' 21' ' ' VAL . 90.9 mt -87.73 117.16 68.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.448 -173.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.458 -0.612 0 C-N-CA 122.691 2.261 . . . . 0.0 111.92 175.26 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 96.3 mttt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -123.63 169.92 10.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.99 0.424 . . . . 0.0 110.76 -169.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 28' ' ' PRO . 47.2 mm -87.06 102.68 12.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.453 ' HB2' HG23 ' A' ' 29' ' ' VAL . 87.7 t80 -59.26 117.95 5.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.666 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -124.06 130.26 52.26 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.797 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 t -143.23 -172.11 3.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.33 124.87 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 41' ' ' LEU . 29.6 m -112.46 162.04 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -91.88 130.97 37.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.532 . . . . 0.0 111.35 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -108.43 121.49 61.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.739 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.4 mtm105 -99.58 154.3 18.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.12 166.58 12.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.355 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 p -82.61 84.9 7.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 111.759 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -174.23 4.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.888 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -86.84 -59.58 2.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.713 0.292 . . . . 0.0 110.988 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.48 6.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.205 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.44 -15.43 30.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.529 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.74 129.79 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 71' ' ' LYS . 13.1 p -119.17 129.93 25.12 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.164 0.506 . . . . 0.0 111.758 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 37.5 Cg_endo -69.1 125.81 12.95 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 111.59 170.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.503 HG12 ' SG ' ' A' ' 69' ' ' CYS . 30.6 m -113.9 158.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.084 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -141.06 174.17 10.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.751 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.421 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 14.9 m -109.11 127.5 54.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.05 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -65.24 -30.89 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.922 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HB2' HG21 ' A' ' 65' ' ' VAL . 64.3 mttm -111.2 138.73 21.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.1 Cg_exo -65.38 116.88 4.14 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.369 2.046 . . . . 0.0 111.485 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 6' ' ' PHE . 29.3 m -93.37 162.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.997 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 46.1 mt-10 -79.71 145.8 32.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.153 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 33' ' ' LYS . 16.9 pt -71.53 177.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.013 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 74.6 m 70.98 -25.48 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.039 0.536 . . . . 0.0 112.028 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 31' ' ' ILE . 13.9 tttm -84.63 7.53 19.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.173 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -62.07 -34.94 77.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 tt -70.48 -31.52 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.94 -57.03 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.989 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 33' ' ' LYS . 27.5 m-85 -64.63 -36.24 83.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.519 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.1 p -67.24 -37.12 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -54.85 -49.64 70.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 110.346 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.46 -48.71 85.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.234 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HB3' HG12 ' A' ' 10' ' ' VAL . 69.0 mt -70.06 -41.08 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -68.05 -19.86 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 111.049 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -101.27 10.75 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 110.041 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 tp -116.86 118.75 33.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.318 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.98 129.27 55.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.958 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.6 140.23 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.148 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -127.2 71.94 0.47 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.888 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -166.0 123.25 1.04 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 120.811 0.339 . . . . 0.0 110.776 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.49 113.13 3.39 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.839 2.36 . . . . 0.0 111.614 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.13 170.31 9.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.389 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.8 mtmt -103.55 176.33 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.354 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.649 ' HB2' HD22 ' A' ' 72' ' ' ASN . 19.0 t -61.25 135.47 57.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 111.473 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.64 26.79 21.75 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.967 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.687 HD22 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -97.5 133.26 42.31 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.253 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.643 HG23 HG22 ' A' ' 68' ' ' ILE . 8.6 t -93.07 124.59 45.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.471 -176.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 m -96.99 -39.51 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 111.215 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.3 t -127.74 121.2 29.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HG2' HG11 ' A' ' 55' ' ' VAL . 59.6 mttm -106.06 128.85 54.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.857 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.738 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.7 t-20 58.91 48.84 10.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.65 0.738 . . . . 0.0 109.169 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.453 HG12 ' HG2' ' A' ' 61' ' ' MET . 11.6 tt -60.16 127.09 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.108 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.453 ' HG2' HG12 ' A' ' 60' ' ' ILE . 98.2 mmm 63.51 21.78 12.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.159 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.738 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 3.4 t-20 57.8 79.4 0.2 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.452 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.0 p -138.65 -55.72 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.068 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.0 -9.4 6.32 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 27' ' ' LYS . 95.4 t -79.89 132.01 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 110.579 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.99 114.57 28.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.1 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.89 114.03 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.643 HG22 HG23 ' A' ' 55' ' ' VAL . 20.6 pt -118.37 140.75 40.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.0 -173.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.687 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.9 m -92.2 146.34 23.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -119.38 11.15 12.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 0.0 112.223 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.483 ' HG3' ' HD2' ' A' ' 22' ' ' PRO . 68.5 mmtt -96.41 155.24 16.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.953 -0.467 . . . . 0.0 109.919 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.649 HD22 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -106.55 104.89 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.78 132.08 43.31 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.462 -0.33 0 C-N-CA 122.462 2.108 . . . . 0.0 112.044 178.157 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 52.0 mttp . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.18 156.27 49.27 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.965 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -63.4 110.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.028 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -76.55 106.84 8.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 24' ' ' LYS . 74.3 p -110.41 134.21 52.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -153.75 -167.1 2.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.37 132.31 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.91 149.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -87.8 114.08 24.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.682 ' HB ' ' HE3' ' A' ' 16' ' ' LYS . 6.6 t -84.85 139.35 17.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.189 -168.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpt85 -105.8 137.77 43.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.91 -178.3 16.38 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.412 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 t -81.4 110.28 16.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.084 0.468 . . . . 0.0 110.564 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.925 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -163.07 168.48 20.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -95.79 -20.67 18.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.558 ' HB2' HD22 ' A' ' 73' ' ' LEU . 78.9 m-85 -107.46 111.36 23.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.925 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 86.7 m-20 -76.67 -19.6 57.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.09 138.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.585 0.231 . . . . 0.0 110.422 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' A' ' 71' ' ' LYS . 5.8 p -135.34 139.83 32.63 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.831 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.407 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 53.6 Cg_endo -72.81 130.68 16.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.572 2.181 . . . . 0.0 112.505 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.22 162.42 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.557 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 7' ' ' THR . 22.2 ptmt -143.53 170.75 15.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.159 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -109.23 128.27 54.92 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.607 ' OD1' ' HB2' ' A' ' 66' ' ' ASP . 2.0 p-10 -75.72 -0.91 22.5 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HB2' HG21 ' A' ' 65' ' ' VAL . 43.3 mtmt -132.36 142.09 43.67 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.01 135.98 66.38 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.474 2.116 . . . . 0.0 112.328 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 t -105.37 130.91 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.863 -175.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 28.6 tt0 -60.11 121.39 11.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.0 tp -60.9 -21.46 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -171.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.61 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.945 -0.472 . . . . 0.0 111.421 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 62.9 mttp -105.7 1.23 26.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.565 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -59.64 -31.25 69.35 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.37 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -78.04 -30.05 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' HG21 ' A' ' 40' ' ' VAL . 26.0 t0 -78.41 -43.33 27.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 30.2 m-85 -56.52 -47.26 79.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.6 p -65.71 -37.26 85.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -60.7 -43.07 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.75 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 36' ' ' ASP . 58.0 t -63.26 -44.11 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.591 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.75 -21.48 66.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.3 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.3 m -81.79 -11.59 58.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.048 0.451 . . . . 0.0 110.704 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -105.89 -26.14 11.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.726 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 46' ' ' VAL . 40.2 tp -81.84 94.83 7.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.739 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -97.35 90.3 5.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.174 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.494 HG23 ' HG ' ' A' ' 44' ' ' LEU . 22.2 m -142.06 173.49 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.67 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.74 173.1 25.73 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.548 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 50' ' ' THR . 13.6 p 177.23 141.25 0.24 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -42.06 105.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.918 2.412 . . . . 0.0 112.374 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.586 HG21 HG11 ' A' ' 48' ' ' VAL . 1.7 p -130.23 167.03 19.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.069 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -127.07 62.75 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.66 -174.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.524 ' HB2' HD22 ' A' ' 72' ' ' ASN . 23.2 t 69.2 150.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.728 174.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.17 24.49 70.48 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.958 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 7.7 p30 -96.46 128.53 43.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.025 0.441 . . . . 0.0 110.506 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 58' ' ' LYS . 49.1 t -79.21 113.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.195 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.04 -50.18 17.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.965 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 36.7 t -130.75 123.07 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.647 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.685 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 50.3 tttp -106.25 135.4 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.784 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.579 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 6.6 t-20 64.32 31.99 12.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.72 0.638 . . . . 0.0 110.712 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.527 HG12 ' HG3' ' A' ' 61' ' ' MET . 10.8 tt -60.65 134.83 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.527 ' HG3' HG12 ' A' ' 60' ' ' ILE . 76.2 mtp 62.6 18.45 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.942 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 70.67 -2.87 2.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 65' ' ' VAL . 9.6 t -79.69 -8.59 59.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.57 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 59' ' ' ASN . . . 83.16 3.41 90.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.897 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 27' ' ' LYS . 7.9 t -67.05 129.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.899 0.381 . . . . 0.0 110.237 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.685 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 3.1 m-20 -99.35 122.34 42.35 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -87.09 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.3 pt -108.83 134.96 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.411 0.624 . . . . 0.0 111.954 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.518 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 7.5 t -81.12 135.06 35.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.231 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -111.69 -6.32 14.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.991 0.424 . . . . 0.0 111.233 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 62.5 tttp -96.8 138.64 34.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -85.76 128.26 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.84 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.558 HD22 ' HB2' ' A' ' 18' ' ' TYR . 94.2 mt -109.32 102.18 48.35 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.973 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo . . . . . 0 N--CA 1.455 -0.753 0 C-N-CA 122.706 2.27 . . . . 0.0 112.382 176.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 54.4 mmtt . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -131.98 134.59 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.706 0.288 . . . . 0.0 110.856 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 28' ' ' PRO . 36.3 mm -57.75 127.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 111.116 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -102.66 115.58 30.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.544 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 139.42 53.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.833 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.8 m -158.67 179.26 9.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.652 0.263 . . . . 0.0 110.615 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.48 130.19 71.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.158 0.504 . . . . 0.0 110.231 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.76 155.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.76 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -69.37 123.88 22.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.585 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.769 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.7 p -107.43 136.94 40.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.178 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 49.2 mtp180 -125.87 -179.32 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.656 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.94 -160.24 13.52 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.323 -0.942 . . . . 0.0 113.088 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -85.44 15.95 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.775 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.769 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -80.98 179.0 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -125.69 69.33 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.713 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -153.11 178.86 9.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.299 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.91 -23.68 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 0.0 111.116 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.67 149.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.47 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 14.6 p -131.98 131.49 22.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.033 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 14.2 Cg_exo -68.9 131.77 23.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.132 2.555 . . . . 0.0 112.63 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.53 152.63 37.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.956 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HG3' HG13 ' A' ' 68' ' ' ILE . 21.5 ptmt -141.13 173.55 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 0.0 111.034 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -109.67 131.75 54.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.129 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -72.72 -26.05 61.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.806 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.6 mttt -122.33 132.83 24.2 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 5' ' ' ILE . 77.7 Cg_exo -50.31 132.96 35.65 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.082 2.521 . . . . 0.0 112.49 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.2 124.53 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.784 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 43.8 tt0 -63.2 134.86 56.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pt -72.54 67.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.326 1.06 . . . . 0.0 112.247 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.0 p -155.71 -30.96 0.1 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.88 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -94.01 3.54 55.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -51.93 -52.73 48.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.438 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.68 -38.21 57.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.128 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.411 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 4.8 t0 -62.03 -37.63 85.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 63' ' ' THR . 4.5 m-30 -60.23 -50.22 74.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.827 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 p -62.9 -25.54 68.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.209 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 36' ' ' ASP . 94.1 m-20 -65.99 -50.04 65.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.55 -41.7 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.546 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.788 HD21 HD13 ' A' ' 44' ' ' LEU . 47.4 mt -63.12 -29.31 70.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.7 m -72.72 -11.68 60.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 43' ' ' ARG . 56.4 mtt-85 -108.41 3.81 23.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.311 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.788 HD13 HD21 ' A' ' 41' ' ' LEU . 27.5 mt -99.56 119.8 38.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.514 0.674 . . . . 0.0 111.387 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.5 100.89 7.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.626 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 m -90.8 -177.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.728 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -167.71 -168.62 30.11 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.059 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t 68.22 101.27 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 C-N-CA 122.946 0.498 . . . . 0.0 111.178 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 12.3 Cg_endo -58.33 108.45 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.808 2.338 . . . . 0.0 111.939 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.84 -165.27 1.01 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.93 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 44.0 mmtm -128.05 169.87 13.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.024 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.9 p -58.94 136.31 57.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 23.53 34.6 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.732 -0.746 . . . . 0.0 111.877 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.673 HD22 ' HB3' ' A' ' 69' ' ' CYS . 8.5 p30 -97.24 131.34 44.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 HG21 HG21 ' A' ' 68' ' ' ILE . 63.1 t -82.73 108.42 15.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.06 -57.59 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.268 0.556 . . . . 0.0 109.609 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 62.7 m -115.25 94.16 4.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.95 114.16 17.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.733 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t30 65.25 79.71 0.25 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.691 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 tt -71.66 122.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.277 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ttt 68.77 -76.33 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.868 0.73 . . . . 0.0 110.75 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -178.9 82.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.462 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 39.0 p -141.83 -44.02 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.176 -169.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.74 8.01 57.39 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -170.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 27' ' ' LYS . 73.9 t -98.46 131.68 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.184 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.39 116.21 28.68 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 57' ' ' CYS . 48.2 mm -81.78 100.21 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.128 0.49 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.416 HG13 ' HG3' ' A' ' 24' ' ' LYS . 22.1 pt -96.8 145.51 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.301 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.673 ' HB3' HD22 ' A' ' 54' ' ' ASN . 43.6 t -100.39 142.73 31.46 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -115.84 7.19 14.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.326 0.584 . . . . 0.0 110.625 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -96.71 142.24 28.98 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.595 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -93.93 111.79 23.54 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.21 120.37 56.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.448 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 C-N-CA 122.891 2.394 . . . . 0.0 111.628 175.96 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.518 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 94.4 mttt . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -140.65 153.91 46.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.756 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.98 114.26 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 110.988 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -79.94 140.69 36.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.39 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -150.94 133.47 15.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.946 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -150.18 -172.83 4.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.2 138.18 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.714 0.292 . . . . 0.0 110.39 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 44' ' ' LEU . 14.2 p -119.1 149.65 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 20' ' ' VAL . 53.1 mtt180 -82.87 116.75 22.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.191 0.52 . . . . 0.0 110.808 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.402 HG13 ' HE3' ' A' ' 16' ' ' LYS . 21.3 t -88.37 137.51 20.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.959 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.544 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.6 ttp85 -98.52 150.23 21.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.365 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.82 169.71 13.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.332 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.07 27.3 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.242 0.544 . . . . 0.0 111.709 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.494 ' HD2' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -70.93 173.08 7.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.489 176.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -86.18 26.31 1.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -145.21 -179.69 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.718 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -131.31 -34.69 1.39 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 11' ' ' ARG . 22.7 m -134.75 149.34 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.672 0.272 . . . . 0.0 111.129 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -125.68 133.54 25.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.68 120.76 6.88 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.418 2.079 . . . . 0.0 112.171 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.1 140.42 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.926 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.529 ' HZ3' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -129.08 168.86 15.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.127 0.489 . . . . 0.0 110.875 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -108.93 130.9 55.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.602 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 7.5 p30 -80.98 -10.0 59.77 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.632 -172.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.602 ' HE2' ' OD1' ' A' ' 26' ' ' ASN . 26.9 mtmt -130.99 144.53 53.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.532 176.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.85 138.05 76.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.209 2.606 . . . . 0.0 113.541 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 t -106.39 143.29 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.691 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.93 139.86 55.1 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.0 pt -76.34 12.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.6 p -128.9 -3.27 5.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.069 0.462 . . . . 0.0 110.468 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -99.48 -15.35 18.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -65.12 -21.05 66.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.026 0.441 . . . . 0.0 110.632 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.88 -44.31 99.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.092 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 40' ' ' VAL . 1.6 m-20 -58.66 -50.23 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.891 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.524 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.4 m-85 -63.06 -43.22 99.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.11 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -62.81 -36.95 84.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.862 0.363 . . . . 0.0 111.006 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -66.69 -36.35 82.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.783 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 36' ' ' ASP . 96.0 t -69.35 -43.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.394 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 99.7 mt -61.97 -24.2 66.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -65.63 -18.14 65.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.944 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -104.03 -2.05 26.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 HG11 ' A' ' 56' ' ' VAL . 24.1 tp -84.17 53.65 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.238 0.542 . . . . 0.0 111.292 -171.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -78.31 76.66 4.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.22 149.44 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.99 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -119.08 48.99 0.9 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.53 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.17 114.67 16.2 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.613 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 26.0 Cg_exo -62.07 103.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.562 2.174 . . . . 0.0 111.095 171.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.675 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 22.9 p -95.97 173.57 7.37 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' C ' HD22 ' A' ' 54' ' ' ASN . 75.6 mmtt -97.31 -146.94 0.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.337 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.481 ' HB2' HD22 ' A' ' 72' ' ' ASN . 26.6 t -102.3 131.17 49.06 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.3 26.98 19.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.596 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.675 ' ND2' ' HB ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -86.83 112.45 21.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG21 HG23 ' A' ' 68' ' ' ILE . 47.5 t -73.37 106.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG11 HD23 ' A' ' 44' ' ' LEU . 24.4 t -79.37 -46.37 23.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.169 0.509 . . . . 0.0 109.745 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 59.7 m -130.65 109.67 10.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 28.0 ttmt -85.12 129.33 34.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 53.72 69.37 0.72 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 123.812 0.695 . . . . 0.0 109.823 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.0 tt -78.76 125.53 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.317 -173.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 96.4 mmm 64.31 19.22 11.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.94 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 65.02 98.7 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.468 0.48 . . . . 0.0 111.298 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 65' ' ' VAL . 8.4 t -171.46 -34.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.478 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.22 -17.96 5.87 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.156 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.506 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 33.1 m -82.38 142.57 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.306 0.574 . . . . 0.0 112.014 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.406 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -108.23 131.62 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -91.5 114.11 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.421 HG23 HG21 ' A' ' 55' ' ' VAL . 37.7 pt -117.35 134.06 62.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.887 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 54' ' ' ASN . 2.0 p -87.82 134.17 33.74 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.529 HG22 ' HZ3' ' A' ' 24' ' ' LYS . 11.8 t -118.71 17.25 13.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 112.147 -168.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 21' ' ' VAL . 60.4 tttp -117.08 131.05 57.01 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.544 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -82.73 109.36 16.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.71 132.09 39.66 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.62 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo . . . . . 0 C--O 1.237 0.456 0 C-N-CA 122.447 2.098 . . . . 0.0 111.264 172.486 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.516 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.2 mttt . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.307 0.575 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.66 179.74 5.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.554 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.67 116.12 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.25 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.459 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 77.0 t80 -59.36 128.09 35.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -153.52 135.43 14.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.007 0.432 . . . . 0.0 110.097 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -153.2 169.34 23.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.36 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 59.8 t -114.32 118.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 41' ' ' LEU . 34.2 m -117.58 173.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.245 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 1.9 mmt85 -72.8 126.63 30.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.762 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.564 HG11 ' HE2' ' A' ' 16' ' ' LYS . 7.4 p -104.77 129.14 57.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.503 0.668 . . . . 0.0 111.239 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.492 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 41.9 ttt85 -104.65 142.32 34.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.974 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 168.15 12.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.0 m -83.26 102.21 11.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.564 ' HE2' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.98 -174.66 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.928 -179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.24 -0.9 56.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 47.9 m-85 -110.04 143.26 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.732 -0.387 . . . . 0.0 112.021 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -104.64 -10.59 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.756 0.789 . . . . 0.0 109.079 175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.2 m -142.33 148.41 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.414 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 12' ' ' VAL . 7.2 p -134.44 125.89 17.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.195 0.522 . . . . 0.0 111.749 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 5.8 Cg_exo -77.54 113.41 3.51 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.396 2.73 . . . . 0.0 112.306 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.555 HG13 ' SG ' ' A' ' 69' ' ' CYS . 31.5 m -104.82 161.04 4.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.544 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -153.24 178.77 9.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.487 0.66 . . . . 0.0 111.213 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.27 147.2 33.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.13 -3.71 56.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.506 0.669 . . . . 0.0 109.258 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HB3' HG21 ' A' ' 65' ' ' VAL . 34.4 ttmt -128.72 129.84 23.49 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.417 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 38.3 Cg_exo -58.04 132.24 48.25 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 112.429 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 6' ' ' PHE . 18.5 m -117.65 -178.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.516 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -97.96 135.26 39.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 pt -77.01 -19.49 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.307 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 37' ' ' PHE . 56.3 mtpt -93.99 0.79 56.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -53.82 -42.93 68.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.895 0.378 . . . . 0.0 110.676 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.55 -45.04 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.04 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.46 -43.72 80.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.32 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.441 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 47.4 m-85 -61.48 -43.59 98.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.236 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.32 -35.97 80.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.753 0.311 . . . . 0.0 110.715 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.05 -40.99 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' A' ' 10' ' ' VAL . 49.8 mt -62.49 -39.11 92.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.555 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -68.07 -12.91 61.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.417 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.8 ttt85 -95.13 -9.16 34.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.277 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.65 132.85 55.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.588 . . . . 0.0 111.431 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 11' ' ' ARG . 3.3 m-85 -106.99 102.83 12.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.797 173.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.93 157.89 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.258 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . 172.99 -148.91 10.79 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.751 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 85.1 t 72.49 126.13 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.345 0 O-C-N 124.099 0.529 . . . . 0.0 110.789 -175.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.608 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 82.6 Cg_exo -42.92 110.7 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.488 2.792 . . . . 0.0 113.074 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -139.65 169.48 17.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.622 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -95.93 173.57 7.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 110.707 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -68.54 119.83 13.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.439 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 30.47 5.78 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.665 HD22 ' HB2' ' A' ' 69' ' ' CYS . 10.6 p30 -89.1 131.67 35.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.412 HG21 HG21 ' A' ' 68' ' ' ILE . 57.8 t -85.74 127.31 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.856 -175.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.42 -75.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.228 0.537 . . . . 0.0 110.228 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -115.65 98.79 6.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.177 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 87.7 tttt -78.69 128.37 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.649 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 8.7 t-20 63.65 41.86 6.82 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.2 tt -53.27 -50.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.146 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.447 ' HB2' HG21 ' A' ' 63' ' ' THR . 82.1 mtp -114.61 30.93 6.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.649 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 15.6 m120 63.4 23.84 13.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.391 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.447 HG21 ' HB2' ' A' ' 61' ' ' MET . 67.6 p -86.93 -21.08 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.706 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.27 79.24 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.494 -174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 27' ' ' LYS . 41.8 t -90.04 130.44 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.604 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.418 ' OD2' ' HE3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -95.92 107.92 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.5 mm -75.9 120.42 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 35.1 pt -126.43 137.57 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.221 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.665 ' HB2' HD22 ' A' ' 54' ' ' ASN . 3.8 m -86.73 132.88 33.74 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -102.29 6.42 40.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.351 0.596 . . . . 0.0 110.901 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HD3' ' CZ ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -96.75 134.66 39.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.767 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.594 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -86.69 126.97 34.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.3 mp -95.35 109.09 43.31 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 91.6 Cg_endo . . . . . 0 N--CA 1.453 -0.883 0 C-N-CA 123.059 2.506 . . . . 0.0 112.567 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.07 151.7 48.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.656 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -72.5 109.46 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 83.7 t80 -59.31 98.77 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.477 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -112.84 120.42 41.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m -152.78 -159.39 1.0 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.599 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 8.9 p -128.9 138.5 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 120.768 0.318 . . . . 0.0 110.629 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -108.61 143.96 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 42' ' ' SER . 91.3 mtt180 -81.16 134.03 35.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.551 0.691 . . . . 0.0 110.261 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.633 HG11 ' HE2' ' A' ' 16' ' ' LYS . 42.5 t -116.17 150.67 18.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.231 -168.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -106.13 145.93 30.85 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 63.46 0.9 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.665 -175.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -85.27 4.23 35.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.771 ' HG2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -160.89 -178.35 6.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.121 -1.854 . . . . 0.0 107.705 179.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -93.6 75.69 4.38 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.367 -174.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -174.09 143.84 0.94 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.422 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 15.7 m120 -98.75 -33.48 10.9 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.14 163.79 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 73' ' ' LEU . 9.8 p -153.84 140.15 12.66 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 120.668 0.271 . . . . 0.0 110.67 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 72.7 Cg_endo -79.14 145.54 19.38 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.568 2.179 . . . . 0.0 112.863 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.61 168.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.109 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.3 ptpt -141.07 173.78 11.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.39 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 90.7 p -109.17 138.88 44.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.87 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -68.04 -33.23 74.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.993 0.425 . . . . 0.0 110.85 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -115.78 147.17 38.45 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.056 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.51 120.37 7.76 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.771 2.314 . . . . 0.0 111.071 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.45 151.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -51.35 130.38 26.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.172 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 pt -61.12 -18.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -63.38 -35.68 81.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HZ2' ' HG2' ' A' ' 33' ' ' LYS . 28.8 mttm -95.81 10.87 35.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 111.555 -176.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -61.86 -39.75 92.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.45 -40.93 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.386 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.21 -55.04 39.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.566 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.476 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.5 m-30 -67.36 -38.94 85.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.588 -174.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 p -69.05 -31.06 69.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.401 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -62.8 -32.39 73.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -79.94 -45.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.689 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 93.4 mt -63.18 -24.89 68.09 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 11' ' ' ARG . 8.7 p -80.99 -18.84 45.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 110.971 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -99.09 -11.28 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.74 140.86 29.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.998 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -130.52 102.63 6.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.506 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 19.4 m -109.81 141.53 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.136 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.13 -3.01 29.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.584 -176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 14.5 m -58.8 125.81 78.48 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.771 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 33.7 Cg_endo -97.75 68.7 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.703 2.935 . . . . 0.0 112.732 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -179.27 5.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.407 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 13.8 mptt -99.94 -173.24 2.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.711 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t -66.12 146.01 55.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 0.0 111.06 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.71 31.7 35.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.344 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.578 HD22 ' HB3' ' A' ' 69' ' ' CYS . 9.5 p30 -101.43 133.92 45.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.728 0.299 . . . . 0.0 110.281 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 58' ' ' LYS . 50.8 t -79.4 115.13 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 110.699 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.21 -51.56 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.004 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.9 m -127.41 110.18 12.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.897 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HB2' HG12 ' A' ' 55' ' ' VAL . 65.3 tttp -99.04 123.82 43.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.673 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.2 t-20 62.94 60.26 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.503 HG12 ' HG3' ' A' ' 61' ' ' MET . 14.9 tt -76.39 123.0 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.285 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.503 ' HG3' HG12 ' A' ' 60' ' ' ILE . 86.7 mtp 65.73 23.11 11.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.927 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.673 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 11.2 m120 60.14 76.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.114 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -127.85 -44.06 1.5 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.047 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.26 16.24 12.63 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -109.98 136.31 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.52 107.82 18.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.491 0.662 . . . . 0.0 110.055 175.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.69 113.54 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.509 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 18.3 pt -110.88 141.45 26.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.211 0.529 . . . . 0.0 111.774 -174.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.578 ' HB3' HD22 ' A' ' 54' ' ' ASN . 50.2 t -89.65 141.86 28.21 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -116.78 -2.24 11.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.156 0.503 . . . . 0.0 110.96 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -98.05 146.82 25.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.641 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -92.71 123.5 36.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.696 ' CB ' ' HA ' ' A' ' 49' ' ' PRO . 3.6 mm? -81.58 127.11 74.19 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.5 -175.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 13.6 Cg_exo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.739 2.293 . . . . 0.0 113.433 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 88.2 mttt . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.917 0.389 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -119.64 141.73 49.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.149 -172.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -67.34 106.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.969 0.414 . . . . 0.0 110.235 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.42 121.43 17.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 t -141.93 144.98 34.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.982 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.6 m -158.85 170.43 22.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.02 118.7 57.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -105.63 152.24 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -74.97 116.28 15.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.075 0.464 . . . . 0.0 110.515 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.737 HG11 ' HE2' ' A' ' 16' ' ' LYS . 9.0 p -88.98 144.55 8.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.552 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 8.3 ttp180 -122.38 -178.91 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.418 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -171.57 23.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.881 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.5 m -80.53 91.8 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 0.0 110.894 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HE2' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -157.71 -167.7 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.166 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.18 18.56 7.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.357 0.598 . . . . 0.0 110.373 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.521 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 90.5 m-85 -118.43 165.5 13.81 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -125.35 -1.4 7.57 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.232 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 m -149.82 151.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' A' ' 71' ' ' LYS . 7.0 p -144.86 121.37 6.16 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.89 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 24.5 Cg_exo -62.84 114.9 2.61 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.761 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.543 HG11 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -108.57 151.4 10.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.31 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.2 171.95 15.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.176 0.512 . . . . 0.0 111.353 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -109.0 130.13 55.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.875 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -77.96 -9.73 59.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.0 110.206 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HB2' HG21 ' A' ' 65' ' ' VAL . 90.0 mttt -122.22 143.72 39.88 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.499 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 37.2 Cg_endo -66.54 131.06 25.1 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.415 2.077 . . . . 0.0 112.394 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.58 136.8 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.658 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.15 146.18 28.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.875 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.672 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . 11.6 pt -72.92 2.86 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 p -83.66 -32.89 25.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.355 0.598 . . . . 0.0 109.966 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -92.9 -7.22 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.969 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.672 ' HB2' ' HA ' ' A' ' 31' ' ' ILE . 68.2 t90 -57.68 -40.88 80.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.017 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -66.19 -42.18 90.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.759 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 40' ' ' VAL . 1.2 m-20 -60.62 -45.1 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -60.22 -39.99 88.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 m -63.41 -38.8 92.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.85 -38.44 91.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.621 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 36' ' ' ASP . 59.9 t -67.75 -41.44 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.96 -20.45 64.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.062 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.2 t -82.84 5.07 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 110.097 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -125.7 -31.89 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.349 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.6 tp -77.61 111.9 13.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.634 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -117.27 107.42 14.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 56' ' ' VAL . 15.7 m -92.77 121.36 43.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -106.76 24.52 25.24 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.169 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.52 104.42 55.94 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.72 95.9 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.518 2.146 . . . . 0.0 111.345 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.23 156.52 20.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 35.2 mtmm -101.9 78.22 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.814 ' HB2' ' ND2' ' A' ' 72' ' ' ASN . 15.8 t 68.43 159.72 0.17 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.619 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 30.91 63.84 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.558 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -109.66 119.6 39.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.402 0.62 . . . . 0.0 111.245 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 68' ' ' ILE . 21.3 t -81.35 109.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.25 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 46' ' ' VAL . 4.1 m -85.66 -40.32 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.689 0.28 . . . . 0.0 111.027 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.7 m -130.42 100.98 5.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.418 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -85.32 119.94 26.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.9 t30 62.46 75.69 0.39 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.686 0.755 . . . . 0.0 109.358 -170.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tt -72.92 127.9 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.946 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 93.3 mmm 66.38 -80.37 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.835 0.71 . . . . 0.0 110.355 -175.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 61' ' ' MET . 59.2 t30 172.47 80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.103 0.561 . . . . 0.0 109.851 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 t -158.48 15.11 0.19 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.872 0.367 . . . . 0.0 111.367 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.22 -22.37 7.22 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.934 -0.651 . . . . 0.0 114.011 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 27' ' ' LYS . 65.9 t -66.95 121.43 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 117.313 0.556 . . . . 0.0 111.873 -174.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.49 121.97 37.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.904 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.57 122.87 41.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.809 0.338 . . . . 0.0 110.446 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.439 HG21 HG21 ' A' ' 55' ' ' VAL . 20.1 pt -121.44 140.0 46.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.366 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.543 ' SG ' HG11 ' A' ' 23' ' ' VAL . 2.7 m -90.43 122.36 33.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -101.3 8.18 42.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.495 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 49.1 tttp -96.19 145.07 25.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.814 ' ND2' ' HB2' ' A' ' 52' ' ' SER . 0.8 OUTLIER -92.68 103.62 15.98 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.929 -177.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 12' ' ' VAL . 75.2 mt -96.32 111.59 57.16 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.411 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.459 -0.546 0 C-N-CA 122.676 2.251 . . . . 0.0 111.35 176.479 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 45.5 mmtt . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.6 139.77 50.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.883 0.373 . . . . 0.0 110.622 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.82 121.94 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.582 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -75.58 102.02 5.14 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -125.8 127.65 46.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.414 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -154.51 172.13 18.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 110.83 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 20' ' ' VAL . 48.1 t -113.1 117.17 54.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.53 156.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.75 0.31 . . . . 0.0 110.649 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -72.96 102.97 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.578 HG13 ' HE2' ' A' ' 16' ' ' LYS . 10.2 p -85.05 134.33 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.682 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 68.8 mtp180 -126.54 -179.07 4.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.5 -172.86 33.42 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.14 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 p -74.84 99.26 3.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.169 0.509 . . . . 0.0 111.991 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -166.6 178.3 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.496 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -87.56 -27.54 22.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.469 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.585 ' HE2' ' HA ' ' A' ' 73' ' ' LEU . 82.3 m-85 -79.73 171.16 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -126.15 -15.1 5.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 171.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' HG13 ' A' ' 9' ' ' VAL . 11.8 m -148.29 147.47 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.07 132.67 14.86 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.922 0.392 . . . . 0.0 111.204 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 138.96 21.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.643 2.229 . . . . 0.0 112.669 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.19 156.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.417 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -142.63 165.81 26.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.828 0.346 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 p -109.46 142.3 40.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -78.89 -8.29 58.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.242 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.19 134.43 16.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.127 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 52.6 Cg_exo -56.95 136.12 74.78 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.817 2.345 . . . . 0.0 112.183 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.26 145.65 20.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.3 135.01 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 pt -66.33 -9.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.293 . . . . 0.0 111.549 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 m -67.58 -30.73 70.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -86.83 -17.4 33.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.649 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -51.78 -45.44 63.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.148 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.5 -44.98 99.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 111.46 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 40' ' ' VAL . 14.8 t70 -79.46 -32.27 42.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -56.18 -48.7 75.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.122 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -60.99 -44.37 97.51 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.277 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -57.56 -47.19 82.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.731 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 36' ' ' ASP . 87.6 t -64.78 -46.02 93.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.669 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 tp -65.71 -31.93 73.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.857 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -66.8 -20.9 66.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 110.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -104.85 8.91 34.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.4 tp -110.47 84.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 79.6 m-85 -92.78 101.02 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -122.04 159.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.348 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -145.58 -134.4 2.69 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.517 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.46 115.57 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.024 0.53 . . . . 0.0 110.711 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 65.2 Cg_exo -53.54 111.07 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.08 2.52 . . . . 0.0 112.825 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -109.27 -170.91 1.74 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.042 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -127.13 166.75 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.004 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.806 ' HB2' HD22 ' A' ' 72' ' ' ASN . 22.5 t -61.86 131.3 49.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.693 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.54 21.16 32.5 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.634 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.645 HD22 ' HB3' ' A' ' 69' ' ' CYS . 9.7 p30 -89.19 131.73 35.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.75 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 HG23 ' A' ' 68' ' ' ILE . 38.7 t -87.27 106.16 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.119 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.4 -55.76 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.143 0.496 . . . . 0.0 109.809 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 t -130.7 121.11 24.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.403 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.581 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 31.8 ttmt -92.34 112.48 24.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.223 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 62' ' ' ASN . 62.9 t30 58.86 54.93 4.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.619 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.556 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 10.4 tt -46.27 -43.18 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.822 -171.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.483 ' HG3' HG12 ' A' ' 60' ' ' ILE . 84.4 mtp -128.98 29.03 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.491 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' HA ' ' ND2' ' A' ' 59' ' ' ASN . 40.7 t-20 53.81 72.51 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.406 0.622 . . . . 0.0 110.626 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -153.89 13.67 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.0 37.57 83.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.589 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 27' ' ' LYS . 52.0 t -127.08 120.95 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.014 0.435 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.581 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 15.9 m-20 -96.05 121.69 38.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.39 101.98 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 55' ' ' VAL . 13.4 pt -109.15 139.92 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.368 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.645 ' HB3' HD22 ' A' ' 54' ' ' ASN . 43.9 t -95.25 145.24 25.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.258 174.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -121.05 8.91 10.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 110.495 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -96.68 131.37 43.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.806 HD22 ' HB2' ' A' ' 52' ' ' SER . 11.0 m-80 -91.15 116.4 28.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.887 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.585 ' HA ' ' HE2' ' A' ' 18' ' ' TYR . 6.1 mp -96.73 119.59 63.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 122.245 1.963 . . . . 0.0 110.709 172.14 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 10.4 mmmm . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.717 ' HB3' ' HZ2' ' A' ' 34' ' ' TRP . 6.4 t70 -130.11 171.01 13.3 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.3 112.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.102 -0.374 . . . . 0.0 111.309 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.47 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 29.4 t80 -66.34 115.22 6.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.493 . . . . 0.0 110.357 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -123.39 133.42 54.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.777 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.3 t -152.98 -163.55 1.73 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.07 136.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.84 148.75 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.21 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -73.56 143.06 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 111.03 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' ' 18' ' ' TYR . 57.4 t -105.76 146.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.692 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.735 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 19.4 ttp180 -140.38 -179.31 5.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.479 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 13' ' ' ARG . . . 111.7 -154.27 16.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.166 165.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -77.93 20.43 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.322 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -156.4 142.45 18.09 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.24 87.43 7.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.256 0.551 . . . . 0.0 110.285 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.545 ' HB3' HG11 ' A' ' 12' ' ' VAL . 2.2 t80 -117.59 141.71 48.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.53 -69.88 0.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.6 m -136.74 148.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.073 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.9 p -127.44 127.42 24.15 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.659 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 55.6 Cg_endo -71.4 133.83 23.38 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.685 2.257 . . . . 0.0 112.424 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' SG ' ' A' ' 69' ' ' CYS . 27.1 m -119.44 166.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.031 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -147.09 176.35 10.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.383 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 16.3 m -109.15 131.21 55.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.31 -11.32 59.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.964 0.411 . . . . 0.0 110.428 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' A' ' 65' ' ' VAL . 39.5 ttpt -135.78 135.15 21.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.507 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 14.4 Cg_endo -56.28 141.47 88.56 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.499 ' CG1' HG21 ' A' ' 65' ' ' VAL . 4.2 m -122.18 174.21 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.131 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . 25.3 mt-10 -71.36 140.25 50.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 33' ' ' LYS . 36.0 pt -67.54 151.71 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 m 72.69 -32.77 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.116 0.566 . . . . 0.0 111.112 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 31' ' ' ILE . 19.2 tptm -64.26 -16.92 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.717 ' HZ2' ' HB3' ' A' ' 4' ' ' ASP . 52.0 m0 -54.27 -39.07 66.54 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.589 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.15 -36.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.15 -44.54 79.51 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.165 0.507 . . . . 0.0 110.263 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -66.45 -37.26 84.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 t -65.78 -32.27 73.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.291 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.48 -42.6 99.59 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.076 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.63 -47.8 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.869 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.851 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -64.1 -20.59 66.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 110.543 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -104.13 14.8 29.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.857 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.454 HD22 ' HB ' ' A' ' 56' ' ' VAL . 32.0 tp -112.52 139.09 48.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -127.16 97.66 5.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.78 124.64 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.228 0.537 . . . . 0.0 111.055 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.735 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -109.62 175.19 18.61 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.182 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 99.2 t 73.53 134.29 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 123.05 0.54 . . . . 0.0 111.544 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 51.9 Cg_exo -56.61 116.7 3.38 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.859 2.373 . . . . 0.0 111.78 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 p -118.79 169.52 9.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -120.3 169.36 10.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -52.58 118.64 3.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 24.95 9.84 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.115 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.664 HD22 ' HB2' ' A' ' 69' ' ' CYS . 9.8 p30 -88.47 132.34 34.52 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.543 HG22 HG21 ' A' ' 68' ' ' ILE . 34.4 t -88.25 125.47 41.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.07 -175.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' HD22 ' A' ' 44' ' ' LEU . 30.5 m -97.85 -38.15 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.092 0.472 . . . . 0.0 110.258 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.6 m -130.9 105.14 7.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.791 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -95.19 127.48 41.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.12 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 1.6 t-20 54.56 40.37 31.79 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.842 0.713 . . . . 0.0 109.748 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.585 HG12 ' HG2' ' A' ' 61' ' ' MET . 10.4 tt -41.96 -50.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.622 -169.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.585 ' HG2' HG12 ' A' ' 60' ' ' ILE . 25.7 mmt -134.71 49.04 2.25 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.35 -0.219 . . . . 0.0 110.628 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.459 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 8.5 p30 56.71 5.86 0.25 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.841 1.256 . . . . 0.0 113.753 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 65' ' ' VAL . 5.0 t -78.56 -11.68 59.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.311 0.577 . . . . 0.0 110.71 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -6.35 83.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.268 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 27' ' ' LYS . 66.5 t -81.33 126.9 39.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.817 0.341 . . . . 0.0 110.512 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -108.77 123.85 49.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mm -81.68 117.35 27.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.543 HG21 HG22 ' A' ' 55' ' ' VAL . 33.6 pt -121.99 139.85 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.612 -173.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.664 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.8 m -89.32 137.32 32.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -105.38 13.12 30.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.128 0.49 . . . . 0.0 111.454 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HB2' HG23 ' A' ' 21' ' ' VAL . 31.9 mmtt -96.76 142.64 28.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -96.47 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 mt -99.8 112.71 64.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.581 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.457 -0.642 0 C-N-CA 122.994 2.463 . . . . 0.0 112.007 177.07 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.536 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 93.2 mttt . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 154.51 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 28' ' ' PRO . 46.7 mm -73.97 112.79 11.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.431 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.495 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 87.0 t80 -64.01 104.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.592 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -111.02 120.56 42.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -141.47 -166.86 2.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 60.5 t -133.63 129.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.39 152.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -91.96 133.26 35.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 110.307 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 46' ' ' VAL . 2.5 t -118.76 133.31 66.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 112.025 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.554 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 92.4 mtt-85 -108.29 -179.11 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.353 173.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -161.6 21.59 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.453 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.2 m -78.77 74.87 5.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 111.393 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -147.96 166.66 27.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.581 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -89.32 -46.42 8.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.855 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.42 ' O ' ' HD2' ' A' ' 16' ' ' LYS . 85.4 m-85 -83.67 156.8 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -103.35 -3.03 26.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.865 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.407 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 6.5 m -143.51 145.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 73' ' ' LEU . 14.5 p -134.18 129.13 19.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.436 174.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.89 128.89 18.57 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.494 2.129 . . . . 0.0 112.342 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.495 HG12 ' HB3' ' A' ' 69' ' ' CYS . 27.1 m -115.94 161.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.343 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -139.76 178.33 7.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.13 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.21 134.45 51.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.768 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -72.87 -22.25 60.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HB2' HG23 ' A' ' 65' ' ' VAL . 37.7 mtmm -132.42 146.29 60.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.468 ' HA ' HD13 ' A' ' 5' ' ' ILE . 23.9 Cg_exo -63.15 137.62 62.5 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.969 2.446 . . . . 0.0 112.818 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 65' ' ' VAL . 33.4 m -114.99 160.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.411 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.605 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 59.4 mt-10 -68.65 139.7 55.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.433 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 29.7 pt -60.22 -26.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.375 . . . . 0.0 111.675 -177.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 m -74.74 -17.41 60.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.082 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.605 ' HE2' ' OE1' ' A' ' 30' ' ' GLU . 63.8 mttm -90.48 -5.29 56.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.612 0.244 . . . . 0.0 111.334 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.433 ' CD1' ' HA ' ' A' ' 31' ' ' ILE . 10.5 m95 -59.05 -31.26 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.02 -48.3 75.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.462 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' O ' HG22 ' A' ' 40' ' ' VAL . 7.1 m-20 -56.5 -50.63 71.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.49 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 32.4 m-85 -63.07 -37.05 85.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.371 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -63.4 -41.83 98.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.832 -0.167 . . . . 0.0 111.095 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -62.78 -35.27 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.958 0.409 . . . . 0.0 110.679 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 36' ' ' ASP . 59.1 t -70.02 -48.58 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.4 HD21 HG21 ' A' ' 23' ' ' VAL . 8.7 mp -64.61 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.938 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.3 m -66.18 -12.14 54.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.644 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -105.15 -9.29 17.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 109.918 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.11 124.0 43.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.605 -172.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -125.3 117.1 23.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.641 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 56' ' ' VAL . 24.9 m -106.02 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -151.3 47.04 0.59 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.426 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.33 119.73 17.69 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-O 120.562 0.22 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.651 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 55.8 Cg_endo -73.49 97.59 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.581 2.188 . . . . 0.0 111.473 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 p -96.77 170.22 9.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 64.1 mttp -98.27 -149.76 0.35 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.695 171.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.75 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 2.0 p -92.36 119.59 32.06 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.62 58.16 1.21 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.177 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.1 m-80 -127.91 129.24 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.17 110.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.167 0.508 . . . . 0.0 111.322 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.503 HG13 HG11 ' A' ' 46' ' ' VAL . 45.1 t -83.98 -42.61 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.684 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.1 m -130.53 103.6 6.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.443 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -84.23 128.19 34.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.528 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 54.79 52.66 11.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.348 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.489 HG22 HG12 ' A' ' 67' ' ' ILE . 12.7 tt -75.32 135.7 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.403 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.7 mmt 65.07 13.85 8.97 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.477 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.4 13.15 5.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.568 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 65' ' ' VAL . 8.9 t -87.51 -7.49 57.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.449 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.46 66.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.629 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 29' ' ' VAL . 77.1 t -73.07 137.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.113 0.483 . . . . 0.0 110.283 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.94 120.2 38.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 60' ' ' ILE . 44.0 mm -80.04 115.97 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.77 0.319 . . . . 0.0 110.397 -175.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 26.3 pt -116.13 131.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.649 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 54' ' ' ASN . 1.8 p -81.13 139.32 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.75 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 11.7 t -126.13 6.99 7.18 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.395 -173.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.493 ' HB3' HG23 ' A' ' 21' ' ' VAL . 64.2 tttp -99.67 131.12 45.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -76.19 107.17 8.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 21' ' ' VAL . 95.8 mt -81.58 112.62 35.68 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.279 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.459 -0.548 0 C-N-CA 122.487 2.125 . . . . 0.0 112.067 -179.062 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 28' ' ' PRO . 68.2 mttm . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.62 157.13 32.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.575 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 28' ' ' PRO . 47.3 mm -82.74 101.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 81.9 t80 -58.8 106.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.339 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -122.26 128.69 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.068 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -149.54 -168.98 3.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.9 m -121.75 137.53 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.705 0.288 . . . . 0.0 110.34 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.86 152.27 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -89.45 111.18 22.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.576 0.703 . . . . 0.0 110.117 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.569 ' HB ' ' HZ2' ' A' ' 16' ' ' LYS . 3.0 t -98.28 140.01 19.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.608 -173.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 45' ' ' TYR . 67.6 mtm180 -79.75 144.37 33.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.54 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.432 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -70.58 95.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 115.124 -169.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 p -117.37 12.33 14.23 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 165.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -169.96 -168.92 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.359 -171.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.43 -41.36 14.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.609 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 78.2 m-85 -82.4 97.32 8.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 111.498 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.432 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 95.8 m-20 -98.63 10.72 40.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.52 122.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG23 HD13 ' A' ' 73' ' ' LEU . 4.4 p -130.91 139.73 36.49 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.719 -173.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.43 124.39 10.33 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.923 2.415 . . . . 0.0 112.966 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.4 154.61 16.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.516 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -143.98 178.97 7.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.457 ' HB2' HG12 ' A' ' 65' ' ' VAL . 67.8 p -108.93 127.67 54.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.758 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -63.9 -24.32 67.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.863 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HB2' HG21 ' A' ' 65' ' ' VAL . 82.8 mttt -122.68 142.71 38.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' HD11 ' A' ' 5' ' ' ILE . 32.5 Cg_endo -64.81 128.29 20.58 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.232 1.955 . . . . 0.0 112.117 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.04 150.26 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.201 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.07 120.75 14.8 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.19 84.12 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.725 1.25 . . . . 0.0 111.914 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.1 m -138.04 -10.45 1.52 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.081 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -103.46 17.77 23.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -173.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -62.99 -26.84 69.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 110.494 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.2 mt -73.02 -47.91 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.429 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 40' ' ' VAL . 5.8 m-20 -68.29 -39.71 82.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.8 m-30 -64.21 -48.41 75.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -66.43 -30.75 71.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.182 0.515 . . . . 0.0 110.064 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 14.5 t-20 -56.72 -49.66 74.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.028 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 36' ' ' ASP . 47.1 t -70.99 -38.03 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.736 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 81.2 mt -62.01 -25.35 67.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.245 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -77.86 4.3 12.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.004 0.43 . . . . 0.0 111.396 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -141.64 16.75 2.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 0.0 109.963 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.9 tp -115.1 59.43 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.725 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.45 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 78.7 m-85 -83.83 92.05 7.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.738 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG23 HG23 ' A' ' 48' ' ' VAL . 14.9 p -92.18 147.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.99 49.19 0.93 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.1 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.415 HG23 HG23 ' A' ' 46' ' ' VAL . 22.3 m -130.23 128.96 22.81 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 48' ' ' VAL . 23.2 Cg_exo -67.39 133.26 29.74 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.136 2.558 . . . . 0.0 111.589 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.468 ' H ' HD11 ' A' ' 73' ' ' LEU . 2.0 p -133.41 179.68 6.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.961 -174.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -118.92 169.5 9.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 72' ' ' ASN . 11.0 t -59.56 128.71 38.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 0.0 111.805 -173.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.97 26.71 12.1 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.554 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.598 HD22 ' HB3' ' A' ' 69' ' ' CYS . 10.0 p30 -96.42 137.53 35.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 58' ' ' LYS . 62.4 t -77.6 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.69 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.87 -57.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.2 t -130.49 109.25 10.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.915 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HB2' HG11 ' A' ' 55' ' ' VAL . 9.3 tmtm? -84.12 119.82 25.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.623 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 57.46 50.86 10.56 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 110.221 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.646 HG12 ' HG2' ' A' ' 61' ' ' MET . 8.0 tt -49.15 -50.46 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.666 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.646 ' HG2' HG12 ' A' ' 60' ' ' ILE . 95.8 mmm -130.12 45.41 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.791 0.329 . . . . 0.0 110.585 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.04 29.63 19.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.194 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -86.31 -20.05 28.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.689 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.79 87.52 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 27' ' ' LYS . 69.0 t -104.47 138.75 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.212 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' OD2' ' HG2' ' A' ' 58' ' ' LYS . 4.3 m-20 -97.41 106.94 19.35 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.07 107.12 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 33.4 pt -114.69 144.87 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.977 -171.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.598 ' HB3' HD22 ' A' ' 54' ' ' ASN . 10.3 t -89.65 141.97 28.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.046 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -120.07 6.74 10.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -101.74 147.55 26.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.585 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -98.01 110.88 23.37 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.476 HD13 HG23 ' A' ' 21' ' ' VAL . 5.7 mp -87.45 116.1 65.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.988 -176.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 2.9 Cg_exo . . . . . 0 C--O 1.236 0.377 0 C-N-CA 123.013 2.475 . . . . 0.0 111.519 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.3 mttt . . . . . 0 C--O 1.233 0.188 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -140.57 164.4 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.022 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -74.85 113.19 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 72.8 t80 -59.35 108.5 0.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.842 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -126.26 120.98 31.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.381 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -155.79 -156.79 0.67 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 22' ' ' PRO . 25.2 m -132.08 147.03 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.784 0.326 . . . . 0.0 110.465 177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.51 150.42 18.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.017 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.441 ' HD3' HG11 ' A' ' 20' ' ' VAL . 12.0 mmt180 -84.38 121.31 27.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 6.5 t -100.66 118.27 47.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.389 -173.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.44 ' C ' ' HA3' ' A' ' 47' ' ' GLY . 62.5 ttt180 -133.1 104.2 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 47' ' ' GLY . . . 174.42 -171.83 44.88 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -78.3 99.31 6.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -171.78 -166.63 0.44 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.36 -179.372 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -128.35 71.68 1.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -161.28 176.12 11.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -136.12 -50.07 0.69 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 110.551 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.441 HG11 ' HD3' ' A' ' 11' ' ' ARG . 15.9 m -131.11 133.45 62.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.19 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.471 HG22 ' HD3' ' A' ' 71' ' ' LYS . 4.4 p -127.59 140.79 39.01 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.225 -177.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.463 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 47.2 Cg_endo -70.08 137.63 34.98 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.243 1.962 . . . . 0.0 112.199 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -135.25 146.79 29.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.558 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -145.22 178.93 7.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.914 0.388 . . . . 0.0 111.288 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 91.3 p -108.86 129.56 55.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.03 -39.77 72.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.516 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HB3' HG23 ' A' ' 65' ' ' VAL . 32.3 ttmt -119.52 140.25 29.0 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.462 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.91 126.22 20.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.533 2.155 . . . . 0.0 111.924 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.54 156.92 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.646 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.465 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 25.8 mt-10 -67.09 127.29 32.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.9 pt -74.31 -6.8 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 110.877 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.9 t -60.6 -31.96 71.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.331 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.447 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 33.2 mtmm -107.1 14.86 25.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.719 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -57.52 -36.21 71.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.698 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.19 -39.69 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.04 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' HG21 ' A' ' 40' ' ' VAL . 25.7 t0 -71.96 -42.16 66.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 22.3 m-85 -58.08 -46.22 85.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.272 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.0 p -68.98 -28.6 66.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.309 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -72.69 -24.66 61.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.918 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 57.6 t -71.67 -44.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.18 -42.86 91.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.407 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -77.91 2.85 16.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 111.227 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -111.49 -15.89 13.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.537 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 93.3 mt -74.07 -71.66 0.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.861 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 58.5 79.92 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.465 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.3 p -125.22 143.36 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.614 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA3' ' C ' ' A' ' 13' ' ' ARG . . . -139.17 88.98 0.2 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.086 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 60.0 t -128.82 120.61 20.58 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 48' ' ' VAL . 14.2 Cg_endo -57.71 111.13 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 111.779 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 171.66 14.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.548 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -100.55 178.32 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.341 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -68.9 129.17 39.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.57 28.56 10.25 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.285 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.556 HD22 ' HB3' ' A' ' 69' ' ' CYS . 10.8 p30 -88.32 131.32 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG13 ' HD3' ' A' ' 58' ' ' LYS . 37.0 t -88.97 110.71 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.794 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.99 -64.74 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.131 0.491 . . . . 0.0 109.789 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.3 m -100.47 116.69 33.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.311 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HD3' HG13 ' A' ' 55' ' ' VAL . 25.3 mmtt -83.4 104.01 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.6 t30 54.77 66.31 1.27 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.703 0.763 . . . . 0.0 109.595 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.463 HD13 HG12 ' A' ' 40' ' ' VAL . 12.3 tt -61.69 111.25 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.539 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm 63.76 26.17 14.35 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.63 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 m120 62.75 82.68 0.17 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.284 0.564 . . . . 0.0 111.372 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.2 p -133.14 -20.83 2.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.203 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.22 7.45 73.2 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.35 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 27' ' ' LYS . 60.1 t -116.72 129.44 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.049 0.452 . . . . 0.0 110.442 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 55' ' ' VAL . 5.4 p-10 -95.55 126.08 40.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 169.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 mm -83.15 110.89 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.018 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.7 pt -117.4 138.53 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.451 0.643 . . . . 0.0 112.273 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.556 ' HB3' HD22 ' A' ' 54' ' ' ASN . 40.7 t -92.11 145.7 24.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -114.92 -2.74 12.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HD3' HG22 ' A' ' 21' ' ' VAL . 55.9 tttp -97.04 149.88 21.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.591 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -96.76 132.62 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -175.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 21' ' ' VAL . 5.1 mp -111.79 93.98 22.5 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 N--CA 1.452 -0.967 0 C-N-CA 122.776 2.317 . . . . 0.0 113.024 -177.558 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.524 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 94.2 mttt . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -124.19 148.17 47.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.487 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 HG23 HG22 ' A' ' 7' ' ' THR . 42.0 mm -64.6 119.74 9.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.083 0.468 . . . . 0.0 110.959 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 91.6 t80 -78.13 96.01 5.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.034 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.462 HG22 HG23 ' A' ' 5' ' ' ILE . 16.6 p -105.72 125.19 50.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.0 m -149.94 -169.0 3.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 138.83 52.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.3 157.85 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HD2' HG11 ' A' ' 20' ' ' VAL . 33.6 mmm-85 -79.74 133.1 36.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.802 0.334 . . . . 0.0 110.797 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.531 HG13 HG22 ' A' ' 46' ' ' VAL . 2.8 t -120.63 139.1 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.284 0.564 . . . . 0.0 110.669 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.486 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 64.6 ttt-85 -119.43 170.49 9.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.074 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.09 174.35 18.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.634 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.6 p -72.52 86.35 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' HG2' ' HG3' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -178.15 164.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.044 171.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -91.71 34.14 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.374 -0.376 . . . . 0.0 112.011 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 97.5 m-85 -130.55 102.91 6.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 110.31 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.39 -7.06 55.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.546 -176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.428 HG11 ' HD2' ' A' ' 11' ' ' ARG . 15.5 m -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.511 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.495 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.1 p -140.78 138.25 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.435 177.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.98 129.57 14.42 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.558 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -115.58 161.55 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.31 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HG3' HG13 ' A' ' 68' ' ' ILE . 18.3 ptpt -131.34 174.94 9.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 79.8 p -108.93 130.95 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.262 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.78 -44.71 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' HG3' ' HD2' ' A' ' 28' ' ' PRO . 37.5 ttpt -121.09 140.88 31.76 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD2' ' HG3' ' A' ' 27' ' ' LYS . 84.6 Cg_exo -46.92 130.76 16.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.088 2.526 . . . . 0.0 112.835 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.81 127.09 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.667 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 40.9 mt-10 -52.5 135.3 34.12 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.301 176.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 tp -68.26 81.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 122.051 0.929 . . . . 0.0 110.881 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t 179.9 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.217 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.12 -5.69 52.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.295 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -57.56 -34.25 68.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.27 -54.99 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.658 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 7.5 m-20 -62.44 -38.16 88.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.02 -51.42 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.242 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -64.9 -32.01 73.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.632 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 24.9 t-20 -55.56 -54.34 45.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.901 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 36' ' ' ASP . 67.3 t -60.42 -42.93 92.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.98 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.4 mt -60.99 -27.2 68.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -68.28 -10.63 56.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.58 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -130.2 20.07 5.34 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 174.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.3 tp -109.89 115.23 29.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.43 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -117.29 112.69 21.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.369 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.531 HG22 HG13 ' A' ' 12' ' ' VAL . 27.3 m -96.67 178.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -143.98 176.04 23.51 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.089 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.7 t 71.97 139.75 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 122.797 0.439 . . . . 0.0 111.216 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.545 ' HG3' ' HG2' ' A' ' 16' ' ' LYS . 25.1 Cg_exo -64.8 119.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.447 2.098 . . . . 0.0 111.401 170.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.579 ' HB ' ' CG ' ' A' ' 54' ' ' ASN . 40.6 p -101.6 166.34 10.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.826 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.59 -148.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.764 ' HB2' HD22 ' A' ' 72' ' ' ASN . 11.4 t -101.95 120.81 41.0 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.31 49.77 1.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.026 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.583 HD21 ' HB3' ' A' ' 69' ' ' CYS . 1.5 m-80 -108.69 109.11 20.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.505 ' HA ' HG21 ' A' ' 68' ' ' ILE . 94.7 t -69.55 111.38 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 -62.55 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.71 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -130.81 115.3 16.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.032 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 20.6 ptmt -98.18 141.97 30.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.824 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.488 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 11.8 t-20 58.34 41.7 22.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.716 0.77 . . . . 0.0 109.028 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.742 HG12 ' HG2' ' A' ' 61' ' ' MET . 14.4 tt -64.51 133.67 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.41 -173.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.742 ' HG2' HG12 ' A' ' 60' ' ' ILE . 83.7 mmm 63.39 21.85 12.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 65.65 10.91 7.11 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.13 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -69.87 -43.82 71.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.96 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.488 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 117.43 -27.14 7.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 25' ' ' SER . 85.8 t -66.95 140.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.67 0.271 . . . . 0.0 110.766 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 4.2 m-20 -95.63 123.0 38.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.76 106.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.533 HG13 ' HG3' ' A' ' 24' ' ' LYS . 25.7 pt -115.53 132.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.857 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.583 ' HB3' HD21 ' A' ' 54' ' ' ASN . 18.2 t -72.09 142.1 49.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.1 t -126.35 1.83 7.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 64.7 tttp -102.58 129.08 49.03 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.481 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.764 HD22 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -86.23 106.39 17.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.974 -174.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 mt -95.73 126.03 46.76 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.079 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo . . . . . 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.175 . . . . 0.0 111.532 176.388 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.03 -71.48 0.73 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -134.75 163.23 30.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.64 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.3 145.43 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.746 0.308 . . . . 0.0 110.563 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.38 119.73 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.923 0.392 . . . . 0.0 110.277 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 77.0 t80 -60.11 125.71 24.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.155 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.8 m -145.15 120.39 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 178.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.58 120.97 66.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.3 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.74 150.58 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.805 0.336 . . . . 0.0 110.333 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HA ' HG11 ' A' ' 20' ' ' VAL . 91.0 mtt180 -77.22 134.45 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.577 ' CG1' ' HE3' ' A' ' 16' ' ' LYS . 12.0 t -112.85 111.6 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -90.84 100.91 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.448 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.5 14.0 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 t -85.03 99.84 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.58 39.77 0.81 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.356 -175.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.6 tttm 70.74 -66.07 0.31 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.568 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -73.79 -179.06 3.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 111.363 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.0 -36.43 1.98 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.653 0.263 . . . . 0.0 111.245 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' A' ' 11' ' ' ARG . 17.0 m -129.03 158.99 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.218 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.2 p -128.67 133.4 25.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.93 118.8 5.72 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.529 2.152 . . . . 0.0 111.717 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.473 HG12 ' SG ' ' A' ' 69' ' ' CYS . 28.9 m -112.5 150.54 14.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 70' ' ' THR . 18.3 ptpt -136.66 170.56 15.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.969 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 17.0 t -109.45 155.71 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.441 ' ND2' ' HE2' ' A' ' 27' ' ' LYS . 21.1 p-10 -78.04 -32.86 51.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.176 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HE2' ' ND2' ' A' ' 26' ' ' ASN . 51.1 mtmt -122.58 150.86 58.97 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.975 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 23.3 Cg_exo -64.38 136.9 53.06 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.137 2.558 . . . . 0.0 112.971 -176.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.438 HG11 ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -124.57 150.19 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.824 -177.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -69.52 145.7 52.45 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.866 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tt -60.35 -27.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.987 0.422 . . . . 0.0 111.546 -174.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.45 -28.0 68.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 111.059 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.13 -20.73 22.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.711 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -57.55 -43.33 84.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -67.37 -45.59 85.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.135 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.96 -45.8 89.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.449 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.438 ' CE2' HG11 ' A' ' 29' ' ' VAL . 22.1 m-30 -67.51 -37.44 82.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.602 0.239 . . . . 0.0 110.877 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 m -64.44 -33.7 76.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.21 -40.2 95.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.22 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 50.7 t -64.98 -44.3 96.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.338 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.91 -21.92 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.443 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -73.5 -13.59 61.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.381 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 10.3 ptt180 -111.65 1.26 16.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.366 0.603 . . . . 0.0 109.43 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 tt -108.73 133.02 53.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.683 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.96 110.24 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.642 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 43.2 t -78.01 126.72 38.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.96 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.773 -1.203 . . . . 0.0 112.589 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.8 112.14 20.52 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.535 0.207 . . . . 0.0 110.913 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 75' ' ' LYS . 6.1 Cg_exo -75.44 102.95 1.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.774 2.316 . . . . 0.0 110.786 170.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.61 -178.57 4.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.302 0.572 . . . . 0.0 112.352 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.91 -178.23 5.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.367 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 p -74.85 140.13 43.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.462 . . . . 0.0 111.181 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 32.16 16.95 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.712 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.731 HD22 ' HB2' ' A' ' 69' ' ' CYS . 10.4 p30 -96.58 128.4 43.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.313 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 HG21 HG21 ' A' ' 68' ' ' ILE . 47.7 t -83.15 120.53 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.917 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.99 -61.26 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.509 0.671 . . . . 0.0 109.798 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.69 121.38 25.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.286 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -91.81 136.5 33.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.26 56.52 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.452 0.47 . . . . 0.0 110.236 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.37 125.57 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.254 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 96.9 mmm 64.46 23.85 13.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.564 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.5 t30 51.26 69.5 0.64 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.793 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 p -114.49 -35.01 5.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.845 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.67 9.95 34.13 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.454 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 27' ' ' LYS . 1.7 p -104.04 157.28 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -109.29 137.97 46.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mm -111.52 117.19 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 34.3 pt -123.78 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 111.793 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.731 ' HB2' HD22 ' A' ' 54' ' ' ASN . 2.7 m -82.72 134.59 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.5 HG21 ' HE3' ' A' ' 24' ' ' LYS . 12.7 t -109.77 3.9 21.27 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.246 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HB3' HG23 ' A' ' 21' ' ' VAL . 55.7 tptt -96.68 143.6 27.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -90.93 121.12 32.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.8 mm? -98.35 112.27 61.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.91 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 8.6 Cg_endo -87.39 96.36 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.145 2.564 . . . . 0.0 111.719 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 42.7 tttm -69.78 -58.44 3.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.411 0.624 . . . . 0.0 110.685 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -106.95 113.71 27.36 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.632 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.5 m -85.42 80.01 9.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.155 0.502 . . . . 0.0 110.629 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.1 mt -102.06 88.9 3.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.319 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.92 118.18 36.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -112.06 47.6 1.04 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.129 0.49 . . . . 0.0 110.634 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -100.59 -41.64 6.87 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -101.37 150.67 22.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.693 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -79.04 -91.73 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 176.3 142.37 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 39.0 m170 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.952 175.081 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mtt . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.583 0.23 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -133.21 126.41 31.53 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.587 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.488 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 99.4 mttt -105.17 146.59 29.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.536 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.42 148.65 50.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.03 0.443 . . . . 0.0 111.377 -176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.47 HG21 ' O ' ' A' ' 25' ' ' SER . 47.2 mm -61.77 110.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.309 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.93 110.9 3.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -123.89 127.93 48.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.878 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.4 m -154.72 173.85 15.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.2 t -117.26 125.04 73.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.6 156.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.808 0.337 . . . . 0.0 110.664 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -90.24 116.9 28.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.124 0.488 . . . . 0.0 109.788 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 t -108.45 140.76 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.875 -172.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 65.9 mtt-85 -97.53 158.41 15.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.62 157.74 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.05 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 77' ' ' SER . 5.0 p -81.55 45.37 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.461 0.648 . . . . 0.0 111.013 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 33.58 2.32 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.087 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 tptt 69.74 -59.27 0.5 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 0.0 112.056 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -80.91 -177.46 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -143.5 11.4 1.68 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.294 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.5 m -146.31 147.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.024 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 71' ' ' LYS . 9.5 p -137.66 133.71 18.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.562 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -70.47 116.0 4.44 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.804 2.336 . . . . 0.0 112.269 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.555 HG11 ' SG ' ' A' ' 69' ' ' CYS . 34.9 m -105.44 151.33 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.954 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' HB2' ' HZ1' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -136.28 163.27 30.8 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.363 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.47 ' O ' HG21 ' A' ' 5' ' ' ILE . 19.5 m -109.27 131.82 54.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -75.61 -12.68 60.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HB2' HG23 ' A' ' 65' ' ' VAL . 75.0 mmtt -115.98 143.16 30.33 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 17.1 Cg_exo -67.59 120.25 7.27 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.316 2.011 . . . . 0.0 110.923 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.73 148.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.677 -172.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 54.1 mt-10 -64.0 119.53 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -61.32 -22.31 27.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -70.03 -16.54 63.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.996 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -98.8 11.7 37.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -62.95 -35.07 78.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.685 0.279 . . . . 0.0 110.8 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.58 -39.94 85.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.519 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 40' ' ' VAL . 37.2 t70 -61.77 -48.03 82.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.75 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.43 -40.77 89.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.9 m -60.91 -38.94 87.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.934 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.27 -43.47 98.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 36' ' ' ASP . 47.8 t -65.38 -45.1 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.533 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.19 -27.34 69.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.567 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 m -73.73 -5.01 38.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.29 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -113.6 5.08 16.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.239 0.543 . . . . 0.0 109.679 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.8 tp -109.05 42.14 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.022 -172.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -70.19 94.61 0.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.397 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.59 154.23 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.26 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -124.59 98.42 0.56 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.299 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 7.3 p -168.5 126.14 0.89 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.783 0.325 . . . . 0.0 110.763 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 8.5 Cg_exo -72.49 120.99 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.743 2.295 . . . . 0.0 111.373 174.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -122.11 -179.23 4.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.82 173.13 6.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 p -69.84 126.13 28.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 110.83 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 30.05 13.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.759 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.83 HD22 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -88.85 128.04 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 68' ' ' ILE . 22.1 t -88.19 112.83 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.376 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -76.46 -62.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 44.3 t -130.64 108.81 10.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.253 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.9 138.76 32.33 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.55 43.23 16.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.515 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 6.2 tt -50.44 -39.11 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.339 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.86 39.48 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.87 18.82 11.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.11 0.957 . . . . 0.0 109.71 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 65' ' ' VAL . 20.5 p -82.51 -25.4 33.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.164 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.19 15.28 69.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.281 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.55 HG22 ' HB ' ' A' ' 63' ' ' THR . 48.7 t -92.26 139.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.85 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.61 101.01 12.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.81 102.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.8 pt -115.35 136.58 51.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.83 ' HB2' HD22 ' A' ' 54' ' ' ASN . 2.3 m -87.77 135.9 33.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -108.39 0.26 21.01 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.126 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' HG22 ' A' ' 21' ' ' VAL . 66.4 tttp -102.47 140.12 37.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.576 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -89.28 132.31 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.4 mm? -95.64 122.98 57.64 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.257 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 37.6 Cg_exo -60.74 125.56 17.55 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.007 2.472 . . . . 0.0 112.484 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 49' ' ' PRO . 34.1 mmtp -73.43 -24.99 60.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.204 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -85.17 113.65 21.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.728 -173.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 15' ' ' SER . 17.1 p -99.31 48.8 0.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.323 0.582 . . . . 0.0 109.607 174.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.6 pt? -69.01 -5.01 19.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.105 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -78.48 79.22 4.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.631 0.729 . . . . 0.0 110.943 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -118.97 -67.9 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 170.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 67.45 -75.86 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.908 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -130.15 126.38 37.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.508 0.194 . . . . 0.0 110.52 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -96.15 71.52 2.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.429 0.633 . . . . 0.0 110.658 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -143.03 -77.36 0.24 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 . . . . . 0 C--O 1.242 0.68 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.445 175.059 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.801 0.334 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -104.42 114.5 28.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.786 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 60.0 mttm -82.32 126.22 31.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.333 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -140.6 179.64 6.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.0 mm -89.61 101.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.452 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.421 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 75.7 t80 -59.56 107.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.503 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -118.71 127.41 53.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 t -152.99 -171.89 4.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.08 140.74 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -120.72 154.19 24.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.897 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 11' ' ' ARG . 18.7 mtp-105 -82.4 128.73 34.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.402 0.62 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.752 HG11 ' HZ1' ' A' ' 16' ' ' LYS . 15.6 t -97.25 141.95 14.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.326 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -137.29 100.68 4.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 0.0 110.679 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.55 -175.47 47.25 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 t -86.45 78.99 9.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.458 0.646 . . . . 0.0 110.309 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -160.9 148.68 15.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.432 177.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -83.74 37.7 0.6 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.483 ' HB2' HD13 ' A' ' 73' ' ' LEU . 29.4 m-85 -151.75 109.06 3.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -89.52 7.99 33.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.64 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -141.57 132.29 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 71' ' ' LYS . 13.1 p -133.29 131.56 21.67 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.959 0.409 . . . . 0.0 110.896 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.33 124.64 10.09 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.718 2.279 . . . . 0.0 112.396 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -115.79 155.36 17.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.475 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -138.71 171.29 14.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.499 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 18.6 m -109.29 129.28 55.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.257 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -72.92 -21.99 60.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.072 0.463 . . . . 0.0 110.636 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -116.04 135.82 22.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 37.0 Cg_endo -66.13 116.54 4.07 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.449 2.1 . . . . 0.0 112.56 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 6' ' ' PHE . 3.8 m -105.82 148.49 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.983 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 32' ' ' SER . 2.0 mp0 -64.93 141.63 58.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 111.086 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -77.05 22.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.424 0.631 . . . . 0.0 111.279 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' GLU . 25.6 m -114.4 4.15 15.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.347 0.594 . . . . 0.0 109.703 173.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -106.33 16.3 24.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.414 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -52.44 -49.07 65.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.967 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 tt -53.99 -50.77 51.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.071 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 40' ' ' VAL . 45.0 m-20 -65.05 -48.08 75.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.246 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -67.38 -36.46 81.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.294 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -62.86 -41.14 99.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.572 0.225 . . . . 0.0 110.738 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.4 -42.49 98.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.817 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 36' ' ' ASP . 58.7 t -67.51 -49.21 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.137 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.54 -29.68 69.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 111.178 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -72.56 -20.51 61.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 110.481 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 43' ' ' ARG . 12.8 mtp180 -103.51 -1.75 27.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.184 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -107.2 93.46 4.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.124 0.488 . . . . 0.0 110.704 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -96.25 91.29 5.81 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.19 139.26 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.65 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.24 -130.78 5.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.128 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 49' ' ' PRO . 94.0 t 70.41 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 112.081 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' HD2' ' A' ' 75' ' ' LYS . 61.0 Cg_endo -74.74 98.11 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.478 2.119 . . . . 0.0 111.764 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -108.49 163.78 12.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.67 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.9 mtmt -115.93 177.08 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.536 ' HB2' HD22 ' A' ' 72' ' ' ASN . 34.3 t -61.86 131.84 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.914 0.387 . . . . 0.0 111.149 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.18 25.28 19.81 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.054 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.705 HD22 ' HB2' ' A' ' 69' ' ' CYS . 9.3 p30 -95.0 125.19 39.5 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.413 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 68' ' ' ILE . 17.0 t -86.44 109.25 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.69 -40.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.915 0.388 . . . . 0.0 110.169 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.2 t -130.48 105.37 7.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' HZ3' ' CG ' ' A' ' 66' ' ' ASP . 9.5 tmtm? -90.7 129.56 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 60.71 47.93 7.62 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.392 0.433 . . . . 0.0 111.078 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG21 ' O ' ' A' ' 65' ' ' VAL . 12.7 tt -60.98 135.8 25.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.197 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.405 ' HE1' ' HB3' ' A' ' 36' ' ' ASP . 13.5 mmt 64.33 11.5 6.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.226 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 57.94 28.72 16.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.802 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.44 HG23 HG21 ' A' ' 65' ' ' VAL . 9.0 t -101.95 -7.69 22.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.341 0.591 . . . . 0.0 110.345 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.46 5.53 57.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.903 176.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.543 ' O ' HG21 ' A' ' 60' ' ' ILE . 94.8 t -85.01 130.99 35.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.007 0.432 . . . . 0.0 109.958 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.504 ' CG ' ' HZ3' ' A' ' 58' ' ' LYS . 66.4 m-20 -107.08 110.48 22.6 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.287 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -76.97 108.6 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.539 HG21 HG21 ' A' ' 55' ' ' VAL . 25.8 pt -114.7 136.59 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.249 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.7 m -92.02 136.15 33.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -108.86 8.54 26.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 0.0 111.641 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' ' 21' ' ' VAL . 45.1 tttp -102.2 148.31 25.59 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.76 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.582 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -99.87 124.04 44.76 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.753 ' HG ' ' HZ3' ' A' ' 16' ' ' LYS . 2.5 mm? -108.09 120.3 47.28 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.528 -174.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.42 143.48 27.82 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.942 2.428 . . . . 0.0 111.943 175.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HG2' ' N ' ' A' ' 76' ' ' ASP . 53.6 tttm -94.89 165.85 12.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.385 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 6.2 p-10 -72.18 172.86 9.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.609 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.2 t -110.71 125.85 53.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.033 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.69 -13.1 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 111.277 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -88.4 12.06 15.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.828 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -58.04 -35.78 71.81 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.008 0.432 . . . . 0.0 109.938 173.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -106.95 107.73 18.9 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -103.8 104.52 14.54 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -78.51 101.31 7.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.941 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -71.94 131.23 42.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.628 178.108 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -73.35 111.07 8.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.037 0.446 . . . . 0.0 111.126 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -109.28 158.82 17.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.1 136.6 54.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.6 mt -74.05 126.15 34.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.611 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -63.88 117.01 6.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.62 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 m -134.62 120.54 19.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -149.96 -169.55 3.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 20' ' ' VAL . 7.2 p -132.44 127.72 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.25 153.33 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.678 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 11' ' ' ARG . 57.6 mtt180 -75.32 128.9 36.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 21' ' ' VAL . 19.5 t -86.56 125.36 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -110.27 123.0 48.99 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.04 -174.61 24.31 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.704 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 m -72.09 95.39 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.467 ' HZ2' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -139.02 176.97 8.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.392 -175.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.653 ' HB3' ' HB2' ' A' ' 74' ' ' PRO . 51.7 tptt -110.66 -30.6 7.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.252 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.42 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -96.29 138.3 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.467 ' HA ' ' HZ2' ' A' ' 16' ' ' LYS . 56.3 t30 -77.83 -45.42 24.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.767 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 9' ' ' VAL . 18.4 m -128.17 147.63 32.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.397 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 12' ' ' VAL . 9.5 p -128.27 121.4 21.53 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 121.246 0.546 . . . . 0.0 111.406 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 32.4 Cg_exo -59.9 125.45 17.74 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.86 2.373 . . . . 0.0 112.636 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.545 HG13 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -117.86 155.48 19.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.839 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -143.64 177.33 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.038 0.447 . . . . 0.0 111.092 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.529 ' HB3' HG23 ' A' ' 5' ' ' ILE . 40.4 t -109.2 147.08 33.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.734 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -84.04 -8.34 59.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 110.716 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HE2' HG21 ' A' ' 65' ' ' VAL . 37.2 mtmm -139.3 144.48 40.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.582 ' HA ' HG12 ' A' ' 5' ' ' ILE . 23.1 Cg_exo -63.61 129.92 26.53 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.155 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 175.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.029 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 124.02 21.94 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.22 -24.11 35.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.107 0.48 . . . . 0.0 110.993 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -83.69 1.79 40.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.596 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -95.05 7.28 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.8 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -59.07 -30.57 68.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.615 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.588 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 9.1 pt -66.49 -38.65 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.554 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 11.4 m-20 -76.8 -40.12 49.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.561 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -66.03 -51.41 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.745 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 m -63.56 -25.75 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.565 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 9.3 t-20 -59.57 -50.78 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.783 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.22 -40.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.26 -32.02 71.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.358 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.6 t -64.96 -21.14 66.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.828 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 21.2 tpt180 -109.59 1.98 20.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.335 0.588 . . . . 0.0 109.883 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' HG ' HG22 ' A' ' 46' ' ' VAL . 44.5 tp -108.26 92.01 3.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.597 -176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.54 95.71 7.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.304 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.426 HG22 ' HG ' ' A' ' 44' ' ' LEU . 15.7 m -141.75 -157.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.916 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . 137.44 -88.08 0.22 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.297 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t 68.28 117.86 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.215 0 O-C-N 123.919 0.423 . . . . 0.0 110.552 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.843 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 80.6 Cg_exo -43.29 105.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.519 2.813 . . . . 0.0 113.455 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -131.93 -163.89 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.195 -176.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' H ' ' HB ' ' A' ' 50' ' ' THR . 55.1 mtpt -120.88 -175.91 3.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.64 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.772 -175.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.32 22.41 24.73 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.408 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.77 HD22 ' HB2' ' A' ' 69' ' ' CYS . 11.0 p30 -85.32 133.45 34.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.195 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 66' ' ' ASP . 61.4 t -90.92 120.48 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.656 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.26 -52.56 9.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.581 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.4 m -130.9 117.3 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.481 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 1.016 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 49.9 tttp -99.49 132.81 44.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.787 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.7 t30 67.11 39.2 3.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.431 0.634 . . . . 0.0 110.161 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.39 128.46 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.916 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.42 ' HE1' ' HB3' ' A' ' 36' ' ' ASP . 57.1 mtt 66.14 16.36 10.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 0.0 111.444 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.34 36.59 20.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.287 0.565 . . . . 0.0 110.848 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.6 p -82.58 -26.06 32.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.415 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.93 10.19 65.0 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.298 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG21 ' HE2' ' A' ' 27' ' ' LYS . 68.8 t -108.59 131.67 58.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.51 0.195 . . . . 0.0 111.022 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 1.016 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.0 p-10 -99.79 124.89 45.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 109.849 170.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.38 121.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.403 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.5 pt -121.11 138.3 51.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.0 111.687 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.77 ' HB2' HD22 ' A' ' 54' ' ' ASN . 2.9 m -91.09 141.93 28.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -111.68 2.17 17.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 111.072 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.1 tmtt? -96.19 131.91 42.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -83.78 113.38 20.87 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.843 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 73.8 mt -97.4 125.93 43.49 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.653 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 33.2 Cg_exo -60.46 141.0 94.38 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.956 2.438 . . . . 0.0 111.677 176.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -122.39 33.02 5.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.338 -170.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.43 105.4 0.42 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.662 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 p -146.8 52.28 1.1 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.84 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' H ' HD22 ' A' ' 78' ' ' LEU . 3.2 mm? -56.89 -38.55 72.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.655 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.48 111.39 23.04 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -72.29 149.27 44.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.016 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -69.39 108.52 3.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.344 -173.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.7 m80 65.86 95.35 0.06 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.41 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -100.66 155.83 17.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -116.49 173.31 6.68 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.358 0.599 . . . . 0.0 111.309 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 13.4 p80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.536 173.537 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' A' ' 1' ' ' MET . 23.0 m170 -70.57 163.75 26.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.176 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 82.2 mttt -74.26 156.98 36.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.654 -175.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -123.23 158.63 30.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.82 0.343 . . . . 0.0 110.726 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.31 112.39 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.801 0.334 . . . . 0.0 110.735 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 86.2 t80 -63.66 104.21 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 m -115.81 122.67 46.11 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.2 m -148.42 -169.8 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.606 0.241 . . . . 0.0 110.515 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.8 t -123.19 132.03 72.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.4 155.72 11.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -91.63 129.47 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.062 0.458 . . . . 0.0 110.648 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 21' ' ' VAL . 2.6 t -97.67 146.99 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -169.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.493 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 68.9 ttt180 -119.95 147.28 44.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.585 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.16 -168.55 21.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.828 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 p -75.3 99.9 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -157.87 168.82 26.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.233 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.77 -54.28 4.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.83 0.348 . . . . 0.0 111.561 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 70.1 m-85 -86.69 127.12 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.873 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.549 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 16.6 m120 -79.69 -13.72 59.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.173 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.6 m -135.47 139.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.722 HG22 HG23 ' A' ' 12' ' ' VAL . 17.7 m -134.48 134.65 22.63 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.612 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.19 132.47 22.7 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.672 2.248 . . . . 0.0 112.908 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 69' ' ' CYS . 30.7 m -121.66 165.74 17.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.233 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.2 ptpt -148.18 178.99 8.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.086 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.43 ' HB2' HG11 ' A' ' 65' ' ' VAL . 78.9 p -108.97 131.13 55.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.036 0.446 . . . . 0.0 111.131 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -53.4 -41.44 65.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.524 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HB2' HG21 ' A' ' 65' ' ' VAL . 7.1 mtmp? -126.28 151.49 72.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 18.0 Cg_endo -58.0 126.6 22.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.767 2.311 . . . . 0.0 111.969 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.92 157.18 22.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.114 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -73.8 141.72 46.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.717 0.294 . . . . 0.0 110.208 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.6 pt -69.87 -8.1 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 111.16 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -66.06 -25.81 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.454 . . . . 0.0 110.403 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.11 2.48 46.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.914 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -56.01 -52.79 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.1 pt -68.93 -26.66 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.711 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' OD2' ' HE2' ' A' ' 61' ' ' MET . 29.3 t70 -78.24 -46.88 19.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 0.0 110.642 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -61.2 -41.38 96.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 p -66.89 -35.97 81.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.57 -45.55 81.26 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 110.508 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.94 -48.03 87.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.17 -28.78 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.761 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -73.87 -8.82 57.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 43' ' ' ARG . 60.9 mtt180 -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.215 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.419 HD22 ' HG ' ' A' ' 57' ' ' CYS . 45.0 tp -112.43 99.78 8.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.847 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.493 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 17.3 m-85 -88.95 109.48 20.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.636 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.3 120.77 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -120.82 41.23 1.96 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.566 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.42 86.66 56.83 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 71.5 Cg_exo -50.79 118.12 3.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.707 2.271 . . . . 0.0 111.967 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.37 -171.05 2.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.235 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 9.4 mmpt? -95.11 -172.46 2.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.268 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -72.55 136.59 45.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.892 0.377 . . . . 0.0 111.282 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.84 30.14 8.64 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.132 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.482 HD22 ' HB3' ' A' ' 69' ' ' CYS . 10.9 p30 -93.15 133.44 36.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.43 HG12 ' HB3' ' A' ' 66' ' ' ASP . 44.7 t -89.27 105.95 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.692 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.3 -48.19 37.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.153 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.419 ' HG ' HD22 ' A' ' 44' ' ' LEU . 3.2 m -120.33 99.83 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.228 -178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HG2' HG11 ' A' ' 55' ' ' VAL . 57.0 mttp -76.24 102.73 5.95 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.3 m120 55.04 77.68 0.2 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.3 tt -47.26 -51.83 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 123.695 0.622 . . . . 0.0 112.326 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.478 ' HE2' ' OD2' ' A' ' 36' ' ' ASP . 63.3 mtm -141.99 54.59 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.856 0.36 . . . . 0.0 110.445 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 59.83 28.33 17.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.453 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.7 p -83.62 -20.19 34.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.742 -175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.93 80.46 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.34 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG21 ' HB2' ' A' ' 27' ' ' LYS . 71.2 t -112.73 129.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.839 0.352 . . . . 0.0 110.302 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.43 ' HB3' HG12 ' A' ' 55' ' ' VAL . 28.6 m-20 -95.63 134.04 38.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.9 mm -93.2 108.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 22.0 pt -109.43 142.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.482 ' HB3' HD22 ' A' ' 54' ' ' ASN . 53.3 t -92.5 142.0 27.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -113.47 4.74 16.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 111.047 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.59 141.51 29.76 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.895 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.542 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -94.09 112.97 24.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.747 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.421 HD12 HG13 ' A' ' 21' ' ' VAL . 5.9 mp -88.07 127.24 58.24 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 111.524 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -86.97 101.45 0.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.895 2.397 . . . . 0.0 111.154 171.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -93.47 -36.65 12.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.506 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -75.74 121.22 22.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m -138.22 83.4 1.97 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.97 0.414 . . . . 0.0 111.413 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 74.3 mt -86.56 73.7 10.03 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -88.41 136.27 33.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.013 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -115.88 88.88 2.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.439 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -83.31 117.82 23.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -69.62 106.36 3.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.452 0.644 . . . . 0.0 111.208 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -169.1 125.07 0.9 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.038 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -80.35 106.49 12.41 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.665 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.3 t60 . . . . . 0 C--O 1.255 1.348 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.178 -177.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -82.08 112.25 18.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 49.0 mttp -88.08 132.54 34.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.332 174.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.35 -179.94 3.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.48 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 28' ' ' PRO . 29.6 mm -101.84 115.28 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.005 0.431 . . . . 0.0 110.19 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -78.11 122.75 26.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.196 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -141.41 137.44 32.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.962 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -153.44 178.51 9.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.449 HG22 ' HB ' ' A' ' 20' ' ' VAL . 10.4 p -110.91 130.31 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.874 0.369 . . . . 0.0 110.121 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.37 157.57 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.149 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -81.23 127.54 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.324 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' HB ' ' HE2' ' A' ' 16' ' ' LYS . 3.7 t -84.28 130.73 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.96 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 61.8 ttp85 -107.0 155.33 19.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.445 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.15 175.7 22.74 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.87 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 p -79.79 105.17 10.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 0.0 111.007 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HD3' ' H ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -162.68 -175.37 4.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.808 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -119.07 40.12 3.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.428 0.633 . . . . 0.0 110.824 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.514 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 4.2 m-85 -129.72 154.02 47.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.448 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -114.92 -46.45 2.92 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.435 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 9' ' ' VAL . 17.8 m -134.26 142.24 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.009 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG22 ' SG ' ' A' ' 69' ' ' CYS . 15.0 p -129.54 136.66 29.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.428 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.72 124.99 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.62 2.214 . . . . 0.0 112.69 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -113.99 164.5 10.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.977 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -145.36 179.06 7.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -109.16 134.66 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.67 -37.73 73.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.275 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -118.43 150.76 48.54 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.252 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 48.6 Cg_endo -67.3 139.6 50.43 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.499 2.132 . . . . 0.0 113.048 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG11 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -113.56 173.5 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.405 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.513 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 79.9 mt-10 -98.67 135.8 39.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.101 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.85 ' HA ' ' HD1' ' A' ' 34' ' ' TRP . 14.6 tt -55.67 -21.52 10.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.781 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.2 m -57.15 -31.81 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.374 . . . . 0.0 111.562 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -102.87 14.79 31.09 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.85 ' HD1' ' HA ' ' A' ' 31' ' ' ILE . 1.2 m95 -60.05 -44.5 94.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.75 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -67.95 -35.08 70.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' O ' HG21 ' A' ' 40' ' ' VAL . 34.8 t70 -67.78 -43.68 79.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.9 m-30 -69.86 -39.95 76.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.975 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.43 -35.85 78.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.481 . . . . 0.0 109.821 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -58.47 -45.44 88.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.861 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 36' ' ' ASP . 43.7 t -69.09 -48.2 70.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.417 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.0 mt -66.63 -33.2 75.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.5 p -71.55 -11.77 61.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.772 0.32 . . . . 0.0 111.559 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -119.08 10.1 12.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.996 0.427 . . . . 0.0 110.499 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 46' ' ' VAL . 31.5 tp -104.71 127.2 52.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 43.9 m-85 -119.45 97.12 5.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.494 HG23 ' HG ' ' A' ' 44' ' ' LEU . 61.4 t -111.29 140.41 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -124.08 -134.75 4.33 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.992 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t 60.08 79.95 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.205 0.526 . . . . 0.0 109.994 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.47 118.41 5.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.652 2.235 . . . . 0.0 111.691 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -174.27 3.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.884 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -87.79 -177.19 5.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.0 t -67.45 134.1 50.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.761 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.32 25.78 11.96 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.987 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 11.0 p30 -94.03 143.06 26.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.38 115.99 28.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.266 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.29 -56.56 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.972 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.0 t -130.72 118.01 20.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 31.0 tttm -97.71 129.88 44.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.736 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.416 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 14.1 m120 54.98 47.21 22.65 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 123.501 0.501 . . . . 0.0 109.955 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.0 tt -53.95 110.04 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.6 mmt 66.68 31.45 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.246 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 71.34 4.22 4.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -57.59 -42.53 83.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.416 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 111.21 -9.37 28.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.646 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.96 137.46 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 110.231 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 7.0 m-20 -102.18 107.31 18.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -75.3 103.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.3 pt -108.05 146.07 14.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.296 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.454 ' SG ' HG22 ' A' ' 21' ' ' VAL . 2.4 t -90.51 142.32 27.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.475 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -119.22 13.97 12.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.399 0.618 . . . . 0.0 110.63 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -96.58 142.05 29.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -89.97 98.14 11.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 96.6 mt -99.56 117.41 63.81 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.873 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 5.0 Cg_exo -78.67 103.35 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.661 2.24 . . . . 0.0 112.699 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -61.45 -73.9 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.503 0.668 . . . . 0.0 109.438 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -149.0 8.63 0.75 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.777 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 m -85.4 32.17 0.57 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.958 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.7 tp -76.99 100.6 5.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.093 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -109.74 171.58 7.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.492 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -89.08 32.34 0.83 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.28 0.562 . . . . 0.0 109.586 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -115.24 97.53 6.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.873 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 83' ' ' HIS . 40.4 t-80 -157.12 -66.14 0.1 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 173.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.446 ' C ' ' H ' ' A' ' 85' ' ' HIS . 0.1 OUTLIER 158.78 179.79 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.168 176.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -83.86 16.25 2.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.95 0.881 . . . . 0.0 108.767 171.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' A' ' 83' ' ' HIS . 22.2 t-80 . . . . . 0 C--O 1.249 1.068 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.598 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.729 0.776 . . . . 0.0 111.216 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.8 88.62 0.1 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -111.71 144.29 41.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.232 -167.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -140.65 154.44 46.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 28' ' ' PRO . 45.9 mm -69.97 117.13 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.96 0.41 . . . . 0.0 110.741 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.487 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 78.2 t80 -78.53 109.67 12.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 109.827 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -123.53 132.21 53.84 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.564 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -152.77 -165.1 2.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.123 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.622 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 42.7 t -128.31 134.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.541 0.21 . . . . 0.0 110.453 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -119.0 148.64 21.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.39 135.23 40.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.275 0.559 . . . . 0.0 111.53 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.34 141.54 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.577 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -127.13 173.87 9.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.278 . . . . 0.0 110.325 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -177.48 31.0 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.864 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 m -76.12 96.47 3.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.254 0.549 . . . . 0.0 110.674 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.9 -173.44 4.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.649 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -100.73 -52.43 3.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.833 0.349 . . . . 0.0 110.742 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -75.2 124.3 26.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.975 0.417 . . . . 0.0 111.956 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.84 -15.92 56.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.622 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.3 m -142.03 146.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.518 ' HB ' HD13 ' A' ' 73' ' ' LEU . 13.0 p -124.38 134.28 25.39 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.92 126.02 13.33 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.515 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -114.33 162.34 12.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.576 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -144.73 178.93 7.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.914 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 69.1 m -109.12 133.55 52.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.202 0.525 . . . . 0.0 111.306 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -59.52 -44.65 93.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.591 174.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 65' ' ' VAL . 67.1 mttm -121.0 152.45 56.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HA ' HD13 ' A' ' 5' ' ' ILE . 31.6 Cg_exo -61.49 139.52 82.37 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.653 2.236 . . . . 0.0 111.88 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.403 HG22 HG23 ' A' ' 65' ' ' VAL . 5.8 t -112.57 136.11 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.97 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.31 118.8 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.5 tt -55.16 -28.1 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 m -65.33 -18.39 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -100.72 17.51 21.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.487 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -57.39 -40.66 78.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 0.0 109.942 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -62.33 -45.43 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.981 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.589 ' HB3' ' HG3' ' A' ' 61' ' ' MET . 1.8 m-20 -53.48 -54.61 34.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.592 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -63.07 -41.1 99.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -61.23 -47.25 86.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -67.06 -27.26 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.572 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 36' ' ' ASP . 99.1 t -77.35 -46.53 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.636 0.255 . . . . 0.0 110.937 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.32 -30.36 66.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 p -69.69 -22.31 63.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -107.19 10.87 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.166 0.507 . . . . 0.0 110.283 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -114.11 143.33 44.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.912 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -130.96 142.12 50.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.145 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 p -119.49 143.83 29.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 48' ' ' VAL . . . -121.7 163.82 15.02 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.055 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 92.1 t 75.82 128.27 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 123.179 0.592 . . . . 0.0 111.262 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HG3' ' HG2' ' A' ' 75' ' ' LYS . 11.2 Cg_endo -54.13 110.76 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.155 2.57 . . . . 0.0 111.499 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.452 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 p -99.17 -164.16 1.1 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.713 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.425 ' H ' ' HB ' ' A' ' 50' ' ' THR . 19.6 ptmt -127.16 -152.88 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.434 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 32.6 m -98.96 135.63 40.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.73 24.04 11.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.877 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.813 HD21 ' HB2' ' A' ' 69' ' ' CYS . 40.8 m-20 -78.97 99.1 6.69 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG23 HG21 ' A' ' 68' ' ' ILE . 17.9 t -77.79 92.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 m -74.09 -45.52 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.541 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 8.5 t -130.96 120.16 23.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -104.33 144.06 32.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 44.72 39.82 3.71 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.671 0.748 . . . . 0.0 110.847 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.541 ' HB ' ' SG ' ' A' ' 57' ' ' CYS . 5.3 tt -56.0 127.18 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.277 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.589 ' HG3' ' HB3' ' A' ' 36' ' ' ASP . 93.8 mmm 63.59 29.89 15.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 70.2 17.76 7.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.906 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.3 p -78.44 -61.58 1.96 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.86 0.362 . . . . 0.0 111.777 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.31 1.31 9.35 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 27' ' ' LYS . 96.8 t -88.15 139.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 0.0 110.664 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.68 114.65 26.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.231 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -83.13 106.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.8 pt -119.4 133.5 66.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.259 0.552 . . . . 0.0 112.297 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.813 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.9 m -78.4 147.64 33.99 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 10.9 t -132.38 13.82 4.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -112.93 122.34 47.35 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.481 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -67.8 109.96 3.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.518 HD13 ' HB ' ' A' ' 21' ' ' VAL . 90.9 mt -87.73 117.16 68.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.448 -173.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.76 160.88 14.23 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.691 2.261 . . . . 0.0 111.92 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HG2' ' HG3' ' A' ' 49' ' ' PRO . 49.8 mtpt -104.4 -34.65 8.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.161 0.505 . . . . 0.0 109.761 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -109.71 132.09 54.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.02 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.0 m -83.16 99.36 9.87 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.06 106.78 0.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -62.23 111.86 2.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.138 0.494 . . . . 0.0 111.039 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -77.69 76.44 4.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.327 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 147.48 25.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.697 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -139.64 27.25 2.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.022 0.439 . . . . 0.0 111.124 -171.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -131.35 101.91 5.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 68.17 26.65 7.02 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.881 0.848 . . . . 0.0 109.127 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 68.9 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.189 -177.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 tpt . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.729 0.3 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -70.77 106.39 3.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.96 0.41 . . . . 0.0 110.591 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 96.3 mttt -97.72 129.72 44.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -123.63 169.92 10.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.99 0.424 . . . . 0.0 110.76 -169.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.406 HD11 ' HA ' ' A' ' 28' ' ' PRO . 47.2 mm -87.06 102.68 12.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' HB2' HG23 ' A' ' 29' ' ' VAL . 87.7 t80 -59.26 117.95 5.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.666 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -124.06 130.26 52.26 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.797 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 t -143.23 -172.11 3.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.33 124.87 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 41' ' ' LEU . 29.6 m -112.46 162.04 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -91.88 130.97 37.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.532 . . . . 0.0 111.35 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -108.43 121.49 61.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.739 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.4 mtm105 -99.58 154.3 18.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.12 166.58 12.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.355 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 p -82.61 84.9 7.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 111.759 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -174.23 4.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.888 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -86.84 -59.58 2.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.713 0.292 . . . . 0.0 110.988 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.48 6.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.205 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.44 -15.43 30.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.529 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.74 129.79 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 71' ' ' LYS . 13.1 p -119.17 129.93 25.12 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.164 0.506 . . . . 0.0 111.758 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 37.5 Cg_endo -69.1 125.81 12.95 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 111.59 170.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.503 HG12 ' SG ' ' A' ' 69' ' ' CYS . 30.6 m -113.9 158.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.084 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -141.06 174.17 10.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.751 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.421 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 14.9 m -109.11 127.5 54.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.05 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -65.24 -30.89 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.922 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HB2' HG21 ' A' ' 65' ' ' VAL . 64.3 mttm -111.2 138.73 21.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.1 Cg_exo -65.38 116.88 4.14 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.369 2.046 . . . . 0.0 111.485 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 6' ' ' PHE . 29.3 m -93.37 162.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.997 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 46.1 mt-10 -79.71 145.8 32.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.153 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 33' ' ' LYS . 16.9 pt -71.53 177.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.013 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 74.6 m 70.98 -25.48 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.039 0.536 . . . . 0.0 112.028 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 31' ' ' ILE . 13.9 tttm -84.63 7.53 19.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.173 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -62.07 -34.94 77.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 tt -70.48 -31.52 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.94 -57.03 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.989 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 33' ' ' LYS . 27.5 m-85 -64.63 -36.24 83.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.519 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.1 p -67.24 -37.12 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -54.85 -49.64 70.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 110.346 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.46 -48.71 85.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.234 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HB3' HG12 ' A' ' 10' ' ' VAL . 69.0 mt -70.06 -41.08 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -68.05 -19.86 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 111.049 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -101.27 10.75 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 110.041 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 tp -116.86 118.75 33.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.318 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.98 129.27 55.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.958 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.6 140.23 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.148 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -127.2 71.94 0.47 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.888 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -166.0 123.25 1.04 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 120.811 0.339 . . . . 0.0 110.776 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.49 113.13 3.39 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.839 2.36 . . . . 0.0 111.614 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.13 170.31 9.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.389 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.8 mtmt -103.55 176.33 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.354 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.649 ' HB2' HD22 ' A' ' 72' ' ' ASN . 19.0 t -61.25 135.47 57.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 111.473 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.64 26.79 21.75 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.967 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.687 HD22 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -97.5 133.26 42.31 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.253 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.643 HG23 HG22 ' A' ' 68' ' ' ILE . 8.6 t -93.07 124.59 45.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.471 -176.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 m -96.99 -39.51 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 111.215 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.3 t -127.74 121.2 29.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' HG2' HG11 ' A' ' 55' ' ' VAL . 59.6 mttm -106.06 128.85 54.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.857 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.738 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.7 t-20 58.91 48.84 10.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.65 0.738 . . . . 0.0 109.169 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.453 HG12 ' HG2' ' A' ' 61' ' ' MET . 11.6 tt -60.16 127.09 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.108 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.453 ' HG2' HG12 ' A' ' 60' ' ' ILE . 98.2 mmm 63.51 21.78 12.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.159 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.738 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 3.4 t-20 57.8 79.4 0.2 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.452 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.0 p -138.65 -55.72 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.068 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.0 -9.4 6.32 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 27' ' ' LYS . 95.4 t -79.89 132.01 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 110.579 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.99 114.57 28.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.1 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.89 114.03 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.643 HG22 HG23 ' A' ' 55' ' ' VAL . 20.6 pt -118.37 140.75 40.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.0 -173.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.687 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.9 m -92.2 146.34 23.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -119.38 11.15 12.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 0.0 112.223 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.483 ' HG3' ' HD2' ' A' ' 22' ' ' PRO . 68.5 mmtt -96.41 155.24 16.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.953 -0.467 . . . . 0.0 109.919 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.649 HD22 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -106.55 104.89 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.78 132.08 43.31 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.7 106.58 1.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.462 2.108 . . . . 0.0 112.044 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HG3' ' OD2' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -71.99 -75.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.521 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.404 ' OD2' ' HG3' ' A' ' 75' ' ' LYS . 28.6 m-20 -132.9 2.28 3.66 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.268 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.3 p 56.54 -85.59 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.062 0.945 . . . . 0.0 112.261 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -140.69 146.12 37.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.745 0.307 . . . . 0.0 110.504 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.29 146.88 47.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -56.66 -72.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -169.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.8 m170 63.46 -74.85 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.963 0.505 . . . . 0.0 110.998 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -166.93 -72.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -170.74 142.7 2.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -64.97 113.4 3.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.975 0.417 . . . . 0.0 110.691 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.413 177.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HE1' HG21 ' A' ' 31' ' ' ILE . 92.7 mmm . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -77.35 161.92 27.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.398 . . . . 0.0 110.906 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 52.0 mttp -124.39 120.3 31.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.18 156.27 49.27 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.965 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -63.4 110.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.028 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -76.55 106.84 8.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 24' ' ' LYS . 74.3 p -110.41 134.21 52.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -153.75 -167.1 2.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.37 132.31 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.91 149.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -87.8 114.08 24.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.682 ' HB ' ' HE3' ' A' ' 16' ' ' LYS . 6.6 t -84.85 139.35 17.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.189 -168.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpt85 -105.8 137.77 43.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.91 -178.3 16.38 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.412 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 t -81.4 110.28 16.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.084 0.468 . . . . 0.0 110.564 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.925 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -163.07 168.48 20.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.7 ' HD2' ' HB2' ' A' ' 76' ' ' ASP . 80.9 tttt -95.79 -20.67 18.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.558 ' HB2' HD22 ' A' ' 73' ' ' LEU . 78.9 m-85 -107.46 111.36 23.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.925 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 86.7 m-20 -76.67 -19.6 57.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.09 138.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.585 0.231 . . . . 0.0 110.422 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' A' ' 71' ' ' LYS . 5.8 p -135.34 139.83 32.63 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.831 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.407 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 53.6 Cg_endo -72.81 130.68 16.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.572 2.181 . . . . 0.0 112.505 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.22 162.42 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.557 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 7' ' ' THR . 22.2 ptmt -143.53 170.75 15.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.159 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -109.23 128.27 54.92 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.607 ' OD1' ' HB2' ' A' ' 66' ' ' ASP . 2.0 p-10 -75.72 -0.91 22.5 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HB2' HG21 ' A' ' 65' ' ' VAL . 43.3 mtmt -132.36 142.09 43.67 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.01 135.98 66.38 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.474 2.116 . . . . 0.0 112.328 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 t -105.37 130.91 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.863 -175.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 28.6 tt0 -60.11 121.39 11.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.409 HG21 ' HE1' ' A' ' 1' ' ' MET . 11.0 tp -60.9 -21.46 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -171.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -70.72 -11.61 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.945 -0.472 . . . . 0.0 111.421 178.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 62.9 mttp -105.7 1.23 26.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.565 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -59.64 -31.25 69.35 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.37 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -78.04 -30.05 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' HG21 ' A' ' 40' ' ' VAL . 26.0 t0 -78.41 -43.33 27.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 30.2 m-85 -56.52 -47.26 79.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.6 p -65.71 -37.26 85.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -60.7 -43.07 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.75 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 36' ' ' ASP . 58.0 t -63.26 -44.11 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.591 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.75 -21.48 66.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.3 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.3 m -81.79 -11.59 58.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.048 0.451 . . . . 0.0 110.704 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -105.89 -26.14 11.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.726 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 46' ' ' VAL . 40.2 tp -81.84 94.83 7.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.739 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -97.35 90.3 5.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.174 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.494 HG23 ' HG ' ' A' ' 44' ' ' LEU . 22.2 m -142.06 173.49 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.67 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.74 173.1 25.73 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.548 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 50' ' ' THR . 13.6 p 177.23 141.25 0.24 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -42.06 105.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.918 2.412 . . . . 0.0 112.374 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.586 HG21 HG11 ' A' ' 48' ' ' VAL . 1.7 p -130.23 167.03 19.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.069 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -127.07 62.75 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.66 -174.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.524 ' HB2' HD22 ' A' ' 72' ' ' ASN . 23.2 t 69.2 150.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.728 174.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.17 24.49 70.48 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.958 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 7.7 p30 -96.46 128.53 43.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.025 0.441 . . . . 0.0 110.506 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 58' ' ' LYS . 49.1 t -79.21 113.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.195 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.04 -50.18 17.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.965 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.425 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 36.7 t -130.75 123.07 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.647 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.685 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 50.3 tttp -106.25 135.4 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.784 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.579 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 6.6 t-20 64.32 31.99 12.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.72 0.638 . . . . 0.0 110.712 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.527 HG12 ' HG3' ' A' ' 61' ' ' MET . 10.8 tt -60.65 134.83 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.527 ' HG3' HG12 ' A' ' 60' ' ' ILE . 76.2 mtp 62.6 18.45 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.942 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 70.67 -2.87 2.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 65' ' ' VAL . 9.6 t -79.69 -8.59 59.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.57 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 59' ' ' ASN . . . 83.16 3.41 90.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.897 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 27' ' ' LYS . 7.9 t -67.05 129.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.899 0.381 . . . . 0.0 110.237 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.685 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 3.1 m-20 -99.35 122.34 42.35 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -87.09 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.3 pt -108.83 134.96 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.411 0.624 . . . . 0.0 111.954 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.518 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 7.5 t -81.12 135.06 35.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.231 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -111.69 -6.32 14.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.991 0.424 . . . . 0.0 111.233 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 62.5 tttp -96.8 138.64 34.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -85.76 128.26 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.84 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.558 HD22 ' HB2' ' A' ' 18' ' ' TYR . 94.2 mt -109.32 102.18 48.35 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.973 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -89.8 177.25 2.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.706 2.27 . . . . 0.0 112.382 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 8.2 mtpm? -120.1 159.63 24.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.939 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.7 ' HB2' ' HD2' ' A' ' 17' ' ' LYS . 7.3 t70 -108.37 -157.83 0.63 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m 68.68 20.39 8.23 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 122.945 0.498 . . . . 0.0 111.319 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -88.03 138.69 31.23 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.1 pm0 -81.89 40.49 0.61 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.39 -27.8 59.22 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' A' ' 83' ' ' HIS . 15.5 t-80 -103.59 110.6 22.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.857 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -94.1 96.94 9.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.491 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.421 ' HB2' ' CE1' ' A' ' 81' ' ' HIS . 66.3 t60 -96.24 -67.48 0.85 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -129.59 30.99 4.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.194 0.997 . . . . 0.0 108.507 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 C--O 1.243 0.726 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.329 178.116 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.559 0.219 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 61.17 94.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.544 0.688 . . . . 0.0 112.69 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 54.4 mmtt -100.17 127.07 46.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.195 174.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -131.98 134.59 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.706 0.288 . . . . 0.0 110.856 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 28' ' ' PRO . 36.3 mm -57.75 127.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 111.116 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -102.66 115.58 30.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.544 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 139.42 53.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.833 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.8 m -158.67 179.26 9.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.652 0.263 . . . . 0.0 110.615 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.48 130.19 71.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.158 0.504 . . . . 0.0 110.231 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.76 155.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.76 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -69.37 123.88 22.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.585 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.769 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.7 p -107.43 136.94 40.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.178 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 49.2 mtp180 -125.87 -179.32 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.656 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.94 -160.24 13.52 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.323 -0.942 . . . . 0.0 113.088 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -85.44 15.95 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.775 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.769 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -80.98 179.0 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HE3' ' O ' ' A' ' 75' ' ' LYS . 97.2 mttt -125.69 69.33 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.713 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -153.11 178.86 9.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.299 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.91 -23.68 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 0.0 111.116 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.67 149.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.47 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 14.6 p -131.98 131.49 22.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.033 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 14.2 Cg_exo -68.9 131.77 23.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.132 2.555 . . . . 0.0 112.63 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.53 152.63 37.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.956 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HG3' HG13 ' A' ' 68' ' ' ILE . 21.5 ptmt -141.13 173.55 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 0.0 111.034 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -109.67 131.75 54.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.129 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -72.72 -26.05 61.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.806 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.6 mttt -122.33 132.83 24.2 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 5' ' ' ILE . 77.7 Cg_exo -50.31 132.96 35.65 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.082 2.521 . . . . 0.0 112.49 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.2 124.53 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.784 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 43.8 tt0 -63.2 134.86 56.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pt -72.54 67.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.326 1.06 . . . . 0.0 112.247 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.0 p -155.71 -30.96 0.1 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.88 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -94.01 3.54 55.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -51.93 -52.73 48.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.438 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.68 -38.21 57.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.128 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.411 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 4.8 t0 -62.03 -37.63 85.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 63' ' ' THR . 4.5 m-30 -60.23 -50.22 74.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.827 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 p -62.9 -25.54 68.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.209 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 36' ' ' ASP . 94.1 m-20 -65.99 -50.04 65.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.55 -41.7 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.546 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.788 HD21 HD13 ' A' ' 44' ' ' LEU . 47.4 mt -63.12 -29.31 70.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.7 m -72.72 -11.68 60.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 43' ' ' ARG . 56.4 mtt-85 -108.41 3.81 23.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.311 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.788 HD13 HD21 ' A' ' 41' ' ' LEU . 27.5 mt -99.56 119.8 38.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.514 0.674 . . . . 0.0 111.387 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.5 100.89 7.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.626 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 m -90.8 -177.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.728 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -167.71 -168.62 30.11 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.059 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t 68.22 101.27 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 C-N-CA 122.946 0.498 . . . . 0.0 111.178 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.568 ' CG ' ' HG2' ' A' ' 75' ' ' LYS . 12.3 Cg_endo -58.33 108.45 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.808 2.338 . . . . 0.0 111.939 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.84 -165.27 1.01 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.93 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 44.0 mmtm -128.05 169.87 13.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.024 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.9 p -58.94 136.31 57.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 23.53 34.6 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.732 -0.746 . . . . 0.0 111.877 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.673 HD22 ' HB3' ' A' ' 69' ' ' CYS . 8.5 p30 -97.24 131.34 44.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 HG21 HG21 ' A' ' 68' ' ' ILE . 63.1 t -82.73 108.42 15.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.06 -57.59 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.268 0.556 . . . . 0.0 109.609 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 62.7 m -115.25 94.16 4.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.95 114.16 17.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.733 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t30 65.25 79.71 0.25 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.691 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 tt -71.66 122.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.277 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ttt 68.77 -76.33 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.868 0.73 . . . . 0.0 110.75 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -178.9 82.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.462 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 39.0 p -141.83 -44.02 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.176 -169.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.74 8.01 57.39 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -170.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 27' ' ' LYS . 73.9 t -98.46 131.68 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.184 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.39 116.21 28.68 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 57' ' ' CYS . 48.2 mm -81.78 100.21 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.128 0.49 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.416 HG13 ' HG3' ' A' ' 24' ' ' LYS . 22.1 pt -96.8 145.51 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.301 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.673 ' HB3' HD22 ' A' ' 54' ' ' ASN . 43.6 t -100.39 142.73 31.46 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -115.84 7.19 14.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.326 0.584 . . . . 0.0 110.625 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -96.71 142.24 28.98 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.595 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -93.93 111.79 23.54 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.21 120.37 56.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.448 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -85.13 158.9 11.41 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.891 2.394 . . . . 0.0 111.628 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.568 ' HG2' ' CG ' ' A' ' 49' ' ' PRO . 86.9 mttt -100.0 -58.61 1.88 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.628 0.728 . . . . 0.0 109.327 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.09 -177.38 6.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.604 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.1 t -72.64 -27.08 61.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.714 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.8 tp -136.19 138.68 42.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.558 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 3.45 9.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.9 140.78 29.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.205 -171.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -126.26 131.69 51.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.089 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -65.14 -41.63 94.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.012 0.434 . . . . 0.0 110.492 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -111.9 98.41 7.36 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -79.18 157.54 27.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.925 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.25 1.127 0 O-C-N 123.84 0.712 . . . . 0.0 110.877 -178.462 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -153.93 -66.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.936 175.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.518 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 94.4 mttt -124.43 141.75 51.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.229 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -140.65 153.91 46.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.756 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.98 114.26 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 110.988 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -79.94 140.69 36.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.39 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -150.94 133.47 15.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.946 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -150.18 -172.83 4.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.2 138.18 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.714 0.292 . . . . 0.0 110.39 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 44' ' ' LEU . 14.2 p -119.1 149.65 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 20' ' ' VAL . 53.1 mtt180 -82.87 116.75 22.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.191 0.52 . . . . 0.0 110.808 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.402 HG13 ' HE3' ' A' ' 16' ' ' LYS . 21.3 t -88.37 137.51 20.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.959 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.544 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.6 ttp85 -98.52 150.23 21.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.365 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.82 169.71 13.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.332 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.07 27.3 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.242 0.544 . . . . 0.0 111.709 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.494 ' HD2' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -70.93 173.08 7.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.489 176.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -86.18 26.31 1.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -145.21 -179.69 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.718 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -131.31 -34.69 1.39 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 11' ' ' ARG . 22.7 m -134.75 149.34 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.672 0.272 . . . . 0.0 111.129 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -125.68 133.54 25.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.68 120.76 6.88 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.418 2.079 . . . . 0.0 112.171 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.1 140.42 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.926 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.529 ' HZ3' HG22 ' A' ' 70' ' ' THR . 0.8 OUTLIER -129.08 168.86 15.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.127 0.489 . . . . 0.0 110.875 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -108.93 130.9 55.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.602 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 7.5 p30 -80.98 -10.0 59.77 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.632 -172.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.602 ' HE2' ' OD1' ' A' ' 26' ' ' ASN . 26.9 mtmt -130.99 144.53 53.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.532 176.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.85 138.05 76.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.209 2.606 . . . . 0.0 113.541 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.1 t -106.39 143.29 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.691 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.93 139.86 55.1 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.0 pt -76.34 12.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.6 p -128.9 -3.27 5.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.069 0.462 . . . . 0.0 110.468 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -99.48 -15.35 18.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -65.12 -21.05 66.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.026 0.441 . . . . 0.0 110.632 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.88 -44.31 99.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.092 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 40' ' ' VAL . 1.6 m-20 -58.66 -50.23 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.891 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.524 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.4 m-85 -63.06 -43.22 99.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.11 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -62.81 -36.95 84.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.862 0.363 . . . . 0.0 111.006 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -66.69 -36.35 82.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.783 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 36' ' ' ASP . 96.0 t -69.35 -43.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.394 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 99.7 mt -61.97 -24.2 66.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -65.63 -18.14 65.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.944 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -104.03 -2.05 26.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.509 HD23 HG11 ' A' ' 56' ' ' VAL . 24.1 tp -84.17 53.65 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.238 0.542 . . . . 0.0 111.292 -171.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -78.31 76.66 4.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.22 149.44 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.99 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -119.08 48.99 0.9 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.53 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.17 114.67 16.2 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.613 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 26.0 Cg_exo -62.07 103.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.562 2.174 . . . . 0.0 111.095 171.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.675 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 22.9 p -95.97 173.57 7.37 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' C ' HD22 ' A' ' 54' ' ' ASN . 75.6 mmtt -97.31 -146.94 0.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.337 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.481 ' HB2' HD22 ' A' ' 72' ' ' ASN . 26.6 t -102.3 131.17 49.06 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.3 26.98 19.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.596 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.675 ' ND2' ' HB ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -86.83 112.45 21.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 HG21 HG23 ' A' ' 68' ' ' ILE . 47.5 t -73.37 106.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG11 HD23 ' A' ' 44' ' ' LEU . 24.4 t -79.37 -46.37 23.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.169 0.509 . . . . 0.0 109.745 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 59.7 m -130.65 109.67 10.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 28.0 ttmt -85.12 129.33 34.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 53.72 69.37 0.72 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 123.812 0.695 . . . . 0.0 109.823 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.0 tt -78.76 125.53 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.317 -173.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 96.4 mmm 64.31 19.22 11.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.94 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 65.02 98.7 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.468 0.48 . . . . 0.0 111.298 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 65' ' ' VAL . 8.4 t -171.46 -34.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.478 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.22 -17.96 5.87 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.156 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.506 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 33.1 m -82.38 142.57 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.306 0.574 . . . . 0.0 112.014 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.406 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -108.23 131.62 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -91.5 114.11 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.421 HG23 HG21 ' A' ' 55' ' ' VAL . 37.7 pt -117.35 134.06 62.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.887 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 54' ' ' ASN . 2.0 p -87.82 134.17 33.74 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.529 HG22 ' HZ3' ' A' ' 24' ' ' LYS . 11.8 t -118.71 17.25 13.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 112.147 -168.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 21' ' ' VAL . 60.4 tttp -117.08 131.05 57.01 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.544 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -82.73 109.36 16.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.71 132.09 39.66 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.62 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.36 128.05 19.51 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.447 2.098 . . . . 0.0 111.264 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 75' ' ' LYS . 3.1 mtpt -60.37 156.01 16.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.225 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.19 175.84 9.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.435 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.0 p -117.85 133.34 56.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.617 0.246 . . . . 0.0 110.632 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.7 tp -76.64 83.28 3.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.348 0.594 . . . . 0.0 110.065 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HA ' ' CD2' ' A' ' 85' ' ' HIS . 41.6 mt-10 -116.3 -59.21 2.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.692 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.5 t60 55.18 88.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 O-C-N 124.01 0.819 . . . . 0.0 111.172 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -67.72 99.37 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.582 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -158.2 -66.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -161.95 159.19 26.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.44 0.162 . . . . 0.0 110.672 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.7 t60 55.95 79.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 124.03 0.831 . . . . 0.0 112.007 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.512 ' CD2' ' HA ' ' A' ' 79' ' ' GLU . 18.2 t-80 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.435 173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.754 0.312 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -150.83 138.78 19.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.516 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.2 mttt -75.13 114.83 14.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.307 0.575 . . . . 0.0 110.149 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.66 179.74 5.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.554 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.67 116.12 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.25 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.459 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 77.0 t80 -59.36 128.09 35.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -153.52 135.43 14.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.007 0.432 . . . . 0.0 110.097 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -153.2 169.34 23.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.36 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 59.8 t -114.32 118.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 41' ' ' LEU . 34.2 m -117.58 173.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.245 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 1.9 mmt85 -72.8 126.63 30.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.762 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.564 HG11 ' HE2' ' A' ' 16' ' ' LYS . 7.4 p -104.77 129.14 57.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.503 0.668 . . . . 0.0 111.239 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.492 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 41.9 ttt85 -104.65 142.32 34.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.974 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 168.15 12.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.0 m -83.26 102.21 11.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.564 ' HE2' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.98 -174.66 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.928 -179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.24 -0.9 56.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 47.9 m-85 -110.04 143.26 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.732 -0.387 . . . . 0.0 112.021 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -104.64 -10.59 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.756 0.789 . . . . 0.0 109.079 175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.2 m -142.33 148.41 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.414 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 12' ' ' VAL . 7.2 p -134.44 125.89 17.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.195 0.522 . . . . 0.0 111.749 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 5.8 Cg_exo -77.54 113.41 3.51 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.396 2.73 . . . . 0.0 112.306 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.555 HG13 ' SG ' ' A' ' 69' ' ' CYS . 31.5 m -104.82 161.04 4.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.544 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -153.24 178.77 9.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.487 0.66 . . . . 0.0 111.213 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.27 147.2 33.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.13 -3.71 56.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.506 0.669 . . . . 0.0 109.258 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HB3' HG21 ' A' ' 65' ' ' VAL . 34.4 ttmt -128.72 129.84 23.49 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.417 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 38.3 Cg_exo -58.04 132.24 48.25 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 112.429 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 6' ' ' PHE . 18.5 m -117.65 -178.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.516 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -97.96 135.26 39.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 pt -77.01 -19.49 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.307 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 37' ' ' PHE . 56.3 mtpt -93.99 0.79 56.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -53.82 -42.93 68.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.895 0.378 . . . . 0.0 110.676 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.55 -45.04 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.04 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -67.46 -43.72 80.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.32 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.441 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 47.4 m-85 -61.48 -43.59 98.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.236 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.32 -35.97 80.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.753 0.311 . . . . 0.0 110.715 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.05 -40.99 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' A' ' 10' ' ' VAL . 49.8 mt -62.49 -39.11 92.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.555 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -68.07 -12.91 61.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.417 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.8 ttt85 -95.13 -9.16 34.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.277 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.65 132.85 55.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.588 . . . . 0.0 111.431 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 11' ' ' ARG . 3.3 m-85 -106.99 102.83 12.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.797 173.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.93 157.89 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.258 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . 172.99 -148.91 10.79 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.751 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 85.1 t 72.49 126.13 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.345 0 O-C-N 124.099 0.529 . . . . 0.0 110.789 -175.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.608 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 82.6 Cg_exo -42.92 110.7 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.488 2.792 . . . . 0.0 113.074 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -139.65 169.48 17.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.622 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -95.93 173.57 7.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 110.707 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -68.54 119.83 13.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.439 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 30.47 5.78 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.665 HD22 ' HB2' ' A' ' 69' ' ' CYS . 10.6 p30 -89.1 131.67 35.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG21 HG21 ' A' ' 68' ' ' ILE . 57.8 t -85.74 127.31 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.856 -175.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.42 -75.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.228 0.537 . . . . 0.0 110.228 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -115.65 98.79 6.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.177 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 87.7 tttt -78.69 128.37 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.649 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 8.7 t-20 63.65 41.86 6.82 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.2 tt -53.27 -50.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.146 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.447 ' HB2' HG21 ' A' ' 63' ' ' THR . 82.1 mtp -114.61 30.93 6.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.649 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 15.6 m120 63.4 23.84 13.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.391 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.447 HG21 ' HB2' ' A' ' 61' ' ' MET . 67.6 p -86.93 -21.08 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.706 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.27 79.24 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.494 -174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 27' ' ' LYS . 41.8 t -90.04 130.44 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.604 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.418 ' OD2' ' HE3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -95.92 107.92 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.5 mm -75.9 120.42 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 35.1 pt -126.43 137.57 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.221 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.665 ' HB2' HD22 ' A' ' 54' ' ' ASN . 3.8 m -86.73 132.88 33.74 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -102.29 6.42 40.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.351 0.596 . . . . 0.0 110.901 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HD3' ' CZ ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -96.75 134.66 39.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.767 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.594 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -86.69 126.97 34.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.3 mp -95.35 109.09 43.31 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 91.6 Cg_endo -88.82 138.71 3.65 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.059 2.506 . . . . 0.0 112.567 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -117.67 156.25 28.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.29 108.15 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.855 0.36 . . . . 0.0 110.77 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.5 m -127.72 95.34 4.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.726 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.1 tp 65.33 112.75 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.998 0.811 . . . . 0.0 112.661 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -76.57 56.55 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.13 174.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -115.43 -41.59 3.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.217 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 65.63 167.62 0.2 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.987 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -153.22 99.72 2.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.259 172.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -121.14 110.37 16.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.988 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -133.95 88.91 2.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.19 0.519 . . . . 0.0 110.552 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.3 t60 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.49 -0.766 . . . . 0.0 109.641 176.923 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 52.02 81.7 0.08 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.073 -174.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.28 160.69 30.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.057 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.07 151.7 48.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.656 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -72.5 109.46 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 83.7 t80 -59.31 98.77 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.477 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -112.84 120.42 41.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m -152.78 -159.39 1.0 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.599 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 8.9 p -128.9 138.5 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 120.768 0.318 . . . . 0.0 110.629 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -108.61 143.96 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 42' ' ' SER . 91.3 mtt180 -81.16 134.03 35.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.551 0.691 . . . . 0.0 110.261 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.633 HG11 ' HE2' ' A' ' 16' ' ' LYS . 42.5 t -116.17 150.67 18.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.231 -168.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -106.13 145.93 30.85 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 63.46 0.9 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.665 -175.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -85.27 4.23 35.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.771 ' HG2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -160.89 -178.35 6.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.121 -1.854 . . . . 0.0 107.705 179.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -93.6 75.69 4.38 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.367 -174.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -174.09 143.84 0.94 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.422 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 15.7 m120 -98.75 -33.48 10.9 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.14 163.79 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 73' ' ' LEU . 9.8 p -153.84 140.15 12.66 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 120.668 0.271 . . . . 0.0 110.67 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 72.7 Cg_endo -79.14 145.54 19.38 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.568 2.179 . . . . 0.0 112.863 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.61 168.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.109 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.3 ptpt -141.07 173.78 11.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.39 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 90.7 p -109.17 138.88 44.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.87 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -68.04 -33.23 74.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.993 0.425 . . . . 0.0 110.85 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -115.78 147.17 38.45 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.056 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.51 120.37 7.76 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.771 2.314 . . . . 0.0 111.071 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.45 151.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -51.35 130.38 26.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.172 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 pt -61.12 -18.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -63.38 -35.68 81.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HZ2' ' HG2' ' A' ' 33' ' ' LYS . 28.8 mttm -95.81 10.87 35.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 111.555 -176.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -61.86 -39.75 92.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.45 -40.93 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.386 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.21 -55.04 39.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.566 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.476 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.5 m-30 -67.36 -38.94 85.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.588 -174.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 p -69.05 -31.06 69.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.401 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -62.8 -32.39 73.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -79.94 -45.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.689 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 93.4 mt -63.18 -24.89 68.09 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 11' ' ' ARG . 8.7 p -80.99 -18.84 45.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 110.971 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -99.09 -11.28 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.74 140.86 29.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.998 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -130.52 102.63 6.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.506 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 19.4 m -109.81 141.53 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.136 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.13 -3.01 29.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.584 -176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.456 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 14.5 m -58.8 125.81 78.48 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.884 ' HG2' ' HD2' ' A' ' 75' ' ' LYS . 33.7 Cg_endo -97.75 68.7 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.703 2.935 . . . . 0.0 112.732 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -179.27 5.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.407 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 13.8 mptt -99.94 -173.24 2.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.711 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t -66.12 146.01 55.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 0.0 111.06 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.71 31.7 35.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.344 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.578 HD22 ' HB3' ' A' ' 69' ' ' CYS . 9.5 p30 -101.43 133.92 45.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.728 0.299 . . . . 0.0 110.281 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 58' ' ' LYS . 50.8 t -79.4 115.13 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 110.699 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.21 -51.56 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.004 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.9 m -127.41 110.18 12.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.897 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HB2' HG12 ' A' ' 55' ' ' VAL . 65.3 tttp -99.04 123.82 43.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.673 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.2 t-20 62.94 60.26 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.503 HG12 ' HG3' ' A' ' 61' ' ' MET . 14.9 tt -76.39 123.0 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.285 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.503 ' HG3' HG12 ' A' ' 60' ' ' ILE . 86.7 mtp 65.73 23.11 11.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.927 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.673 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 11.2 m120 60.14 76.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.114 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -127.85 -44.06 1.5 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.047 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.26 16.24 12.63 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -109.98 136.31 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.52 107.82 18.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.491 0.662 . . . . 0.0 110.055 175.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.69 113.54 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.509 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 18.3 pt -110.88 141.45 26.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.211 0.529 . . . . 0.0 111.774 -174.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.578 ' HB3' HD22 ' A' ' 54' ' ' ASN . 50.2 t -89.65 141.86 28.21 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -116.78 -2.24 11.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.156 0.503 . . . . 0.0 110.96 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -98.05 146.82 25.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.641 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -92.71 123.5 36.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.696 ' CB ' ' HA ' ' A' ' 49' ' ' PRO . 3.6 mm? -81.58 127.11 74.19 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.5 -175.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 13.6 Cg_exo -68.84 100.0 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.739 2.293 . . . . 0.0 113.433 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.884 ' HD2' ' HG2' ' A' ' 49' ' ' PRO . 65.6 tttt -130.7 -59.81 1.0 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 169.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -69.61 100.53 1.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.311 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.2 m -94.64 123.55 38.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.246 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.0 mt -84.81 -7.52 59.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.648 -174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -85.8 105.66 16.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 110.865 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -76.83 95.17 4.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.375 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.75 136.24 38.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.653 -175.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -81.94 111.38 18.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.568 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -157.78 -47.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.426 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -179.82 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.678 174.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 82.8 t60 . . . . . 0 C--O 1.245 0.823 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.103 172.797 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 121.022 0.439 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -129.89 154.62 47.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 88.2 mttt -74.49 154.24 38.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.917 0.389 . . . . 0.0 110.854 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -119.64 141.73 49.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.149 -172.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -67.34 106.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.969 0.414 . . . . 0.0 110.235 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.42 121.43 17.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 t -141.93 144.98 34.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.982 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.6 m -158.85 170.43 22.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.02 118.7 57.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -105.63 152.24 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -74.97 116.28 15.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.075 0.464 . . . . 0.0 110.515 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.737 HG11 ' HE2' ' A' ' 16' ' ' LYS . 9.0 p -88.98 144.55 8.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.552 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 8.3 ttp180 -122.38 -178.91 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.418 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -171.57 23.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.881 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 76' ' ' ASP . 42.5 m -80.53 91.8 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 0.0 110.894 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.737 ' HE2' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -157.71 -167.7 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.166 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.18 18.56 7.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.357 0.598 . . . . 0.0 110.373 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.521 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 90.5 m-85 -118.43 165.5 13.81 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -125.35 -1.4 7.57 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.232 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 m -149.82 151.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' A' ' 71' ' ' LYS . 7.0 p -144.86 121.37 6.16 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.89 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 24.5 Cg_exo -62.84 114.9 2.61 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.761 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.543 HG11 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -108.57 151.4 10.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.31 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.2 171.95 15.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.176 0.512 . . . . 0.0 111.353 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -109.0 130.13 55.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.875 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -77.96 -9.73 59.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.0 110.206 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HB2' HG21 ' A' ' 65' ' ' VAL . 90.0 mttt -122.22 143.72 39.88 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.499 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 37.2 Cg_endo -66.54 131.06 25.1 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.415 2.077 . . . . 0.0 112.394 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.58 136.8 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.658 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.15 146.18 28.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.875 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.672 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . 11.6 pt -72.92 2.86 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 p -83.66 -32.89 25.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.355 0.598 . . . . 0.0 109.966 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -92.9 -7.22 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.969 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.672 ' HB2' ' HA ' ' A' ' 31' ' ' ILE . 68.2 t90 -57.68 -40.88 80.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.017 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -66.19 -42.18 90.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.759 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 40' ' ' VAL . 1.2 m-20 -60.62 -45.1 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -60.22 -39.99 88.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 m -63.41 -38.8 92.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.85 -38.44 91.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.621 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 36' ' ' ASP . 59.9 t -67.75 -41.44 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.96 -20.45 64.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.062 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.2 t -82.84 5.07 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 110.097 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -125.7 -31.89 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.349 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.6 tp -77.61 111.9 13.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.634 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -117.27 107.42 14.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 56' ' ' VAL . 15.7 m -92.77 121.36 43.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -106.76 24.52 25.24 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.169 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.52 104.42 55.94 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.72 95.9 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.518 2.146 . . . . 0.0 111.345 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.23 156.52 20.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 35.2 mtmm -101.9 78.22 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.814 ' HB2' ' ND2' ' A' ' 72' ' ' ASN . 15.8 t 68.43 159.72 0.17 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.619 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 30.91 63.84 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.558 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -109.66 119.6 39.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.402 0.62 . . . . 0.0 111.245 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 HG21 HG21 ' A' ' 68' ' ' ILE . 21.3 t -81.35 109.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.25 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 46' ' ' VAL . 4.1 m -85.66 -40.32 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.689 0.28 . . . . 0.0 111.027 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.7 m -130.42 100.98 5.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.418 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -85.32 119.94 26.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.9 t30 62.46 75.69 0.39 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.686 0.755 . . . . 0.0 109.358 -170.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tt -72.92 127.9 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.946 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 93.3 mmm 66.38 -80.37 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.835 0.71 . . . . 0.0 110.355 -175.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 61' ' ' MET . 59.2 t30 172.47 80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.103 0.561 . . . . 0.0 109.851 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 t -158.48 15.11 0.19 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.872 0.367 . . . . 0.0 111.367 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.22 -22.37 7.22 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.934 -0.651 . . . . 0.0 114.011 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 27' ' ' LYS . 65.9 t -66.95 121.43 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 117.313 0.556 . . . . 0.0 111.873 -174.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.49 121.97 37.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.904 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.57 122.87 41.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.809 0.338 . . . . 0.0 110.446 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.439 HG21 HG21 ' A' ' 55' ' ' VAL . 20.1 pt -121.44 140.0 46.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.366 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.543 ' SG ' HG11 ' A' ' 23' ' ' VAL . 2.7 m -90.43 122.36 33.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -101.3 8.18 42.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.495 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 49.1 tttp -96.19 145.07 25.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.814 ' ND2' ' HB2' ' A' ' 52' ' ' SER . 0.8 OUTLIER -92.68 103.62 15.98 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.929 -177.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 12' ' ' VAL . 75.2 mt -96.32 111.59 57.16 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.411 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -75.01 115.65 4.35 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.676 2.251 . . . . 0.0 111.35 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HE2' ' OG ' ' A' ' 77' ' ' SER . 87.0 tttt -75.77 126.1 30.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.351 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 15' ' ' SER . 23.0 t70 -111.59 90.26 3.29 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.449 ' OG ' ' HE2' ' A' ' 75' ' ' LYS . 48.2 m -77.84 99.67 6.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.26 -173.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.66 -26.24 9.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.021 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.14 37.5 0.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.43 0.634 . . . . 0.0 110.471 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 0.6 OUTLIER -151.24 164.86 35.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.545 -178.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 80' ' ' HIS . 24.3 m170 75.75 -58.39 0.55 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -47.78 -66.25 0.43 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -169.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 84' ' ' HIS . 6.3 p80 -140.68 11.27 2.27 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.653 -175.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 83' ' ' HIS . 22.6 t60 72.19 144.15 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.559 0.537 . . . . 0.0 110.759 -175.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.538 176.828 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.68 30.82 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.867 0.841 . . . . 0.0 110.103 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 45.5 mmtt -83.5 110.04 17.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.462 172.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.6 139.77 50.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.883 0.373 . . . . 0.0 110.622 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.82 121.94 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.582 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -75.58 102.02 5.14 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -125.8 127.65 46.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.414 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -154.51 172.13 18.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 110.83 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 20' ' ' VAL . 48.1 t -113.1 117.17 54.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.53 156.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.75 0.31 . . . . 0.0 110.649 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -72.96 102.97 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.578 HG13 ' HE2' ' A' ' 16' ' ' LYS . 10.2 p -85.05 134.33 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.682 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 68.8 mtp180 -126.54 -179.07 4.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.5 -172.86 33.42 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.14 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 p -74.84 99.26 3.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.169 0.509 . . . . 0.0 111.991 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -166.6 178.3 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.496 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -87.56 -27.54 22.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.469 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.585 ' HE2' ' HA ' ' A' ' 73' ' ' LEU . 82.3 m-85 -79.73 171.16 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -126.15 -15.1 5.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 171.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' HB ' HG13 ' A' ' 9' ' ' VAL . 11.8 m -148.29 147.47 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.07 132.67 14.86 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.922 0.392 . . . . 0.0 111.204 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 138.96 21.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.643 2.229 . . . . 0.0 112.669 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.19 156.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.417 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -142.63 165.81 26.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.828 0.346 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 p -109.46 142.3 40.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -78.89 -8.29 58.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.242 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.19 134.43 16.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.127 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 52.6 Cg_exo -56.95 136.12 74.78 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.817 2.345 . . . . 0.0 112.183 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.26 145.65 20.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.3 135.01 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 pt -66.33 -9.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.293 . . . . 0.0 111.549 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 m -67.58 -30.73 70.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -86.83 -17.4 33.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.649 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -51.78 -45.44 63.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.148 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.5 -44.98 99.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 111.46 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 40' ' ' VAL . 14.8 t70 -79.46 -32.27 42.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -56.18 -48.7 75.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.122 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -60.99 -44.37 97.51 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.277 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -57.56 -47.19 82.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.731 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 36' ' ' ASP . 87.6 t -64.78 -46.02 93.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.669 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 tp -65.71 -31.93 73.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.857 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -66.8 -20.9 66.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 110.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -104.85 8.91 34.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.4 tp -110.47 84.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 79.6 m-85 -92.78 101.02 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -122.04 159.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.348 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -145.58 -134.4 2.69 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.517 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.46 115.57 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.024 0.53 . . . . 0.0 110.711 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 65.2 Cg_exo -53.54 111.07 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.08 2.52 . . . . 0.0 112.825 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -109.27 -170.91 1.74 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.042 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -127.13 166.75 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.004 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.806 ' HB2' HD22 ' A' ' 72' ' ' ASN . 22.5 t -61.86 131.3 49.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.693 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.54 21.16 32.5 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.634 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.645 HD22 ' HB3' ' A' ' 69' ' ' CYS . 9.7 p30 -89.19 131.73 35.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.75 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 HG23 ' A' ' 68' ' ' ILE . 38.7 t -87.27 106.16 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.119 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.4 -55.76 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.143 0.496 . . . . 0.0 109.809 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 t -130.7 121.11 24.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.403 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.581 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 31.8 ttmt -92.34 112.48 24.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.223 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 62' ' ' ASN . 62.9 t30 58.86 54.93 4.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.619 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.556 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 10.4 tt -46.27 -43.18 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.822 -171.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.483 ' HG3' HG12 ' A' ' 60' ' ' ILE . 84.4 mtp -128.98 29.03 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.491 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' HA ' ' ND2' ' A' ' 59' ' ' ASN . 40.7 t-20 53.81 72.51 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.406 0.622 . . . . 0.0 110.626 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -153.89 13.67 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.0 37.57 83.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.589 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 27' ' ' LYS . 52.0 t -127.08 120.95 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.014 0.435 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.581 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 15.9 m-20 -96.05 121.69 38.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.39 101.98 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 55' ' ' VAL . 13.4 pt -109.15 139.92 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.368 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.645 ' HB3' HD22 ' A' ' 54' ' ' ASN . 43.9 t -95.25 145.24 25.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.258 174.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -121.05 8.91 10.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 110.495 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -96.68 131.37 43.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.806 HD22 ' HB2' ' A' ' 52' ' ' SER . 11.0 m-80 -91.15 116.4 28.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.887 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.585 ' HA ' ' HE2' ' A' ' 18' ' ' TYR . 6.1 mp -96.73 119.59 63.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.21 123.1 13.03 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.245 1.963 . . . . 0.0 110.709 172.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.482 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 13.2 tptm -69.95 -71.23 0.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.114 -171.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -118.17 101.28 8.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.251 -173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.3 t -69.34 99.73 1.24 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.62 90.37 3.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.383 0.611 . . . . 0.0 111.292 -174.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.91 97.98 4.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.83 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -110.6 11.12 22.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.372 0.606 . . . . 0.0 110.583 -175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -90.05 164.08 14.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.14 0.495 . . . . 0.0 110.117 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -97.57 178.65 5.11 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -57.5 -50.71 72.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.726 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -166.24 -58.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 173.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.101 171.7 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -166.21 121.53 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.214 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 10.4 mmmm -91.69 113.07 25.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.449 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.717 ' HB3' ' HZ2' ' A' ' 34' ' ' TRP . 6.4 t70 -130.11 171.01 13.3 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.3 112.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.102 -0.374 . . . . 0.0 111.309 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.47 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 29.4 t80 -66.34 115.22 6.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.493 . . . . 0.0 110.357 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -123.39 133.42 54.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.777 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.3 t -152.98 -163.55 1.73 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.07 136.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.84 148.75 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.21 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -73.56 143.06 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 111.03 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' ' 18' ' ' TYR . 57.4 t -105.76 146.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.692 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.735 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 19.4 ttp180 -140.38 -179.31 5.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.479 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 13' ' ' ARG . . . 111.7 -154.27 16.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.166 165.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -77.93 20.43 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.322 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -156.4 142.45 18.09 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.24 87.43 7.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.256 0.551 . . . . 0.0 110.285 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.545 ' HB3' HG11 ' A' ' 12' ' ' VAL . 2.2 t80 -117.59 141.71 48.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.53 -69.88 0.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.6 m -136.74 148.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.073 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.9 p -127.44 127.42 24.15 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.659 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 55.6 Cg_endo -71.4 133.83 23.38 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.685 2.257 . . . . 0.0 112.424 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' SG ' ' A' ' 69' ' ' CYS . 27.1 m -119.44 166.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.031 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -147.09 176.35 10.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.383 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 16.3 m -109.15 131.21 55.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.31 -11.32 59.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.964 0.411 . . . . 0.0 110.428 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' A' ' 65' ' ' VAL . 39.5 ttpt -135.78 135.15 21.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.507 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 14.4 Cg_endo -56.28 141.47 88.56 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.499 ' CG1' HG21 ' A' ' 65' ' ' VAL . 4.2 m -122.18 174.21 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.131 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . 25.3 mt-10 -71.36 140.25 50.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 33' ' ' LYS . 36.0 pt -67.54 151.71 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 m 72.69 -32.77 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.116 0.566 . . . . 0.0 111.112 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 31' ' ' ILE . 19.2 tptm -64.26 -16.92 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.717 ' HZ2' ' HB3' ' A' ' 4' ' ' ASP . 52.0 m0 -54.27 -39.07 66.54 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.589 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.15 -36.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.15 -44.54 79.51 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.165 0.507 . . . . 0.0 110.263 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -66.45 -37.26 84.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 t -65.78 -32.27 73.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.291 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.48 -42.6 99.59 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.076 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.63 -47.8 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.869 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.851 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -64.1 -20.59 66.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 110.543 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -104.13 14.8 29.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.857 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.454 HD22 ' HB ' ' A' ' 56' ' ' VAL . 32.0 tp -112.52 139.09 48.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -127.16 97.66 5.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.78 124.64 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.228 0.537 . . . . 0.0 111.055 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.735 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -109.62 175.19 18.61 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.182 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 99.2 t 73.53 134.29 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 123.05 0.54 . . . . 0.0 111.544 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 51.9 Cg_exo -56.61 116.7 3.38 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.859 2.373 . . . . 0.0 111.78 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 p -118.79 169.52 9.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -120.3 169.36 10.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -52.58 118.64 3.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 24.95 9.84 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.115 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.664 HD22 ' HB2' ' A' ' 69' ' ' CYS . 9.8 p30 -88.47 132.34 34.52 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.543 HG22 HG21 ' A' ' 68' ' ' ILE . 34.4 t -88.25 125.47 41.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.07 -175.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' HD22 ' A' ' 44' ' ' LEU . 30.5 m -97.85 -38.15 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.092 0.472 . . . . 0.0 110.258 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.6 m -130.9 105.14 7.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.791 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -95.19 127.48 41.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.12 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 1.6 t-20 54.56 40.37 31.79 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.842 0.713 . . . . 0.0 109.748 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.585 HG12 ' HG2' ' A' ' 61' ' ' MET . 10.4 tt -41.96 -50.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.622 -169.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.585 ' HG2' HG12 ' A' ' 60' ' ' ILE . 25.7 mmt -134.71 49.04 2.25 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.35 -0.219 . . . . 0.0 110.628 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.459 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 8.5 p30 56.71 5.86 0.25 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.841 1.256 . . . . 0.0 113.753 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 65' ' ' VAL . 5.0 t -78.56 -11.68 59.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.311 0.577 . . . . 0.0 110.71 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -6.35 83.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.268 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 27' ' ' LYS . 66.5 t -81.33 126.9 39.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.817 0.341 . . . . 0.0 110.512 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -108.77 123.85 49.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mm -81.68 117.35 27.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.543 HG21 HG22 ' A' ' 55' ' ' VAL . 33.6 pt -121.99 139.85 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.612 -173.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.664 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.8 m -89.32 137.32 32.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -105.38 13.12 30.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.128 0.49 . . . . 0.0 111.454 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HB2' HG23 ' A' ' 21' ' ' VAL . 31.9 mmtt -96.76 142.64 28.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -96.47 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 mt -99.8 112.71 64.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.581 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -91.58 -171.87 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.994 2.463 . . . . 0.0 112.007 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 8.5 mtpm? -108.03 101.4 10.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.64 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 63.13 -169.64 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.931 0.77 . . . . 0.0 111.302 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 p -99.84 87.66 3.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.065 0.46 . . . . 0.0 110.546 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.2 mt -97.36 -26.94 14.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.428 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -166.31 153.55 9.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -73.2 -17.8 61.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 0.0 110.729 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.6 m80 70.3 167.92 0.3 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.323 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -144.35 125.87 14.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.897 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -94.75 -15.43 23.85 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.3 m170 -105.05 -173.52 2.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.158 173.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.311 179.621 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -140.24 82.58 1.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 0.0 110.203 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.536 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 93.2 mttt -130.43 130.58 44.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.512 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 154.51 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 28' ' ' PRO . 46.7 mm -73.97 112.79 11.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.431 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.495 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 87.0 t80 -64.01 104.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.592 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -111.02 120.56 42.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -141.47 -166.86 2.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 60.5 t -133.63 129.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.39 152.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -91.96 133.26 35.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 110.307 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 46' ' ' VAL . 2.5 t -118.76 133.31 66.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 112.025 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.554 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 92.4 mtt-85 -108.29 -179.11 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.353 173.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -161.6 21.59 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.453 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.2 m -78.77 74.87 5.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 111.393 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.651 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -147.96 166.66 27.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.581 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -89.32 -46.42 8.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.855 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.42 ' O ' ' HD2' ' A' ' 16' ' ' LYS . 85.4 m-85 -83.67 156.8 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -103.35 -3.03 26.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.865 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.407 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 6.5 m -143.51 145.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 73' ' ' LEU . 14.5 p -134.18 129.13 19.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.436 174.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.89 128.89 18.57 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.494 2.129 . . . . 0.0 112.342 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.495 HG12 ' HB3' ' A' ' 69' ' ' CYS . 27.1 m -115.94 161.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.343 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -139.76 178.33 7.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.13 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.21 134.45 51.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.768 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -72.87 -22.25 60.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HB2' HG23 ' A' ' 65' ' ' VAL . 37.7 mtmm -132.42 146.29 60.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.468 ' HA ' HD13 ' A' ' 5' ' ' ILE . 23.9 Cg_exo -63.15 137.62 62.5 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.969 2.446 . . . . 0.0 112.818 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 65' ' ' VAL . 33.4 m -114.99 160.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.411 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.605 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 59.4 mt-10 -68.65 139.7 55.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.433 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 29.7 pt -60.22 -26.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.375 . . . . 0.0 111.675 -177.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 m -74.74 -17.41 60.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.082 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.605 ' HE2' ' OE1' ' A' ' 30' ' ' GLU . 63.8 mttm -90.48 -5.29 56.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.612 0.244 . . . . 0.0 111.334 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.433 ' CD1' ' HA ' ' A' ' 31' ' ' ILE . 10.5 m95 -59.05 -31.26 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.02 -48.3 75.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.462 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' O ' HG22 ' A' ' 40' ' ' VAL . 7.1 m-20 -56.5 -50.63 71.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.49 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 32.4 m-85 -63.07 -37.05 85.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.371 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -63.4 -41.83 98.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.832 -0.167 . . . . 0.0 111.095 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -62.78 -35.27 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.958 0.409 . . . . 0.0 110.679 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 36' ' ' ASP . 59.1 t -70.02 -48.58 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.4 HD21 HG21 ' A' ' 23' ' ' VAL . 8.7 mp -64.61 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.938 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.3 m -66.18 -12.14 54.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.644 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -105.15 -9.29 17.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 109.918 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.11 124.0 43.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.605 -172.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -125.3 117.1 23.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.641 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 56' ' ' VAL . 24.9 m -106.02 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -151.3 47.04 0.59 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.426 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.33 119.73 17.69 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-O 120.562 0.22 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.651 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 55.8 Cg_endo -73.49 97.59 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.581 2.188 . . . . 0.0 111.473 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 p -96.77 170.22 9.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 64.1 mttp -98.27 -149.76 0.35 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.695 171.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.75 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 2.0 p -92.36 119.59 32.06 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.62 58.16 1.21 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.177 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 21.1 m-80 -127.91 129.24 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.17 110.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.167 0.508 . . . . 0.0 111.322 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.503 HG13 HG11 ' A' ' 46' ' ' VAL . 45.1 t -83.98 -42.61 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.684 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.1 m -130.53 103.6 6.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.443 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -84.23 128.19 34.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.528 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 54.79 52.66 11.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.348 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.489 HG22 HG12 ' A' ' 67' ' ' ILE . 12.7 tt -75.32 135.7 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.403 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.7 mmt 65.07 13.85 8.97 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.477 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.4 13.15 5.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.568 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 65' ' ' VAL . 8.9 t -87.51 -7.49 57.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.449 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.46 66.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.629 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 29' ' ' VAL . 77.1 t -73.07 137.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.113 0.483 . . . . 0.0 110.283 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.94 120.2 38.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 60' ' ' ILE . 44.0 mm -80.04 115.97 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.77 0.319 . . . . 0.0 110.397 -175.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 26.3 pt -116.13 131.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.649 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 54' ' ' ASN . 1.8 p -81.13 139.32 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.75 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 11.7 t -126.13 6.99 7.18 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.395 -173.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.493 ' HB3' HG23 ' A' ' 21' ' ' VAL . 64.2 tttp -99.67 131.12 45.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.8 OUTLIER -76.19 107.17 8.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 21' ' ' VAL . 95.8 mt -81.58 112.62 35.68 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.279 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.94 117.79 4.77 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.487 2.125 . . . . 0.0 112.067 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -69.67 107.99 3.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.013 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.24 65.72 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.658 0.742 . . . . 0.0 110.611 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.6 t -174.48 127.33 0.33 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.407 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.3 mt -105.51 158.21 16.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.226 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -74.17 95.14 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -104.19 110.37 22.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.729 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -143.43 121.03 11.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.895 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -91.58 131.12 37.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.091 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -162.5 40.76 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.267 0.556 . . . . 0.0 109.815 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -79.03 47.75 0.8 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.48 0.657 . . . . 0.0 110.512 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 . . . . . 0 C--O 1.249 1.075 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.269 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.959 ' HE1' ' HA ' ' A' ' 1' ' ' MET . 6.4 mmt . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 62.1 -94.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.669 0.605 . . . . 0.0 110.01 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 28' ' ' PRO . 68.2 mttm -107.93 140.52 40.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.62 157.13 32.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.575 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 28' ' ' PRO . 47.3 mm -82.74 101.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 81.9 t80 -58.8 106.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.339 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -122.26 128.69 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.068 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -149.54 -168.98 3.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.9 m -121.75 137.53 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.705 0.288 . . . . 0.0 110.34 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.86 152.27 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -89.45 111.18 22.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.576 0.703 . . . . 0.0 110.117 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.569 ' HB ' ' HZ2' ' A' ' 16' ' ' LYS . 3.0 t -98.28 140.01 19.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.608 -173.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 45' ' ' TYR . 67.6 mtm180 -79.75 144.37 33.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.54 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -70.58 95.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 115.124 -169.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 p -117.37 12.33 14.23 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 165.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.609 ' HE2' ' O ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -169.96 -168.92 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.359 -171.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.43 -41.36 14.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.609 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 78.2 m-85 -82.4 97.32 8.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 111.498 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.432 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 95.8 m-20 -98.63 10.72 40.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.52 122.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG23 HD13 ' A' ' 73' ' ' LEU . 4.4 p -130.91 139.73 36.49 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.719 -173.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.43 124.39 10.33 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.923 2.415 . . . . 0.0 112.966 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.4 154.61 16.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.516 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -143.98 178.97 7.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.457 ' HB2' HG12 ' A' ' 65' ' ' VAL . 67.8 p -108.93 127.67 54.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.758 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -63.9 -24.32 67.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.863 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HB2' HG21 ' A' ' 65' ' ' VAL . 82.8 mttt -122.68 142.71 38.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HA ' HD11 ' A' ' 5' ' ' ILE . 32.5 Cg_endo -64.81 128.29 20.58 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.232 1.955 . . . . 0.0 112.117 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.04 150.26 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.201 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.07 120.75 14.8 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.19 84.12 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.725 1.25 . . . . 0.0 111.914 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.1 m -138.04 -10.45 1.52 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.081 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -103.46 17.77 23.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -173.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -62.99 -26.84 69.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 110.494 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.2 mt -73.02 -47.91 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.429 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 40' ' ' VAL . 5.8 m-20 -68.29 -39.71 82.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.8 m-30 -64.21 -48.41 75.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -66.43 -30.75 71.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.182 0.515 . . . . 0.0 110.064 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 14.5 t-20 -56.72 -49.66 74.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.028 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 36' ' ' ASP . 47.1 t -70.99 -38.03 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.736 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 81.2 mt -62.01 -25.35 67.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.245 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -77.86 4.3 12.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.004 0.43 . . . . 0.0 111.396 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -141.64 16.75 2.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 0.0 109.963 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.9 tp -115.1 59.43 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.725 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.45 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 78.7 m-85 -83.83 92.05 7.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.738 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG23 HG23 ' A' ' 48' ' ' VAL . 14.9 p -92.18 147.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.99 49.19 0.93 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.1 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG23 HG23 ' A' ' 46' ' ' VAL . 22.3 m -130.23 128.96 22.81 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.703 ' HG2' ' HD2' ' A' ' 75' ' ' LYS . 23.2 Cg_exo -67.39 133.26 29.74 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.136 2.558 . . . . 0.0 111.589 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.468 ' H ' HD11 ' A' ' 73' ' ' LEU . 2.0 p -133.41 179.68 6.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.961 -174.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -118.92 169.5 9.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.46 ' HB2' HD22 ' A' ' 72' ' ' ASN . 11.0 t -59.56 128.71 38.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 0.0 111.805 -173.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.97 26.71 12.1 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.554 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.598 HD22 ' HB3' ' A' ' 69' ' ' CYS . 10.0 p30 -96.42 137.53 35.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 58' ' ' LYS . 62.4 t -77.6 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.69 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.87 -57.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.2 t -130.49 109.25 10.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.915 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HB2' HG11 ' A' ' 55' ' ' VAL . 9.3 tmtm? -84.12 119.82 25.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.623 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 57.46 50.86 10.56 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 110.221 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.646 HG12 ' HG2' ' A' ' 61' ' ' MET . 8.0 tt -49.15 -50.46 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.666 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.646 ' HG2' HG12 ' A' ' 60' ' ' ILE . 95.8 mmm -130.12 45.41 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.791 0.329 . . . . 0.0 110.585 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.04 29.63 19.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.194 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -86.31 -20.05 28.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.689 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.79 87.52 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 27' ' ' LYS . 69.0 t -104.47 138.75 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.212 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' OD2' ' HG2' ' A' ' 58' ' ' LYS . 4.3 m-20 -97.41 106.94 19.35 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.07 107.12 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 33.4 pt -114.69 144.87 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.977 -171.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.598 ' HB3' HD22 ' A' ' 54' ' ' ASN . 10.3 t -89.65 141.97 28.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.046 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -120.07 6.74 10.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -101.74 147.55 26.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.585 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -98.01 110.88 23.37 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.476 HD13 HG23 ' A' ' 21' ' ' VAL . 5.7 mp -87.45 116.1 65.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.988 -176.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 2.9 Cg_exo -77.27 148.45 26.99 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 123.013 2.475 . . . . 0.0 111.519 175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.703 ' HD2' ' HG2' ' A' ' 49' ' ' PRO . 56.2 tttm -145.34 158.23 43.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.544 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 79.2 -177.09 0.09 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.07 0.948 . . . . 0.0 110.75 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.5 m -110.53 18.28 19.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.46 -171.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.12 136.37 52.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -70.66 145.11 50.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.787 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -147.83 97.06 2.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.539 0.685 . . . . 0.0 110.17 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -123.13 116.64 23.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.848 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -80.5 104.88 11.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 110.767 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -144.16 121.1 11.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.167 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -67.96 107.15 2.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 111.125 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 13.5 p80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.867 177.479 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -142.62 17.94 2.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.917 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.3 mttt -103.53 142.0 35.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.915 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -140.57 164.4 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.022 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -74.85 113.19 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 72.8 t80 -59.35 108.5 0.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.842 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -126.26 120.98 31.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.381 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -155.79 -156.79 0.67 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 22' ' ' PRO . 25.2 m -132.08 147.03 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.784 0.326 . . . . 0.0 110.465 177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.51 150.42 18.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.017 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.441 ' HD3' HG11 ' A' ' 20' ' ' VAL . 12.0 mmt180 -84.38 121.31 27.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 6.5 t -100.66 118.27 47.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.389 -173.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' C ' ' HA3' ' A' ' 47' ' ' GLY . 62.5 ttt180 -133.1 104.2 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 47' ' ' GLY . . . 174.42 -171.83 44.88 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -78.3 99.31 6.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -171.78 -166.63 0.44 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.36 -179.372 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -128.35 71.68 1.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -161.28 176.12 11.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -136.12 -50.07 0.69 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 110.551 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.441 HG11 ' HD3' ' A' ' 11' ' ' ARG . 15.9 m -131.11 133.45 62.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.19 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.471 HG22 ' HD3' ' A' ' 71' ' ' LYS . 4.4 p -127.59 140.79 39.01 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.225 -177.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.463 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 47.2 Cg_endo -70.08 137.63 34.98 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.243 1.962 . . . . 0.0 112.199 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -135.25 146.79 29.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.558 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -145.22 178.93 7.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.914 0.388 . . . . 0.0 111.288 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 91.3 p -108.86 129.56 55.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.03 -39.77 72.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.516 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HB3' HG23 ' A' ' 65' ' ' VAL . 32.3 ttmt -119.52 140.25 29.0 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.462 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.91 126.22 20.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.533 2.155 . . . . 0.0 111.924 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.54 156.92 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.646 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.465 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 25.8 mt-10 -67.09 127.29 32.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.9 pt -74.31 -6.8 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 110.877 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.9 t -60.6 -31.96 71.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.331 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.447 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 33.2 mtmm -107.1 14.86 25.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.719 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -57.52 -36.21 71.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.698 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.19 -39.69 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.04 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' HG21 ' A' ' 40' ' ' VAL . 25.7 t0 -71.96 -42.16 66.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 22.3 m-85 -58.08 -46.22 85.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.272 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.0 p -68.98 -28.6 66.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.309 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -72.69 -24.66 61.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.918 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 57.6 t -71.67 -44.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.18 -42.86 91.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.407 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -77.91 2.85 16.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 111.227 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -111.49 -15.89 13.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.537 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 93.3 mt -74.07 -71.66 0.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.861 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 58.5 79.92 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.465 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.3 p -125.22 143.36 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.614 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA3' ' C ' ' A' ' 13' ' ' ARG . . . -139.17 88.98 0.2 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.086 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 60.0 t -128.82 120.61 20.58 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 48' ' ' VAL . 14.2 Cg_endo -57.71 111.13 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 111.779 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 171.66 14.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.548 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -100.55 178.32 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.341 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -68.9 129.17 39.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.57 28.56 10.25 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.285 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.556 HD22 ' HB3' ' A' ' 69' ' ' CYS . 10.8 p30 -88.32 131.32 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG13 ' HD3' ' A' ' 58' ' ' LYS . 37.0 t -88.97 110.71 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.794 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.99 -64.74 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.131 0.491 . . . . 0.0 109.789 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.3 m -100.47 116.69 33.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.311 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' HD3' HG13 ' A' ' 55' ' ' VAL . 25.3 mmtt -83.4 104.01 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.6 t30 54.77 66.31 1.27 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.703 0.763 . . . . 0.0 109.595 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.463 HD13 HG12 ' A' ' 40' ' ' VAL . 12.3 tt -61.69 111.25 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.539 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm 63.76 26.17 14.35 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.63 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 m120 62.75 82.68 0.17 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.284 0.564 . . . . 0.0 111.372 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.2 p -133.14 -20.83 2.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.203 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.22 7.45 73.2 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.35 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 27' ' ' LYS . 60.1 t -116.72 129.44 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.049 0.452 . . . . 0.0 110.442 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 55' ' ' VAL . 5.4 p-10 -95.55 126.08 40.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 169.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 mm -83.15 110.89 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.018 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.7 pt -117.4 138.53 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.451 0.643 . . . . 0.0 112.273 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.556 ' HB3' HD22 ' A' ' 54' ' ' ASN . 40.7 t -92.11 145.7 24.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -114.92 -2.74 12.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HD3' HG22 ' A' ' 21' ' ' VAL . 55.9 tttp -97.04 149.88 21.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.591 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -96.76 132.62 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -175.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 21' ' ' VAL . 5.1 mp -111.79 93.98 22.5 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -92.24 137.9 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.776 2.317 . . . . 0.0 113.024 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -142.47 112.16 6.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.09 120.89 32.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.7 p -146.98 114.91 6.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.985 0.421 . . . . 0.0 112.085 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 78' ' ' LEU . 6.4 mp -77.2 105.11 8.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -85.36 80.95 8.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -164.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 58.04 26.63 13.79 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 168.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -88.47 28.72 1.07 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.47 0.652 . . . . 0.0 110.343 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -161.72 96.73 1.04 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.086 0.469 . . . . 0.0 110.105 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -171.36 -55.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -87.9 55.58 3.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 . . . . . 0 C--O 1.249 1.07 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.764 -172.687 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mmm . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.686 0.279 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -88.92 -18.72 26.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.342 0.591 . . . . 0.0 109.854 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 94.2 mttt -115.59 122.2 44.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.561 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -124.19 148.17 47.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.487 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 HG23 HG22 ' A' ' 7' ' ' THR . 42.0 mm -64.6 119.74 9.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.083 0.468 . . . . 0.0 110.959 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 91.6 t80 -78.13 96.01 5.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.034 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.462 HG22 HG23 ' A' ' 5' ' ' ILE . 16.6 p -105.72 125.19 50.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.0 m -149.94 -169.0 3.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 138.83 52.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.3 157.85 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HD2' HG11 ' A' ' 20' ' ' VAL . 33.6 mmm-85 -79.74 133.1 36.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.802 0.334 . . . . 0.0 110.797 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.531 HG13 HG22 ' A' ' 46' ' ' VAL . 2.8 t -120.63 139.1 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.284 0.564 . . . . 0.0 110.669 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.486 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 64.6 ttt-85 -119.43 170.49 9.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.074 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.09 174.35 18.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.634 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.6 p -72.52 86.35 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' HG2' ' HG3' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -178.15 164.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.044 171.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -91.71 34.14 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.374 -0.376 . . . . 0.0 112.011 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 97.5 m-85 -130.55 102.91 6.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 110.31 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.39 -7.06 55.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.546 -176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.428 HG11 ' HD2' ' A' ' 11' ' ' ARG . 15.5 m -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.511 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.495 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.1 p -140.78 138.25 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.435 177.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.98 129.57 14.42 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.558 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -115.58 161.55 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.31 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HG3' HG13 ' A' ' 68' ' ' ILE . 18.3 ptpt -131.34 174.94 9.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 79.8 p -108.93 130.95 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.262 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.78 -44.71 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' HG3' ' HD2' ' A' ' 28' ' ' PRO . 37.5 ttpt -121.09 140.88 31.76 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD2' ' HG3' ' A' ' 27' ' ' LYS . 84.6 Cg_exo -46.92 130.76 16.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.088 2.526 . . . . 0.0 112.835 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.81 127.09 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.667 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 40.9 mt-10 -52.5 135.3 34.12 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.301 176.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 tp -68.26 81.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 122.051 0.929 . . . . 0.0 110.881 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t 179.9 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.217 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.12 -5.69 52.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.295 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -57.56 -34.25 68.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.27 -54.99 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.658 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 7.5 m-20 -62.44 -38.16 88.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.02 -51.42 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.242 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -64.9 -32.01 73.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.632 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 24.9 t-20 -55.56 -54.34 45.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.901 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 36' ' ' ASP . 67.3 t -60.42 -42.93 92.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.98 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.4 mt -60.99 -27.2 68.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -68.28 -10.63 56.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.58 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -130.2 20.07 5.34 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 174.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.3 tp -109.89 115.23 29.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.43 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -117.29 112.69 21.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.369 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.531 HG22 HG13 ' A' ' 12' ' ' VAL . 27.3 m -96.67 178.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -143.98 176.04 23.51 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.089 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.7 t 71.97 139.75 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 122.797 0.439 . . . . 0.0 111.216 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.653 ' HG2' ' HA ' ' A' ' 75' ' ' LYS . 25.1 Cg_exo -64.8 119.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.447 2.098 . . . . 0.0 111.401 170.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.579 ' HB ' ' CG ' ' A' ' 54' ' ' ASN . 40.6 p -101.6 166.34 10.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.826 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.59 -148.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.764 ' HB2' HD22 ' A' ' 72' ' ' ASN . 11.4 t -101.95 120.81 41.0 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.31 49.77 1.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.026 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.583 HD21 ' HB3' ' A' ' 69' ' ' CYS . 1.5 m-80 -108.69 109.11 20.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.505 ' HA ' HG21 ' A' ' 68' ' ' ILE . 94.7 t -69.55 111.38 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 -62.55 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.71 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -130.81 115.3 16.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.032 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 20.6 ptmt -98.18 141.97 30.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.824 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.488 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 11.8 t-20 58.34 41.7 22.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.716 0.77 . . . . 0.0 109.028 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.742 HG12 ' HG2' ' A' ' 61' ' ' MET . 14.4 tt -64.51 133.67 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.41 -173.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.742 ' HG2' HG12 ' A' ' 60' ' ' ILE . 83.7 mmm 63.39 21.85 12.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 65.65 10.91 7.11 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.13 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -69.87 -43.82 71.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.96 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.488 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 117.43 -27.14 7.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 25' ' ' SER . 85.8 t -66.95 140.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.67 0.271 . . . . 0.0 110.766 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 4.2 m-20 -95.63 123.0 38.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.76 106.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.533 HG13 ' HG3' ' A' ' 24' ' ' LYS . 25.7 pt -115.53 132.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.857 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.583 ' HB3' HD21 ' A' ' 54' ' ' ASN . 18.2 t -72.09 142.1 49.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.1 t -126.35 1.83 7.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 64.7 tttp -102.58 129.08 49.03 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.481 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.764 HD22 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -86.23 106.39 17.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.974 -174.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.9 mt -95.73 126.03 46.76 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.079 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.34 132.19 47.34 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.175 . . . . 0.0 111.532 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.653 ' HA ' ' HG2' ' A' ' 49' ' ' PRO . 51.8 tttm -95.38 -82.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.53 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.89 93.18 6.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.969 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 t -86.89 93.27 9.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.466 0.651 . . . . 0.0 110.215 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -92.42 61.12 3.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.648 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.51 133.98 43.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.625 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -79.65 119.82 23.13 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -58.25 -48.95 78.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.343 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -145.54 -76.05 0.21 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.616 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -151.22 116.22 5.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.492 -174.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -151.55 129.32 11.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.285 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.6 p80 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.251 175.404 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.3 145.43 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.746 0.308 . . . . 0.0 110.563 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.38 119.73 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.923 0.392 . . . . 0.0 110.277 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 77.0 t80 -60.11 125.71 24.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.155 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.8 m -145.15 120.39 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 178.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.58 120.97 66.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.3 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.74 150.58 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.805 0.336 . . . . 0.0 110.333 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.538 ' HA ' HG12 ' A' ' 20' ' ' VAL . 91.0 mtt180 -77.22 134.45 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.597 ' CG1' ' HE3' ' A' ' 16' ' ' LYS . 12.0 t -112.85 111.6 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -90.84 100.91 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.448 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.5 14.0 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 t -85.03 99.84 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.597 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -149.58 39.77 0.81 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.356 -175.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.6 tttm 70.74 -66.07 0.31 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.568 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -73.79 -179.06 3.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 111.363 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.0 -36.43 1.98 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.653 0.263 . . . . 0.0 111.245 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 11' ' ' ARG . 17.0 m -129.03 158.99 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.218 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.2 p -128.67 133.4 25.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.93 118.8 5.72 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.529 2.152 . . . . 0.0 111.717 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 69' ' ' CYS . 28.9 m -112.5 150.54 14.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.51 ' HE3' HG21 ' A' ' 70' ' ' THR . 18.3 ptpt -136.66 170.56 15.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.969 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 17.0 t -109.45 155.71 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.468 HD21 ' HE2' ' A' ' 27' ' ' LYS . 21.1 p-10 -78.04 -32.86 51.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.176 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' HD21 ' A' ' 26' ' ' ASN . 51.1 mtmt -122.58 150.86 58.97 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.975 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 23.3 Cg_exo -64.38 136.9 53.06 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.137 2.558 . . . . 0.0 112.971 -176.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -124.57 150.19 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.824 -177.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -69.52 145.7 52.45 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.866 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tt -60.35 -27.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.987 0.422 . . . . 0.0 111.546 -174.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.45 -28.0 68.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 111.059 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.13 -20.73 22.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.711 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -57.55 -43.33 84.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -67.37 -45.59 85.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.135 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.96 -45.8 89.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.449 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CE2' HG11 ' A' ' 29' ' ' VAL . 22.1 m-30 -67.51 -37.44 82.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.602 0.239 . . . . 0.0 110.877 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 m -64.44 -33.7 76.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.21 -40.2 95.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.22 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 50.7 t -64.98 -44.3 96.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.338 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.91 -21.92 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.443 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -73.5 -13.59 61.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.381 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 10.3 ptt180 -111.65 1.26 16.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.366 0.603 . . . . 0.0 109.43 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 tt -108.73 133.02 53.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.683 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.96 110.24 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.642 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 43.2 t -78.01 126.72 38.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.96 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.773 -1.203 . . . . 0.0 112.589 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.8 112.14 20.52 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.535 0.207 . . . . 0.0 110.913 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 6.1 Cg_exo -75.44 102.95 1.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.774 2.316 . . . . 0.0 110.786 170.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.61 -178.57 4.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.302 0.572 . . . . 0.0 112.352 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.91 -178.23 5.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.367 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 p -74.85 140.13 43.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.462 . . . . 0.0 111.181 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 32.16 16.95 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.712 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.3 p-10 -96.58 128.4 43.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.313 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG22 HG22 ' A' ' 68' ' ' ILE . 47.7 t -83.15 120.53 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.917 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.99 -61.26 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.509 0.671 . . . . 0.0 109.798 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.69 121.38 25.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.286 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -91.81 136.5 33.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.26 56.52 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.452 0.47 . . . . 0.0 110.236 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.37 125.57 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.254 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 96.9 mmm 64.46 23.85 13.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.564 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.5 t30 51.26 69.5 0.64 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.793 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 p -114.49 -35.01 5.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.845 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.67 9.95 34.13 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.454 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 27' ' ' LYS . 1.7 p -104.04 157.28 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -109.29 137.97 46.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mm -111.52 117.19 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 34.3 pt -123.78 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 111.793 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.7 m -82.72 134.59 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.51 HG21 ' HE3' ' A' ' 24' ' ' LYS . 12.7 t -109.77 3.9 21.27 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.246 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.532 ' HB3' HG23 ' A' ' 21' ' ' VAL . 55.7 tptt -96.68 143.6 27.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -90.93 121.12 32.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.8 mm? -98.35 112.27 61.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.91 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 8.6 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 123.145 2.564 . . . . 0.0 111.719 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.529 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 99.4 mttt . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.42 148.65 50.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.03 0.443 . . . . 0.0 111.377 -176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 25' ' ' SER . 47.2 mm -61.77 110.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.309 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.93 110.9 3.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -123.89 127.93 48.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.878 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.4 m -154.72 173.85 15.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.2 t -117.26 125.04 73.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.6 156.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.808 0.337 . . . . 0.0 110.664 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 11' ' ' ARG . 21.7 mtp85 -90.24 116.9 28.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.124 0.488 . . . . 0.0 109.788 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 t -108.45 140.76 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.875 -172.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 65.9 mtt-85 -97.53 158.41 15.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.62 157.74 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.05 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -81.55 45.37 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.461 0.648 . . . . 0.0 111.013 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 33.58 2.32 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.087 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 tptt 69.74 -59.27 0.5 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 0.0 112.056 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -80.91 -177.46 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -143.5 11.4 1.68 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.294 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.521 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.5 m -146.31 147.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.024 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 71' ' ' LYS . 9.5 p -137.66 133.71 18.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.562 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -70.47 116.0 4.44 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.804 2.336 . . . . 0.0 112.269 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.9 m -105.44 151.33 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.954 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 163.27 30.8 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.363 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 5' ' ' ILE . 19.5 m -109.27 131.82 54.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -75.61 -12.68 60.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 65' ' ' VAL . 75.0 mmtt -115.98 143.16 30.33 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 17.1 Cg_exo -67.59 120.25 7.27 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.316 2.011 . . . . 0.0 110.923 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.73 148.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.677 -172.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.529 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 54.1 mt-10 -64.0 119.53 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -61.32 -22.31 27.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -70.03 -16.54 63.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.996 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -98.8 11.7 37.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -62.95 -35.07 78.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.685 0.279 . . . . 0.0 110.8 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.58 -39.94 85.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.519 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 40' ' ' VAL . 37.2 t70 -61.77 -48.03 82.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.75 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.43 -40.77 89.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.9 m -60.91 -38.94 87.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.934 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.27 -43.47 98.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 36' ' ' ASP . 47.8 t -65.38 -45.1 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.533 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.19 -27.34 69.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.567 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 m -73.73 -5.01 38.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.29 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -113.6 5.08 16.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.239 0.543 . . . . 0.0 109.679 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.8 tp -109.05 42.14 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.022 -172.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -70.19 94.61 0.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.397 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.59 154.23 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.26 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -124.59 98.42 0.56 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.299 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 7.3 p -168.5 126.14 0.89 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.783 0.325 . . . . 0.0 110.763 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 8.5 Cg_exo -72.49 120.99 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.743 2.295 . . . . 0.0 111.373 174.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -122.11 -179.23 4.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.82 173.13 6.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 p -69.84 126.13 28.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 110.83 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 30.05 13.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.759 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.6 p-10 -88.85 128.04 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 68' ' ' ILE . 22.1 t -88.19 112.83 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.376 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -76.46 -62.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 44.3 t -130.64 108.81 10.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.253 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.9 138.76 32.33 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.55 43.23 16.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 6.2 tt -50.44 -39.11 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.339 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.86 39.48 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.87 18.82 11.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.11 0.957 . . . . 0.0 109.71 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 65' ' ' VAL . 20.5 p -82.51 -25.4 33.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.164 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.19 15.28 69.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.281 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 27' ' ' LYS . 48.7 t -92.26 139.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.85 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.61 101.01 12.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.81 102.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.8 pt -115.35 136.58 51.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.559 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.3 m -87.77 135.9 33.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -108.39 0.26 21.01 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.126 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HB3' HG23 ' A' ' 21' ' ' VAL . 66.4 tttp -102.47 140.12 37.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -89.28 132.31 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.4 mm? -95.64 122.98 57.64 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.257 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 37.6 Cg_exo . . . . . 0 C--O 1.233 0.26 0 C-N-CA 123.007 2.472 . . . . 0.0 112.484 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 60.0 mttm . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.678 0.275 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -140.6 179.64 6.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.0 mm -89.61 101.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.452 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 75.7 t80 -59.56 107.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.503 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -118.71 127.41 53.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 t -152.99 -171.89 4.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.08 140.74 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -120.72 154.19 24.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.897 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 11' ' ' ARG . 18.7 mtp-105 -82.4 128.73 34.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.402 0.62 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.534 HG11 ' NZ ' ' A' ' 16' ' ' LYS . 15.6 t -97.25 141.95 14.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.326 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -137.29 100.68 4.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 0.0 110.679 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.55 -175.47 47.25 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 t -86.45 78.99 9.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.458 0.646 . . . . 0.0 110.309 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.534 ' NZ ' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -160.9 148.68 15.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.432 177.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -83.74 37.7 0.6 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.496 ' HB2' HD12 ' A' ' 73' ' ' LEU . 29.4 m-85 -151.75 109.06 3.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -89.52 7.99 33.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.64 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -141.57 132.29 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 71' ' ' LYS . 13.1 p -133.29 131.56 21.67 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.959 0.409 . . . . 0.0 110.896 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.33 124.64 10.09 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.718 2.279 . . . . 0.0 112.396 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.472 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -115.79 155.36 17.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.475 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -138.71 171.29 14.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.499 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 18.6 m -109.29 129.28 55.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.257 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -72.92 -21.99 60.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.072 0.463 . . . . 0.0 110.636 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -116.04 135.82 22.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 37.0 Cg_endo -66.13 116.54 4.07 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.449 2.1 . . . . 0.0 112.56 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 6' ' ' PHE . 3.8 m -105.82 148.49 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.983 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 2.0 mp0 -64.93 141.63 58.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 111.086 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -77.05 22.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.424 0.631 . . . . 0.0 111.279 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.6 m -114.4 4.15 15.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.347 0.594 . . . . 0.0 109.703 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -106.33 16.3 24.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.414 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -52.44 -49.07 65.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.967 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 tt -53.99 -50.77 51.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.071 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 40' ' ' VAL . 45.0 m-20 -65.05 -48.08 75.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.246 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -67.38 -36.46 81.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.294 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -62.86 -41.14 99.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.572 0.225 . . . . 0.0 110.738 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.4 -42.49 98.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.817 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 36' ' ' ASP . 58.7 t -67.51 -49.21 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.137 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.54 -29.68 69.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 111.178 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -72.56 -20.51 61.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 110.481 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 43' ' ' ARG . 12.8 mtp180 -103.51 -1.75 27.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.184 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -107.2 93.46 4.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.124 0.488 . . . . 0.0 110.704 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -96.25 91.29 5.81 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.19 139.26 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.65 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.24 -130.78 5.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.128 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.428 HG13 ' HD2' ' A' ' 49' ' ' PRO . 94.0 t 70.41 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 112.081 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' HG13 ' A' ' 48' ' ' VAL . 61.0 Cg_endo -74.74 98.11 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.478 2.119 . . . . 0.0 111.764 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -108.49 163.78 12.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.67 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.9 mtmt -115.93 177.08 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 t -61.86 131.84 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.914 0.387 . . . . 0.0 111.149 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.18 25.28 19.81 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.054 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.3 p-10 -95.0 125.19 39.5 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.413 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.537 HG22 HG22 ' A' ' 68' ' ' ILE . 17.0 t -86.44 109.25 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.69 -40.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.915 0.388 . . . . 0.0 110.169 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.2 t -130.48 105.37 7.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HG2' ' OD1' ' A' ' 66' ' ' ASP . 9.5 tmtm? -90.7 129.56 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 60.71 47.93 7.62 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.392 0.433 . . . . 0.0 111.078 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 65' ' ' VAL . 12.7 tt -60.98 135.8 25.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.197 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.5 mmt 64.33 11.5 6.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.226 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 57.94 28.72 16.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.802 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 65' ' ' VAL . 9.0 t -101.95 -7.69 22.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.341 0.591 . . . . 0.0 110.345 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.46 5.53 57.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.903 176.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.552 ' O ' HG22 ' A' ' 60' ' ' ILE . 94.8 t -85.01 130.99 35.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.007 0.432 . . . . 0.0 109.958 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 66.4 m-20 -107.08 110.48 22.6 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.287 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -76.97 108.6 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.537 HG22 HG22 ' A' ' 55' ' ' VAL . 25.8 pt -114.7 136.59 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.249 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.472 ' SG ' HG12 ' A' ' 23' ' ' VAL . 1.7 m -92.02 136.15 33.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -108.86 8.54 26.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 0.0 111.641 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HB3' HG23 ' A' ' 21' ' ' VAL . 45.1 tttp -102.2 148.31 25.59 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.76 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 2.1 m120 -99.87 124.04 44.76 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 18' ' ' TYR . 2.5 mm? -108.09 120.3 47.28 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.528 -174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.237 0.443 0 C-N-CA 122.942 2.428 . . . . 0.0 111.943 175.453 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.1 136.6 54.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.566 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.6 mt -74.05 126.15 34.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.611 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -63.88 117.01 6.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.62 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 m -134.62 120.54 19.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -149.96 -169.55 3.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 20' ' ' VAL . 7.2 p -132.44 127.72 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.25 153.33 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.678 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 11' ' ' ARG . 57.6 mtt180 -75.32 128.9 36.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.546 HG13 ' HA3' ' A' ' 47' ' ' GLY . 19.5 t -86.56 125.36 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -110.27 123.0 48.99 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . 144.04 -174.61 24.31 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.704 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 m -72.09 95.39 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -139.02 176.97 8.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.392 -175.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 74' ' ' PRO . 51.7 tptt -110.66 -30.6 7.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.252 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.416 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -96.29 138.3 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 16' ' ' LYS . 56.3 t30 -77.83 -45.42 24.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.767 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 9' ' ' VAL . 18.4 m -128.17 147.63 32.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.397 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 12' ' ' VAL . 9.5 p -128.27 121.4 21.53 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 121.246 0.546 . . . . 0.0 111.406 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 32.4 Cg_exo -59.9 125.45 17.74 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.86 2.373 . . . . 0.0 112.636 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.553 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -117.86 155.48 19.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.839 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -143.64 177.33 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.038 0.447 . . . . 0.0 111.092 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' HG23 ' A' ' 5' ' ' ILE . 40.4 t -109.2 147.08 33.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.734 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -84.04 -8.34 59.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 110.716 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' HG22 ' A' ' 65' ' ' VAL . 37.2 mtmm -139.3 144.48 40.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HA ' HG12 ' A' ' 5' ' ' ILE . 23.1 Cg_exo -63.61 129.92 26.53 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.155 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 175.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.029 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 124.02 21.94 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.22 -24.11 35.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.107 0.48 . . . . 0.0 110.993 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -83.69 1.79 40.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.596 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -95.05 7.28 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.8 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -59.07 -30.57 68.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.615 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 9.1 pt -66.49 -38.65 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.554 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -76.8 -40.12 49.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.561 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -66.03 -51.41 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.745 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 m -63.56 -25.75 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.565 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.601 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 9.3 t-20 -59.57 -50.78 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.783 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.22 -40.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.26 -32.02 71.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.358 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.6 t -64.96 -21.14 66.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.828 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 21.2 tpt180 -109.59 1.98 20.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.335 0.588 . . . . 0.0 109.883 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 46' ' ' VAL . 44.5 tp -108.26 92.01 3.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.597 -176.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.54 95.71 7.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.304 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 44' ' ' LEU . 15.7 m -141.75 -157.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.916 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . 137.44 -88.08 0.22 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.297 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t 68.28 117.86 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.215 0 O-C-N 123.919 0.423 . . . . 0.0 110.552 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.886 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 80.6 Cg_exo -43.29 105.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.519 2.813 . . . . 0.0 113.455 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.93 -163.89 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.195 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -120.88 -175.91 3.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.64 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.772 -175.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.32 22.41 24.73 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.408 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.2 p-10 -85.32 133.45 34.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.195 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 66' ' ' ASP . 61.4 t -90.92 120.48 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.656 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.26 -52.56 9.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.581 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.4 m -130.9 117.3 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.481 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 1.005 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 49.9 tttp -99.49 132.81 44.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.787 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.7 t30 67.11 39.2 3.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.431 0.634 . . . . 0.0 110.161 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.39 128.46 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.916 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 57.1 mtt 66.14 16.36 10.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 0.0 111.444 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.34 36.59 20.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.287 0.565 . . . . 0.0 110.848 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.6 p -82.58 -26.06 32.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.415 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.93 10.19 65.0 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.298 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG22 ' HE2' ' A' ' 27' ' ' LYS . 68.8 t -108.59 131.67 58.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.51 0.195 . . . . 0.0 111.022 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 1.005 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.0 p-10 -99.79 124.89 45.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 109.849 170.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.38 121.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.403 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.5 pt -121.11 138.3 51.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.0 111.687 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.553 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.9 m -91.09 141.93 28.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -111.68 2.17 17.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 111.072 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.505 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.1 tmtt? -96.19 131.91 42.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.78 113.38 20.87 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.886 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 73.8 mt -97.4 125.93 43.49 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.654 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 33.2 Cg_exo . . . . . 0 C--N 1.348 0.527 0 C-N-CA 122.956 2.438 . . . . 0.0 111.677 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 82.2 mttt . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.658 0.266 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -123.23 158.63 30.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.82 0.343 . . . . 0.0 110.726 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.31 112.39 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.801 0.334 . . . . 0.0 110.735 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 86.2 t80 -63.66 104.21 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 m -115.81 122.67 46.11 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.2 m -148.42 -169.8 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.606 0.241 . . . . 0.0 110.515 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.8 t -123.19 132.03 72.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.4 155.72 11.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -91.63 129.47 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.062 0.458 . . . . 0.0 110.648 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.719 HG22 HG22 ' A' ' 21' ' ' VAL . 2.6 t -97.67 146.99 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -169.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 68.9 ttt180 -119.95 147.28 44.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.585 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.16 -168.55 21.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.828 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 p -75.3 99.9 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -157.87 168.82 26.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.233 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.77 -54.28 4.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.83 0.348 . . . . 0.0 111.561 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 70.1 m-85 -86.69 127.12 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.873 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.575 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 16.6 m120 -79.69 -13.72 59.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.173 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.6 m -135.47 139.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.719 HG22 HG22 ' A' ' 12' ' ' VAL . 17.7 m -134.48 134.65 22.63 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.612 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.19 132.47 22.7 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.672 2.248 . . . . 0.0 112.908 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 69' ' ' CYS . 30.7 m -121.66 165.74 17.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.233 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.2 ptpt -148.18 178.99 8.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.086 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.479 ' HB2' HG11 ' A' ' 65' ' ' VAL . 78.9 p -108.97 131.13 55.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.036 0.446 . . . . 0.0 111.131 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -53.4 -41.44 65.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.524 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HB2' HG22 ' A' ' 65' ' ' VAL . 7.1 mtmp? -126.28 151.49 72.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 18.0 Cg_endo -58.0 126.6 22.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.767 2.311 . . . . 0.0 111.969 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.92 157.18 22.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.114 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -73.8 141.72 46.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.717 0.294 . . . . 0.0 110.208 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.6 pt -69.87 -8.1 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 111.16 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -66.06 -25.81 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.454 . . . . 0.0 110.403 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.11 2.48 46.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.914 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -56.01 -52.79 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.1 pt -68.93 -26.66 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.711 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.24 -46.88 19.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 0.0 110.642 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -61.2 -41.38 96.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 p -66.89 -35.97 81.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.57 -45.55 81.26 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 110.508 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.94 -48.03 87.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.17 -28.78 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.761 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -73.87 -8.82 57.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 43' ' ' ARG . 60.9 mtt180 -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.215 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.43 99.78 8.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.847 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 17.3 m-85 -88.95 109.48 20.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.636 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.3 120.77 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -120.82 41.23 1.96 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.566 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.42 86.66 56.83 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 71.5 Cg_exo -50.79 118.12 3.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.707 2.271 . . . . 0.0 111.967 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.37 -171.05 2.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.235 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 9.4 mmpt? -95.11 -172.46 2.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.268 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -72.55 136.59 45.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.892 0.377 . . . . 0.0 111.282 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.84 30.14 8.64 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.132 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.9 p30 -93.15 133.44 36.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 66' ' ' ASP . 44.7 t -89.27 105.95 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.692 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.3 -48.19 37.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.153 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.33 99.83 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.228 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HG2' HG11 ' A' ' 55' ' ' VAL . 57.0 mttp -76.24 102.73 5.95 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.3 m120 55.04 77.68 0.2 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.3 tt -47.26 -51.83 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 123.695 0.622 . . . . 0.0 112.326 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtm -141.99 54.59 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.856 0.36 . . . . 0.0 110.445 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 59.83 28.33 17.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.453 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.7 p -83.62 -20.19 34.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.742 -175.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.93 80.46 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.34 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 27' ' ' LYS . 71.2 t -112.73 129.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.839 0.352 . . . . 0.0 110.302 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB3' HG13 ' A' ' 55' ' ' VAL . 28.6 m-20 -95.63 134.04 38.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.9 mm -93.2 108.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.411 HG22 HG22 ' A' ' 55' ' ' VAL . 22.0 pt -109.43 142.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.466 ' HB3' HD21 ' A' ' 54' ' ' ASN . 53.3 t -92.5 142.0 27.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -113.47 4.74 16.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 111.047 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.59 141.51 29.76 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.895 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.09 112.97 24.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.747 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 HG11 ' A' ' 21' ' ' VAL . 5.9 mp -88.07 127.24 58.24 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 111.524 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.454 -0.841 0 C-N-CA 122.895 2.397 . . . . 0.0 111.154 171.482 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.563 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 49.0 mttp . . . . . 0 C--O 1.235 0.329 0 CA-C-O 120.718 0.294 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.35 -179.94 3.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.48 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 28' ' ' PRO . 29.6 mm -101.84 115.28 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.005 0.431 . . . . 0.0 110.19 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -78.11 122.75 26.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.196 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -141.41 137.44 32.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.962 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -153.44 178.51 9.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 20' ' ' VAL . 10.4 p -110.91 130.31 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.874 0.369 . . . . 0.0 110.121 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.37 157.57 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.149 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -81.23 127.54 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.324 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.474 ' HB ' ' HE2' ' A' ' 16' ' ' LYS . 3.7 t -84.28 130.73 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.96 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.487 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 61.8 ttp85 -107.0 155.33 19.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.445 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.15 175.7 22.74 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.87 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 p -79.79 105.17 10.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 0.0 111.007 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HD3' ' H ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -162.68 -175.37 4.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.808 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -119.07 40.12 3.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.428 0.633 . . . . 0.0 110.824 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.59 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 4.2 m-85 -129.72 154.02 47.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.448 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -114.92 -46.45 2.92 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.435 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 9' ' ' VAL . 17.8 m -134.26 142.24 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.009 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 12' ' ' VAL . 15.0 p -129.54 136.66 29.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.428 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.72 124.99 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.62 2.214 . . . . 0.0 112.69 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -113.99 164.5 10.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.977 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -145.36 179.06 7.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -109.16 134.66 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.67 -37.73 73.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.275 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -118.43 150.76 48.54 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.252 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 48.6 Cg_endo -67.3 139.6 50.43 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.499 2.132 . . . . 0.0 113.048 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -113.56 173.5 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.405 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.563 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 79.9 mt-10 -98.67 135.8 39.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.101 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.856 ' HA ' ' HD1' ' A' ' 34' ' ' TRP . 14.6 tt -55.67 -21.52 10.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.781 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.2 m -57.15 -31.81 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.374 . . . . 0.0 111.562 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 33' ' ' LYS . 28.2 mtpp -102.87 14.79 31.09 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.856 ' HD1' ' HA ' ' A' ' 31' ' ' ILE . 1.2 m95 -60.05 -44.5 94.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.75 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -67.95 -35.08 70.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 40' ' ' VAL . 34.8 t70 -67.78 -43.68 79.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.9 m-30 -69.86 -39.95 76.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.975 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.43 -35.85 78.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.481 . . . . 0.0 109.821 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -58.47 -45.44 88.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.861 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 36' ' ' ASP . 43.7 t -69.09 -48.2 70.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.417 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.0 mt -66.63 -33.2 75.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.5 p -71.55 -11.77 61.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.772 0.32 . . . . 0.0 111.559 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -119.08 10.1 12.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.996 0.427 . . . . 0.0 110.499 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.507 ' HG ' HG23 ' A' ' 46' ' ' VAL . 31.5 tp -104.71 127.2 52.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 43.9 m-85 -119.45 97.12 5.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.507 HG23 ' HG ' ' A' ' 44' ' ' LEU . 61.4 t -111.29 140.41 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -124.08 -134.75 4.33 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.992 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t 60.08 79.95 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.205 0.526 . . . . 0.0 109.994 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.47 118.41 5.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.652 2.235 . . . . 0.0 111.691 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -174.27 3.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.884 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -87.79 -177.19 5.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.0 t -67.45 134.1 50.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.761 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.32 25.78 11.96 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.987 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 11.0 p30 -94.03 143.06 26.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.38 115.99 28.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.266 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.29 -56.56 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.972 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.0 t -130.72 118.01 20.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 31.0 tttm -97.71 129.88 44.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.736 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.417 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 14.1 m120 54.98 47.21 22.65 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 123.501 0.501 . . . . 0.0 109.955 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.0 tt -53.95 110.04 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.6 mmt 66.68 31.45 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.246 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 71.34 4.22 4.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -57.59 -42.53 83.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.417 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 111.21 -9.37 28.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.646 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.96 137.46 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 110.231 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 7.0 m-20 -102.18 107.31 18.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -75.3 103.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.3 pt -108.05 146.07 14.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.296 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' A' ' 21' ' ' VAL . 2.4 t -90.51 142.32 27.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.475 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -119.22 13.97 12.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.399 0.618 . . . . 0.0 110.63 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -96.58 142.05 29.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -89.97 98.14 11.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 96.6 mt -99.56 117.41 63.81 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.873 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 5.0 Cg_exo . . . . . 0 N--CA 1.457 -0.648 0 C-N-CA 122.661 2.24 . . . . 0.0 112.699 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.264 0.554 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -140.65 154.44 46.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.97 117.13 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.96 0.41 . . . . 0.0 110.741 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.497 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 78.2 t80 -78.53 109.67 12.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 109.827 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -123.53 132.21 53.84 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.564 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -152.77 -165.1 2.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.123 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.626 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 42.7 t -128.31 134.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.541 0.21 . . . . 0.0 110.453 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -119.0 148.64 21.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.39 135.23 40.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.275 0.559 . . . . 0.0 111.53 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.34 141.54 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.577 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -127.13 173.87 9.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.278 . . . . 0.0 110.325 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -177.48 31.0 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.864 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 m -76.12 96.47 3.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.254 0.549 . . . . 0.0 110.674 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.9 -173.44 4.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.649 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -100.73 -52.43 3.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.833 0.349 . . . . 0.0 110.742 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -75.2 124.3 26.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.975 0.417 . . . . 0.0 111.956 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.84 -15.92 56.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.626 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.3 m -142.03 146.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 73' ' ' LEU . 13.0 p -124.38 134.28 25.39 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.92 126.02 13.33 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.525 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -114.33 162.34 12.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.576 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -144.73 178.93 7.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.914 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 69.1 m -109.12 133.55 52.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.202 0.525 . . . . 0.0 111.306 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -59.52 -44.65 93.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.591 174.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 65' ' ' VAL . 67.1 mttm -121.0 152.45 56.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.49 139.52 82.37 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.653 2.236 . . . . 0.0 111.88 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 65' ' ' VAL . 5.8 t -112.57 136.11 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.97 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.31 118.8 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.5 tt -55.16 -28.1 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 m -65.33 -18.39 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mtpp -100.72 17.51 21.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.487 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -57.39 -40.66 78.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 0.0 109.942 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -62.33 -45.43 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.981 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HB3' ' HG3' ' A' ' 61' ' ' MET . 1.8 m-20 -53.48 -54.61 34.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.592 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -63.07 -41.1 99.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -61.23 -47.25 86.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -67.06 -27.26 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.572 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 36' ' ' ASP . 99.1 t -77.35 -46.53 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.636 0.255 . . . . 0.0 110.937 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.32 -30.36 66.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 p -69.69 -22.31 63.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -107.19 10.87 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.166 0.507 . . . . 0.0 110.283 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -114.11 143.33 44.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.912 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -130.96 142.12 50.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.145 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 p -119.49 143.83 29.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 48' ' ' VAL . . . -121.7 163.82 15.02 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.055 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 92.1 t 75.82 128.27 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 123.179 0.592 . . . . 0.0 111.262 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.13 110.76 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.155 2.57 . . . . 0.0 111.499 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.45 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 p -99.17 -164.16 1.1 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.713 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' H ' ' HB ' ' A' ' 50' ' ' THR . 19.6 ptmt -127.16 -152.88 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.434 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 32.6 m -98.96 135.63 40.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.73 24.04 11.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.877 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.847 HD22 ' HB2' ' A' ' 69' ' ' CYS . 40.8 m-20 -78.97 99.1 6.69 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 68' ' ' ILE . 17.9 t -77.79 92.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 m -74.09 -45.52 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 8.5 t -130.96 120.16 23.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -104.33 144.06 32.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 44.72 39.82 3.71 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.671 0.748 . . . . 0.0 110.847 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.559 ' HB ' ' SG ' ' A' ' 57' ' ' CYS . 5.3 tt -56.0 127.18 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.277 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.603 ' HG3' ' HB3' ' A' ' 36' ' ' ASP . 93.8 mmm 63.59 29.89 15.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 70.2 17.76 7.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.906 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.3 p -78.44 -61.58 1.96 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.86 0.362 . . . . 0.0 111.777 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.31 1.31 9.35 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 27' ' ' LYS . 96.8 t -88.15 139.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 0.0 110.664 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.68 114.65 26.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.231 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -83.13 106.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.8 pt -119.4 133.5 66.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.259 0.552 . . . . 0.0 112.297 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.847 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.9 m -78.4 147.64 33.99 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 10.9 t -132.38 13.82 4.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -112.93 122.34 47.35 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.481 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -67.8 109.96 3.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 21' ' ' VAL . 90.9 mt -87.73 117.16 68.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.448 -173.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.458 -0.612 0 C-N-CA 122.691 2.261 . . . . 0.0 111.92 175.26 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 96.3 mttt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -123.63 169.92 10.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.99 0.424 . . . . 0.0 110.76 -169.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.06 102.68 12.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 29' ' ' VAL . 87.7 t80 -59.26 117.95 5.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.666 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -124.06 130.26 52.26 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.797 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 t -143.23 -172.11 3.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.33 124.87 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 41' ' ' LEU . 29.6 m -112.46 162.04 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -91.88 130.97 37.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.532 . . . . 0.0 111.35 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -108.43 121.49 61.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.739 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.445 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.4 mtm105 -99.58 154.3 18.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.12 166.58 12.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.355 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 p -82.61 84.9 7.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 111.759 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -174.23 4.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.888 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -86.84 -59.58 2.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.713 0.292 . . . . 0.0 110.988 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.48 6.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.205 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.44 -15.43 30.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.529 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.74 129.79 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.1 p -119.17 129.93 25.12 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.164 0.506 . . . . 0.0 111.758 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 37.5 Cg_endo -69.1 125.81 12.95 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 111.59 170.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 69' ' ' CYS . 30.6 m -113.9 158.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.084 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -141.06 174.17 10.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.751 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 14.9 m -109.11 127.5 54.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.05 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -65.24 -30.89 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.922 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB2' HG22 ' A' ' 65' ' ' VAL . 64.3 mttm -111.2 138.73 21.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.1 Cg_exo -65.38 116.88 4.14 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.369 2.046 . . . . 0.0 111.485 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 6' ' ' PHE . 29.3 m -93.37 162.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.997 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 46.1 mt-10 -79.71 145.8 32.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.153 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 33' ' ' LYS . 16.9 pt -71.53 177.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.013 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 74.6 m 70.98 -25.48 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.039 0.536 . . . . 0.0 112.028 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.457 ' HD3' ' CZ ' ' A' ' 37' ' ' PHE . 13.9 tttm -84.63 7.53 19.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.173 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -62.07 -34.94 77.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 tt -70.48 -31.52 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 25.3 t70 -65.94 -57.03 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.989 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CZ ' ' HD3' ' A' ' 33' ' ' LYS . 27.5 m-85 -64.63 -36.24 83.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.519 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.1 p -67.24 -37.12 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -54.85 -49.64 70.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 110.346 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.46 -48.71 85.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.234 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 10' ' ' VAL . 69.0 mt -70.06 -41.08 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -68.05 -19.86 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 111.049 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -101.27 10.75 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 110.041 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 tp -116.86 118.75 33.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.318 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.98 129.27 55.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.958 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.6 140.23 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.148 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -127.2 71.94 0.47 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.888 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -166.0 123.25 1.04 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 120.811 0.339 . . . . 0.0 110.776 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.49 113.13 3.39 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.839 2.36 . . . . 0.0 111.614 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.13 170.31 9.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.389 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.8 mtmt -103.55 176.33 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.354 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.0 t -61.25 135.47 57.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 111.473 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.64 26.79 21.75 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.967 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.702 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -97.5 133.26 42.31 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.253 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 68' ' ' ILE . 8.6 t -93.07 124.59 45.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.471 -176.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 m -96.99 -39.51 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 111.215 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.3 t -127.74 121.2 29.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' HG11 ' A' ' 55' ' ' VAL . 59.6 mttm -106.06 128.85 54.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.857 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.747 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.7 t-20 58.91 48.84 10.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.65 0.738 . . . . 0.0 109.169 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.491 HG12 ' HG2' ' A' ' 61' ' ' MET . 11.6 tt -60.16 127.09 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.108 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.491 ' HG2' HG12 ' A' ' 60' ' ' ILE . 98.2 mmm 63.51 21.78 12.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.159 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.747 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 3.4 t-20 57.8 79.4 0.2 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.452 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.0 p -138.65 -55.72 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.068 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.0 -9.4 6.32 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 27' ' ' LYS . 95.4 t -79.89 132.01 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 110.579 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.99 114.57 28.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.1 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.89 114.03 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.656 HG22 HG22 ' A' ' 55' ' ' VAL . 20.6 pt -118.37 140.75 40.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.0 -173.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.702 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.9 m -92.2 146.34 23.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -119.38 11.15 12.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 0.0 112.223 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.589 ' HB2' HG23 ' A' ' 21' ' ' VAL . 68.5 mmtt -96.41 155.24 16.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.953 -0.467 . . . . 0.0 109.919 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 2.2 m-20 -106.55 104.89 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.78 132.08 43.31 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.462 -0.33 0 C-N-CA 122.462 2.108 . . . . 0.0 112.044 178.157 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 52.0 mttp . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.18 156.27 49.27 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.965 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -63.4 110.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.028 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -76.55 106.84 8.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 24' ' ' LYS . 74.3 p -110.41 134.21 52.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -153.75 -167.1 2.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.37 132.31 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.91 149.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -87.8 114.08 24.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HB ' ' HE3' ' A' ' 16' ' ' LYS . 6.6 t -84.85 139.35 17.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.189 -168.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpt85 -105.8 137.77 43.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.91 -178.3 16.38 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.412 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 t -81.4 110.28 16.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.084 0.468 . . . . 0.0 110.564 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.948 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -163.07 168.48 20.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -95.79 -20.67 18.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' HD22 ' A' ' 73' ' ' LEU . 78.9 m-85 -107.46 111.36 23.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.948 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 86.7 m-20 -76.67 -19.6 57.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.09 138.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.585 0.231 . . . . 0.0 110.422 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 71' ' ' LYS . 5.8 p -135.34 139.83 32.63 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.831 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 53.6 Cg_endo -72.81 130.68 16.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.572 2.181 . . . . 0.0 112.505 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.22 162.42 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.557 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HB3' HG22 ' A' ' 7' ' ' THR . 22.2 ptmt -143.53 170.75 15.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.159 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -109.23 128.27 54.92 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 66' ' ' ASP . 2.0 p-10 -75.72 -0.91 22.5 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 65' ' ' VAL . 43.3 mtmt -132.36 142.09 43.67 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.01 135.98 66.38 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.474 2.116 . . . . 0.0 112.328 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 t -105.37 130.91 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.863 -175.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 28.6 tt0 -60.11 121.39 11.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.0 tp -60.9 -21.46 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -171.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.61 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.945 -0.472 . . . . 0.0 111.421 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 62.9 mttp -105.7 1.23 26.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.565 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -59.64 -31.25 69.35 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.37 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -78.04 -30.05 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 40' ' ' VAL . 26.0 t0 -78.41 -43.33 27.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 30.2 m-85 -56.52 -47.26 79.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.6 p -65.71 -37.26 85.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -60.7 -43.07 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.75 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 36' ' ' ASP . 58.0 t -63.26 -44.11 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.591 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.75 -21.48 66.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.3 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.3 m -81.79 -11.59 58.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.048 0.451 . . . . 0.0 110.704 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -105.89 -26.14 11.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.726 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 46' ' ' VAL . 40.2 tp -81.84 94.83 7.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.739 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -97.35 90.3 5.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.174 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.508 HG22 ' HG ' ' A' ' 44' ' ' LEU . 22.2 m -142.06 173.49 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.67 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.74 173.1 25.73 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.548 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.599 HG13 HG23 ' A' ' 50' ' ' THR . 13.6 p 177.23 141.25 0.24 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -42.06 105.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.918 2.412 . . . . 0.0 112.374 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.599 HG23 HG13 ' A' ' 48' ' ' VAL . 1.7 p -130.23 167.03 19.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.069 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -127.07 62.75 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.66 -174.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 t 69.2 150.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.728 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.17 24.49 70.48 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.958 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 7.7 p30 -96.46 128.53 43.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.025 0.441 . . . . 0.0 110.506 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 58' ' ' LYS . 49.1 t -79.21 113.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.195 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.04 -50.18 17.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.965 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 36.7 t -130.75 123.07 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.647 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.692 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 50.3 tttp -106.25 135.4 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.784 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.582 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 6.6 t-20 64.32 31.99 12.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.72 0.638 . . . . 0.0 110.712 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.547 HG12 ' HG3' ' A' ' 61' ' ' MET . 10.8 tt -60.65 134.83 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.547 ' HG3' HG12 ' A' ' 60' ' ' ILE . 76.2 mtp 62.6 18.45 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.942 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 70.67 -2.87 2.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 65' ' ' VAL . 9.6 t -79.69 -8.59 59.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.57 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 59' ' ' ASN . . . 83.16 3.41 90.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.897 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 27' ' ' LYS . 7.9 t -67.05 129.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.899 0.381 . . . . 0.0 110.237 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.692 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 3.1 m-20 -99.35 122.34 42.35 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -87.09 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.3 pt -108.83 134.96 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.411 0.624 . . . . 0.0 111.954 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.531 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 7.5 t -81.12 135.06 35.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.231 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -111.69 -6.32 14.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.991 0.424 . . . . 0.0 111.233 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 62.5 tttp -96.8 138.64 34.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.76 128.26 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.84 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 18' ' ' TYR . 94.2 mt -109.32 102.18 48.35 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.973 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo . . . . . 0 N--CA 1.455 -0.753 0 C-N-CA 122.706 2.27 . . . . 0.0 112.382 176.892 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 54.4 mmtt . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -131.98 134.59 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.706 0.288 . . . . 0.0 110.856 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 28' ' ' PRO . 36.3 mm -57.75 127.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 111.116 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -102.66 115.58 30.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.544 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 139.42 53.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.833 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.8 m -158.67 179.26 9.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.652 0.263 . . . . 0.0 110.615 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.48 130.19 71.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.158 0.504 . . . . 0.0 110.231 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.76 155.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.76 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 9.5 mmt180 -69.37 123.88 22.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.585 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.788 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.7 p -107.43 136.94 40.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.178 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 49.2 mtp180 -125.87 -179.32 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.656 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.94 -160.24 13.52 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.323 -0.942 . . . . 0.0 113.088 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -85.44 15.95 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.775 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.788 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -80.98 179.0 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -125.69 69.33 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.713 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.45 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 40.5 m-85 -153.11 178.86 9.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.299 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.91 -23.68 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 0.0 111.116 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.67 149.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 14.6 p -131.98 131.49 22.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.033 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 14.2 Cg_exo -68.9 131.77 23.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.132 2.555 . . . . 0.0 112.63 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.53 152.63 37.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.956 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HG3' HG13 ' A' ' 68' ' ' ILE . 21.5 ptmt -141.13 173.55 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 0.0 111.034 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -109.67 131.75 54.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.129 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -72.72 -26.05 61.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.806 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.6 mttt -122.33 132.83 24.2 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HA ' HD13 ' A' ' 5' ' ' ILE . 77.7 Cg_exo -50.31 132.96 35.65 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.082 2.521 . . . . 0.0 112.49 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.2 124.53 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.784 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 43.8 tt0 -63.2 134.86 56.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pt -72.54 67.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.326 1.06 . . . . 0.0 112.247 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.0 p -155.71 -30.96 0.1 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.88 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -94.01 3.54 55.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -51.93 -52.73 48.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.438 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.68 -38.21 57.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.128 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.8 t0 -62.03 -37.63 85.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 63' ' ' THR . 4.5 m-30 -60.23 -50.22 74.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.827 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 p -62.9 -25.54 68.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.209 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -65.99 -50.04 65.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 36' ' ' ASP . 42.1 t -63.55 -41.7 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.806 HD23 HD12 ' A' ' 44' ' ' LEU . 47.4 mt -63.12 -29.31 70.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.7 m -72.72 -11.68 60.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HD3' HH11 ' A' ' 43' ' ' ARG . 56.4 mtt-85 -108.41 3.81 23.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.311 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.806 HD12 HD23 ' A' ' 41' ' ' LEU . 27.5 mt -99.56 119.8 38.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.514 0.674 . . . . 0.0 111.387 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.5 100.89 7.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.626 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 m -90.8 -177.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.728 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -167.71 -168.62 30.11 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.059 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t 68.22 101.27 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 C-N-CA 122.946 0.498 . . . . 0.0 111.178 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 12.3 Cg_endo -58.33 108.45 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.808 2.338 . . . . 0.0 111.939 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.84 -165.27 1.01 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.93 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 44.0 mmtm -128.05 169.87 13.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.024 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.9 p -58.94 136.31 57.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 23.53 34.6 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.732 -0.746 . . . . 0.0 111.877 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.671 HD21 ' HB3' ' A' ' 69' ' ' CYS . 8.5 p30 -97.24 131.34 44.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 68' ' ' ILE . 63.1 t -82.73 108.42 15.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.06 -57.59 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.268 0.556 . . . . 0.0 109.609 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 62.7 m -115.25 94.16 4.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.95 114.16 17.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.733 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t30 65.25 79.71 0.25 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.691 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 tt -71.66 122.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.277 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ttt 68.77 -76.33 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.868 0.73 . . . . 0.0 110.75 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -178.9 82.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.515 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 39.0 p -141.83 -44.02 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.176 -169.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.74 8.01 57.39 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -170.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 27' ' ' LYS . 73.9 t -98.46 131.68 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.184 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.39 116.21 28.68 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 57' ' ' CYS . 48.2 mm -81.78 100.21 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.128 0.49 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.45 HG13 ' HG3' ' A' ' 24' ' ' LYS . 22.1 pt -96.8 145.51 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.301 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.671 ' HB3' HD21 ' A' ' 54' ' ' ASN . 43.6 t -100.39 142.73 31.46 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -115.84 7.19 14.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.326 0.584 . . . . 0.0 110.625 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -96.71 142.24 28.98 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 2.6 m-20 -93.93 111.79 23.54 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.21 120.37 56.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.448 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 C-N-CA 122.891 2.394 . . . . 0.0 111.628 175.96 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 94.4 mttt . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -140.65 153.91 46.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.756 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.98 114.26 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 110.988 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.4 ' HB3' HG21 ' A' ' 29' ' ' VAL . 64.7 t80 -79.94 140.69 36.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.39 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -150.94 133.47 15.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.946 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -150.18 -172.83 4.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.2 138.18 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.714 0.292 . . . . 0.0 110.39 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 44' ' ' LEU . 14.2 p -119.1 149.65 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.473 ' HA ' HG12 ' A' ' 20' ' ' VAL . 53.1 mtt180 -82.87 116.75 22.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.191 0.52 . . . . 0.0 110.808 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG12 ' HE3' ' A' ' 16' ' ' LYS . 21.3 t -88.37 137.51 20.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.959 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.561 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.6 ttp85 -98.52 150.23 21.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.365 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.82 169.71 13.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.332 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.07 27.3 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.242 0.544 . . . . 0.0 111.709 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.589 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -70.93 173.08 7.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.489 176.255 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -86.18 26.31 1.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -145.21 -179.69 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.718 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -131.31 -34.69 1.39 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 11' ' ' ARG . 22.7 m -134.75 149.34 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.672 0.272 . . . . 0.0 111.129 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -125.68 133.54 25.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.68 120.76 6.88 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.418 2.079 . . . . 0.0 112.171 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.1 140.42 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.926 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.08 168.86 15.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.127 0.489 . . . . 0.0 110.875 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -108.93 130.9 55.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.607 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 7.5 p30 -80.98 -10.0 59.77 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.632 -172.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.607 ' HE2' ' OD1' ' A' ' 26' ' ' ASN . 26.9 mtmt -130.99 144.53 53.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.532 176.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 50.9 Cg_exo -54.85 138.05 76.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.209 2.606 . . . . 0.0 113.541 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 6' ' ' PHE . 28.1 t -106.39 143.29 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.691 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.93 139.86 55.1 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.0 pt -76.34 12.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.6 p -128.9 -3.27 5.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.069 0.462 . . . . 0.0 110.468 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -99.48 -15.35 18.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -65.12 -21.05 66.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.026 0.441 . . . . 0.0 110.632 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.88 -44.31 99.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.092 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.6 m-20 -58.66 -50.23 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.891 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.4 m-85 -63.06 -43.22 99.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.11 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -62.81 -36.95 84.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.862 0.363 . . . . 0.0 111.006 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -66.69 -36.35 82.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.783 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 36' ' ' ASP . 96.0 t -69.35 -43.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.394 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 99.7 mt -61.97 -24.2 66.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -65.63 -18.14 65.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.944 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -104.03 -2.05 26.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 56' ' ' VAL . 24.1 tp -84.17 53.65 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.238 0.542 . . . . 0.0 111.292 -171.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -78.31 76.66 4.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.22 149.44 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.99 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -119.08 48.99 0.9 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.53 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.17 114.67 16.2 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.613 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 26.0 Cg_exo -62.07 103.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.562 2.174 . . . . 0.0 111.095 171.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.675 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 22.9 p -95.97 173.57 7.37 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' HD21 ' A' ' 54' ' ' ASN . 75.6 mmtt -97.31 -146.94 0.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.337 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.6 t -102.3 131.17 49.06 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 170.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.3 26.98 19.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.596 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.675 ' ND2' ' HB ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -86.83 112.45 21.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 68' ' ' ILE . 47.5 t -73.37 106.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.534 HG11 HD21 ' A' ' 44' ' ' LEU . 24.4 t -79.37 -46.37 23.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.169 0.509 . . . . 0.0 109.745 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 59.7 m -130.65 109.67 10.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 28.0 ttmt -85.12 129.33 34.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 53.72 69.37 0.72 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 123.812 0.695 . . . . 0.0 109.823 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.458 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.0 tt -78.76 125.53 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.317 -173.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.422 ' HG2' HG12 ' A' ' 60' ' ' ILE . 96.4 mmm 64.31 19.22 11.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.94 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 65.02 98.7 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.468 0.48 . . . . 0.0 111.298 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 65' ' ' VAL . 8.4 t -171.46 -34.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.478 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.22 -17.96 5.87 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.156 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.534 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 33.1 m -82.38 142.57 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.306 0.574 . . . . 0.0 112.014 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -108.23 131.62 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -91.5 114.11 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 55' ' ' VAL . 37.7 pt -117.35 134.06 62.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.887 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 54' ' ' ASN . 2.0 p -87.82 134.17 33.74 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -118.71 17.25 13.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 112.147 -168.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HB3' HG23 ' A' ' 21' ' ' VAL . 60.4 tttp -117.08 131.05 57.01 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -82.73 109.36 16.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.71 132.09 39.66 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.62 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo . . . . . 0 C--O 1.237 0.456 0 C-N-CA 122.447 2.098 . . . . 0.0 111.264 172.486 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.564 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.2 mttt . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.307 0.575 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.66 179.74 5.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.554 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.67 116.12 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.25 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.597 ' HB2' HG21 ' A' ' 29' ' ' VAL . 77.0 t80 -59.36 128.09 35.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -153.52 135.43 14.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.007 0.432 . . . . 0.0 110.097 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -153.2 169.34 23.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.36 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 59.8 t -114.32 118.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 41' ' ' LEU . 34.2 m -117.58 173.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.245 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.465 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 1.9 mmt85 -72.8 126.63 30.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.762 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.579 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.4 p -104.77 129.14 57.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.503 0.668 . . . . 0.0 111.239 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.504 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 41.9 ttt85 -104.65 142.32 34.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.974 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 168.15 12.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.0 m -83.26 102.21 11.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.98 -174.66 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.928 -179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.24 -0.9 56.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.49 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 47.9 m-85 -110.04 143.26 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.732 -0.387 . . . . 0.0 112.021 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -104.64 -10.59 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.756 0.789 . . . . 0.0 109.079 175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.2 m -142.33 148.41 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.414 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 12' ' ' VAL . 7.2 p -134.44 125.89 17.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.195 0.522 . . . . 0.0 111.749 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 5.8 Cg_exo -77.54 113.41 3.51 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.396 2.73 . . . . 0.0 112.306 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 ' SG ' ' A' ' 69' ' ' CYS . 31.5 m -104.82 161.04 4.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.544 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -153.24 178.77 9.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.487 0.66 . . . . 0.0 111.213 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.27 147.2 33.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.13 -3.71 56.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.506 0.669 . . . . 0.0 109.258 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB3' HG22 ' A' ' 65' ' ' VAL . 34.4 ttmt -128.72 129.84 23.49 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.417 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 38.3 Cg_exo -58.04 132.24 48.25 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 112.429 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' A' ' 6' ' ' PHE . 18.5 m -117.65 -178.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.564 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -97.96 135.26 39.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 pt -77.01 -19.49 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.307 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 37' ' ' PHE . 56.3 mtpt -93.99 0.79 56.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -53.82 -42.93 68.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.895 0.378 . . . . 0.0 110.676 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.55 -45.04 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.04 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 40' ' ' VAL . 8.9 t70 -67.46 -43.72 80.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.32 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.438 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 47.4 m-85 -61.48 -43.59 98.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.236 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.32 -35.97 80.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.753 0.311 . . . . 0.0 110.715 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 60' ' ' ILE . 61.7 t -67.05 -40.99 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.563 ' HB3' HG11 ' A' ' 10' ' ' VAL . 49.8 mt -62.49 -39.11 92.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.555 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -68.07 -12.91 61.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.417 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.8 ttt85 -95.13 -9.16 34.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.277 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.65 132.85 55.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.588 . . . . 0.0 111.431 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 11' ' ' ARG . 3.3 m-85 -106.99 102.83 12.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.797 173.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.93 157.89 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.258 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . 172.99 -148.91 10.79 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.751 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 85.1 t 72.49 126.13 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.345 0 O-C-N 124.099 0.529 . . . . 0.0 110.789 -175.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.682 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 82.6 Cg_exo -42.92 110.7 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.488 2.792 . . . . 0.0 113.074 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -139.65 169.48 17.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.622 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -95.93 173.57 7.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 110.707 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -68.54 119.83 13.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.439 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 30.47 5.78 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.4 p-10 -89.1 131.67 35.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 68' ' ' ILE . 57.8 t -85.74 127.31 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.856 -175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.42 -75.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.228 0.537 . . . . 0.0 110.228 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -115.65 98.79 6.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.177 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 87.7 tttt -78.69 128.37 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 8.7 t-20 63.65 41.86 6.82 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.439 HD11 HG11 ' A' ' 40' ' ' VAL . 6.2 tt -53.27 -50.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.146 -172.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.435 ' HB2' HG23 ' A' ' 63' ' ' THR . 82.1 mtp -114.61 30.93 6.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.653 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 15.6 m120 63.4 23.84 13.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.391 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 61' ' ' MET . 67.6 p -86.93 -21.08 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.706 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.27 79.24 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.494 -174.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 27' ' ' LYS . 41.8 t -90.04 130.44 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.604 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' OD2' ' HE3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -95.92 107.92 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.066 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.5 mm -75.9 120.42 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 35.1 pt -126.43 137.57 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.221 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.569 ' SG ' HG12 ' A' ' 23' ' ' VAL . 3.8 m -86.73 132.88 33.74 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -102.29 6.42 40.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.351 0.596 . . . . 0.0 110.901 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.49 ' HD3' ' CZ ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -96.75 134.66 39.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.767 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 2.3 m-20 -86.69 126.97 34.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.682 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.3 mp -95.35 109.09 43.31 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 91.6 Cg_endo . . . . . 0 N--CA 1.453 -0.883 0 C-N-CA 123.059 2.506 . . . . 0.0 112.567 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.07 151.7 48.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.656 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -72.5 109.46 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 83.7 t80 -59.31 98.77 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.477 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -112.84 120.42 41.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m -152.78 -159.39 1.0 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.599 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 8.9 p -128.9 138.5 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 120.768 0.318 . . . . 0.0 110.629 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -108.61 143.96 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 42' ' ' SER . 91.3 mtt180 -81.16 134.03 35.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.551 0.691 . . . . 0.0 110.261 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.639 HG11 ' HE2' ' A' ' 16' ' ' LYS . 42.5 t -116.17 150.67 18.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.231 -168.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -106.13 145.93 30.85 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 63.46 0.9 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.665 -175.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -85.27 4.23 35.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.757 ' HG2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -160.89 -178.35 6.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.121 -1.854 . . . . 0.0 107.705 179.079 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -93.6 75.69 4.38 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.367 -174.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -174.09 143.84 0.94 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 15.7 m120 -98.75 -33.48 10.9 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.14 163.79 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' HB ' HD11 ' A' ' 73' ' ' LEU . 9.8 p -153.84 140.15 12.66 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 120.668 0.271 . . . . 0.0 110.67 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 72.7 Cg_endo -79.14 145.54 19.38 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.568 2.179 . . . . 0.0 112.863 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.61 168.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.109 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.3 ptpt -141.07 173.78 11.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.39 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 90.7 p -109.17 138.88 44.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.87 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -68.04 -33.23 74.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.993 0.425 . . . . 0.0 110.85 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -115.78 147.17 38.45 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.056 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.51 120.37 7.76 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.771 2.314 . . . . 0.0 111.071 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.45 151.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -51.35 130.38 26.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.172 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 pt -61.12 -18.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -63.38 -35.68 81.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -95.81 10.87 35.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 111.555 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -61.86 -39.75 92.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.45 -40.93 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.386 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.21 -55.04 39.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.566 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.5 m-30 -67.36 -38.94 85.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.588 -174.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 p -69.05 -31.06 69.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.401 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -62.8 -32.39 73.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -79.94 -45.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.689 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 93.4 mt -63.18 -24.89 68.09 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' A' ' 11' ' ' ARG . 8.7 p -80.99 -18.84 45.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 110.971 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -99.09 -11.28 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.74 140.86 29.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.998 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -130.52 102.63 6.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.506 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 19.4 m -109.81 141.53 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.136 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.13 -3.01 29.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.584 -176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.478 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 14.5 m -58.8 125.81 78.48 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.757 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 33.7 Cg_endo -97.75 68.7 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.703 2.935 . . . . 0.0 112.732 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -179.27 5.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.407 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.585 ' HG3' ' ND2' ' A' ' 72' ' ' ASN . 13.8 mptt -99.94 -173.24 2.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.711 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t -66.12 146.01 55.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 0.0 111.06 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.71 31.7 35.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.344 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 69' ' ' CYS . 9.5 p30 -101.43 133.92 45.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.728 0.299 . . . . 0.0 110.281 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 58' ' ' LYS . 50.8 t -79.4 115.13 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 110.699 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.21 -51.56 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.004 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.9 m -127.41 110.18 12.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.897 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' HG11 ' A' ' 55' ' ' VAL . 65.3 tttp -99.04 123.82 43.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.679 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.2 t-20 62.94 60.26 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.519 HG12 ' HG3' ' A' ' 61' ' ' MET . 14.9 tt -76.39 123.0 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.285 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.519 ' HG3' HG12 ' A' ' 60' ' ' ILE . 86.7 mtp 65.73 23.11 11.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.927 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.679 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 11.2 m120 60.14 76.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.114 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -127.85 -44.06 1.5 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.047 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.26 16.24 12.63 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -109.98 136.31 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.52 107.82 18.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.491 0.662 . . . . 0.0 110.055 175.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.69 113.54 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.509 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.3 pt -110.88 141.45 26.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.211 0.529 . . . . 0.0 111.774 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.55 ' HB3' HD21 ' A' ' 54' ' ' ASN . 50.2 t -89.65 141.86 28.21 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -116.78 -2.24 11.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.156 0.503 . . . . 0.0 110.96 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -98.05 146.82 25.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.585 ' ND2' ' HG3' ' A' ' 51' ' ' LYS . 2.6 m-20 -92.71 123.5 36.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.736 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.6 mm? -81.58 127.11 74.19 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.5 -175.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 13.6 Cg_exo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.739 2.293 . . . . 0.0 113.433 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 88.2 mttt . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.917 0.389 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -119.64 141.73 49.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.149 -172.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -67.34 106.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.969 0.414 . . . . 0.0 110.235 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.42 121.43 17.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 t -141.93 144.98 34.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.982 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.6 m -158.85 170.43 22.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.02 118.7 57.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -105.63 152.24 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -74.97 116.28 15.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.075 0.464 . . . . 0.0 110.515 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.748 HG13 ' HE2' ' A' ' 16' ' ' LYS . 9.0 p -88.98 144.55 8.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.552 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 8.3 ttp180 -122.38 -178.91 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.418 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -171.57 23.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.881 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.5 m -80.53 91.8 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 0.0 110.894 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.748 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -157.71 -167.7 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.166 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.18 18.56 7.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.357 0.598 . . . . 0.0 110.373 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.543 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 90.5 m-85 -118.43 165.5 13.81 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -125.35 -1.4 7.57 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.232 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 m -149.82 151.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.0 p -144.86 121.37 6.16 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.89 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 24.5 Cg_exo -62.84 114.9 2.61 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.761 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.55 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -108.57 151.4 10.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.31 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.2 171.95 15.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.176 0.512 . . . . 0.0 111.353 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -109.0 130.13 55.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.875 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -77.96 -9.73 59.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.0 110.206 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 65' ' ' VAL . 90.0 mttt -122.22 143.72 39.88 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.499 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 37.2 Cg_endo -66.54 131.06 25.1 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.415 2.077 . . . . 0.0 112.394 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.58 136.8 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.658 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 4.7 pt-20 -84.15 146.18 28.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.875 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.705 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . 11.6 pt -72.92 2.86 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 p -83.66 -32.89 25.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.355 0.598 . . . . 0.0 109.966 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -92.9 -7.22 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.969 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.705 ' HB2' ' HA ' ' A' ' 31' ' ' ILE . 68.2 t90 -57.68 -40.88 80.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.017 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -66.19 -42.18 90.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.759 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.2 m-20 -60.62 -45.1 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -60.22 -39.99 88.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 m -63.41 -38.8 92.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.85 -38.44 91.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.621 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 36' ' ' ASP . 59.9 t -67.75 -41.44 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.96 -20.45 64.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.062 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.2 t -82.84 5.07 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 110.097 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -125.7 -31.89 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.349 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.6 tp -77.61 111.9 13.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.634 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -117.27 107.42 14.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 56' ' ' VAL . 15.7 m -92.77 121.36 43.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -106.76 24.52 25.24 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.169 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.52 104.42 55.94 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.72 95.9 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.518 2.146 . . . . 0.0 111.345 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.23 156.52 20.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 35.2 mtmm -101.9 78.22 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.68 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 15.8 t 68.43 159.72 0.17 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.619 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 30.91 63.84 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.558 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -109.66 119.6 39.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.402 0.62 . . . . 0.0 111.245 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG22 HG22 ' A' ' 68' ' ' ILE . 21.3 t -81.35 109.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.25 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 46' ' ' VAL . 4.1 m -85.66 -40.32 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.689 0.28 . . . . 0.0 111.027 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.7 m -130.42 100.98 5.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.418 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -85.32 119.94 26.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.9 t30 62.46 75.69 0.39 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.686 0.755 . . . . 0.0 109.358 -170.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tt -72.92 127.9 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.946 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 93.3 mmm 66.38 -80.37 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.835 0.71 . . . . 0.0 110.355 -175.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' MET . 59.2 t30 172.47 80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.103 0.561 . . . . 0.0 109.851 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 t -158.48 15.11 0.19 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.872 0.367 . . . . 0.0 111.367 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.22 -22.37 7.22 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.934 -0.651 . . . . 0.0 114.011 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 27' ' ' LYS . 65.9 t -66.95 121.43 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 117.313 0.556 . . . . 0.0 111.873 -174.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.49 121.97 37.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.904 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.57 122.87 41.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.809 0.338 . . . . 0.0 110.446 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 55' ' ' VAL . 20.1 pt -121.44 140.0 46.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.366 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.55 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.7 m -90.43 122.36 33.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -101.3 8.18 42.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 49.1 tttp -96.19 145.07 25.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.68 ' OD1' ' HB2' ' A' ' 52' ' ' SER . 2.2 m120 -92.68 103.62 15.98 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.929 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 12' ' ' VAL . 75.2 mt -96.32 111.59 57.16 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.411 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.459 -0.546 0 C-N-CA 122.676 2.251 . . . . 0.0 111.35 176.479 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 45.5 mmtt . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.6 139.77 50.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.883 0.373 . . . . 0.0 110.622 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.82 121.94 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.582 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -75.58 102.02 5.14 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -125.8 127.65 46.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.414 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -154.51 172.13 18.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 110.83 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.488 HG12 ' HB ' ' A' ' 20' ' ' VAL . 48.1 t -113.1 117.17 54.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.53 156.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.75 0.31 . . . . 0.0 110.649 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -72.96 102.97 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.587 HG13 ' HE2' ' A' ' 16' ' ' LYS . 10.2 p -85.05 134.33 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.699 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 68.8 mtp180 -126.54 -179.07 4.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.5 -172.86 33.42 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.14 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 p -74.84 99.26 3.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.169 0.509 . . . . 0.0 111.991 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -166.6 178.3 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.496 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -87.56 -27.54 22.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.469 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.595 ' HE2' ' HA ' ' A' ' 73' ' ' LEU . 82.3 m-85 -79.73 171.16 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -126.15 -15.1 5.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 171.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 9' ' ' VAL . 11.8 m -148.29 147.47 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.07 132.67 14.86 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.922 0.392 . . . . 0.0 111.204 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 138.96 21.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.643 2.229 . . . . 0.0 112.669 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.19 156.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.417 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -142.63 165.81 26.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.828 0.346 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 p -109.46 142.3 40.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -78.89 -8.29 58.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.242 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.19 134.43 16.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.127 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 52.6 Cg_exo -56.95 136.12 74.78 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.817 2.345 . . . . 0.0 112.183 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.26 145.65 20.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.3 135.01 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 pt -66.33 -9.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.293 . . . . 0.0 111.549 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 m -67.58 -30.73 70.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 87.9 mttt -86.83 -17.4 33.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.649 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -51.78 -45.44 63.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.148 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.5 -44.98 99.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 111.46 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 40' ' ' VAL . 14.8 t70 -79.46 -32.27 42.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 1.7 m-85 -56.18 -48.7 75.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.122 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -60.99 -44.37 97.51 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.277 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -57.56 -47.19 82.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.731 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 36' ' ' ASP . 87.6 t -64.78 -46.02 93.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.669 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 tp -65.71 -31.93 73.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.857 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -66.8 -20.9 66.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 110.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 43' ' ' ARG . 55.0 mtm180 -104.85 8.91 34.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.4 tp -110.47 84.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.591 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 79.6 m-85 -92.78 101.02 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -122.04 159.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.348 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -145.58 -134.4 2.69 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.517 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.46 115.57 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.024 0.53 . . . . 0.0 110.711 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 65.2 Cg_exo -53.54 111.07 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.08 2.52 . . . . 0.0 112.825 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -109.27 -170.91 1.74 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.042 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -127.13 166.75 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.004 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.53 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 22.5 t -61.86 131.3 49.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.693 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.54 21.16 32.5 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.634 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.434 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 2.1 p-10 -89.19 131.73 35.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.75 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 68' ' ' ILE . 38.7 t -87.27 106.16 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.119 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.4 -55.76 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.143 0.496 . . . . 0.0 109.809 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 t -130.7 121.11 24.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.403 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 31.8 ttmt -92.34 112.48 24.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.223 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 62' ' ' ASN . 62.9 t30 58.86 54.93 4.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.619 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.527 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 10.4 tt -46.27 -43.18 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.822 -171.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.501 ' HG3' HG12 ' A' ' 60' ' ' ILE . 84.4 mtp -128.98 29.03 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.491 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.424 ' HA ' ' ND2' ' A' ' 59' ' ' ASN . 40.7 t-20 53.81 72.51 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.406 0.622 . . . . 0.0 110.626 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -153.89 13.67 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.0 37.57 83.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.589 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 27' ' ' LYS . 52.0 t -127.08 120.95 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.014 0.435 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.592 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 15.9 m-20 -96.05 121.69 38.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.39 101.98 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.449 HG22 HG22 ' A' ' 55' ' ' VAL . 13.4 pt -109.15 139.92 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.368 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 43.9 t -95.25 145.24 25.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.258 174.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -121.05 8.91 10.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 110.495 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 24.9 tptp -96.68 131.37 43.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.53 ' OD1' ' HB2' ' A' ' 52' ' ' SER . 8.8 m120 -91.15 116.4 28.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.887 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.595 ' HA ' ' HE2' ' A' ' 18' ' ' TYR . 6.1 mp -96.73 119.59 63.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 122.245 1.963 . . . . 0.0 110.709 172.14 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 10.4 mmmm . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.719 ' HB3' ' HZ2' ' A' ' 34' ' ' TRP . 6.4 t70 -130.11 171.01 13.3 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.3 112.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.102 -0.374 . . . . 0.0 111.309 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.477 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 29.4 t80 -66.34 115.22 6.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.493 . . . . 0.0 110.357 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -123.39 133.42 54.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.777 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.3 t -152.98 -163.55 1.73 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 20' ' ' VAL . 8.8 p -141.07 136.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.84 148.75 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.21 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -73.56 143.06 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 111.03 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 18' ' ' TYR . 57.4 t -105.76 146.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.692 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.75 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 19.4 ttp180 -140.38 -179.31 5.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.479 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' N ' ' HG2' ' A' ' 13' ' ' ARG . . . 111.7 -154.27 16.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.166 165.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -77.93 20.43 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.322 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -156.4 142.45 18.09 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.068 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.24 87.43 7.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.256 0.551 . . . . 0.0 110.285 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' HB3' HG11 ' A' ' 12' ' ' VAL . 2.2 t80 -117.59 141.71 48.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -77.53 -69.88 0.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.4 ' HB ' ' CG2' ' A' ' 9' ' ' VAL . 17.6 m -136.74 148.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.073 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.9 p -127.44 127.42 24.15 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.659 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 55.6 Cg_endo -71.4 133.83 23.38 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.685 2.257 . . . . 0.0 112.424 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 69' ' ' CYS . 27.1 m -119.44 166.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.031 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -147.09 176.35 10.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.383 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 16.3 m -109.15 131.21 55.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -78.31 -11.32 59.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.964 0.411 . . . . 0.0 110.428 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HB3' HG22 ' A' ' 65' ' ' VAL . 39.5 ttpt -135.78 135.15 21.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 14.4 Cg_endo -56.28 141.47 88.56 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 65' ' ' VAL . 4.2 m -122.18 174.21 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.131 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . 25.3 mt-10 -71.36 140.25 50.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 33' ' ' LYS . 36.0 pt -67.54 151.71 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 m 72.69 -32.77 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.116 0.566 . . . . 0.0 111.112 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 30' ' ' GLU . 19.2 tptm -64.26 -16.92 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 174.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.719 ' HZ2' ' HB3' ' A' ' 4' ' ' ASP . 52.0 m0 -54.27 -39.07 66.54 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.589 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.15 -36.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.15 -44.54 79.51 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.165 0.507 . . . . 0.0 110.263 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -66.45 -37.26 84.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 t -65.78 -32.27 73.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.291 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.48 -42.6 99.59 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.076 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.63 -47.8 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.869 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.851 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -64.1 -20.59 66.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 110.543 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -104.13 14.8 29.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.857 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 56' ' ' VAL . 32.0 tp -112.52 139.09 48.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -127.16 97.66 5.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.78 124.64 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.228 0.537 . . . . 0.0 111.055 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.75 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -109.62 175.19 18.61 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.182 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 99.2 t 73.53 134.29 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 123.05 0.54 . . . . 0.0 111.544 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.61 116.7 3.38 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.859 2.373 . . . . 0.0 111.78 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 p -118.79 169.52 9.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -120.3 169.36 10.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -52.58 118.64 3.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 24.95 9.84 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.115 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.7 p-10 -88.47 132.34 34.52 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 68' ' ' ILE . 34.4 t -88.25 125.47 41.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.07 -175.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.471 ' HB ' HD21 ' A' ' 44' ' ' LEU . 30.5 m -97.85 -38.15 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.092 0.472 . . . . 0.0 110.258 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.6 m -130.9 105.14 7.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.791 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -95.19 127.48 41.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.12 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 1.6 t-20 54.56 40.37 31.79 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.842 0.713 . . . . 0.0 109.748 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.597 HG12 ' HG2' ' A' ' 61' ' ' MET . 10.4 tt -41.96 -50.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.622 -169.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.597 ' HG2' HG12 ' A' ' 60' ' ' ILE . 25.7 mmt -134.71 49.04 2.25 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.35 -0.219 . . . . 0.0 110.628 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 8.5 p30 56.71 5.86 0.25 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.841 1.256 . . . . 0.0 113.753 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.592 HG23 ' H ' ' A' ' 65' ' ' VAL . 5.0 t -78.56 -11.68 59.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.311 0.577 . . . . 0.0 110.71 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -6.35 83.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.268 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.592 ' H ' HG23 ' A' ' 63' ' ' THR . 66.5 t -81.33 126.9 39.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.817 0.341 . . . . 0.0 110.512 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -108.77 123.85 49.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mm -81.68 117.35 27.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' VAL . 33.6 pt -121.99 139.85 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.612 -173.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 23' ' ' VAL . 1.8 m -89.32 137.32 32.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -105.38 13.12 30.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.128 0.49 . . . . 0.0 111.454 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 21' ' ' VAL . 31.9 mmtt -96.76 142.64 28.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -96.47 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 mt -99.8 112.71 64.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.581 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.457 -0.642 0 C-N-CA 122.994 2.463 . . . . 0.0 112.007 177.07 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 93.2 mttt . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 154.51 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 28' ' ' PRO . 46.7 mm -73.97 112.79 11.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.431 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.528 ' HB2' HG21 ' A' ' 29' ' ' VAL . 87.0 t80 -64.01 104.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.592 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -111.02 120.56 42.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -141.47 -166.86 2.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 60.5 t -133.63 129.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.39 152.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -91.96 133.26 35.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 110.307 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 HG23 ' A' ' 46' ' ' VAL . 2.5 t -118.76 133.31 66.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 112.025 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.566 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 92.4 mtt-85 -108.29 -179.11 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.353 173.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -161.6 21.59 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.453 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.2 m -78.77 74.87 5.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 111.393 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -147.96 166.66 27.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.581 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -89.32 -46.42 8.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.855 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.422 ' O ' ' HD2' ' A' ' 16' ' ' LYS . 85.4 m-85 -83.67 156.8 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -103.35 -3.03 26.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.865 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 6.5 m -143.51 145.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -134.18 129.13 19.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.436 174.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HG2' ' HB2' ' A' ' 71' ' ' LYS . 36.0 Cg_endo -67.89 128.89 18.57 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.494 2.129 . . . . 0.0 112.342 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 69' ' ' CYS . 27.1 m -115.94 161.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.343 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -139.76 178.33 7.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.13 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.21 134.45 51.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.768 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -72.87 -22.25 60.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HB2' HG22 ' A' ' 65' ' ' VAL . 37.7 mtmm -132.42 146.29 60.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' HD13 ' A' ' 5' ' ' ILE . 23.9 Cg_exo -63.15 137.62 62.5 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.969 2.446 . . . . 0.0 112.818 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 6' ' ' PHE . 33.4 m -114.99 160.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.411 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.608 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 59.4 mt-10 -68.65 139.7 55.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 29.7 pt -60.22 -26.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.375 . . . . 0.0 111.675 -177.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 m -74.74 -17.41 60.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.082 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.608 ' HE2' ' OE1' ' A' ' 30' ' ' GLU . 63.8 mttm -90.48 -5.29 56.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.612 0.244 . . . . 0.0 111.334 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.442 ' CD1' ' HA ' ' A' ' 31' ' ' ILE . 10.5 m95 -59.05 -31.26 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.02 -48.3 75.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.462 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 40' ' ' VAL . 7.1 m-20 -56.5 -50.63 71.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.49 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.434 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 32.4 m-85 -63.07 -37.05 85.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.371 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -63.4 -41.83 98.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.832 -0.167 . . . . 0.0 111.095 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -62.78 -35.27 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.958 0.409 . . . . 0.0 110.679 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 36' ' ' ASP . 59.1 t -70.02 -48.58 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.61 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.938 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.3 m -66.18 -12.14 54.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.644 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -105.15 -9.29 17.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 109.918 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.11 124.0 43.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.605 -172.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -125.3 117.1 23.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.641 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.514 HG11 HG13 ' A' ' 56' ' ' VAL . 24.9 m -106.02 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -151.3 47.04 0.59 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.426 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.33 119.73 17.69 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-O 120.562 0.22 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.66 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 55.8 Cg_endo -73.49 97.59 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.581 2.188 . . . . 0.0 111.473 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 p -96.77 170.22 9.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 64.1 mttp -98.27 -149.76 0.35 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.695 171.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 2.0 p -92.36 119.59 32.06 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.62 58.16 1.21 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.177 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.511 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 13.2 m120 -127.91 129.24 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.17 110.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.167 0.508 . . . . 0.0 111.322 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 HG11 ' A' ' 46' ' ' VAL . 45.1 t -83.98 -42.61 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.684 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.1 m -130.53 103.6 6.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.443 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -84.23 128.19 34.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.528 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 54.79 52.66 11.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.348 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.554 HG21 HG12 ' A' ' 67' ' ' ILE . 12.7 tt -75.32 135.7 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.403 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.7 mmt 65.07 13.85 8.97 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.477 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.4 13.15 5.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.568 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 65' ' ' VAL . 8.9 t -87.51 -7.49 57.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.449 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.46 66.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.629 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.516 ' H ' HG23 ' A' ' 63' ' ' THR . 77.1 t -73.07 137.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.113 0.483 . . . . 0.0 110.283 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.94 120.2 38.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.554 HG12 HG21 ' A' ' 60' ' ' ILE . 44.0 mm -80.04 115.97 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.77 0.319 . . . . 0.0 110.397 -175.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 26.3 pt -116.13 131.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.649 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.52 ' HB3' HG12 ' A' ' 23' ' ' VAL . 1.8 p -81.13 139.32 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 11.7 t -126.13 6.99 7.18 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.395 -173.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.532 ' HB3' HG23 ' A' ' 21' ' ' VAL . 64.2 tttp -99.67 131.12 45.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 2.7 m-20 -76.19 107.17 8.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.506 HD11 ' HB ' ' A' ' 21' ' ' VAL . 95.8 mt -81.58 112.62 35.68 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.279 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.459 -0.548 0 C-N-CA 122.487 2.125 . . . . 0.0 112.067 -179.062 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 28' ' ' PRO . 68.2 mttm . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.62 157.13 32.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.575 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.3 mm -82.74 101.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 81.9 t80 -58.8 106.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.339 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -122.26 128.69 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.068 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -149.54 -168.98 3.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.9 m -121.75 137.53 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.705 0.288 . . . . 0.0 110.34 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.86 152.27 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -89.45 111.18 22.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.576 0.703 . . . . 0.0 110.117 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.608 ' HB ' ' HZ1' ' A' ' 16' ' ' LYS . 3.0 t -98.28 140.01 19.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.608 -173.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 45' ' ' TYR . 67.6 mtm180 -79.75 144.37 33.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.54 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -70.58 95.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 115.124 -169.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 p -117.37 12.33 14.23 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 165.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HZ1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -169.96 -168.92 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.359 -171.136 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.43 -41.36 14.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.602 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 78.2 m-85 -82.4 97.32 8.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 111.498 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 95.8 m-20 -98.63 10.72 40.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.52 122.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 73' ' ' LEU . 4.4 p -130.91 139.73 36.49 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.719 -173.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.43 124.39 10.33 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.923 2.415 . . . . 0.0 112.966 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.4 154.61 16.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.516 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -143.98 178.97 7.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB2' HG11 ' A' ' 65' ' ' VAL . 67.8 p -108.93 127.67 54.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.758 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -63.9 -24.32 67.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.863 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB2' HG22 ' A' ' 65' ' ' VAL . 82.8 mttt -122.68 142.71 38.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HB2' ' CB ' ' A' ' 3' ' ' LYS . 32.5 Cg_endo -64.81 128.29 20.58 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.232 1.955 . . . . 0.0 112.117 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.04 150.26 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.201 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.07 120.75 14.8 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.19 84.12 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.725 1.25 . . . . 0.0 111.914 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.1 m -138.04 -10.45 1.52 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.081 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -103.46 17.77 23.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -173.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -62.99 -26.84 69.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 110.494 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 64.2 mt -73.02 -47.91 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.429 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 40' ' ' VAL . 5.8 m-20 -68.29 -39.71 82.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.546 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.8 m-30 -64.21 -48.41 75.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -66.43 -30.75 71.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.182 0.515 . . . . 0.0 110.064 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 14.5 t-20 -56.72 -49.66 74.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.028 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 36' ' ' ASP . 47.1 t -70.99 -38.03 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.736 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 81.2 mt -62.01 -25.35 67.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.245 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -77.86 4.3 12.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.004 0.43 . . . . 0.0 111.396 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -141.64 16.75 2.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 0.0 109.963 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.9 tp -115.1 59.43 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.725 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 78.7 m-85 -83.83 92.05 7.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.738 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 48' ' ' VAL . 14.9 p -92.18 147.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.99 49.19 0.93 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.1 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 22.3 m -130.23 128.96 22.81 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 48' ' ' VAL . 23.2 Cg_exo -67.39 133.26 29.74 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.136 2.558 . . . . 0.0 111.589 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.509 ' H ' HD13 ' A' ' 73' ' ' LEU . 2.0 p -133.41 179.68 6.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.961 -174.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -118.92 169.5 9.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 t -59.56 128.71 38.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 0.0 111.805 -173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.97 26.71 12.1 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.554 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.591 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.0 p30 -96.42 137.53 35.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' A' ' 58' ' ' LYS . 62.4 t -77.6 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.69 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.87 -57.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.2 t -130.49 109.25 10.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.915 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' HG11 ' A' ' 55' ' ' VAL . 9.3 tmtm? -84.12 119.82 25.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.623 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 57.46 50.86 10.56 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 110.221 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.651 HG12 ' HG2' ' A' ' 61' ' ' MET . 8.0 tt -49.15 -50.46 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.666 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.651 ' HG2' HG12 ' A' ' 60' ' ' ILE . 95.8 mmm -130.12 45.41 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.791 0.329 . . . . 0.0 110.585 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.04 29.63 19.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.194 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -86.31 -20.05 28.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.689 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.79 87.52 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 27' ' ' LYS . 69.0 t -104.47 138.75 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.212 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 58' ' ' LYS . 4.3 m-20 -97.41 106.94 19.35 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.07 107.12 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 55' ' ' VAL . 33.4 pt -114.69 144.87 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.977 -171.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.591 ' HB3' HD21 ' A' ' 54' ' ' ASN . 10.3 t -89.65 141.97 28.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.046 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -120.07 6.74 10.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 56.7 tttp -101.74 147.55 26.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.01 110.88 23.37 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 21' ' ' VAL . 5.7 mp -87.45 116.1 65.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.988 -176.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 2.9 Cg_exo . . . . . 0 C--O 1.236 0.377 0 C-N-CA 123.013 2.475 . . . . 0.0 111.519 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.3 mttt . . . . . 0 C--O 1.233 0.188 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -140.57 164.4 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.022 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -74.85 113.19 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 72.8 t80 -59.35 108.5 0.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.842 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -126.26 120.98 31.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.381 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -155.79 -156.79 0.67 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.2 m -132.08 147.03 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.784 0.326 . . . . 0.0 110.465 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.51 150.42 18.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.017 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.463 ' HD3' HG12 ' A' ' 20' ' ' VAL . 12.0 mmt180 -84.38 121.31 27.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 6.5 t -100.66 118.27 47.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.389 -173.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' C ' ' HA3' ' A' ' 47' ' ' GLY . 62.5 ttt180 -133.1 104.2 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 47' ' ' GLY . . . 174.42 -171.83 44.88 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -78.3 99.31 6.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -171.78 -166.63 0.44 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.36 -179.372 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -128.35 71.68 1.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -161.28 176.12 11.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -136.12 -50.07 0.69 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 110.551 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.463 HG12 ' HD3' ' A' ' 11' ' ' ARG . 15.9 m -131.11 133.45 62.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.19 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 73' ' ' LEU . 4.4 p -127.59 140.79 39.01 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.225 -177.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 47.2 Cg_endo -70.08 137.63 34.98 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.243 1.962 . . . . 0.0 112.199 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -135.25 146.79 29.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.558 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -145.22 178.93 7.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.914 0.388 . . . . 0.0 111.288 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.515 ' HB2' HG11 ' A' ' 65' ' ' VAL . 91.3 p -108.86 129.56 55.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.03 -39.77 72.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.516 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 65' ' ' VAL . 32.3 ttmt -119.52 140.25 29.0 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.462 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.91 126.22 20.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.533 2.155 . . . . 0.0 111.924 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.54 156.92 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.646 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 25.8 mt-10 -67.09 127.29 32.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.9 pt -74.31 -6.8 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 110.877 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.9 t -60.6 -31.96 71.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.331 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.447 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 33.2 mtmm -107.1 14.86 25.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.719 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -57.52 -36.21 71.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.698 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.19 -39.69 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.04 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 40' ' ' VAL . 25.7 t0 -71.96 -42.16 66.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 22.3 m-85 -58.08 -46.22 85.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.272 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.0 p -68.98 -28.6 66.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.309 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -72.69 -24.66 61.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.918 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 57.6 t -71.67 -44.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.18 -42.86 91.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.407 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -77.91 2.85 16.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 111.227 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -111.49 -15.89 13.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.537 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 93.3 mt -74.07 -71.66 0.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.861 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 58.5 79.92 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.465 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.3 p -125.22 143.36 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.614 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' C ' ' A' ' 13' ' ' ARG . . . -139.17 88.98 0.2 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.086 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 60.0 t -128.82 120.61 20.58 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' VAL . 14.2 Cg_endo -57.71 111.13 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 111.779 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 171.66 14.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.548 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -100.55 178.32 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.341 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -68.9 129.17 39.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.57 28.56 10.25 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.285 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.8 p30 -88.32 131.32 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 66' ' ' ASP . 37.0 t -88.97 110.71 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.794 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.99 -64.74 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.131 0.491 . . . . 0.0 109.789 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.412 ' HB3' ' HB ' ' A' ' 60' ' ' ILE . 70.3 m -100.47 116.69 33.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.311 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HD3' HG12 ' A' ' 55' ' ' VAL . 25.3 mmtt -83.4 104.01 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.6 t30 54.77 66.31 1.27 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.703 0.763 . . . . 0.0 109.595 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.48 HD11 HG11 ' A' ' 40' ' ' VAL . 12.3 tt -61.69 111.25 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.539 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm 63.76 26.17 14.35 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.63 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 m120 62.75 82.68 0.17 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.284 0.564 . . . . 0.0 111.372 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.2 p -133.14 -20.83 2.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.203 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.22 7.45 73.2 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.35 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 27' ' ' LYS . 60.1 t -116.72 129.44 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.049 0.452 . . . . 0.0 110.442 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.492 ' HB2' HG13 ' A' ' 55' ' ' VAL . 5.4 p-10 -95.55 126.08 40.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 169.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 mm -83.15 110.89 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.018 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.7 pt -117.4 138.53 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.451 0.643 . . . . 0.0 112.273 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.555 ' HB3' HD21 ' A' ' 54' ' ' ASN . 40.7 t -92.11 145.7 24.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -114.92 -2.74 12.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HD3' HG23 ' A' ' 21' ' ' VAL . 55.9 tttp -97.04 149.88 21.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -96.76 132.62 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.493 HD11 HG21 ' A' ' 21' ' ' VAL . 5.1 mp -111.79 93.98 22.5 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 N--CA 1.452 -0.967 0 C-N-CA 122.776 2.317 . . . . 0.0 113.024 -177.558 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 94.2 mttt . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -124.19 148.17 47.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.487 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.468 HG22 HG23 ' A' ' 7' ' ' THR . 42.0 mm -64.6 119.74 9.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.083 0.468 . . . . 0.0 110.959 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 91.6 t80 -78.13 96.01 5.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.034 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 5' ' ' ILE . 16.6 p -105.72 125.19 50.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 60.0 m -149.94 -169.0 3.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 138.83 52.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.3 157.85 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.459 ' HD2' HG12 ' A' ' 20' ' ' VAL . 33.6 mmm-85 -79.74 133.1 36.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.802 0.334 . . . . 0.0 110.797 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 46' ' ' VAL . 2.8 t -120.63 139.1 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.284 0.564 . . . . 0.0 110.669 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 64.6 ttt-85 -119.43 170.49 9.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.074 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.09 174.35 18.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.634 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.6 p -72.52 86.35 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.549 ' HG2' ' HG3' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -178.15 164.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.044 171.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -91.71 34.14 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.374 -0.376 . . . . 0.0 112.011 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.418 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 97.5 m-85 -130.55 102.91 6.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 110.31 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.39 -7.06 55.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.546 -176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.459 HG12 ' HD2' ' A' ' 11' ' ' ARG . 15.5 m -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.511 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.512 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.1 p -140.78 138.25 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.435 177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' SER . 55.2 Cg_endo -72.98 129.57 14.42 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.558 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 69' ' ' CYS . 30.1 m -115.58 161.55 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.569 ' HG3' HG13 ' A' ' 68' ' ' ILE . 18.3 ptpt -131.34 174.94 9.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.481 ' HB2' HG11 ' A' ' 65' ' ' VAL . 79.8 p -108.93 130.95 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.262 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.78 -44.71 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HG3' ' HD2' ' A' ' 28' ' ' PRO . 37.5 ttpt -121.09 140.88 31.76 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.538 ' HD2' ' HG3' ' A' ' 27' ' ' LYS . 84.6 Cg_exo -46.92 130.76 16.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.088 2.526 . . . . 0.0 112.835 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.81 127.09 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.667 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 40.9 mt-10 -52.5 135.3 34.12 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.301 176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 tp -68.26 81.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 122.051 0.929 . . . . 0.0 110.881 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t 179.9 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.217 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.12 -5.69 52.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.295 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -57.56 -34.25 68.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.27 -54.99 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.658 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 7.5 m-20 -62.44 -38.16 88.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.02 -51.42 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.242 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -64.9 -32.01 73.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.632 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 24.9 t-20 -55.56 -54.34 45.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.901 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 36' ' ' ASP . 67.3 t -60.42 -42.93 92.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.98 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.4 mt -60.99 -27.2 68.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -68.28 -10.63 56.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.58 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -130.2 20.07 5.34 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 174.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.3 tp -109.89 115.23 29.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.43 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -117.29 112.69 21.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.369 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.551 HG23 HG13 ' A' ' 12' ' ' VAL . 27.3 m -96.67 178.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -143.98 176.04 23.51 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.089 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.7 t 71.97 139.75 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 122.797 0.439 . . . . 0.0 111.216 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HG3' ' HG2' ' A' ' 16' ' ' LYS . 25.1 Cg_exo -64.8 119.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.447 2.098 . . . . 0.0 111.401 170.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.587 ' HB ' ' CG ' ' A' ' 54' ' ' ASN . 40.6 p -101.6 166.34 10.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.826 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.59 -148.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 t -101.95 120.81 41.0 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.31 49.77 1.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.026 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.587 ' CG ' ' HB ' ' A' ' 50' ' ' THR . 1.5 m-80 -108.69 109.11 20.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 68' ' ' ILE . 94.7 t -69.55 111.38 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 -62.55 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.71 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -130.81 115.3 16.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.032 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 20.6 ptmt -98.18 141.97 30.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.824 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.497 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 11.8 t-20 58.34 41.7 22.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.716 0.77 . . . . 0.0 109.028 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.773 HG12 ' HG2' ' A' ' 61' ' ' MET . 14.4 tt -64.51 133.67 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.41 -173.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.773 ' HG2' HG12 ' A' ' 60' ' ' ILE . 83.7 mmm 63.39 21.85 12.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.9 t30 65.65 10.91 7.11 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.13 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -69.87 -43.82 71.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.96 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.497 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 117.43 -27.14 7.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 25' ' ' SER . 85.8 t -66.95 140.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.67 0.271 . . . . 0.0 110.766 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 4.2 m-20 -95.63 123.0 38.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.76 106.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.569 HG13 ' HG3' ' A' ' 24' ' ' LYS . 25.7 pt -115.53 132.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.857 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.578 ' HB3' HD22 ' A' ' 54' ' ' ASN . 18.2 t -72.09 142.1 49.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.1 t -126.35 1.83 7.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 64.7 tttp -102.58 129.08 49.03 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.481 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -86.23 106.39 17.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.974 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 62.9 mt -95.73 126.03 46.76 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.079 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 73' ' ' LEU . 15.6 Cg_endo . . . . . 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.175 . . . . 0.0 111.532 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.03 -71.48 0.73 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -134.75 163.23 30.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.64 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.3 145.43 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.746 0.308 . . . . 0.0 110.563 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.38 119.73 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.923 0.392 . . . . 0.0 110.277 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 77.0 t80 -60.11 125.71 24.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.155 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.8 m -145.15 120.39 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 178.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.58 120.97 66.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.3 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.74 150.58 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.805 0.336 . . . . 0.0 110.333 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.538 ' HA ' HG12 ' A' ' 20' ' ' VAL . 91.0 mtt180 -77.22 134.45 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.597 ' CG1' ' HE3' ' A' ' 16' ' ' LYS . 12.0 t -112.85 111.6 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -90.84 100.91 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.448 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.5 14.0 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 t -85.03 99.84 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.58 39.77 0.81 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.356 -175.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.6 tttm 70.74 -66.07 0.31 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.568 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -73.79 -179.06 3.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 111.363 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.0 -36.43 1.98 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.653 0.263 . . . . 0.0 111.245 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 11' ' ' ARG . 17.0 m -129.03 158.99 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.218 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.2 p -128.67 133.4 25.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.93 118.8 5.72 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.529 2.152 . . . . 0.0 111.717 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 69' ' ' CYS . 28.9 m -112.5 150.54 14.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.51 ' HE3' HG21 ' A' ' 70' ' ' THR . 18.3 ptpt -136.66 170.56 15.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.969 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 17.0 t -109.45 155.71 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.468 HD21 ' HE2' ' A' ' 27' ' ' LYS . 21.1 p-10 -78.04 -32.86 51.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.176 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' HD21 ' A' ' 26' ' ' ASN . 51.1 mtmt -122.58 150.86 58.97 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.975 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 23.3 Cg_exo -64.38 136.9 53.06 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.137 2.558 . . . . 0.0 112.971 -176.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -124.57 150.19 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.824 -177.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -69.52 145.7 52.45 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.866 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tt -60.35 -27.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.987 0.422 . . . . 0.0 111.546 -174.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.45 -28.0 68.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 111.059 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.13 -20.73 22.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.711 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -57.55 -43.33 84.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -67.37 -45.59 85.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.135 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.96 -45.8 89.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.449 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CE2' HG11 ' A' ' 29' ' ' VAL . 22.1 m-30 -67.51 -37.44 82.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.602 0.239 . . . . 0.0 110.877 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 m -64.44 -33.7 76.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.21 -40.2 95.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.22 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 50.7 t -64.98 -44.3 96.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.338 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.91 -21.92 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.443 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -73.5 -13.59 61.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.381 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 10.3 ptt180 -111.65 1.26 16.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.366 0.603 . . . . 0.0 109.43 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 tt -108.73 133.02 53.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.683 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.96 110.24 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.642 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 43.2 t -78.01 126.72 38.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.96 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.773 -1.203 . . . . 0.0 112.589 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.8 112.14 20.52 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.535 0.207 . . . . 0.0 110.913 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 6.1 Cg_exo -75.44 102.95 1.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.774 2.316 . . . . 0.0 110.786 170.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.61 -178.57 4.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.302 0.572 . . . . 0.0 112.352 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.91 -178.23 5.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.367 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 p -74.85 140.13 43.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.462 . . . . 0.0 111.181 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 32.16 16.95 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.712 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.3 p-10 -96.58 128.4 43.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.313 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG22 HG22 ' A' ' 68' ' ' ILE . 47.7 t -83.15 120.53 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.917 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.99 -61.26 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.509 0.671 . . . . 0.0 109.798 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.69 121.38 25.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.286 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -91.81 136.5 33.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.26 56.52 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.452 0.47 . . . . 0.0 110.236 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.37 125.57 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.254 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 96.9 mmm 64.46 23.85 13.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.564 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.5 t30 51.26 69.5 0.64 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.793 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 p -114.49 -35.01 5.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.845 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.67 9.95 34.13 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.454 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 27' ' ' LYS . 1.7 p -104.04 157.28 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -109.29 137.97 46.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mm -111.52 117.19 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 34.3 pt -123.78 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 111.793 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.7 m -82.72 134.59 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.51 HG21 ' HE3' ' A' ' 24' ' ' LYS . 12.7 t -109.77 3.9 21.27 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.246 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' HB3' HG23 ' A' ' 21' ' ' VAL . 55.7 tptt -96.68 143.6 27.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -90.93 121.12 32.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.8 mm? -98.35 112.27 61.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.91 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 8.6 Cg_endo -87.39 96.36 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.145 2.564 . . . . 0.0 111.719 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 42.7 tttm -69.78 -58.44 3.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.411 0.624 . . . . 0.0 110.685 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -106.95 113.71 27.36 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.632 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.5 m -85.42 80.01 9.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.155 0.502 . . . . 0.0 110.629 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.1 mt -102.06 88.9 3.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.319 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.92 118.18 36.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -112.06 47.6 1.04 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.129 0.49 . . . . 0.0 110.634 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -100.59 -41.64 6.87 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -101.37 150.67 22.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.693 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -79.04 -91.73 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 176.3 142.37 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 39.0 m170 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.952 175.081 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mtt . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.583 0.23 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -133.21 126.41 31.53 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.587 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.529 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 99.4 mttt -105.17 146.59 29.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.536 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.42 148.65 50.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.03 0.443 . . . . 0.0 111.377 -176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 25' ' ' SER . 47.2 mm -61.77 110.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.309 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.93 110.9 3.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -123.89 127.93 48.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.878 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.4 m -154.72 173.85 15.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.2 t -117.26 125.04 73.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.6 156.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.808 0.337 . . . . 0.0 110.664 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 11' ' ' ARG . 21.7 mtp85 -90.24 116.9 28.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.124 0.488 . . . . 0.0 109.788 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 t -108.45 140.76 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.875 -172.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 65.9 mtt-85 -97.53 158.41 15.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.62 157.74 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.05 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 77' ' ' SER . 5.0 p -81.55 45.37 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.461 0.648 . . . . 0.0 111.013 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 33.58 2.32 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.087 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 tptt 69.74 -59.27 0.5 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 0.0 112.056 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -80.91 -177.46 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -143.5 11.4 1.68 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.294 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.521 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.5 m -146.31 147.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.024 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 71' ' ' LYS . 9.5 p -137.66 133.71 18.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.562 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -70.47 116.0 4.44 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.804 2.336 . . . . 0.0 112.269 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.9 m -105.44 151.33 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.954 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 163.27 30.8 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.363 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 5' ' ' ILE . 19.5 m -109.27 131.82 54.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -75.61 -12.68 60.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 65' ' ' VAL . 75.0 mmtt -115.98 143.16 30.33 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 17.1 Cg_exo -67.59 120.25 7.27 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.316 2.011 . . . . 0.0 110.923 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.73 148.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.677 -172.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.529 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 54.1 mt-10 -64.0 119.53 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -61.32 -22.31 27.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -70.03 -16.54 63.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.996 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -98.8 11.7 37.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -62.95 -35.07 78.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.685 0.279 . . . . 0.0 110.8 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.58 -39.94 85.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.519 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 40' ' ' VAL . 37.2 t70 -61.77 -48.03 82.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.75 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.43 -40.77 89.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.9 m -60.91 -38.94 87.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.934 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.27 -43.47 98.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 36' ' ' ASP . 47.8 t -65.38 -45.1 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.533 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.19 -27.34 69.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.567 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 m -73.73 -5.01 38.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.29 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -113.6 5.08 16.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.239 0.543 . . . . 0.0 109.679 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.8 tp -109.05 42.14 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.022 -172.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -70.19 94.61 0.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.397 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.59 154.23 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.26 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -124.59 98.42 0.56 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.299 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 7.3 p -168.5 126.14 0.89 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.783 0.325 . . . . 0.0 110.763 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.638 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 8.5 Cg_exo -72.49 120.99 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.743 2.295 . . . . 0.0 111.373 174.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -122.11 -179.23 4.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.82 173.13 6.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 p -69.84 126.13 28.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 110.83 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 30.05 13.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.759 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.6 p-10 -88.85 128.04 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 68' ' ' ILE . 22.1 t -88.19 112.83 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.376 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -76.46 -62.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 44.3 t -130.64 108.81 10.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.253 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.9 138.76 32.33 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.55 43.23 16.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 6.2 tt -50.44 -39.11 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.339 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.86 39.48 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.87 18.82 11.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.11 0.957 . . . . 0.0 109.71 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 65' ' ' VAL . 20.5 p -82.51 -25.4 33.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.164 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.19 15.28 69.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.281 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 27' ' ' LYS . 48.7 t -92.26 139.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.85 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.61 101.01 12.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.81 102.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.8 pt -115.35 136.58 51.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.559 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.3 m -87.77 135.9 33.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -108.39 0.26 21.01 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.126 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HB3' HG23 ' A' ' 21' ' ' VAL . 66.4 tttp -102.47 140.12 37.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -89.28 132.31 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.4 mm? -95.64 122.98 57.64 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.257 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 37.6 Cg_exo -60.74 125.56 17.55 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.007 2.472 . . . . 0.0 112.484 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HD3' ' HB2' ' A' ' 49' ' ' PRO . 34.1 mmtp -73.43 -24.99 60.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.204 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -85.17 113.65 21.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.728 -173.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 15' ' ' SER . 17.1 p -99.31 48.8 0.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.323 0.582 . . . . 0.0 109.607 174.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.6 pt? -69.01 -5.01 19.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.105 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -78.48 79.22 4.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.631 0.729 . . . . 0.0 110.943 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -118.97 -67.9 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 170.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 67.45 -75.86 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.908 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -130.15 126.38 37.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.508 0.194 . . . . 0.0 110.52 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -96.15 71.52 2.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.429 0.633 . . . . 0.0 110.658 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -143.03 -77.36 0.24 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 . . . . . 0 C--O 1.242 0.68 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.445 175.059 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.801 0.334 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -104.42 114.5 28.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.786 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 60.0 mttm -82.32 126.22 31.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.333 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -140.6 179.64 6.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.0 mm -89.61 101.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.452 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 75.7 t80 -59.56 107.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.503 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -118.71 127.41 53.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 t -152.99 -171.89 4.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.08 140.74 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -120.72 154.19 24.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.897 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 11' ' ' ARG . 18.7 mtp-105 -82.4 128.73 34.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.402 0.62 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.534 HG11 ' NZ ' ' A' ' 16' ' ' LYS . 15.6 t -97.25 141.95 14.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.326 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -137.29 100.68 4.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 0.0 110.679 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.55 -175.47 47.25 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 t -86.45 78.99 9.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.458 0.646 . . . . 0.0 110.309 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.534 ' NZ ' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -160.9 148.68 15.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.432 177.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -83.74 37.7 0.6 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.496 ' HB2' HD12 ' A' ' 73' ' ' LEU . 29.4 m-85 -151.75 109.06 3.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -89.52 7.99 33.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.64 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -141.57 132.29 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 71' ' ' LYS . 13.1 p -133.29 131.56 21.67 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.959 0.409 . . . . 0.0 110.896 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.33 124.64 10.09 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.718 2.279 . . . . 0.0 112.396 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.472 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -115.79 155.36 17.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.475 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -138.71 171.29 14.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.499 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 18.6 m -109.29 129.28 55.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.257 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -72.92 -21.99 60.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.072 0.463 . . . . 0.0 110.636 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -116.04 135.82 22.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 37.0 Cg_endo -66.13 116.54 4.07 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.449 2.1 . . . . 0.0 112.56 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 6' ' ' PHE . 3.8 m -105.82 148.49 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.983 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 2.0 mp0 -64.93 141.63 58.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 111.086 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -77.05 22.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.424 0.631 . . . . 0.0 111.279 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.6 m -114.4 4.15 15.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.347 0.594 . . . . 0.0 109.703 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -106.33 16.3 24.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.414 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -52.44 -49.07 65.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.967 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 tt -53.99 -50.77 51.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.071 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 40' ' ' VAL . 45.0 m-20 -65.05 -48.08 75.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.246 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -67.38 -36.46 81.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.294 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -62.86 -41.14 99.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.572 0.225 . . . . 0.0 110.738 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.4 -42.49 98.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.817 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 36' ' ' ASP . 58.7 t -67.51 -49.21 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.137 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.54 -29.68 69.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 111.178 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -72.56 -20.51 61.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 110.481 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 43' ' ' ARG . 12.8 mtp180 -103.51 -1.75 27.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.184 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -107.2 93.46 4.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.124 0.488 . . . . 0.0 110.704 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -96.25 91.29 5.81 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.19 139.26 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.65 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.24 -130.78 5.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.128 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.428 HG13 ' HD2' ' A' ' 49' ' ' PRO . 94.0 t 70.41 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 112.081 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' HG13 ' A' ' 48' ' ' VAL . 61.0 Cg_endo -74.74 98.11 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.478 2.119 . . . . 0.0 111.764 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -108.49 163.78 12.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.67 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.9 mtmt -115.93 177.08 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 t -61.86 131.84 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.914 0.387 . . . . 0.0 111.149 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.18 25.28 19.81 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.054 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.3 p-10 -95.0 125.19 39.5 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.413 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.537 HG22 HG22 ' A' ' 68' ' ' ILE . 17.0 t -86.44 109.25 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.69 -40.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.915 0.388 . . . . 0.0 110.169 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.2 t -130.48 105.37 7.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HG2' ' OD1' ' A' ' 66' ' ' ASP . 9.5 tmtm? -90.7 129.56 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 60.71 47.93 7.62 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.392 0.433 . . . . 0.0 111.078 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 65' ' ' VAL . 12.7 tt -60.98 135.8 25.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.197 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.5 mmt 64.33 11.5 6.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.226 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 57.94 28.72 16.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.802 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 65' ' ' VAL . 9.0 t -101.95 -7.69 22.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.341 0.591 . . . . 0.0 110.345 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.46 5.53 57.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.903 176.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.552 ' O ' HG22 ' A' ' 60' ' ' ILE . 94.8 t -85.01 130.99 35.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.007 0.432 . . . . 0.0 109.958 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 66.4 m-20 -107.08 110.48 22.6 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.287 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -76.97 108.6 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.537 HG22 HG22 ' A' ' 55' ' ' VAL . 25.8 pt -114.7 136.59 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.249 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.472 ' SG ' HG12 ' A' ' 23' ' ' VAL . 1.7 m -92.02 136.15 33.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -108.86 8.54 26.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 0.0 111.641 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HB3' HG23 ' A' ' 21' ' ' VAL . 45.1 tttp -102.2 148.31 25.59 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.76 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 2.1 m120 -99.87 124.04 44.76 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 18' ' ' TYR . 2.5 mm? -108.09 120.3 47.28 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.528 -174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.42 143.48 27.82 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.942 2.428 . . . . 0.0 111.943 175.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HG2' ' N ' ' A' ' 76' ' ' ASP . 53.6 tttm -94.89 165.85 12.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.385 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 6.2 p-10 -72.18 172.86 9.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.609 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.2 t -110.71 125.85 53.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.033 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.69 -13.1 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 111.277 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -88.4 12.06 15.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.828 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -58.04 -35.78 71.81 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.008 0.432 . . . . 0.0 109.938 173.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -106.95 107.73 18.9 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -103.8 104.52 14.54 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -78.51 101.31 7.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.941 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -71.94 131.23 42.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.628 178.108 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -73.35 111.07 8.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.037 0.446 . . . . 0.0 111.126 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -109.28 158.82 17.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.1 136.6 54.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.566 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.6 mt -74.05 126.15 34.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.611 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -63.88 117.01 6.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.62 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 m -134.62 120.54 19.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -149.96 -169.55 3.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 20' ' ' VAL . 7.2 p -132.44 127.72 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.25 153.33 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.678 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 11' ' ' ARG . 57.6 mtt180 -75.32 128.9 36.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.546 HG13 ' HA3' ' A' ' 47' ' ' GLY . 19.5 t -86.56 125.36 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -110.27 123.0 48.99 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . 144.04 -174.61 24.31 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.704 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 m -72.09 95.39 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -139.02 176.97 8.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.392 -175.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 74' ' ' PRO . 51.7 tptt -110.66 -30.6 7.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.252 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.416 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -96.29 138.3 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 16' ' ' LYS . 56.3 t30 -77.83 -45.42 24.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.767 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 9' ' ' VAL . 18.4 m -128.17 147.63 32.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.397 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 12' ' ' VAL . 9.5 p -128.27 121.4 21.53 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 121.246 0.546 . . . . 0.0 111.406 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 32.4 Cg_exo -59.9 125.45 17.74 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.86 2.373 . . . . 0.0 112.636 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.553 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -117.86 155.48 19.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.839 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -143.64 177.33 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.038 0.447 . . . . 0.0 111.092 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' HG23 ' A' ' 5' ' ' ILE . 40.4 t -109.2 147.08 33.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.734 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -84.04 -8.34 59.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 110.716 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' HG22 ' A' ' 65' ' ' VAL . 37.2 mtmm -139.3 144.48 40.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HA ' HG12 ' A' ' 5' ' ' ILE . 23.1 Cg_exo -63.61 129.92 26.53 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.155 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 175.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.029 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 124.02 21.94 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.22 -24.11 35.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.107 0.48 . . . . 0.0 110.993 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -83.69 1.79 40.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.596 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -95.05 7.28 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.8 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -59.07 -30.57 68.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.615 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 9.1 pt -66.49 -38.65 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.554 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -76.8 -40.12 49.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.561 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -66.03 -51.41 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.745 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 m -63.56 -25.75 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.565 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.601 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 9.3 t-20 -59.57 -50.78 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.783 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.22 -40.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.26 -32.02 71.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.358 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.6 t -64.96 -21.14 66.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.828 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 21.2 tpt180 -109.59 1.98 20.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.335 0.588 . . . . 0.0 109.883 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 46' ' ' VAL . 44.5 tp -108.26 92.01 3.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.597 -176.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.54 95.71 7.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.304 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 44' ' ' LEU . 15.7 m -141.75 -157.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.916 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . 137.44 -88.08 0.22 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.297 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t 68.28 117.86 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.215 0 O-C-N 123.919 0.423 . . . . 0.0 110.552 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.886 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 80.6 Cg_exo -43.29 105.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.519 2.813 . . . . 0.0 113.455 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.93 -163.89 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.195 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -120.88 -175.91 3.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.64 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.772 -175.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.32 22.41 24.73 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.408 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.2 p-10 -85.32 133.45 34.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.195 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 66' ' ' ASP . 61.4 t -90.92 120.48 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.656 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.26 -52.56 9.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.581 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.4 m -130.9 117.3 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.481 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 1.005 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 49.9 tttp -99.49 132.81 44.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.787 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.7 t30 67.11 39.2 3.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.431 0.634 . . . . 0.0 110.161 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.39 128.46 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.916 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 57.1 mtt 66.14 16.36 10.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 0.0 111.444 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.34 36.59 20.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.287 0.565 . . . . 0.0 110.848 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.6 p -82.58 -26.06 32.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.415 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.93 10.19 65.0 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.298 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG22 ' HE2' ' A' ' 27' ' ' LYS . 68.8 t -108.59 131.67 58.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.51 0.195 . . . . 0.0 111.022 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 1.005 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.0 p-10 -99.79 124.89 45.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 109.849 170.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.38 121.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.403 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.5 pt -121.11 138.3 51.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.0 111.687 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.553 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.9 m -91.09 141.93 28.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -111.68 2.17 17.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 111.072 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.505 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.1 tmtt? -96.19 131.91 42.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.78 113.38 20.87 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.886 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 73.8 mt -97.4 125.93 43.49 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.654 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 33.2 Cg_exo -60.46 141.0 94.38 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.956 2.438 . . . . 0.0 111.677 176.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -122.39 33.02 5.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.338 -170.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.43 105.4 0.42 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.662 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 p -146.8 52.28 1.1 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.84 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.478 ' H ' HD22 ' A' ' 78' ' ' LEU . 3.2 mm? -56.89 -38.55 72.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.655 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.48 111.39 23.04 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -72.29 149.27 44.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.016 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -69.39 108.52 3.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.344 -173.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.7 m80 65.86 95.35 0.06 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.41 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -100.66 155.83 17.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -116.49 173.31 6.68 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.358 0.599 . . . . 0.0 111.309 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 13.4 p80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.536 173.537 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.417 ' O ' ' HG2' ' A' ' 1' ' ' MET . 23.0 m170 -70.57 163.75 26.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.176 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 82.2 mttt -74.26 156.98 36.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.654 -175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -123.23 158.63 30.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.82 0.343 . . . . 0.0 110.726 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.31 112.39 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.801 0.334 . . . . 0.0 110.735 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 86.2 t80 -63.66 104.21 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 m -115.81 122.67 46.11 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.2 m -148.42 -169.8 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.606 0.241 . . . . 0.0 110.515 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.8 t -123.19 132.03 72.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.4 155.72 11.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -91.63 129.47 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.062 0.458 . . . . 0.0 110.648 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.719 HG22 HG22 ' A' ' 21' ' ' VAL . 2.6 t -97.67 146.99 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -169.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 68.9 ttt180 -119.95 147.28 44.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.585 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.16 -168.55 21.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.828 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 p -75.3 99.9 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -157.87 168.82 26.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.233 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.77 -54.28 4.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.83 0.348 . . . . 0.0 111.561 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 70.1 m-85 -86.69 127.12 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.873 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.575 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 16.6 m120 -79.69 -13.72 59.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.173 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.6 m -135.47 139.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.719 HG22 HG22 ' A' ' 12' ' ' VAL . 17.7 m -134.48 134.65 22.63 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.612 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.19 132.47 22.7 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.672 2.248 . . . . 0.0 112.908 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 69' ' ' CYS . 30.7 m -121.66 165.74 17.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.233 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.2 ptpt -148.18 178.99 8.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.086 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.479 ' HB2' HG11 ' A' ' 65' ' ' VAL . 78.9 p -108.97 131.13 55.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.036 0.446 . . . . 0.0 111.131 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -53.4 -41.44 65.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.524 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HB2' HG22 ' A' ' 65' ' ' VAL . 7.1 mtmp? -126.28 151.49 72.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 18.0 Cg_endo -58.0 126.6 22.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.767 2.311 . . . . 0.0 111.969 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.92 157.18 22.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.114 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -73.8 141.72 46.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.717 0.294 . . . . 0.0 110.208 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.6 pt -69.87 -8.1 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 111.16 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -66.06 -25.81 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.454 . . . . 0.0 110.403 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.11 2.48 46.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.914 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -56.01 -52.79 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.1 pt -68.93 -26.66 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.711 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.24 -46.88 19.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 0.0 110.642 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -61.2 -41.38 96.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 p -66.89 -35.97 81.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.57 -45.55 81.26 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 110.508 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.94 -48.03 87.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.17 -28.78 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.761 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -73.87 -8.82 57.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 43' ' ' ARG . 60.9 mtt180 -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.215 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.43 99.78 8.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.847 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 17.3 m-85 -88.95 109.48 20.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.636 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.3 120.77 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -120.82 41.23 1.96 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.566 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.42 86.66 56.83 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 71.5 Cg_exo -50.79 118.12 3.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.707 2.271 . . . . 0.0 111.967 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.37 -171.05 2.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.235 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 9.4 mmpt? -95.11 -172.46 2.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.268 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -72.55 136.59 45.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.892 0.377 . . . . 0.0 111.282 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.84 30.14 8.64 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.132 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.9 p30 -93.15 133.44 36.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 66' ' ' ASP . 44.7 t -89.27 105.95 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.692 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.3 -48.19 37.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.153 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.33 99.83 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.228 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HG2' HG11 ' A' ' 55' ' ' VAL . 57.0 mttp -76.24 102.73 5.95 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.3 m120 55.04 77.68 0.2 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.3 tt -47.26 -51.83 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 123.695 0.622 . . . . 0.0 112.326 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtm -141.99 54.59 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.856 0.36 . . . . 0.0 110.445 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 59.83 28.33 17.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.453 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.7 p -83.62 -20.19 34.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.742 -175.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.93 80.46 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.34 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 27' ' ' LYS . 71.2 t -112.73 129.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.839 0.352 . . . . 0.0 110.302 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB3' HG13 ' A' ' 55' ' ' VAL . 28.6 m-20 -95.63 134.04 38.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.9 mm -93.2 108.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.411 HG22 HG22 ' A' ' 55' ' ' VAL . 22.0 pt -109.43 142.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.466 ' HB3' HD21 ' A' ' 54' ' ' ASN . 53.3 t -92.5 142.0 27.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -113.47 4.74 16.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 111.047 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.59 141.51 29.76 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.895 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.09 112.97 24.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.747 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 HG11 ' A' ' 21' ' ' VAL . 5.9 mp -88.07 127.24 58.24 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 111.524 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -86.97 101.45 0.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.895 2.397 . . . . 0.0 111.154 171.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 49' ' ' PRO . 14.5 ptmm? -93.47 -36.65 12.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.506 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -75.74 121.22 22.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m -138.22 83.4 1.97 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.97 0.414 . . . . 0.0 111.413 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 74.3 mt -86.56 73.7 10.03 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -88.41 136.27 33.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.013 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -115.88 88.88 2.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.439 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -83.31 117.82 23.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -69.62 106.36 3.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.452 0.644 . . . . 0.0 111.208 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -169.1 125.07 0.9 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.038 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -80.35 106.49 12.41 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.665 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.3 t60 . . . . . 0 C--O 1.255 1.348 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.178 -177.942 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -82.08 112.25 18.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.563 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 49.0 mttp -88.08 132.54 34.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.332 174.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.35 -179.94 3.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.48 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 28' ' ' PRO . 29.6 mm -101.84 115.28 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.005 0.431 . . . . 0.0 110.19 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -78.11 122.75 26.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.196 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -141.41 137.44 32.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.962 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -153.44 178.51 9.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 20' ' ' VAL . 10.4 p -110.91 130.31 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.874 0.369 . . . . 0.0 110.121 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.37 157.57 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.149 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -81.23 127.54 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.324 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.474 ' HB ' ' HE2' ' A' ' 16' ' ' LYS . 3.7 t -84.28 130.73 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.96 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 61.8 ttp85 -107.0 155.33 19.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.445 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.15 175.7 22.74 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.87 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 p -79.79 105.17 10.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 0.0 111.007 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HD3' ' H ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -162.68 -175.37 4.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.808 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -119.07 40.12 3.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.428 0.633 . . . . 0.0 110.824 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.59 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 4.2 m-85 -129.72 154.02 47.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.448 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -114.92 -46.45 2.92 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.435 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 9' ' ' VAL . 17.8 m -134.26 142.24 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.009 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 12' ' ' VAL . 15.0 p -129.54 136.66 29.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.428 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.72 124.99 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.62 2.214 . . . . 0.0 112.69 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -113.99 164.5 10.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.977 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -145.36 179.06 7.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -109.16 134.66 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.67 -37.73 73.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.275 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -118.43 150.76 48.54 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.252 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 48.6 Cg_endo -67.3 139.6 50.43 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.499 2.132 . . . . 0.0 113.048 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -113.56 173.5 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.405 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.563 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 79.9 mt-10 -98.67 135.8 39.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.101 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.856 ' HA ' ' HD1' ' A' ' 34' ' ' TRP . 14.6 tt -55.67 -21.52 10.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.781 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.2 m -57.15 -31.81 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.374 . . . . 0.0 111.562 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 33' ' ' LYS . 28.2 mtpp -102.87 14.79 31.09 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.856 ' HD1' ' HA ' ' A' ' 31' ' ' ILE . 1.2 m95 -60.05 -44.5 94.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.75 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -67.95 -35.08 70.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 40' ' ' VAL . 34.8 t70 -67.78 -43.68 79.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.9 m-30 -69.86 -39.95 76.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.975 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.43 -35.85 78.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.481 . . . . 0.0 109.821 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -58.47 -45.44 88.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.861 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 36' ' ' ASP . 43.7 t -69.09 -48.2 70.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.417 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.0 mt -66.63 -33.2 75.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.5 p -71.55 -11.77 61.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.772 0.32 . . . . 0.0 111.559 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -119.08 10.1 12.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.996 0.427 . . . . 0.0 110.499 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.507 ' HG ' HG23 ' A' ' 46' ' ' VAL . 31.5 tp -104.71 127.2 52.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 43.9 m-85 -119.45 97.12 5.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.507 HG23 ' HG ' ' A' ' 44' ' ' LEU . 61.4 t -111.29 140.41 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -124.08 -134.75 4.33 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.992 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t 60.08 79.95 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.205 0.526 . . . . 0.0 109.994 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.47 118.41 5.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.652 2.235 . . . . 0.0 111.691 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -174.27 3.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.884 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -87.79 -177.19 5.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.0 t -67.45 134.1 50.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.761 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.32 25.78 11.96 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.987 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 11.0 p30 -94.03 143.06 26.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.38 115.99 28.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.266 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.29 -56.56 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.972 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.0 t -130.72 118.01 20.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 31.0 tttm -97.71 129.88 44.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.736 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.417 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 14.1 m120 54.98 47.21 22.65 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 123.501 0.501 . . . . 0.0 109.955 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.0 tt -53.95 110.04 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.6 mmt 66.68 31.45 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.246 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 71.34 4.22 4.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -57.59 -42.53 83.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 111.21 -9.37 28.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.646 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.96 137.46 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 110.231 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 7.0 m-20 -102.18 107.31 18.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -75.3 103.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.3 pt -108.05 146.07 14.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.296 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' A' ' 21' ' ' VAL . 2.4 t -90.51 142.32 27.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.475 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -119.22 13.97 12.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.399 0.618 . . . . 0.0 110.63 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -96.58 142.05 29.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -89.97 98.14 11.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 96.6 mt -99.56 117.41 63.81 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.873 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 5.0 Cg_exo -78.67 103.35 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.661 2.24 . . . . 0.0 112.699 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -61.45 -73.9 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.503 0.668 . . . . 0.0 109.438 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -149.0 8.63 0.75 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.777 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 m -85.4 32.17 0.57 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.958 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.7 tp -76.99 100.6 5.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.093 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -109.74 171.58 7.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.492 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -89.08 32.34 0.83 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.28 0.562 . . . . 0.0 109.586 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -115.24 97.53 6.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.873 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 83' ' ' HIS . 40.4 t-80 -157.12 -66.14 0.1 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 173.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER 158.78 179.79 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.168 176.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -83.86 16.25 2.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.95 0.881 . . . . 0.0 108.767 171.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' H ' ' C ' ' A' ' 83' ' ' HIS . 22.2 t-80 . . . . . 0 C--O 1.249 1.068 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.598 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.729 0.776 . . . . 0.0 111.216 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.8 88.62 0.1 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -111.71 144.29 41.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.232 -167.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -140.65 154.44 46.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.97 117.13 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.96 0.41 . . . . 0.0 110.741 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 78.2 t80 -78.53 109.67 12.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 109.827 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -123.53 132.21 53.84 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.564 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -152.77 -165.1 2.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.123 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.626 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 42.7 t -128.31 134.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.541 0.21 . . . . 0.0 110.453 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -119.0 148.64 21.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.39 135.23 40.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.275 0.559 . . . . 0.0 111.53 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.34 141.54 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.577 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -127.13 173.87 9.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.278 . . . . 0.0 110.325 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -177.48 31.0 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.864 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 m -76.12 96.47 3.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.254 0.549 . . . . 0.0 110.674 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.9 -173.44 4.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.649 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -100.73 -52.43 3.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.833 0.349 . . . . 0.0 110.742 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -75.2 124.3 26.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.975 0.417 . . . . 0.0 111.956 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.84 -15.92 56.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.626 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.3 m -142.03 146.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 73' ' ' LEU . 13.0 p -124.38 134.28 25.39 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.92 126.02 13.33 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.525 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -114.33 162.34 12.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.576 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -144.73 178.93 7.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.914 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 69.1 m -109.12 133.55 52.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.202 0.525 . . . . 0.0 111.306 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -59.52 -44.65 93.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.591 174.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 65' ' ' VAL . 67.1 mttm -121.0 152.45 56.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.49 139.52 82.37 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.653 2.236 . . . . 0.0 111.88 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 65' ' ' VAL . 5.8 t -112.57 136.11 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.97 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.31 118.8 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.5 tt -55.16 -28.1 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 m -65.33 -18.39 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mtpp -100.72 17.51 21.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.487 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -57.39 -40.66 78.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 0.0 109.942 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -62.33 -45.43 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.981 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HB3' ' HG3' ' A' ' 61' ' ' MET . 1.8 m-20 -53.48 -54.61 34.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.592 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -63.07 -41.1 99.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -61.23 -47.25 86.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -67.06 -27.26 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.572 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 36' ' ' ASP . 99.1 t -77.35 -46.53 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.636 0.255 . . . . 0.0 110.937 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.32 -30.36 66.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 p -69.69 -22.31 63.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -107.19 10.87 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.166 0.507 . . . . 0.0 110.283 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -114.11 143.33 44.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.912 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -130.96 142.12 50.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.145 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 p -119.49 143.83 29.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 48' ' ' VAL . . . -121.7 163.82 15.02 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.055 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 92.1 t 75.82 128.27 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 123.179 0.592 . . . . 0.0 111.262 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HG3' ' HG2' ' A' ' 75' ' ' LYS . 11.2 Cg_endo -54.13 110.76 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.155 2.57 . . . . 0.0 111.499 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.45 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 p -99.17 -164.16 1.1 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.713 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' H ' ' HB ' ' A' ' 50' ' ' THR . 19.6 ptmt -127.16 -152.88 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.434 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 32.6 m -98.96 135.63 40.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.73 24.04 11.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.877 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.847 HD22 ' HB2' ' A' ' 69' ' ' CYS . 40.8 m-20 -78.97 99.1 6.69 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 68' ' ' ILE . 17.9 t -77.79 92.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 m -74.09 -45.52 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 8.5 t -130.96 120.16 23.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -104.33 144.06 32.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 44.72 39.82 3.71 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.671 0.748 . . . . 0.0 110.847 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.559 ' HB ' ' SG ' ' A' ' 57' ' ' CYS . 5.3 tt -56.0 127.18 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.277 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.603 ' HG3' ' HB3' ' A' ' 36' ' ' ASP . 93.8 mmm 63.59 29.89 15.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 70.2 17.76 7.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.906 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.3 p -78.44 -61.58 1.96 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.86 0.362 . . . . 0.0 111.777 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.31 1.31 9.35 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 27' ' ' LYS . 96.8 t -88.15 139.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 0.0 110.664 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.68 114.65 26.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.231 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -83.13 106.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.8 pt -119.4 133.5 66.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.259 0.552 . . . . 0.0 112.297 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.847 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.9 m -78.4 147.64 33.99 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 10.9 t -132.38 13.82 4.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -112.93 122.34 47.35 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.481 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -67.8 109.96 3.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 21' ' ' VAL . 90.9 mt -87.73 117.16 68.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.448 -173.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.76 160.88 14.23 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.691 2.261 . . . . 0.0 111.92 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HG2' ' HG3' ' A' ' 49' ' ' PRO . 49.8 mtpt -104.4 -34.65 8.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.161 0.505 . . . . 0.0 109.761 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -109.71 132.09 54.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.02 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.0 m -83.16 99.36 9.87 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.06 106.78 0.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -62.23 111.86 2.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.138 0.494 . . . . 0.0 111.039 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -77.69 76.44 4.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.327 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 147.48 25.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.697 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -139.64 27.25 2.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.022 0.439 . . . . 0.0 111.124 -171.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -131.35 101.91 5.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 68.17 26.65 7.02 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.881 0.848 . . . . 0.0 109.127 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 68.9 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.189 -177.844 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 tpt . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.729 0.3 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -70.77 106.39 3.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.96 0.41 . . . . 0.0 110.591 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 96.3 mttt -97.72 129.72 44.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -123.63 169.92 10.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.99 0.424 . . . . 0.0 110.76 -169.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.06 102.68 12.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 29' ' ' VAL . 87.7 t80 -59.26 117.95 5.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.666 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -124.06 130.26 52.26 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.797 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 t -143.23 -172.11 3.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.33 124.87 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 41' ' ' LEU . 29.6 m -112.46 162.04 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -91.88 130.97 37.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.532 . . . . 0.0 111.35 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -108.43 121.49 61.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.739 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.445 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.4 mtm105 -99.58 154.3 18.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.12 166.58 12.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.355 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 p -82.61 84.9 7.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 111.759 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -174.23 4.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.888 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -86.84 -59.58 2.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.713 0.292 . . . . 0.0 110.988 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.48 6.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.205 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.44 -15.43 30.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.529 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.74 129.79 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.1 p -119.17 129.93 25.12 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.164 0.506 . . . . 0.0 111.758 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 37.5 Cg_endo -69.1 125.81 12.95 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 111.59 170.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 69' ' ' CYS . 30.6 m -113.9 158.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.084 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -141.06 174.17 10.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.751 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 14.9 m -109.11 127.5 54.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.05 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -65.24 -30.89 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.922 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB2' HG22 ' A' ' 65' ' ' VAL . 64.3 mttm -111.2 138.73 21.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.1 Cg_exo -65.38 116.88 4.14 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.369 2.046 . . . . 0.0 111.485 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 6' ' ' PHE . 29.3 m -93.37 162.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.997 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 46.1 mt-10 -79.71 145.8 32.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.153 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 33' ' ' LYS . 16.9 pt -71.53 177.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.013 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 74.6 m 70.98 -25.48 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.039 0.536 . . . . 0.0 112.028 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.457 ' HD3' ' CZ ' ' A' ' 37' ' ' PHE . 13.9 tttm -84.63 7.53 19.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.173 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -62.07 -34.94 77.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 tt -70.48 -31.52 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 25.3 t70 -65.94 -57.03 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.989 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CZ ' ' HD3' ' A' ' 33' ' ' LYS . 27.5 m-85 -64.63 -36.24 83.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.519 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.1 p -67.24 -37.12 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -54.85 -49.64 70.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 110.346 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.46 -48.71 85.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.234 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 10' ' ' VAL . 69.0 mt -70.06 -41.08 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -68.05 -19.86 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 111.049 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -101.27 10.75 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 110.041 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 tp -116.86 118.75 33.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.318 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.98 129.27 55.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.958 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.6 140.23 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.148 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -127.2 71.94 0.47 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.888 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -166.0 123.25 1.04 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 120.811 0.339 . . . . 0.0 110.776 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.49 113.13 3.39 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.839 2.36 . . . . 0.0 111.614 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.13 170.31 9.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.389 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.8 mtmt -103.55 176.33 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.354 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.0 t -61.25 135.47 57.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 111.473 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.64 26.79 21.75 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.967 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.702 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -97.5 133.26 42.31 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.253 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 68' ' ' ILE . 8.6 t -93.07 124.59 45.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.471 -176.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 m -96.99 -39.51 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 111.215 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.3 t -127.74 121.2 29.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' HG11 ' A' ' 55' ' ' VAL . 59.6 mttm -106.06 128.85 54.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.857 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.747 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.7 t-20 58.91 48.84 10.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.65 0.738 . . . . 0.0 109.169 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.491 HG12 ' HG2' ' A' ' 61' ' ' MET . 11.6 tt -60.16 127.09 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.108 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.491 ' HG2' HG12 ' A' ' 60' ' ' ILE . 98.2 mmm 63.51 21.78 12.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.159 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.747 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 3.4 t-20 57.8 79.4 0.2 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.452 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.0 p -138.65 -55.72 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.068 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.0 -9.4 6.32 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 27' ' ' LYS . 95.4 t -79.89 132.01 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 110.579 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.99 114.57 28.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.1 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.89 114.03 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.656 HG22 HG22 ' A' ' 55' ' ' VAL . 20.6 pt -118.37 140.75 40.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.0 -173.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.702 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.9 m -92.2 146.34 23.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -119.38 11.15 12.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 0.0 112.223 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.589 ' HB2' HG23 ' A' ' 21' ' ' VAL . 68.5 mmtt -96.41 155.24 16.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.953 -0.467 . . . . 0.0 109.919 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 2.2 m-20 -106.55 104.89 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.78 132.08 43.31 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.7 106.58 1.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.462 2.108 . . . . 0.0 112.044 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HG3' ' OD2' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -71.99 -75.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.521 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.417 ' OD2' ' HG3' ' A' ' 75' ' ' LYS . 28.6 m-20 -132.9 2.28 3.66 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.268 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 76' ' ' ASP . 80.3 p 56.54 -85.59 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.062 0.945 . . . . 0.0 112.261 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -140.69 146.12 37.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.745 0.307 . . . . 0.0 110.504 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.29 146.88 47.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -56.66 -72.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -169.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.8 m170 63.46 -74.85 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.963 0.505 . . . . 0.0 110.998 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -166.93 -72.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -170.74 142.7 2.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -64.97 113.4 3.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.975 0.417 . . . . 0.0 110.691 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.413 177.9 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -77.35 161.92 27.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.398 . . . . 0.0 110.906 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 52.0 mttp -124.39 120.3 31.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.18 156.27 49.27 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.965 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -63.4 110.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.028 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -76.55 106.84 8.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 24' ' ' LYS . 74.3 p -110.41 134.21 52.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -153.75 -167.1 2.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.37 132.31 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.91 149.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -87.8 114.08 24.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HB ' ' HE3' ' A' ' 16' ' ' LYS . 6.6 t -84.85 139.35 17.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.189 -168.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpt85 -105.8 137.77 43.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.91 -178.3 16.38 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.412 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 t -81.4 110.28 16.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.084 0.468 . . . . 0.0 110.564 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.948 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -163.07 168.48 20.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.726 ' HD2' ' HB2' ' A' ' 76' ' ' ASP . 80.9 tttt -95.79 -20.67 18.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' HD22 ' A' ' 73' ' ' LEU . 78.9 m-85 -107.46 111.36 23.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.948 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 86.7 m-20 -76.67 -19.6 57.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.09 138.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.585 0.231 . . . . 0.0 110.422 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 71' ' ' LYS . 5.8 p -135.34 139.83 32.63 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.831 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 53.6 Cg_endo -72.81 130.68 16.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.572 2.181 . . . . 0.0 112.505 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.22 162.42 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.557 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HB3' HG22 ' A' ' 7' ' ' THR . 22.2 ptmt -143.53 170.75 15.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.159 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -109.23 128.27 54.92 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 66' ' ' ASP . 2.0 p-10 -75.72 -0.91 22.5 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 65' ' ' VAL . 43.3 mtmt -132.36 142.09 43.67 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.01 135.98 66.38 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.474 2.116 . . . . 0.0 112.328 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 t -105.37 130.91 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.863 -175.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 28.6 tt0 -60.11 121.39 11.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.0 tp -60.9 -21.46 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -171.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.61 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.945 -0.472 . . . . 0.0 111.421 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 62.9 mttp -105.7 1.23 26.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.565 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -59.64 -31.25 69.35 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.37 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -78.04 -30.05 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 40' ' ' VAL . 26.0 t0 -78.41 -43.33 27.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 30.2 m-85 -56.52 -47.26 79.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.6 p -65.71 -37.26 85.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -60.7 -43.07 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.75 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 36' ' ' ASP . 58.0 t -63.26 -44.11 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.591 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.75 -21.48 66.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.3 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.3 m -81.79 -11.59 58.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.048 0.451 . . . . 0.0 110.704 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -105.89 -26.14 11.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.726 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 46' ' ' VAL . 40.2 tp -81.84 94.83 7.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.739 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -97.35 90.3 5.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.174 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG22 ' HG ' ' A' ' 44' ' ' LEU . 22.2 m -142.06 173.49 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.67 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.74 173.1 25.73 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.548 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.599 HG13 HG23 ' A' ' 50' ' ' THR . 13.6 p 177.23 141.25 0.24 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -42.06 105.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.918 2.412 . . . . 0.0 112.374 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.599 HG23 HG13 ' A' ' 48' ' ' VAL . 1.7 p -130.23 167.03 19.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.069 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -127.07 62.75 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.66 -174.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 t 69.2 150.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.728 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.17 24.49 70.48 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.958 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 7.7 p30 -96.46 128.53 43.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.025 0.441 . . . . 0.0 110.506 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 58' ' ' LYS . 49.1 t -79.21 113.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.195 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.04 -50.18 17.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.965 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 36.7 t -130.75 123.07 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.647 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.692 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 50.3 tttp -106.25 135.4 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.784 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.582 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 6.6 t-20 64.32 31.99 12.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.72 0.638 . . . . 0.0 110.712 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.547 HG12 ' HG3' ' A' ' 61' ' ' MET . 10.8 tt -60.65 134.83 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.547 ' HG3' HG12 ' A' ' 60' ' ' ILE . 76.2 mtp 62.6 18.45 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.942 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 70.67 -2.87 2.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 65' ' ' VAL . 9.6 t -79.69 -8.59 59.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.57 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 59' ' ' ASN . . . 83.16 3.41 90.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.897 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 27' ' ' LYS . 7.9 t -67.05 129.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.899 0.381 . . . . 0.0 110.237 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.692 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 3.1 m-20 -99.35 122.34 42.35 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -87.09 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.3 pt -108.83 134.96 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.411 0.624 . . . . 0.0 111.954 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.531 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 7.5 t -81.12 135.06 35.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.231 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -111.69 -6.32 14.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.991 0.424 . . . . 0.0 111.233 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 62.5 tttp -96.8 138.64 34.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.76 128.26 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.84 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 18' ' ' TYR . 94.2 mt -109.32 102.18 48.35 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.973 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -89.8 177.25 2.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.706 2.27 . . . . 0.0 112.382 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 8.2 mtpm? -120.1 159.63 24.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.939 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.726 ' HB2' ' HD2' ' A' ' 17' ' ' LYS . 7.3 t70 -108.37 -157.83 0.63 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m 68.68 20.39 8.23 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 122.945 0.498 . . . . 0.0 111.319 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -88.03 138.69 31.23 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.1 pm0 -81.89 40.49 0.61 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.39 -27.8 59.22 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -103.59 110.6 22.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.857 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -94.1 96.94 9.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.491 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -96.24 -67.48 0.85 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -129.59 30.99 4.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.194 0.997 . . . . 0.0 108.507 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 . . . . . 0 C--O 1.243 0.726 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.329 178.116 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.559 0.219 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 61.17 94.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.544 0.688 . . . . 0.0 112.69 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 54.4 mmtt -100.17 127.07 46.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.195 174.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -131.98 134.59 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.706 0.288 . . . . 0.0 110.856 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 28' ' ' PRO . 36.3 mm -57.75 127.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 111.116 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -102.66 115.58 30.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.544 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 139.42 53.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.833 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.8 m -158.67 179.26 9.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.652 0.263 . . . . 0.0 110.615 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.48 130.19 71.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.158 0.504 . . . . 0.0 110.231 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.76 155.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.76 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 9.5 mmt180 -69.37 123.88 22.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.585 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.788 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.7 p -107.43 136.94 40.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.178 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 49.2 mtp180 -125.87 -179.32 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.656 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.94 -160.24 13.52 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.323 -0.942 . . . . 0.0 113.088 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -85.44 15.95 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.775 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.788 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -80.98 179.0 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 75' ' ' LYS . 97.2 mttt -125.69 69.33 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.713 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.45 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 40.5 m-85 -153.11 178.86 9.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.299 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.91 -23.68 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 0.0 111.116 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.67 149.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 14.6 p -131.98 131.49 22.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.033 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 14.2 Cg_exo -68.9 131.77 23.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.132 2.555 . . . . 0.0 112.63 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.53 152.63 37.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.956 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HG3' HG13 ' A' ' 68' ' ' ILE . 21.5 ptmt -141.13 173.55 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 0.0 111.034 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -109.67 131.75 54.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.129 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -72.72 -26.05 61.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.806 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.6 mttt -122.33 132.83 24.2 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HA ' HD13 ' A' ' 5' ' ' ILE . 77.7 Cg_exo -50.31 132.96 35.65 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.082 2.521 . . . . 0.0 112.49 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.2 124.53 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.784 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 43.8 tt0 -63.2 134.86 56.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pt -72.54 67.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.326 1.06 . . . . 0.0 112.247 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.0 p -155.71 -30.96 0.1 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.88 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -94.01 3.54 55.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -51.93 -52.73 48.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.438 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.68 -38.21 57.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.128 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 40' ' ' VAL . 4.8 t0 -62.03 -37.63 85.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 63' ' ' THR . 4.5 m-30 -60.23 -50.22 74.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.827 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 p -62.9 -25.54 68.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.209 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -65.99 -50.04 65.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 36' ' ' ASP . 42.1 t -63.55 -41.7 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.806 HD23 HD12 ' A' ' 44' ' ' LEU . 47.4 mt -63.12 -29.31 70.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.7 m -72.72 -11.68 60.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HD3' HH11 ' A' ' 43' ' ' ARG . 56.4 mtt-85 -108.41 3.81 23.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.311 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.806 HD12 HD23 ' A' ' 41' ' ' LEU . 27.5 mt -99.56 119.8 38.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.514 0.674 . . . . 0.0 111.387 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.5 100.89 7.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.626 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 m -90.8 -177.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.728 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -167.71 -168.62 30.11 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.059 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t 68.22 101.27 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 C-N-CA 122.946 0.498 . . . . 0.0 111.178 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.581 ' CG ' ' HG2' ' A' ' 75' ' ' LYS . 12.3 Cg_endo -58.33 108.45 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.808 2.338 . . . . 0.0 111.939 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.84 -165.27 1.01 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.93 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 44.0 mmtm -128.05 169.87 13.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.024 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.9 p -58.94 136.31 57.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 23.53 34.6 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.732 -0.746 . . . . 0.0 111.877 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.671 HD21 ' HB3' ' A' ' 69' ' ' CYS . 8.5 p30 -97.24 131.34 44.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 68' ' ' ILE . 63.1 t -82.73 108.42 15.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.06 -57.59 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.268 0.556 . . . . 0.0 109.609 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 62.7 m -115.25 94.16 4.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.95 114.16 17.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.733 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t30 65.25 79.71 0.25 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.691 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 tt -71.66 122.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.277 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ttt 68.77 -76.33 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.868 0.73 . . . . 0.0 110.75 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -178.9 82.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.515 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 39.0 p -141.83 -44.02 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.176 -169.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.74 8.01 57.39 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -170.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 27' ' ' LYS . 73.9 t -98.46 131.68 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.184 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.39 116.21 28.68 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 57' ' ' CYS . 48.2 mm -81.78 100.21 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.128 0.49 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.45 HG13 ' HG3' ' A' ' 24' ' ' LYS . 22.1 pt -96.8 145.51 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.301 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.671 ' HB3' HD21 ' A' ' 54' ' ' ASN . 43.6 t -100.39 142.73 31.46 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -115.84 7.19 14.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.326 0.584 . . . . 0.0 110.625 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -96.71 142.24 28.98 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 2.6 m-20 -93.93 111.79 23.54 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.21 120.37 56.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.448 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -85.13 158.9 11.41 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.891 2.394 . . . . 0.0 111.628 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.581 ' HG2' ' CG ' ' A' ' 49' ' ' PRO . 86.9 mttt -100.0 -58.61 1.88 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.628 0.728 . . . . 0.0 109.327 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.09 -177.38 6.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.604 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.1 t -72.64 -27.08 61.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.714 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 80' ' ' HIS . 42.8 tp -136.19 138.68 42.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.558 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 3.45 9.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.449 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.9 140.78 29.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.205 -171.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -126.26 131.69 51.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.089 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -65.14 -41.63 94.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.012 0.434 . . . . 0.0 110.492 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -111.9 98.41 7.36 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -79.18 157.54 27.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.925 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.25 1.127 0 O-C-N 123.84 0.712 . . . . 0.0 110.877 -178.462 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -153.93 -66.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.936 175.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 94.4 mttt -124.43 141.75 51.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.229 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -140.65 153.91 46.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.756 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.98 114.26 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 110.988 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.4 ' HB3' HG21 ' A' ' 29' ' ' VAL . 64.7 t80 -79.94 140.69 36.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.39 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -150.94 133.47 15.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.946 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -150.18 -172.83 4.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.2 138.18 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.714 0.292 . . . . 0.0 110.39 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 44' ' ' LEU . 14.2 p -119.1 149.65 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.473 ' HA ' HG12 ' A' ' 20' ' ' VAL . 53.1 mtt180 -82.87 116.75 22.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.191 0.52 . . . . 0.0 110.808 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG12 ' HE3' ' A' ' 16' ' ' LYS . 21.3 t -88.37 137.51 20.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.959 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.561 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.6 ttp85 -98.52 150.23 21.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.365 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.82 169.71 13.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.332 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.07 27.3 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.242 0.544 . . . . 0.0 111.709 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.589 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -70.93 173.08 7.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.489 176.255 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -86.18 26.31 1.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -145.21 -179.69 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.718 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -131.31 -34.69 1.39 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 11' ' ' ARG . 22.7 m -134.75 149.34 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.672 0.272 . . . . 0.0 111.129 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -125.68 133.54 25.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.68 120.76 6.88 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.418 2.079 . . . . 0.0 112.171 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.1 140.42 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.926 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.08 168.86 15.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.127 0.489 . . . . 0.0 110.875 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -108.93 130.9 55.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.607 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 7.5 p30 -80.98 -10.0 59.77 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.632 -172.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.607 ' HE2' ' OD1' ' A' ' 26' ' ' ASN . 26.9 mtmt -130.99 144.53 53.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.532 176.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 50.9 Cg_exo -54.85 138.05 76.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.209 2.606 . . . . 0.0 113.541 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 6' ' ' PHE . 28.1 t -106.39 143.29 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.691 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.93 139.86 55.1 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.0 pt -76.34 12.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.6 p -128.9 -3.27 5.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.069 0.462 . . . . 0.0 110.468 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -99.48 -15.35 18.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -65.12 -21.05 66.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.026 0.441 . . . . 0.0 110.632 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.88 -44.31 99.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.092 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.6 m-20 -58.66 -50.23 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.891 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.4 m-85 -63.06 -43.22 99.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.11 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -62.81 -36.95 84.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.862 0.363 . . . . 0.0 111.006 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -66.69 -36.35 82.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.783 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 36' ' ' ASP . 96.0 t -69.35 -43.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.394 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 99.7 mt -61.97 -24.2 66.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -65.63 -18.14 65.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.944 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -104.03 -2.05 26.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 56' ' ' VAL . 24.1 tp -84.17 53.65 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.238 0.542 . . . . 0.0 111.292 -171.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -78.31 76.66 4.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.22 149.44 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.99 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -119.08 48.99 0.9 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.53 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.17 114.67 16.2 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.613 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 26.0 Cg_exo -62.07 103.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.562 2.174 . . . . 0.0 111.095 171.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.675 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 22.9 p -95.97 173.57 7.37 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' HD21 ' A' ' 54' ' ' ASN . 75.6 mmtt -97.31 -146.94 0.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.337 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.6 t -102.3 131.17 49.06 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 170.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.3 26.98 19.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.596 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.675 ' ND2' ' HB ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -86.83 112.45 21.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 68' ' ' ILE . 47.5 t -73.37 106.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.534 HG11 HD21 ' A' ' 44' ' ' LEU . 24.4 t -79.37 -46.37 23.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.169 0.509 . . . . 0.0 109.745 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 59.7 m -130.65 109.67 10.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 28.0 ttmt -85.12 129.33 34.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 53.72 69.37 0.72 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 123.812 0.695 . . . . 0.0 109.823 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.458 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.0 tt -78.76 125.53 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.317 -173.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.422 ' HG2' HG12 ' A' ' 60' ' ' ILE . 96.4 mmm 64.31 19.22 11.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.94 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 65.02 98.7 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.468 0.48 . . . . 0.0 111.298 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 65' ' ' VAL . 8.4 t -171.46 -34.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.478 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.22 -17.96 5.87 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.156 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.534 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 33.1 m -82.38 142.57 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.306 0.574 . . . . 0.0 112.014 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -108.23 131.62 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -91.5 114.11 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 55' ' ' VAL . 37.7 pt -117.35 134.06 62.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.887 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 54' ' ' ASN . 2.0 p -87.82 134.17 33.74 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -118.71 17.25 13.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 112.147 -168.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HB3' HG23 ' A' ' 21' ' ' VAL . 60.4 tttp -117.08 131.05 57.01 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -82.73 109.36 16.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.71 132.09 39.66 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.62 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.36 128.05 19.51 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.447 2.098 . . . . 0.0 111.264 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 75' ' ' LYS . 3.1 mtpt -60.37 156.01 16.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.225 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.19 175.84 9.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.435 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.0 p -117.85 133.34 56.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.617 0.246 . . . . 0.0 110.632 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.7 tp -76.64 83.28 3.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.348 0.594 . . . . 0.0 110.065 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.535 ' HA ' ' CD2' ' A' ' 85' ' ' HIS . 41.6 mt-10 -116.3 -59.21 2.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.692 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.5 t60 55.18 88.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 O-C-N 124.01 0.819 . . . . 0.0 111.172 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -67.72 99.37 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.582 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -158.2 -66.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -161.95 159.19 26.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.44 0.162 . . . . 0.0 110.672 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.7 t60 55.95 79.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 124.03 0.831 . . . . 0.0 112.007 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.535 ' CD2' ' HA ' ' A' ' 79' ' ' GLU . 18.2 t-80 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.435 173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.754 0.312 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -150.83 138.78 19.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.564 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.2 mttt -75.13 114.83 14.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.307 0.575 . . . . 0.0 110.149 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.66 179.74 5.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.554 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.67 116.12 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.25 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.597 ' HB2' HG21 ' A' ' 29' ' ' VAL . 77.0 t80 -59.36 128.09 35.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -153.52 135.43 14.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.007 0.432 . . . . 0.0 110.097 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -153.2 169.34 23.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.36 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 59.8 t -114.32 118.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 41' ' ' LEU . 34.2 m -117.58 173.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.245 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.465 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 1.9 mmt85 -72.8 126.63 30.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.762 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.579 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.4 p -104.77 129.14 57.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.503 0.668 . . . . 0.0 111.239 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.504 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 41.9 ttt85 -104.65 142.32 34.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.974 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 168.15 12.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.0 m -83.26 102.21 11.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.98 -174.66 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.928 -179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.24 -0.9 56.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.49 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 47.9 m-85 -110.04 143.26 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.732 -0.387 . . . . 0.0 112.021 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -104.64 -10.59 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.756 0.789 . . . . 0.0 109.079 175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.2 m -142.33 148.41 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.414 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 12' ' ' VAL . 7.2 p -134.44 125.89 17.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.195 0.522 . . . . 0.0 111.749 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 5.8 Cg_exo -77.54 113.41 3.51 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.396 2.73 . . . . 0.0 112.306 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 ' SG ' ' A' ' 69' ' ' CYS . 31.5 m -104.82 161.04 4.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.544 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -153.24 178.77 9.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.487 0.66 . . . . 0.0 111.213 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.27 147.2 33.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.13 -3.71 56.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.506 0.669 . . . . 0.0 109.258 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB3' HG22 ' A' ' 65' ' ' VAL . 34.4 ttmt -128.72 129.84 23.49 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.417 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 38.3 Cg_exo -58.04 132.24 48.25 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 112.429 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' A' ' 6' ' ' PHE . 18.5 m -117.65 -178.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.564 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -97.96 135.26 39.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 pt -77.01 -19.49 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.307 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 37' ' ' PHE . 56.3 mtpt -93.99 0.79 56.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -53.82 -42.93 68.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.895 0.378 . . . . 0.0 110.676 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.55 -45.04 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.04 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 40' ' ' VAL . 8.9 t70 -67.46 -43.72 80.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.32 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.438 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 47.4 m-85 -61.48 -43.59 98.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.236 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.32 -35.97 80.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.753 0.311 . . . . 0.0 110.715 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 60' ' ' ILE . 61.7 t -67.05 -40.99 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.563 ' HB3' HG11 ' A' ' 10' ' ' VAL . 49.8 mt -62.49 -39.11 92.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.555 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -68.07 -12.91 61.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.417 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.8 ttt85 -95.13 -9.16 34.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.277 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.65 132.85 55.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.588 . . . . 0.0 111.431 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 11' ' ' ARG . 3.3 m-85 -106.99 102.83 12.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.797 173.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.93 157.89 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.258 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . 172.99 -148.91 10.79 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.751 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 85.1 t 72.49 126.13 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.345 0 O-C-N 124.099 0.529 . . . . 0.0 110.789 -175.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.682 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 82.6 Cg_exo -42.92 110.7 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.488 2.792 . . . . 0.0 113.074 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -139.65 169.48 17.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.622 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -95.93 173.57 7.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 110.707 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -68.54 119.83 13.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.439 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 30.47 5.78 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.4 p-10 -89.1 131.67 35.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 68' ' ' ILE . 57.8 t -85.74 127.31 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.856 -175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.42 -75.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.228 0.537 . . . . 0.0 110.228 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -115.65 98.79 6.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.177 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 87.7 tttt -78.69 128.37 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 8.7 t-20 63.65 41.86 6.82 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.439 HD11 HG11 ' A' ' 40' ' ' VAL . 6.2 tt -53.27 -50.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.146 -172.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.435 ' HB2' HG23 ' A' ' 63' ' ' THR . 82.1 mtp -114.61 30.93 6.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.653 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 15.6 m120 63.4 23.84 13.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.391 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 61' ' ' MET . 67.6 p -86.93 -21.08 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.706 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.27 79.24 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.494 -174.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 27' ' ' LYS . 41.8 t -90.04 130.44 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.604 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' OD2' ' HE3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -95.92 107.92 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.066 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.5 mm -75.9 120.42 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 35.1 pt -126.43 137.57 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.221 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.569 ' SG ' HG12 ' A' ' 23' ' ' VAL . 3.8 m -86.73 132.88 33.74 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -102.29 6.42 40.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.351 0.596 . . . . 0.0 110.901 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.49 ' HD3' ' CZ ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -96.75 134.66 39.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.767 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 2.3 m-20 -86.69 126.97 34.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.682 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.3 mp -95.35 109.09 43.31 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 91.6 Cg_endo -88.82 138.71 3.65 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.059 2.506 . . . . 0.0 112.567 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -117.67 156.25 28.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.29 108.15 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.855 0.36 . . . . 0.0 110.77 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.5 m -127.72 95.34 4.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.726 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.1 tp 65.33 112.75 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.998 0.811 . . . . 0.0 112.661 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -76.57 56.55 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.13 174.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -115.43 -41.59 3.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.217 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 65.63 167.62 0.2 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.987 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -153.22 99.72 2.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.259 172.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -121.14 110.37 16.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.988 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -133.95 88.91 2.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.19 0.519 . . . . 0.0 110.552 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.3 t60 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.49 -0.766 . . . . 0.0 109.641 176.923 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 52.02 81.7 0.08 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.073 -174.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.28 160.69 30.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.057 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.07 151.7 48.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.656 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -72.5 109.46 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 83.7 t80 -59.31 98.77 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.477 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -112.84 120.42 41.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m -152.78 -159.39 1.0 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.599 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 8.9 p -128.9 138.5 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 120.768 0.318 . . . . 0.0 110.629 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -108.61 143.96 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 42' ' ' SER . 91.3 mtt180 -81.16 134.03 35.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.551 0.691 . . . . 0.0 110.261 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.639 HG11 ' HE2' ' A' ' 16' ' ' LYS . 42.5 t -116.17 150.67 18.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.231 -168.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -106.13 145.93 30.85 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 63.46 0.9 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.665 -175.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -85.27 4.23 35.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.757 ' HG2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -160.89 -178.35 6.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.121 -1.854 . . . . 0.0 107.705 179.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -93.6 75.69 4.38 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.367 -174.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -174.09 143.84 0.94 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 15.7 m120 -98.75 -33.48 10.9 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.14 163.79 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' HB ' HD11 ' A' ' 73' ' ' LEU . 9.8 p -153.84 140.15 12.66 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 120.668 0.271 . . . . 0.0 110.67 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 72.7 Cg_endo -79.14 145.54 19.38 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.568 2.179 . . . . 0.0 112.863 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.61 168.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.109 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.3 ptpt -141.07 173.78 11.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.39 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 90.7 p -109.17 138.88 44.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.87 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -68.04 -33.23 74.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.993 0.425 . . . . 0.0 110.85 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -115.78 147.17 38.45 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.056 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.51 120.37 7.76 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.771 2.314 . . . . 0.0 111.071 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.45 151.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -51.35 130.38 26.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.172 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 pt -61.12 -18.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -63.38 -35.68 81.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -95.81 10.87 35.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 111.555 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -61.86 -39.75 92.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.45 -40.93 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.386 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.21 -55.04 39.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.566 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.5 m-30 -67.36 -38.94 85.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.588 -174.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 p -69.05 -31.06 69.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.401 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -62.8 -32.39 73.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -79.94 -45.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.689 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 93.4 mt -63.18 -24.89 68.09 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' A' ' 11' ' ' ARG . 8.7 p -80.99 -18.84 45.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 110.971 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -99.09 -11.28 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.74 140.86 29.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.998 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -130.52 102.63 6.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.506 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 19.4 m -109.81 141.53 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.136 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.13 -3.01 29.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.584 -176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.478 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 14.5 m -58.8 125.81 78.48 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.919 ' HG2' ' HD2' ' A' ' 75' ' ' LYS . 33.7 Cg_endo -97.75 68.7 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.703 2.935 . . . . 0.0 112.732 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -179.27 5.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.407 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.585 ' HG3' ' ND2' ' A' ' 72' ' ' ASN . 13.8 mptt -99.94 -173.24 2.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.711 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t -66.12 146.01 55.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 0.0 111.06 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.71 31.7 35.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.344 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 69' ' ' CYS . 9.5 p30 -101.43 133.92 45.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.728 0.299 . . . . 0.0 110.281 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 58' ' ' LYS . 50.8 t -79.4 115.13 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 110.699 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.21 -51.56 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.004 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.9 m -127.41 110.18 12.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.897 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' HG11 ' A' ' 55' ' ' VAL . 65.3 tttp -99.04 123.82 43.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.679 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.2 t-20 62.94 60.26 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.519 HG12 ' HG3' ' A' ' 61' ' ' MET . 14.9 tt -76.39 123.0 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.285 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.519 ' HG3' HG12 ' A' ' 60' ' ' ILE . 86.7 mtp 65.73 23.11 11.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.927 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.679 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 11.2 m120 60.14 76.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.114 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -127.85 -44.06 1.5 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.047 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.26 16.24 12.63 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -109.98 136.31 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.52 107.82 18.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.491 0.662 . . . . 0.0 110.055 175.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.69 113.54 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.509 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.3 pt -110.88 141.45 26.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.211 0.529 . . . . 0.0 111.774 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.55 ' HB3' HD21 ' A' ' 54' ' ' ASN . 50.2 t -89.65 141.86 28.21 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -116.78 -2.24 11.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.156 0.503 . . . . 0.0 110.96 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -98.05 146.82 25.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.585 ' ND2' ' HG3' ' A' ' 51' ' ' LYS . 2.6 m-20 -92.71 123.5 36.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.736 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.6 mm? -81.58 127.11 74.19 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.5 -175.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 13.6 Cg_exo -68.84 100.0 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.739 2.293 . . . . 0.0 113.433 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.919 ' HD2' ' HG2' ' A' ' 49' ' ' PRO . 65.6 tttt -130.7 -59.81 1.0 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 169.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -69.61 100.53 1.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.311 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.2 m -94.64 123.55 38.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.246 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.0 mt -84.81 -7.52 59.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.648 -174.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -85.8 105.66 16.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 110.865 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -76.83 95.17 4.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.375 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.75 136.24 38.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.653 -175.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -81.94 111.38 18.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.568 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -157.78 -47.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.426 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -179.82 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.678 174.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 82.8 t60 . . . . . 0 C--O 1.245 0.823 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.103 172.797 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 121.022 0.439 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -129.89 154.62 47.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 88.2 mttt -74.49 154.24 38.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.917 0.389 . . . . 0.0 110.854 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -119.64 141.73 49.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.149 -172.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -67.34 106.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.969 0.414 . . . . 0.0 110.235 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.42 121.43 17.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 t -141.93 144.98 34.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.982 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.6 m -158.85 170.43 22.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.02 118.7 57.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -105.63 152.24 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -74.97 116.28 15.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.075 0.464 . . . . 0.0 110.515 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.748 HG13 ' HE2' ' A' ' 16' ' ' LYS . 9.0 p -88.98 144.55 8.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.552 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 8.3 ttp180 -122.38 -178.91 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.418 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -171.57 23.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.881 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 76' ' ' ASP . 42.5 m -80.53 91.8 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 0.0 110.894 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.748 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -157.71 -167.7 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.166 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.18 18.56 7.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.357 0.598 . . . . 0.0 110.373 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.543 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 90.5 m-85 -118.43 165.5 13.81 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -125.35 -1.4 7.57 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.232 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 m -149.82 151.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.0 p -144.86 121.37 6.16 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.89 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 24.5 Cg_exo -62.84 114.9 2.61 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.761 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.55 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -108.57 151.4 10.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.31 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.2 171.95 15.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.176 0.512 . . . . 0.0 111.353 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -109.0 130.13 55.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.875 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -77.96 -9.73 59.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.0 110.206 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 65' ' ' VAL . 90.0 mttt -122.22 143.72 39.88 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.499 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 37.2 Cg_endo -66.54 131.06 25.1 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.415 2.077 . . . . 0.0 112.394 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.58 136.8 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.658 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 4.7 pt-20 -84.15 146.18 28.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.875 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.705 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . 11.6 pt -72.92 2.86 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 p -83.66 -32.89 25.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.355 0.598 . . . . 0.0 109.966 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -92.9 -7.22 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.969 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' HB2' ' HA ' ' A' ' 31' ' ' ILE . 68.2 t90 -57.68 -40.88 80.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.017 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -66.19 -42.18 90.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.759 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.2 m-20 -60.62 -45.1 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -60.22 -39.99 88.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 m -63.41 -38.8 92.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.85 -38.44 91.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.621 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 36' ' ' ASP . 59.9 t -67.75 -41.44 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.96 -20.45 64.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.062 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.2 t -82.84 5.07 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 110.097 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -125.7 -31.89 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.349 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.6 tp -77.61 111.9 13.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.634 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -117.27 107.42 14.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 56' ' ' VAL . 15.7 m -92.77 121.36 43.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -106.76 24.52 25.24 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.169 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.52 104.42 55.94 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.72 95.9 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.518 2.146 . . . . 0.0 111.345 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.23 156.52 20.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 35.2 mtmm -101.9 78.22 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.68 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 15.8 t 68.43 159.72 0.17 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.619 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 30.91 63.84 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.558 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -109.66 119.6 39.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.402 0.62 . . . . 0.0 111.245 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG22 HG22 ' A' ' 68' ' ' ILE . 21.3 t -81.35 109.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.25 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 46' ' ' VAL . 4.1 m -85.66 -40.32 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.689 0.28 . . . . 0.0 111.027 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.7 m -130.42 100.98 5.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.418 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -85.32 119.94 26.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.9 t30 62.46 75.69 0.39 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.686 0.755 . . . . 0.0 109.358 -170.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tt -72.92 127.9 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.946 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 93.3 mmm 66.38 -80.37 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.835 0.71 . . . . 0.0 110.355 -175.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' MET . 59.2 t30 172.47 80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.103 0.561 . . . . 0.0 109.851 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 t -158.48 15.11 0.19 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.872 0.367 . . . . 0.0 111.367 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.22 -22.37 7.22 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.934 -0.651 . . . . 0.0 114.011 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 27' ' ' LYS . 65.9 t -66.95 121.43 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 117.313 0.556 . . . . 0.0 111.873 -174.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.49 121.97 37.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.904 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.57 122.87 41.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.809 0.338 . . . . 0.0 110.446 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 55' ' ' VAL . 20.1 pt -121.44 140.0 46.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.366 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.55 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.7 m -90.43 122.36 33.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -101.3 8.18 42.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 49.1 tttp -96.19 145.07 25.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.68 ' OD1' ' HB2' ' A' ' 52' ' ' SER . 2.2 m120 -92.68 103.62 15.98 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.929 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 12' ' ' VAL . 75.2 mt -96.32 111.59 57.16 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.411 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -75.01 115.65 4.35 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.676 2.251 . . . . 0.0 111.35 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HE2' ' OG ' ' A' ' 77' ' ' SER . 87.0 tttt -75.77 126.1 30.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.351 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 15' ' ' SER . 23.0 t70 -111.59 90.26 3.29 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.45 ' OG ' ' HE2' ' A' ' 75' ' ' LYS . 48.2 m -77.84 99.67 6.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.26 -173.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.66 -26.24 9.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.021 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.14 37.5 0.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.43 0.634 . . . . 0.0 110.471 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 0.6 OUTLIER -151.24 164.86 35.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.545 -178.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 80' ' ' HIS . 24.3 m170 75.75 -58.39 0.55 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -47.78 -66.25 0.43 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -169.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 84' ' ' HIS . 6.3 p80 -140.68 11.27 2.27 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.653 -175.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.518 ' HB3' ' O ' ' A' ' 83' ' ' HIS . 22.6 t60 72.19 144.15 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.559 0.537 . . . . 0.0 110.759 -175.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.538 176.828 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.68 30.82 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.867 0.841 . . . . 0.0 110.103 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 45.5 mmtt -83.5 110.04 17.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.462 172.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.6 139.77 50.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.883 0.373 . . . . 0.0 110.622 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.82 121.94 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.582 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -75.58 102.02 5.14 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -125.8 127.65 46.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.414 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -154.51 172.13 18.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 110.83 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.488 HG12 ' HB ' ' A' ' 20' ' ' VAL . 48.1 t -113.1 117.17 54.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.53 156.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.75 0.31 . . . . 0.0 110.649 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -72.96 102.97 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.587 HG13 ' HE2' ' A' ' 16' ' ' LYS . 10.2 p -85.05 134.33 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.699 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 68.8 mtp180 -126.54 -179.07 4.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.5 -172.86 33.42 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.14 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 p -74.84 99.26 3.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.169 0.509 . . . . 0.0 111.991 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -166.6 178.3 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.496 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -87.56 -27.54 22.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.469 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.595 ' HE2' ' HA ' ' A' ' 73' ' ' LEU . 82.3 m-85 -79.73 171.16 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -126.15 -15.1 5.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 171.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 9' ' ' VAL . 11.8 m -148.29 147.47 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.07 132.67 14.86 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.922 0.392 . . . . 0.0 111.204 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 138.96 21.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.643 2.229 . . . . 0.0 112.669 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.19 156.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.417 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -142.63 165.81 26.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.828 0.346 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 p -109.46 142.3 40.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -78.89 -8.29 58.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.242 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.19 134.43 16.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.127 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 52.6 Cg_exo -56.95 136.12 74.78 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.817 2.345 . . . . 0.0 112.183 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.26 145.65 20.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.3 135.01 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 pt -66.33 -9.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.293 . . . . 0.0 111.549 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 m -67.58 -30.73 70.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 87.9 mttt -86.83 -17.4 33.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.649 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -51.78 -45.44 63.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.148 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.5 -44.98 99.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 111.46 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 40' ' ' VAL . 14.8 t70 -79.46 -32.27 42.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 1.7 m-85 -56.18 -48.7 75.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.122 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -60.99 -44.37 97.51 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.277 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -57.56 -47.19 82.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.731 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 36' ' ' ASP . 87.6 t -64.78 -46.02 93.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.669 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 tp -65.71 -31.93 73.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.857 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -66.8 -20.9 66.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 110.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 43' ' ' ARG . 55.0 mtm180 -104.85 8.91 34.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.4 tp -110.47 84.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.591 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 79.6 m-85 -92.78 101.02 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -122.04 159.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.348 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -145.58 -134.4 2.69 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.517 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.46 115.57 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.024 0.53 . . . . 0.0 110.711 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 65.2 Cg_exo -53.54 111.07 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.08 2.52 . . . . 0.0 112.825 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -109.27 -170.91 1.74 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.042 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -127.13 166.75 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.004 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.53 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 22.5 t -61.86 131.3 49.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.693 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.54 21.16 32.5 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.634 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.434 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 2.1 p-10 -89.19 131.73 35.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.75 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 68' ' ' ILE . 38.7 t -87.27 106.16 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.119 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.4 -55.76 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.143 0.496 . . . . 0.0 109.809 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 t -130.7 121.11 24.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.403 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 31.8 ttmt -92.34 112.48 24.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.223 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 62' ' ' ASN . 62.9 t30 58.86 54.93 4.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.619 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.527 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 10.4 tt -46.27 -43.18 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.822 -171.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.501 ' HG3' HG12 ' A' ' 60' ' ' ILE . 84.4 mtp -128.98 29.03 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.491 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.424 ' HA ' ' ND2' ' A' ' 59' ' ' ASN . 40.7 t-20 53.81 72.51 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.406 0.622 . . . . 0.0 110.626 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -153.89 13.67 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.0 37.57 83.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.589 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 27' ' ' LYS . 52.0 t -127.08 120.95 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.014 0.435 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.592 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 15.9 m-20 -96.05 121.69 38.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.39 101.98 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.449 HG22 HG22 ' A' ' 55' ' ' VAL . 13.4 pt -109.15 139.92 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.368 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 43.9 t -95.25 145.24 25.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.258 174.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -121.05 8.91 10.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 110.495 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 24.9 tptp -96.68 131.37 43.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.53 ' OD1' ' HB2' ' A' ' 52' ' ' SER . 8.8 m120 -91.15 116.4 28.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.887 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.595 ' HA ' ' HE2' ' A' ' 18' ' ' TYR . 6.1 mp -96.73 119.59 63.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.21 123.1 13.03 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.245 1.963 . . . . 0.0 110.709 172.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 13.2 tptm -69.95 -71.23 0.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.114 -171.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.414 ' OD2' ' HG3' ' A' ' 75' ' ' LYS . 35.6 m-20 -118.17 101.28 8.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.251 -173.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.3 t -69.34 99.73 1.24 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.62 90.37 3.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.383 0.611 . . . . 0.0 111.292 -174.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.91 97.98 4.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.83 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -110.6 11.12 22.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.372 0.606 . . . . 0.0 110.583 -175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -90.05 164.08 14.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.14 0.495 . . . . 0.0 110.117 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -97.57 178.65 5.11 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -57.5 -50.71 72.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.726 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -166.24 -58.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 173.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.101 171.7 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -166.21 121.53 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.214 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 10.4 mmmm -91.69 113.07 25.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.449 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.719 ' HB3' ' HZ2' ' A' ' 34' ' ' TRP . 6.4 t70 -130.11 171.01 13.3 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.3 112.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.102 -0.374 . . . . 0.0 111.309 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.477 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 29.4 t80 -66.34 115.22 6.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.493 . . . . 0.0 110.357 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -123.39 133.42 54.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.777 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.3 t -152.98 -163.55 1.73 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 20' ' ' VAL . 8.8 p -141.07 136.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.84 148.75 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.21 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -73.56 143.06 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 111.03 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 18' ' ' TYR . 57.4 t -105.76 146.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.692 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.75 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 19.4 ttp180 -140.38 -179.31 5.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.479 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' N ' ' HG2' ' A' ' 13' ' ' ARG . . . 111.7 -154.27 16.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.166 165.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -77.93 20.43 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.322 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -156.4 142.45 18.09 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.068 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.24 87.43 7.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.256 0.551 . . . . 0.0 110.285 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' HB3' HG11 ' A' ' 12' ' ' VAL . 2.2 t80 -117.59 141.71 48.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -77.53 -69.88 0.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.4 ' HB ' ' CG2' ' A' ' 9' ' ' VAL . 17.6 m -136.74 148.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.073 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.9 p -127.44 127.42 24.15 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.659 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 55.6 Cg_endo -71.4 133.83 23.38 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.685 2.257 . . . . 0.0 112.424 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 69' ' ' CYS . 27.1 m -119.44 166.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.031 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -147.09 176.35 10.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.383 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 16.3 m -109.15 131.21 55.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -78.31 -11.32 59.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.964 0.411 . . . . 0.0 110.428 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HB3' HG22 ' A' ' 65' ' ' VAL . 39.5 ttpt -135.78 135.15 21.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 14.4 Cg_endo -56.28 141.47 88.56 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 65' ' ' VAL . 4.2 m -122.18 174.21 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.131 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . 25.3 mt-10 -71.36 140.25 50.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 33' ' ' LYS . 36.0 pt -67.54 151.71 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 m 72.69 -32.77 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.116 0.566 . . . . 0.0 111.112 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 30' ' ' GLU . 19.2 tptm -64.26 -16.92 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 174.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.719 ' HZ2' ' HB3' ' A' ' 4' ' ' ASP . 52.0 m0 -54.27 -39.07 66.54 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.589 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.15 -36.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.15 -44.54 79.51 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.165 0.507 . . . . 0.0 110.263 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -66.45 -37.26 84.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 t -65.78 -32.27 73.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.291 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.48 -42.6 99.59 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.076 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.63 -47.8 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.869 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.851 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -64.1 -20.59 66.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 110.543 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -104.13 14.8 29.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.857 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 56' ' ' VAL . 32.0 tp -112.52 139.09 48.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -127.16 97.66 5.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.78 124.64 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.228 0.537 . . . . 0.0 111.055 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.75 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -109.62 175.19 18.61 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.182 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 99.2 t 73.53 134.29 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 123.05 0.54 . . . . 0.0 111.544 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.61 116.7 3.38 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.859 2.373 . . . . 0.0 111.78 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 p -118.79 169.52 9.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -120.3 169.36 10.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -52.58 118.64 3.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 24.95 9.84 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.115 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 2.7 p-10 -88.47 132.34 34.52 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 68' ' ' ILE . 34.4 t -88.25 125.47 41.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.07 -175.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.471 ' HB ' HD21 ' A' ' 44' ' ' LEU . 30.5 m -97.85 -38.15 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.092 0.472 . . . . 0.0 110.258 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.6 m -130.9 105.14 7.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.791 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -95.19 127.48 41.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.12 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 1.6 t-20 54.56 40.37 31.79 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.842 0.713 . . . . 0.0 109.748 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.597 HG12 ' HG2' ' A' ' 61' ' ' MET . 10.4 tt -41.96 -50.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.622 -169.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.597 ' HG2' HG12 ' A' ' 60' ' ' ILE . 25.7 mmt -134.71 49.04 2.25 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.35 -0.219 . . . . 0.0 110.628 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 8.5 p30 56.71 5.86 0.25 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.841 1.256 . . . . 0.0 113.753 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.592 HG23 ' H ' ' A' ' 65' ' ' VAL . 5.0 t -78.56 -11.68 59.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.311 0.577 . . . . 0.0 110.71 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -6.35 83.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.268 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.592 ' H ' HG23 ' A' ' 63' ' ' THR . 66.5 t -81.33 126.9 39.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.817 0.341 . . . . 0.0 110.512 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -108.77 123.85 49.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mm -81.68 117.35 27.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' VAL . 33.6 pt -121.99 139.85 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.612 -173.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 23' ' ' VAL . 1.8 m -89.32 137.32 32.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -105.38 13.12 30.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.128 0.49 . . . . 0.0 111.454 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 21' ' ' VAL . 31.9 mmtt -96.76 142.64 28.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -96.47 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 mt -99.8 112.71 64.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.581 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -91.58 -171.87 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.994 2.463 . . . . 0.0 112.007 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 8.5 mtpm? -108.03 101.4 10.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.64 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 63.13 -169.64 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.931 0.77 . . . . 0.0 111.302 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 p -99.84 87.66 3.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.065 0.46 . . . . 0.0 110.546 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.2 mt -97.36 -26.94 14.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.428 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -166.31 153.55 9.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -73.2 -17.8 61.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 0.0 110.729 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.6 m80 70.3 167.92 0.3 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.323 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -144.35 125.87 14.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.897 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -94.75 -15.43 23.85 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.3 m170 -105.05 -173.52 2.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.158 173.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.311 179.621 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -140.24 82.58 1.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 0.0 110.203 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 93.2 mttt -130.43 130.58 44.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.512 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 154.51 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 28' ' ' PRO . 46.7 mm -73.97 112.79 11.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.431 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.528 ' HB2' HG21 ' A' ' 29' ' ' VAL . 87.0 t80 -64.01 104.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.592 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -111.02 120.56 42.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -141.47 -166.86 2.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 60.5 t -133.63 129.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.39 152.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -91.96 133.26 35.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 110.307 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 HG23 ' A' ' 46' ' ' VAL . 2.5 t -118.76 133.31 66.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 112.025 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.566 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 92.4 mtt-85 -108.29 -179.11 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.353 173.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -161.6 21.59 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.453 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.2 m -78.77 74.87 5.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 111.393 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -147.96 166.66 27.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.581 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -89.32 -46.42 8.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.855 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.422 ' O ' ' HD2' ' A' ' 16' ' ' LYS . 85.4 m-85 -83.67 156.8 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -103.35 -3.03 26.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.865 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 6.5 m -143.51 145.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -134.18 129.13 19.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.436 174.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HG2' ' HB2' ' A' ' 71' ' ' LYS . 36.0 Cg_endo -67.89 128.89 18.57 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.494 2.129 . . . . 0.0 112.342 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 69' ' ' CYS . 27.1 m -115.94 161.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.343 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -139.76 178.33 7.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.13 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.21 134.45 51.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.768 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -72.87 -22.25 60.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HB2' HG22 ' A' ' 65' ' ' VAL . 37.7 mtmm -132.42 146.29 60.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' HD13 ' A' ' 5' ' ' ILE . 23.9 Cg_exo -63.15 137.62 62.5 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.969 2.446 . . . . 0.0 112.818 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 6' ' ' PHE . 33.4 m -114.99 160.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.411 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.608 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 59.4 mt-10 -68.65 139.7 55.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 29.7 pt -60.22 -26.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.375 . . . . 0.0 111.675 -177.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 m -74.74 -17.41 60.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.082 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.608 ' HE2' ' OE1' ' A' ' 30' ' ' GLU . 63.8 mttm -90.48 -5.29 56.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.612 0.244 . . . . 0.0 111.334 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.442 ' CD1' ' HA ' ' A' ' 31' ' ' ILE . 10.5 m95 -59.05 -31.26 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.02 -48.3 75.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.462 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 40' ' ' VAL . 7.1 m-20 -56.5 -50.63 71.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.49 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.434 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 32.4 m-85 -63.07 -37.05 85.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.371 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -63.4 -41.83 98.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.832 -0.167 . . . . 0.0 111.095 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -62.78 -35.27 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.958 0.409 . . . . 0.0 110.679 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 36' ' ' ASP . 59.1 t -70.02 -48.58 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.61 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.938 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.3 m -66.18 -12.14 54.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.644 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -105.15 -9.29 17.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 109.918 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.11 124.0 43.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.605 -172.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -125.3 117.1 23.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.641 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.514 HG11 HG13 ' A' ' 56' ' ' VAL . 24.9 m -106.02 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -151.3 47.04 0.59 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.426 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.33 119.73 17.69 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-O 120.562 0.22 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.66 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 55.8 Cg_endo -73.49 97.59 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.581 2.188 . . . . 0.0 111.473 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 p -96.77 170.22 9.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 64.1 mttp -98.27 -149.76 0.35 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.695 171.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 2.0 p -92.36 119.59 32.06 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.62 58.16 1.21 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.177 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.511 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 13.2 m120 -127.91 129.24 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.17 110.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.167 0.508 . . . . 0.0 111.322 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 HG11 ' A' ' 46' ' ' VAL . 45.1 t -83.98 -42.61 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.684 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.1 m -130.53 103.6 6.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.443 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -84.23 128.19 34.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.528 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 54.79 52.66 11.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.348 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.554 HG21 HG12 ' A' ' 67' ' ' ILE . 12.7 tt -75.32 135.7 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.403 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.7 mmt 65.07 13.85 8.97 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.477 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.4 13.15 5.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.568 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 65' ' ' VAL . 8.9 t -87.51 -7.49 57.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.449 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.46 66.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.629 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.516 ' H ' HG23 ' A' ' 63' ' ' THR . 77.1 t -73.07 137.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.113 0.483 . . . . 0.0 110.283 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.94 120.2 38.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.554 HG12 HG21 ' A' ' 60' ' ' ILE . 44.0 mm -80.04 115.97 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.77 0.319 . . . . 0.0 110.397 -175.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 26.3 pt -116.13 131.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.649 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.52 ' HB3' HG12 ' A' ' 23' ' ' VAL . 1.8 p -81.13 139.32 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 11.7 t -126.13 6.99 7.18 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.395 -173.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' HB3' HG23 ' A' ' 21' ' ' VAL . 64.2 tttp -99.67 131.12 45.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 2.7 m-20 -76.19 107.17 8.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.506 HD11 ' HB ' ' A' ' 21' ' ' VAL . 95.8 mt -81.58 112.62 35.68 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.279 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.94 117.79 4.77 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.487 2.125 . . . . 0.0 112.067 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -69.67 107.99 3.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.013 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.24 65.72 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.658 0.742 . . . . 0.0 110.611 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.6 t -174.48 127.33 0.33 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.407 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.3 mt -105.51 158.21 16.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.226 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -74.17 95.14 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -104.19 110.37 22.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.729 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -143.43 121.03 11.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.895 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -91.58 131.12 37.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.091 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -162.5 40.76 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.267 0.556 . . . . 0.0 109.815 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -79.03 47.75 0.8 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.48 0.657 . . . . 0.0 110.512 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 . . . . . 0 C--O 1.249 1.075 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.269 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.628 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 6.4 mmt . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 62.1 -94.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.669 0.605 . . . . 0.0 110.01 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 28' ' ' PRO . 68.2 mttm -107.93 140.52 40.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.62 157.13 32.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.575 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.3 mm -82.74 101.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 81.9 t80 -58.8 106.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.339 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -122.26 128.69 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.068 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -149.54 -168.98 3.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.9 m -121.75 137.53 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.705 0.288 . . . . 0.0 110.34 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.86 152.27 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -89.45 111.18 22.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.576 0.703 . . . . 0.0 110.117 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.608 ' HB ' ' HZ1' ' A' ' 16' ' ' LYS . 3.0 t -98.28 140.01 19.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.608 -173.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 45' ' ' TYR . 67.6 mtm180 -79.75 144.37 33.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.54 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -70.58 95.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 115.124 -169.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 p -117.37 12.33 14.23 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 165.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HZ1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -169.96 -168.92 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.359 -171.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.43 -41.36 14.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.602 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 78.2 m-85 -82.4 97.32 8.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 111.498 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 95.8 m-20 -98.63 10.72 40.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.52 122.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 73' ' ' LEU . 4.4 p -130.91 139.73 36.49 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.719 -173.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.43 124.39 10.33 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.923 2.415 . . . . 0.0 112.966 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.4 154.61 16.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.516 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -143.98 178.97 7.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB2' HG11 ' A' ' 65' ' ' VAL . 67.8 p -108.93 127.67 54.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.758 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -63.9 -24.32 67.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.863 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB2' HG22 ' A' ' 65' ' ' VAL . 82.8 mttt -122.68 142.71 38.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HB2' ' CB ' ' A' ' 3' ' ' LYS . 32.5 Cg_endo -64.81 128.29 20.58 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.232 1.955 . . . . 0.0 112.117 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.04 150.26 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.201 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.07 120.75 14.8 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.19 84.12 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.725 1.25 . . . . 0.0 111.914 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.1 m -138.04 -10.45 1.52 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.081 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -103.46 17.77 23.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -173.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -62.99 -26.84 69.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 110.494 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 64.2 mt -73.02 -47.91 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.429 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 40' ' ' VAL . 5.8 m-20 -68.29 -39.71 82.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.546 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.8 m-30 -64.21 -48.41 75.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -66.43 -30.75 71.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.182 0.515 . . . . 0.0 110.064 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 14.5 t-20 -56.72 -49.66 74.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.028 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 36' ' ' ASP . 47.1 t -70.99 -38.03 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.736 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 81.2 mt -62.01 -25.35 67.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.245 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -77.86 4.3 12.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.004 0.43 . . . . 0.0 111.396 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -141.64 16.75 2.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 0.0 109.963 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.9 tp -115.1 59.43 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.725 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 78.7 m-85 -83.83 92.05 7.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.738 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 48' ' ' VAL . 14.9 p -92.18 147.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.99 49.19 0.93 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.1 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 22.3 m -130.23 128.96 22.81 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.724 ' HG2' ' HD2' ' A' ' 75' ' ' LYS . 23.2 Cg_exo -67.39 133.26 29.74 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.136 2.558 . . . . 0.0 111.589 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.509 ' H ' HD13 ' A' ' 73' ' ' LEU . 2.0 p -133.41 179.68 6.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.961 -174.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -118.92 169.5 9.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 t -59.56 128.71 38.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 0.0 111.805 -173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.97 26.71 12.1 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.554 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.591 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.0 p30 -96.42 137.53 35.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' A' ' 58' ' ' LYS . 62.4 t -77.6 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.69 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.87 -57.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.2 t -130.49 109.25 10.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.915 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' HG11 ' A' ' 55' ' ' VAL . 9.3 tmtm? -84.12 119.82 25.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.623 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 57.46 50.86 10.56 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 110.221 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.651 HG12 ' HG2' ' A' ' 61' ' ' MET . 8.0 tt -49.15 -50.46 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.666 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.651 ' HG2' HG12 ' A' ' 60' ' ' ILE . 95.8 mmm -130.12 45.41 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.791 0.329 . . . . 0.0 110.585 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.04 29.63 19.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.194 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -86.31 -20.05 28.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.689 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.79 87.52 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 27' ' ' LYS . 69.0 t -104.47 138.75 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.212 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 58' ' ' LYS . 4.3 m-20 -97.41 106.94 19.35 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.07 107.12 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 55' ' ' VAL . 33.4 pt -114.69 144.87 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.977 -171.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.591 ' HB3' HD21 ' A' ' 54' ' ' ASN . 10.3 t -89.65 141.97 28.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.046 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -120.07 6.74 10.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 56.7 tttp -101.74 147.55 26.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -98.01 110.88 23.37 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 21' ' ' VAL . 5.7 mp -87.45 116.1 65.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.988 -176.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 2.9 Cg_exo -77.27 148.45 26.99 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 123.013 2.475 . . . . 0.0 111.519 175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.724 ' HD2' ' HG2' ' A' ' 49' ' ' PRO . 56.2 tttm -145.34 158.23 43.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.544 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 79.2 -177.09 0.09 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.07 0.948 . . . . 0.0 110.75 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.5 m -110.53 18.28 19.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.46 -171.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.12 136.37 52.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -70.66 145.11 50.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.787 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -147.83 97.06 2.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.539 0.685 . . . . 0.0 110.17 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -123.13 116.64 23.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.848 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -80.5 104.88 11.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 110.767 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -144.16 121.1 11.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.167 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -67.96 107.15 2.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 111.125 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 13.5 p80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.867 177.479 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -142.62 17.94 2.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.917 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.3 mttt -103.53 142.0 35.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.915 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -140.57 164.4 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.022 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -74.85 113.19 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 72.8 t80 -59.35 108.5 0.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.842 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -126.26 120.98 31.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.381 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -155.79 -156.79 0.67 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.2 m -132.08 147.03 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.784 0.326 . . . . 0.0 110.465 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.51 150.42 18.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.017 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.463 ' HD3' HG12 ' A' ' 20' ' ' VAL . 12.0 mmt180 -84.38 121.31 27.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 6.5 t -100.66 118.27 47.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.389 -173.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' C ' ' HA3' ' A' ' 47' ' ' GLY . 62.5 ttt180 -133.1 104.2 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 47' ' ' GLY . . . 174.42 -171.83 44.88 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -78.3 99.31 6.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -171.78 -166.63 0.44 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.36 -179.372 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -128.35 71.68 1.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -161.28 176.12 11.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -136.12 -50.07 0.69 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 110.551 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.463 HG12 ' HD3' ' A' ' 11' ' ' ARG . 15.9 m -131.11 133.45 62.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.19 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 73' ' ' LEU . 4.4 p -127.59 140.79 39.01 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.225 -177.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 47.2 Cg_endo -70.08 137.63 34.98 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.243 1.962 . . . . 0.0 112.199 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -135.25 146.79 29.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.558 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -145.22 178.93 7.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.914 0.388 . . . . 0.0 111.288 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.515 ' HB2' HG11 ' A' ' 65' ' ' VAL . 91.3 p -108.86 129.56 55.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.03 -39.77 72.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.516 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 65' ' ' VAL . 32.3 ttmt -119.52 140.25 29.0 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.462 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.91 126.22 20.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.533 2.155 . . . . 0.0 111.924 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.54 156.92 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.646 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 25.8 mt-10 -67.09 127.29 32.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.9 pt -74.31 -6.8 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 110.877 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.9 t -60.6 -31.96 71.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.331 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.447 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 33.2 mtmm -107.1 14.86 25.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.719 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -57.52 -36.21 71.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.698 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.19 -39.69 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.04 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 40' ' ' VAL . 25.7 t0 -71.96 -42.16 66.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 22.3 m-85 -58.08 -46.22 85.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.272 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.0 p -68.98 -28.6 66.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.309 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -72.69 -24.66 61.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.918 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 57.6 t -71.67 -44.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.18 -42.86 91.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.407 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -77.91 2.85 16.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 111.227 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -111.49 -15.89 13.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.537 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 93.3 mt -74.07 -71.66 0.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.861 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 58.5 79.92 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.465 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.3 p -125.22 143.36 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.614 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' C ' ' A' ' 13' ' ' ARG . . . -139.17 88.98 0.2 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.086 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 60.0 t -128.82 120.61 20.58 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' VAL . 14.2 Cg_endo -57.71 111.13 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 111.779 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 171.66 14.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.548 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -100.55 178.32 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.341 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -68.9 129.17 39.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.57 28.56 10.25 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.285 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.8 p30 -88.32 131.32 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 66' ' ' ASP . 37.0 t -88.97 110.71 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.794 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.99 -64.74 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.131 0.491 . . . . 0.0 109.789 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.412 ' HB3' ' HB ' ' A' ' 60' ' ' ILE . 70.3 m -100.47 116.69 33.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.311 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HD3' HG12 ' A' ' 55' ' ' VAL . 25.3 mmtt -83.4 104.01 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.6 t30 54.77 66.31 1.27 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.703 0.763 . . . . 0.0 109.595 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.48 HD11 HG11 ' A' ' 40' ' ' VAL . 12.3 tt -61.69 111.25 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.539 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm 63.76 26.17 14.35 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.63 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 m120 62.75 82.68 0.17 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.284 0.564 . . . . 0.0 111.372 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.2 p -133.14 -20.83 2.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.203 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.22 7.45 73.2 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.35 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 27' ' ' LYS . 60.1 t -116.72 129.44 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.049 0.452 . . . . 0.0 110.442 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' HB2' HG13 ' A' ' 55' ' ' VAL . 5.4 p-10 -95.55 126.08 40.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 169.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 mm -83.15 110.89 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.018 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.7 pt -117.4 138.53 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.451 0.643 . . . . 0.0 112.273 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.555 ' HB3' HD21 ' A' ' 54' ' ' ASN . 40.7 t -92.11 145.7 24.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -114.92 -2.74 12.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HD3' HG23 ' A' ' 21' ' ' VAL . 55.9 tttp -97.04 149.88 21.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -96.76 132.62 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.493 HD11 HG21 ' A' ' 21' ' ' VAL . 5.1 mp -111.79 93.98 22.5 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -92.24 137.9 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.776 2.317 . . . . 0.0 113.024 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -142.47 112.16 6.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.09 120.89 32.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.7 p -146.98 114.91 6.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.985 0.421 . . . . 0.0 112.085 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 78' ' ' LEU . 6.4 mp -77.2 105.11 8.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -85.36 80.95 8.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -164.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 58.04 26.63 13.79 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 168.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -88.47 28.72 1.07 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.47 0.652 . . . . 0.0 110.343 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -161.72 96.73 1.04 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.086 0.469 . . . . 0.0 110.105 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -171.36 -55.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -87.9 55.58 3.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 . . . . . 0 C--O 1.249 1.07 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.764 -172.687 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mmm . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.686 0.279 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -88.92 -18.72 26.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.342 0.591 . . . . 0.0 109.854 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 94.2 mttt -115.59 122.2 44.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.561 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -124.19 148.17 47.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.487 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.468 HG22 HG23 ' A' ' 7' ' ' THR . 42.0 mm -64.6 119.74 9.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.083 0.468 . . . . 0.0 110.959 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 91.6 t80 -78.13 96.01 5.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.034 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 5' ' ' ILE . 16.6 p -105.72 125.19 50.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 60.0 m -149.94 -169.0 3.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 138.83 52.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.3 157.85 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.459 ' HD2' HG12 ' A' ' 20' ' ' VAL . 33.6 mmm-85 -79.74 133.1 36.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.802 0.334 . . . . 0.0 110.797 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 46' ' ' VAL . 2.8 t -120.63 139.1 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.284 0.564 . . . . 0.0 110.669 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 64.6 ttt-85 -119.43 170.49 9.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.074 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.09 174.35 18.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.634 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.6 p -72.52 86.35 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.549 ' HG2' ' HG3' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -178.15 164.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.044 171.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -91.71 34.14 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.374 -0.376 . . . . 0.0 112.011 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 97.5 m-85 -130.55 102.91 6.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 110.31 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.39 -7.06 55.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.546 -176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.459 HG12 ' HD2' ' A' ' 11' ' ' ARG . 15.5 m -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.511 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.512 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.1 p -140.78 138.25 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.435 177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' SER . 55.2 Cg_endo -72.98 129.57 14.42 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.558 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 69' ' ' CYS . 30.1 m -115.58 161.55 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.569 ' HG3' HG13 ' A' ' 68' ' ' ILE . 18.3 ptpt -131.34 174.94 9.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.481 ' HB2' HG11 ' A' ' 65' ' ' VAL . 79.8 p -108.93 130.95 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.262 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.78 -44.71 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HG3' ' HD2' ' A' ' 28' ' ' PRO . 37.5 ttpt -121.09 140.88 31.76 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.538 ' HD2' ' HG3' ' A' ' 27' ' ' LYS . 84.6 Cg_exo -46.92 130.76 16.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.088 2.526 . . . . 0.0 112.835 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.81 127.09 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.667 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 40.9 mt-10 -52.5 135.3 34.12 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.301 176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 tp -68.26 81.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 122.051 0.929 . . . . 0.0 110.881 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t 179.9 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.217 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.12 -5.69 52.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.295 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -57.56 -34.25 68.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.27 -54.99 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.658 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 7.5 m-20 -62.44 -38.16 88.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.02 -51.42 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.242 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -64.9 -32.01 73.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.632 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 24.9 t-20 -55.56 -54.34 45.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.901 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 36' ' ' ASP . 67.3 t -60.42 -42.93 92.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.98 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.4 mt -60.99 -27.2 68.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -68.28 -10.63 56.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.58 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -130.2 20.07 5.34 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 174.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.3 tp -109.89 115.23 29.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.43 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -117.29 112.69 21.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.369 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.551 HG23 HG13 ' A' ' 12' ' ' VAL . 27.3 m -96.67 178.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -143.98 176.04 23.51 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.089 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.7 t 71.97 139.75 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 122.797 0.439 . . . . 0.0 111.216 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HG2' ' HA ' ' A' ' 75' ' ' LYS . 25.1 Cg_exo -64.8 119.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.447 2.098 . . . . 0.0 111.401 170.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.587 ' HB ' ' CG ' ' A' ' 54' ' ' ASN . 40.6 p -101.6 166.34 10.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.826 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.59 -148.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 t -101.95 120.81 41.0 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.31 49.77 1.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.026 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.587 ' CG ' ' HB ' ' A' ' 50' ' ' THR . 1.5 m-80 -108.69 109.11 20.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 68' ' ' ILE . 94.7 t -69.55 111.38 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 -62.55 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.71 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -130.81 115.3 16.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.032 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 20.6 ptmt -98.18 141.97 30.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.824 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.497 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 11.8 t-20 58.34 41.7 22.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.716 0.77 . . . . 0.0 109.028 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.773 HG12 ' HG2' ' A' ' 61' ' ' MET . 14.4 tt -64.51 133.67 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.41 -173.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.773 ' HG2' HG12 ' A' ' 60' ' ' ILE . 83.7 mmm 63.39 21.85 12.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.9 t30 65.65 10.91 7.11 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.13 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -69.87 -43.82 71.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.96 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.497 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 117.43 -27.14 7.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 25' ' ' SER . 85.8 t -66.95 140.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.67 0.271 . . . . 0.0 110.766 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 4.2 m-20 -95.63 123.0 38.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.76 106.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.569 HG13 ' HG3' ' A' ' 24' ' ' LYS . 25.7 pt -115.53 132.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.857 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.578 ' HB3' HD22 ' A' ' 54' ' ' ASN . 18.2 t -72.09 142.1 49.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.1 t -126.35 1.83 7.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 64.7 tttp -102.58 129.08 49.03 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.481 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -86.23 106.39 17.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.974 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 62.9 mt -95.73 126.03 46.76 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.079 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 73' ' ' LEU . 15.6 Cg_endo -58.34 132.19 47.34 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.175 . . . . 0.0 111.532 176.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 49' ' ' PRO . 51.8 tttm -95.38 -82.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.53 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.89 93.18 6.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.969 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 t -86.89 93.27 9.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.466 0.651 . . . . 0.0 110.215 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -92.42 61.12 3.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.648 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.51 133.98 43.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.625 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -79.65 119.82 23.13 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -58.25 -48.95 78.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.343 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -145.54 -76.05 0.21 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.616 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -151.22 116.22 5.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.492 -174.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -151.55 129.32 11.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.285 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.6 p80 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.251 175.404 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.3 145.43 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.746 0.308 . . . . 0.0 110.563 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.38 119.73 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.923 0.392 . . . . 0.0 110.277 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 77.0 t80 -60.11 125.71 24.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.155 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.8 m -145.15 120.39 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 178.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.58 120.97 66.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.3 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.74 150.58 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.805 0.336 . . . . 0.0 110.333 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.538 ' HA ' HG12 ' A' ' 20' ' ' VAL . 91.0 mtt180 -77.22 134.45 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.597 ' CG1' ' HE3' ' A' ' 16' ' ' LYS . 12.0 t -112.85 111.6 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -90.84 100.91 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.448 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.5 14.0 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 t -85.03 99.84 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.597 ' HE3' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -149.58 39.77 0.81 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.356 -175.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.6 tttm 70.74 -66.07 0.31 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.568 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -73.79 -179.06 3.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 111.363 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.0 -36.43 1.98 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.653 0.263 . . . . 0.0 111.245 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 11' ' ' ARG . 17.0 m -129.03 158.99 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.218 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.2 p -128.67 133.4 25.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.93 118.8 5.72 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.529 2.152 . . . . 0.0 111.717 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 69' ' ' CYS . 28.9 m -112.5 150.54 14.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.51 ' HE3' HG21 ' A' ' 70' ' ' THR . 18.3 ptpt -136.66 170.56 15.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.969 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 17.0 t -109.45 155.71 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.468 HD21 ' HE2' ' A' ' 27' ' ' LYS . 21.1 p-10 -78.04 -32.86 51.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.176 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' HD21 ' A' ' 26' ' ' ASN . 51.1 mtmt -122.58 150.86 58.97 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.975 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 23.3 Cg_exo -64.38 136.9 53.06 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.137 2.558 . . . . 0.0 112.971 -176.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -124.57 150.19 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.824 -177.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -69.52 145.7 52.45 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.866 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tt -60.35 -27.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.987 0.422 . . . . 0.0 111.546 -174.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.45 -28.0 68.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 111.059 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.13 -20.73 22.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.711 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -57.55 -43.33 84.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -67.37 -45.59 85.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.135 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.96 -45.8 89.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.449 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CE2' HG11 ' A' ' 29' ' ' VAL . 22.1 m-30 -67.51 -37.44 82.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.602 0.239 . . . . 0.0 110.877 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 m -64.44 -33.7 76.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.21 -40.2 95.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.22 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 50.7 t -64.98 -44.3 96.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.338 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.91 -21.92 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.443 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -73.5 -13.59 61.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.381 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 10.3 ptt180 -111.65 1.26 16.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.366 0.603 . . . . 0.0 109.43 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 tt -108.73 133.02 53.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.683 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.96 110.24 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.642 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 43.2 t -78.01 126.72 38.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.96 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.773 -1.203 . . . . 0.0 112.589 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.8 112.14 20.52 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.535 0.207 . . . . 0.0 110.913 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 6.1 Cg_exo -75.44 102.95 1.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.774 2.316 . . . . 0.0 110.786 170.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.61 -178.57 4.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.302 0.572 . . . . 0.0 112.352 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.91 -178.23 5.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.367 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 p -74.85 140.13 43.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.462 . . . . 0.0 111.181 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 32.16 16.95 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.712 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.719 HD21 ' HB2' ' A' ' 69' ' ' CYS . 10.4 p30 -96.58 128.4 43.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.313 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG22 HG22 ' A' ' 68' ' ' ILE . 47.7 t -83.15 120.53 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.917 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.99 -61.26 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.509 0.671 . . . . 0.0 109.798 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.69 121.38 25.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.286 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -91.81 136.5 33.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.26 56.52 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.452 0.47 . . . . 0.0 110.236 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.37 125.57 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.254 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 96.9 mmm 64.46 23.85 13.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.564 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.5 t30 51.26 69.5 0.64 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.793 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 p -114.49 -35.01 5.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.845 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.67 9.95 34.13 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.454 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 27' ' ' LYS . 1.7 p -104.04 157.28 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -109.29 137.97 46.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mm -111.52 117.19 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 34.3 pt -123.78 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 111.793 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.719 ' HB2' HD21 ' A' ' 54' ' ' ASN . 2.7 m -82.72 134.59 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.51 HG21 ' HE3' ' A' ' 24' ' ' LYS . 12.7 t -109.77 3.9 21.27 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.246 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.532 ' HB3' HG23 ' A' ' 21' ' ' VAL . 55.7 tptt -96.68 143.6 27.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -90.93 121.12 32.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.8 mm? -98.35 112.27 61.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.91 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 8.6 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 123.145 2.564 . . . . 0.0 111.719 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.529 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 99.4 mttt . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.42 148.65 50.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.03 0.443 . . . . 0.0 111.377 -176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 25' ' ' SER . 47.2 mm -61.77 110.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.309 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.93 110.9 3.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -123.89 127.93 48.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.878 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.4 m -154.72 173.85 15.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.2 t -117.26 125.04 73.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.6 156.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.808 0.337 . . . . 0.0 110.664 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 11' ' ' ARG . 21.7 mtp85 -90.24 116.9 28.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.124 0.488 . . . . 0.0 109.788 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 t -108.45 140.76 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.875 -172.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 65.9 mtt-85 -97.53 158.41 15.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.62 157.74 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.05 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -81.55 45.37 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.461 0.648 . . . . 0.0 111.013 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 33.58 2.32 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.087 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 tptt 69.74 -59.27 0.5 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 0.0 112.056 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -80.91 -177.46 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -143.5 11.4 1.68 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.294 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.521 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.5 m -146.31 147.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.024 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 71' ' ' LYS . 9.5 p -137.66 133.71 18.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.562 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -70.47 116.0 4.44 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.804 2.336 . . . . 0.0 112.269 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.9 m -105.44 151.33 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.954 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 163.27 30.8 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.363 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 5' ' ' ILE . 19.5 m -109.27 131.82 54.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -75.61 -12.68 60.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 65' ' ' VAL . 75.0 mmtt -115.98 143.16 30.33 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 17.1 Cg_exo -67.59 120.25 7.27 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.316 2.011 . . . . 0.0 110.923 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.73 148.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.677 -172.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.529 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 54.1 mt-10 -64.0 119.53 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -61.32 -22.31 27.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -70.03 -16.54 63.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.996 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -98.8 11.7 37.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -62.95 -35.07 78.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.685 0.279 . . . . 0.0 110.8 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.58 -39.94 85.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.519 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 40' ' ' VAL . 37.2 t70 -61.77 -48.03 82.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.75 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.43 -40.77 89.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.9 m -60.91 -38.94 87.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.934 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.27 -43.47 98.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 36' ' ' ASP . 47.8 t -65.38 -45.1 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.533 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.19 -27.34 69.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.567 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 m -73.73 -5.01 38.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.29 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -113.6 5.08 16.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.239 0.543 . . . . 0.0 109.679 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.8 tp -109.05 42.14 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.022 -172.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -70.19 94.61 0.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.397 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.59 154.23 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.26 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -124.59 98.42 0.56 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.299 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 7.3 p -168.5 126.14 0.89 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.783 0.325 . . . . 0.0 110.763 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 8.5 Cg_exo -72.49 120.99 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.743 2.295 . . . . 0.0 111.373 174.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -122.11 -179.23 4.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.82 173.13 6.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.424 ' CB ' HD21 ' A' ' 72' ' ' ASN . 2.1 p -69.84 126.13 28.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 110.83 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 30.05 13.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.759 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.852 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -88.85 128.04 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 68' ' ' ILE . 22.1 t -88.19 112.83 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.376 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -76.46 -62.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 44.3 t -130.64 108.81 10.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.253 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.9 138.76 32.33 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.55 43.23 16.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 6.2 tt -50.44 -39.11 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.339 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.86 39.48 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.87 18.82 11.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.11 0.957 . . . . 0.0 109.71 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 65' ' ' VAL . 20.5 p -82.51 -25.4 33.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.164 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.19 15.28 69.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.281 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 27' ' ' LYS . 48.7 t -92.26 139.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.85 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.61 101.01 12.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.81 102.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.8 pt -115.35 136.58 51.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.852 ' HB2' HD21 ' A' ' 54' ' ' ASN . 2.3 m -87.77 135.9 33.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -108.39 0.26 21.01 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.126 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HB3' HG23 ' A' ' 21' ' ' VAL . 66.4 tttp -102.47 140.12 37.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.593 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -89.28 132.31 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.4 mm? -95.64 122.98 57.64 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.257 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 37.6 Cg_exo . . . . . 0 C--O 1.233 0.26 0 C-N-CA 123.007 2.472 . . . . 0.0 112.484 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 60.0 mttm . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.678 0.275 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -140.6 179.64 6.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.0 mm -89.61 101.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.452 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 75.7 t80 -59.56 107.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.503 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -118.71 127.41 53.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 t -152.99 -171.89 4.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.08 140.74 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -120.72 154.19 24.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.897 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 11' ' ' ARG . 18.7 mtp-105 -82.4 128.73 34.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.402 0.62 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.534 HG11 ' NZ ' ' A' ' 16' ' ' LYS . 15.6 t -97.25 141.95 14.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.326 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -137.29 100.68 4.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 0.0 110.679 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.55 -175.47 47.25 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 t -86.45 78.99 9.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.458 0.646 . . . . 0.0 110.309 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.534 ' NZ ' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -160.9 148.68 15.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.432 177.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -83.74 37.7 0.6 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.496 ' HB2' HD12 ' A' ' 73' ' ' LEU . 29.4 m-85 -151.75 109.06 3.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -89.52 7.99 33.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.64 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -141.57 132.29 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 71' ' ' LYS . 13.1 p -133.29 131.56 21.67 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.959 0.409 . . . . 0.0 110.896 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.33 124.64 10.09 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.718 2.279 . . . . 0.0 112.396 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.472 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -115.79 155.36 17.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.475 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -138.71 171.29 14.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.499 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 18.6 m -109.29 129.28 55.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.257 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -72.92 -21.99 60.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.072 0.463 . . . . 0.0 110.636 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -116.04 135.82 22.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 37.0 Cg_endo -66.13 116.54 4.07 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.449 2.1 . . . . 0.0 112.56 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 6' ' ' PHE . 3.8 m -105.82 148.49 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.983 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 2.0 mp0 -64.93 141.63 58.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 111.086 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -77.05 22.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.424 0.631 . . . . 0.0 111.279 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.6 m -114.4 4.15 15.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.347 0.594 . . . . 0.0 109.703 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -106.33 16.3 24.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.414 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -52.44 -49.07 65.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.967 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 tt -53.99 -50.77 51.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.071 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 40' ' ' VAL . 45.0 m-20 -65.05 -48.08 75.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.246 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -67.38 -36.46 81.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.294 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -62.86 -41.14 99.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.572 0.225 . . . . 0.0 110.738 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.4 -42.49 98.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.817 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 36' ' ' ASP . 58.7 t -67.51 -49.21 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.137 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.54 -29.68 69.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 111.178 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -72.56 -20.51 61.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 110.481 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 43' ' ' ARG . 12.8 mtp180 -103.51 -1.75 27.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.184 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -107.2 93.46 4.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.124 0.488 . . . . 0.0 110.704 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -96.25 91.29 5.81 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.19 139.26 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.65 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.24 -130.78 5.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.128 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.428 HG13 ' HD2' ' A' ' 49' ' ' PRO . 94.0 t 70.41 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 112.081 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' HG13 ' A' ' 48' ' ' VAL . 61.0 Cg_endo -74.74 98.11 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.478 2.119 . . . . 0.0 111.764 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -108.49 163.78 12.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.67 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.9 mtmt -115.93 177.08 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.596 ' HB2' HD21 ' A' ' 72' ' ' ASN . 34.3 t -61.86 131.84 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.914 0.387 . . . . 0.0 111.149 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.18 25.28 19.81 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.054 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.731 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.3 p30 -95.0 125.19 39.5 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.413 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.537 HG22 HG22 ' A' ' 68' ' ' ILE . 17.0 t -86.44 109.25 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.69 -40.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.915 0.388 . . . . 0.0 110.169 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.2 t -130.48 105.37 7.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HG2' ' OD1' ' A' ' 66' ' ' ASP . 9.5 tmtm? -90.7 129.56 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 60.71 47.93 7.62 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.392 0.433 . . . . 0.0 111.078 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 65' ' ' VAL . 12.7 tt -60.98 135.8 25.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.197 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.5 mmt 64.33 11.5 6.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.226 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 57.94 28.72 16.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.802 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 65' ' ' VAL . 9.0 t -101.95 -7.69 22.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.341 0.591 . . . . 0.0 110.345 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.46 5.53 57.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.903 176.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.552 ' O ' HG22 ' A' ' 60' ' ' ILE . 94.8 t -85.01 130.99 35.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.007 0.432 . . . . 0.0 109.958 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 66.4 m-20 -107.08 110.48 22.6 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.287 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -76.97 108.6 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.537 HG22 HG22 ' A' ' 55' ' ' VAL . 25.8 pt -114.7 136.59 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.249 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.731 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.7 m -92.02 136.15 33.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -108.86 8.54 26.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 0.0 111.641 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HB3' HG23 ' A' ' 21' ' ' VAL . 45.1 tttp -102.2 148.31 25.59 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.76 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.596 HD21 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -99.87 124.04 44.76 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 18' ' ' TYR . 2.5 mm? -108.09 120.3 47.28 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.528 -174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.237 0.443 0 C-N-CA 122.942 2.428 . . . . 0.0 111.943 175.453 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.1 136.6 54.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.566 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.6 mt -74.05 126.15 34.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.611 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -63.88 117.01 6.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.62 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 m -134.62 120.54 19.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -149.96 -169.55 3.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 20' ' ' VAL . 7.2 p -132.44 127.72 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.25 153.33 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.678 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 11' ' ' ARG . 57.6 mtt180 -75.32 128.9 36.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.546 HG13 ' HA3' ' A' ' 47' ' ' GLY . 19.5 t -86.56 125.36 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -110.27 123.0 48.99 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . 144.04 -174.61 24.31 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.704 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 m -72.09 95.39 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -139.02 176.97 8.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.392 -175.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 74' ' ' PRO . 51.7 tptt -110.66 -30.6 7.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.252 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.416 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -96.29 138.3 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 16' ' ' LYS . 56.3 t30 -77.83 -45.42 24.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.767 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 9' ' ' VAL . 18.4 m -128.17 147.63 32.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.397 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 12' ' ' VAL . 9.5 p -128.27 121.4 21.53 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 121.246 0.546 . . . . 0.0 111.406 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 32.4 Cg_exo -59.9 125.45 17.74 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.86 2.373 . . . . 0.0 112.636 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.553 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -117.86 155.48 19.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.839 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -143.64 177.33 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.038 0.447 . . . . 0.0 111.092 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' HG23 ' A' ' 5' ' ' ILE . 40.4 t -109.2 147.08 33.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.734 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -84.04 -8.34 59.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 110.716 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' HG22 ' A' ' 65' ' ' VAL . 37.2 mtmm -139.3 144.48 40.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HA ' HG12 ' A' ' 5' ' ' ILE . 23.1 Cg_exo -63.61 129.92 26.53 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.155 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 175.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.029 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 124.02 21.94 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.22 -24.11 35.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.107 0.48 . . . . 0.0 110.993 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -83.69 1.79 40.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.596 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -95.05 7.28 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.8 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -59.07 -30.57 68.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.615 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 9.1 pt -66.49 -38.65 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.554 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -76.8 -40.12 49.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.561 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -66.03 -51.41 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.745 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 m -63.56 -25.75 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.565 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.601 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 9.3 t-20 -59.57 -50.78 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.783 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.22 -40.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.26 -32.02 71.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.358 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.6 t -64.96 -21.14 66.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.828 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 21.2 tpt180 -109.59 1.98 20.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.335 0.588 . . . . 0.0 109.883 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 46' ' ' VAL . 44.5 tp -108.26 92.01 3.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.597 -176.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.54 95.71 7.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.304 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 44' ' ' LEU . 15.7 m -141.75 -157.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.916 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . 137.44 -88.08 0.22 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.297 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t 68.28 117.86 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.215 0 O-C-N 123.919 0.423 . . . . 0.0 110.552 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.886 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 80.6 Cg_exo -43.29 105.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.519 2.813 . . . . 0.0 113.455 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.93 -163.89 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.195 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -120.88 -175.91 3.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.64 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.772 -175.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.32 22.41 24.73 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.408 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.79 HD21 ' HB2' ' A' ' 69' ' ' CYS . 11.0 p30 -85.32 133.45 34.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.195 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 66' ' ' ASP . 61.4 t -90.92 120.48 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.656 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.26 -52.56 9.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.581 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.4 m -130.9 117.3 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.481 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 1.005 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 49.9 tttp -99.49 132.81 44.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.787 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.7 t30 67.11 39.2 3.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.431 0.634 . . . . 0.0 110.161 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.39 128.46 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.916 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 57.1 mtt 66.14 16.36 10.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 0.0 111.444 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.34 36.59 20.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.287 0.565 . . . . 0.0 110.848 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.6 p -82.58 -26.06 32.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.415 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.93 10.19 65.0 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.298 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG22 ' HE2' ' A' ' 27' ' ' LYS . 68.8 t -108.59 131.67 58.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.51 0.195 . . . . 0.0 111.022 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 1.005 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.0 p-10 -99.79 124.89 45.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 109.849 170.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.38 121.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.403 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.5 pt -121.11 138.3 51.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.0 111.687 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.79 ' HB2' HD21 ' A' ' 54' ' ' ASN . 2.9 m -91.09 141.93 28.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -111.68 2.17 17.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 111.072 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.505 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.1 tmtt? -96.19 131.91 42.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -83.78 113.38 20.87 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.886 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 73.8 mt -97.4 125.93 43.49 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.654 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 33.2 Cg_exo . . . . . 0 C--N 1.348 0.527 0 C-N-CA 122.956 2.438 . . . . 0.0 111.677 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 82.2 mttt . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.658 0.266 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -123.23 158.63 30.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.82 0.343 . . . . 0.0 110.726 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.31 112.39 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.801 0.334 . . . . 0.0 110.735 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 86.2 t80 -63.66 104.21 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 m -115.81 122.67 46.11 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.2 m -148.42 -169.8 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.606 0.241 . . . . 0.0 110.515 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.8 t -123.19 132.03 72.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.4 155.72 11.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -91.63 129.47 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.062 0.458 . . . . 0.0 110.648 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.719 HG22 HG22 ' A' ' 21' ' ' VAL . 2.6 t -97.67 146.99 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -169.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 68.9 ttt180 -119.95 147.28 44.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.585 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.16 -168.55 21.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.828 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 p -75.3 99.9 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -157.87 168.82 26.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.233 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.77 -54.28 4.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.83 0.348 . . . . 0.0 111.561 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 70.1 m-85 -86.69 127.12 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.873 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.575 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 16.6 m120 -79.69 -13.72 59.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.173 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.6 m -135.47 139.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.719 HG22 HG22 ' A' ' 12' ' ' VAL . 17.7 m -134.48 134.65 22.63 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.612 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.19 132.47 22.7 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.672 2.248 . . . . 0.0 112.908 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 69' ' ' CYS . 30.7 m -121.66 165.74 17.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.233 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.2 ptpt -148.18 178.99 8.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.086 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.479 ' HB2' HG11 ' A' ' 65' ' ' VAL . 78.9 p -108.97 131.13 55.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.036 0.446 . . . . 0.0 111.131 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -53.4 -41.44 65.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.524 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HB2' HG22 ' A' ' 65' ' ' VAL . 7.1 mtmp? -126.28 151.49 72.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 18.0 Cg_endo -58.0 126.6 22.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.767 2.311 . . . . 0.0 111.969 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.92 157.18 22.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.114 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -73.8 141.72 46.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.717 0.294 . . . . 0.0 110.208 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.6 pt -69.87 -8.1 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 111.16 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -66.06 -25.81 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.454 . . . . 0.0 110.403 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.11 2.48 46.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.914 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -56.01 -52.79 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.1 pt -68.93 -26.66 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.711 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.24 -46.88 19.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 0.0 110.642 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -61.2 -41.38 96.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 p -66.89 -35.97 81.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.57 -45.55 81.26 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 110.508 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.94 -48.03 87.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.17 -28.78 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.761 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -73.87 -8.82 57.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 43' ' ' ARG . 60.9 mtt180 -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.215 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.43 99.78 8.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.847 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 17.3 m-85 -88.95 109.48 20.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.636 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.3 120.77 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -120.82 41.23 1.96 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.566 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.42 86.66 56.83 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 71.5 Cg_exo -50.79 118.12 3.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.707 2.271 . . . . 0.0 111.967 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.37 -171.05 2.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.235 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 9.4 mmpt? -95.11 -172.46 2.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.268 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -72.55 136.59 45.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.892 0.377 . . . . 0.0 111.282 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.84 30.14 8.64 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.132 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.9 p30 -93.15 133.44 36.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 66' ' ' ASP . 44.7 t -89.27 105.95 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.692 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.3 -48.19 37.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.153 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.33 99.83 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.228 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HG2' HG11 ' A' ' 55' ' ' VAL . 57.0 mttp -76.24 102.73 5.95 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.3 m120 55.04 77.68 0.2 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.3 tt -47.26 -51.83 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 123.695 0.622 . . . . 0.0 112.326 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtm -141.99 54.59 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.856 0.36 . . . . 0.0 110.445 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 59.83 28.33 17.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.453 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.7 p -83.62 -20.19 34.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.742 -175.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.93 80.46 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.34 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 27' ' ' LYS . 71.2 t -112.73 129.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.839 0.352 . . . . 0.0 110.302 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB3' HG13 ' A' ' 55' ' ' VAL . 28.6 m-20 -95.63 134.04 38.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.9 mm -93.2 108.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.411 HG22 HG22 ' A' ' 55' ' ' VAL . 22.0 pt -109.43 142.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.466 ' HB3' HD21 ' A' ' 54' ' ' ASN . 53.3 t -92.5 142.0 27.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -113.47 4.74 16.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 111.047 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.59 141.51 29.76 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.895 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -94.09 112.97 24.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.747 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 HG11 ' A' ' 21' ' ' VAL . 5.9 mp -88.07 127.24 58.24 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 111.524 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.454 -0.841 0 C-N-CA 122.895 2.397 . . . . 0.0 111.154 171.482 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.563 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 49.0 mttp . . . . . 0 C--O 1.235 0.329 0 CA-C-O 120.718 0.294 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.35 -179.94 3.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.48 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 28' ' ' PRO . 29.6 mm -101.84 115.28 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.005 0.431 . . . . 0.0 110.19 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -78.11 122.75 26.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.196 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -141.41 137.44 32.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.962 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -153.44 178.51 9.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 20' ' ' VAL . 10.4 p -110.91 130.31 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.874 0.369 . . . . 0.0 110.121 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.37 157.57 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.149 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -81.23 127.54 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.324 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.474 ' HB ' ' HE2' ' A' ' 16' ' ' LYS . 3.7 t -84.28 130.73 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.96 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.487 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 61.8 ttp85 -107.0 155.33 19.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.445 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.15 175.7 22.74 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.87 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 p -79.79 105.17 10.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 0.0 111.007 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HD3' ' H ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -162.68 -175.37 4.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.808 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -119.07 40.12 3.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.428 0.633 . . . . 0.0 110.824 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.59 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 4.2 m-85 -129.72 154.02 47.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.448 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -114.92 -46.45 2.92 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.435 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 9' ' ' VAL . 17.8 m -134.26 142.24 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.009 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 12' ' ' VAL . 15.0 p -129.54 136.66 29.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.428 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.72 124.99 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.62 2.214 . . . . 0.0 112.69 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -113.99 164.5 10.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.977 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -145.36 179.06 7.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -109.16 134.66 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.67 -37.73 73.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.275 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -118.43 150.76 48.54 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.252 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 48.6 Cg_endo -67.3 139.6 50.43 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.499 2.132 . . . . 0.0 113.048 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -113.56 173.5 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.405 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.563 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 79.9 mt-10 -98.67 135.8 39.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.101 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.856 ' HA ' ' HD1' ' A' ' 34' ' ' TRP . 14.6 tt -55.67 -21.52 10.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.781 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.2 m -57.15 -31.81 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.374 . . . . 0.0 111.562 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 33' ' ' LYS . 28.2 mtpp -102.87 14.79 31.09 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.856 ' HD1' ' HA ' ' A' ' 31' ' ' ILE . 1.2 m95 -60.05 -44.5 94.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.75 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -67.95 -35.08 70.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 40' ' ' VAL . 34.8 t70 -67.78 -43.68 79.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.9 m-30 -69.86 -39.95 76.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.975 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.43 -35.85 78.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.481 . . . . 0.0 109.821 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -58.47 -45.44 88.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.861 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 36' ' ' ASP . 43.7 t -69.09 -48.2 70.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.417 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.0 mt -66.63 -33.2 75.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.5 p -71.55 -11.77 61.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.772 0.32 . . . . 0.0 111.559 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -119.08 10.1 12.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.996 0.427 . . . . 0.0 110.499 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.507 ' HG ' HG23 ' A' ' 46' ' ' VAL . 31.5 tp -104.71 127.2 52.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 43.9 m-85 -119.45 97.12 5.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.507 HG23 ' HG ' ' A' ' 44' ' ' LEU . 61.4 t -111.29 140.41 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -124.08 -134.75 4.33 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.992 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t 60.08 79.95 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.205 0.526 . . . . 0.0 109.994 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.47 118.41 5.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.652 2.235 . . . . 0.0 111.691 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -174.27 3.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.884 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -87.79 -177.19 5.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.446 ' HB2' HD21 ' A' ' 72' ' ' ASN . 32.0 t -67.45 134.1 50.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.761 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.32 25.78 11.96 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.987 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 11.0 p30 -94.03 143.06 26.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.38 115.99 28.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.266 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.29 -56.56 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.972 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.0 t -130.72 118.01 20.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 31.0 tttm -97.71 129.88 44.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.736 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.417 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 14.1 m120 54.98 47.21 22.65 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 123.501 0.501 . . . . 0.0 109.955 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.0 tt -53.95 110.04 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.6 mmt 66.68 31.45 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.246 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 71.34 4.22 4.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -57.59 -42.53 83.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.417 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 111.21 -9.37 28.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.646 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.96 137.46 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 110.231 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 7.0 m-20 -102.18 107.31 18.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -75.3 103.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.3 pt -108.05 146.07 14.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.296 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' A' ' 21' ' ' VAL . 2.4 t -90.51 142.32 27.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.475 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -119.22 13.97 12.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.399 0.618 . . . . 0.0 110.63 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -96.58 142.05 29.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 52' ' ' SER . 5.9 m120 -89.97 98.14 11.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 96.6 mt -99.56 117.41 63.81 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.873 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 5.0 Cg_exo . . . . . 0 N--CA 1.457 -0.648 0 C-N-CA 122.661 2.24 . . . . 0.0 112.699 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.264 0.554 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -140.65 154.44 46.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.97 117.13 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.96 0.41 . . . . 0.0 110.741 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.497 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 78.2 t80 -78.53 109.67 12.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 109.827 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -123.53 132.21 53.84 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.564 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -152.77 -165.1 2.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.123 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.626 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 42.7 t -128.31 134.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.541 0.21 . . . . 0.0 110.453 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -119.0 148.64 21.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.39 135.23 40.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.275 0.559 . . . . 0.0 111.53 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.34 141.54 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.577 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -127.13 173.87 9.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.278 . . . . 0.0 110.325 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -177.48 31.0 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.864 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 m -76.12 96.47 3.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.254 0.549 . . . . 0.0 110.674 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.9 -173.44 4.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.649 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -100.73 -52.43 3.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.833 0.349 . . . . 0.0 110.742 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -75.2 124.3 26.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.975 0.417 . . . . 0.0 111.956 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.84 -15.92 56.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.626 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.3 m -142.03 146.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 73' ' ' LEU . 13.0 p -124.38 134.28 25.39 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.92 126.02 13.33 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.525 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -114.33 162.34 12.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.576 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -144.73 178.93 7.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.914 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 69.1 m -109.12 133.55 52.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.202 0.525 . . . . 0.0 111.306 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -59.52 -44.65 93.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.591 174.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 65' ' ' VAL . 67.1 mttm -121.0 152.45 56.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.49 139.52 82.37 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.653 2.236 . . . . 0.0 111.88 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 65' ' ' VAL . 5.8 t -112.57 136.11 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.97 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.31 118.8 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.5 tt -55.16 -28.1 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 m -65.33 -18.39 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mtpp -100.72 17.51 21.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.487 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -57.39 -40.66 78.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 0.0 109.942 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -62.33 -45.43 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.981 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HB3' ' HG3' ' A' ' 61' ' ' MET . 1.8 m-20 -53.48 -54.61 34.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.592 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -63.07 -41.1 99.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -61.23 -47.25 86.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -67.06 -27.26 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.572 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 36' ' ' ASP . 99.1 t -77.35 -46.53 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.636 0.255 . . . . 0.0 110.937 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.32 -30.36 66.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 p -69.69 -22.31 63.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -107.19 10.87 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.166 0.507 . . . . 0.0 110.283 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -114.11 143.33 44.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.912 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -130.96 142.12 50.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.145 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 p -119.49 143.83 29.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 48' ' ' VAL . . . -121.7 163.82 15.02 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.055 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 92.1 t 75.82 128.27 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 123.179 0.592 . . . . 0.0 111.262 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.13 110.76 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.155 2.57 . . . . 0.0 111.499 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.45 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 p -99.17 -164.16 1.1 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.713 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' H ' ' HB ' ' A' ' 50' ' ' THR . 19.6 ptmt -127.16 -152.88 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.434 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 32.6 m -98.96 135.63 40.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.73 24.04 11.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.877 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.847 HD22 ' HB2' ' A' ' 69' ' ' CYS . 40.8 m-20 -78.97 99.1 6.69 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 68' ' ' ILE . 17.9 t -77.79 92.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 m -74.09 -45.52 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 8.5 t -130.96 120.16 23.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -104.33 144.06 32.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 44.72 39.82 3.71 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.671 0.748 . . . . 0.0 110.847 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.559 ' HB ' ' SG ' ' A' ' 57' ' ' CYS . 5.3 tt -56.0 127.18 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.277 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.603 ' HG3' ' HB3' ' A' ' 36' ' ' ASP . 93.8 mmm 63.59 29.89 15.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 70.2 17.76 7.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.906 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.3 p -78.44 -61.58 1.96 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.86 0.362 . . . . 0.0 111.777 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.31 1.31 9.35 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 27' ' ' LYS . 96.8 t -88.15 139.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 0.0 110.664 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.68 114.65 26.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.231 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -83.13 106.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.8 pt -119.4 133.5 66.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.259 0.552 . . . . 0.0 112.297 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.847 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.9 m -78.4 147.64 33.99 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 10.9 t -132.38 13.82 4.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -112.93 122.34 47.35 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.481 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -67.8 109.96 3.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 21' ' ' VAL . 90.9 mt -87.73 117.16 68.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.448 -173.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.458 -0.612 0 C-N-CA 122.691 2.261 . . . . 0.0 111.92 175.26 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 96.3 mttt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -123.63 169.92 10.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.99 0.424 . . . . 0.0 110.76 -169.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.06 102.68 12.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 29' ' ' VAL . 87.7 t80 -59.26 117.95 5.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.666 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -124.06 130.26 52.26 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.797 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 t -143.23 -172.11 3.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.33 124.87 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 41' ' ' LEU . 29.6 m -112.46 162.04 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -91.88 130.97 37.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.532 . . . . 0.0 111.35 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -108.43 121.49 61.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.739 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.445 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.4 mtm105 -99.58 154.3 18.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.12 166.58 12.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.355 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 p -82.61 84.9 7.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 111.759 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -174.23 4.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.888 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -86.84 -59.58 2.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.713 0.292 . . . . 0.0 110.988 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.48 6.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.205 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.44 -15.43 30.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.529 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.74 129.79 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.1 p -119.17 129.93 25.12 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.164 0.506 . . . . 0.0 111.758 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 37.5 Cg_endo -69.1 125.81 12.95 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 111.59 170.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 69' ' ' CYS . 30.6 m -113.9 158.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.084 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -141.06 174.17 10.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.751 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 14.9 m -109.11 127.5 54.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.05 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -65.24 -30.89 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.922 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB2' HG22 ' A' ' 65' ' ' VAL . 64.3 mttm -111.2 138.73 21.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.1 Cg_exo -65.38 116.88 4.14 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.369 2.046 . . . . 0.0 111.485 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 6' ' ' PHE . 29.3 m -93.37 162.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.997 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 46.1 mt-10 -79.71 145.8 32.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.153 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 33' ' ' LYS . 16.9 pt -71.53 177.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.013 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 74.6 m 70.98 -25.48 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.039 0.536 . . . . 0.0 112.028 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.457 ' HD3' ' CZ ' ' A' ' 37' ' ' PHE . 13.9 tttm -84.63 7.53 19.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.173 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -62.07 -34.94 77.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 tt -70.48 -31.52 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 25.3 t70 -65.94 -57.03 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.989 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CZ ' ' HD3' ' A' ' 33' ' ' LYS . 27.5 m-85 -64.63 -36.24 83.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.519 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.1 p -67.24 -37.12 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -54.85 -49.64 70.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 110.346 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.46 -48.71 85.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.234 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 10' ' ' VAL . 69.0 mt -70.06 -41.08 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -68.05 -19.86 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 111.049 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -101.27 10.75 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 110.041 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 tp -116.86 118.75 33.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.318 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.98 129.27 55.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.958 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.6 140.23 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.148 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -127.2 71.94 0.47 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.888 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -166.0 123.25 1.04 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 120.811 0.339 . . . . 0.0 110.776 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.49 113.13 3.39 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.839 2.36 . . . . 0.0 111.614 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.13 170.31 9.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.389 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.8 mtmt -103.55 176.33 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.354 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.706 ' HB2' HD21 ' A' ' 72' ' ' ASN . 19.0 t -61.25 135.47 57.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 111.473 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.64 26.79 21.75 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.967 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.702 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -97.5 133.26 42.31 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.253 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 68' ' ' ILE . 8.6 t -93.07 124.59 45.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.471 -176.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 m -96.99 -39.51 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 111.215 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.3 t -127.74 121.2 29.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' HG11 ' A' ' 55' ' ' VAL . 59.6 mttm -106.06 128.85 54.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.857 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.747 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.7 t-20 58.91 48.84 10.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.65 0.738 . . . . 0.0 109.169 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.491 HG12 ' HG2' ' A' ' 61' ' ' MET . 11.6 tt -60.16 127.09 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.108 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.491 ' HG2' HG12 ' A' ' 60' ' ' ILE . 98.2 mmm 63.51 21.78 12.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.159 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.747 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 3.4 t-20 57.8 79.4 0.2 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.452 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.0 p -138.65 -55.72 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.068 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.0 -9.4 6.32 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 27' ' ' LYS . 95.4 t -79.89 132.01 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 110.579 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.99 114.57 28.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.1 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.89 114.03 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.656 HG22 HG22 ' A' ' 55' ' ' VAL . 20.6 pt -118.37 140.75 40.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.0 -173.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.702 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.9 m -92.2 146.34 23.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -119.38 11.15 12.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 0.0 112.223 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.589 ' HB2' HG23 ' A' ' 21' ' ' VAL . 68.5 mmtt -96.41 155.24 16.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.953 -0.467 . . . . 0.0 109.919 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.706 HD21 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -106.55 104.89 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.78 132.08 43.31 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.462 -0.33 0 C-N-CA 122.462 2.108 . . . . 0.0 112.044 178.157 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 52.0 mttp . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.18 156.27 49.27 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.965 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -63.4 110.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.028 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -76.55 106.84 8.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 24' ' ' LYS . 74.3 p -110.41 134.21 52.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -153.75 -167.1 2.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.37 132.31 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.91 149.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -87.8 114.08 24.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HB ' ' HE3' ' A' ' 16' ' ' LYS . 6.6 t -84.85 139.35 17.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.189 -168.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpt85 -105.8 137.77 43.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.91 -178.3 16.38 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.412 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 t -81.4 110.28 16.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.084 0.468 . . . . 0.0 110.564 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.948 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -163.07 168.48 20.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -95.79 -20.67 18.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' HD22 ' A' ' 73' ' ' LEU . 78.9 m-85 -107.46 111.36 23.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.948 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 86.7 m-20 -76.67 -19.6 57.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.09 138.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.585 0.231 . . . . 0.0 110.422 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 71' ' ' LYS . 5.8 p -135.34 139.83 32.63 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.831 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 53.6 Cg_endo -72.81 130.68 16.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.572 2.181 . . . . 0.0 112.505 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.22 162.42 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.557 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HB3' HG22 ' A' ' 7' ' ' THR . 22.2 ptmt -143.53 170.75 15.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.159 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -109.23 128.27 54.92 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 66' ' ' ASP . 2.0 p-10 -75.72 -0.91 22.5 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 65' ' ' VAL . 43.3 mtmt -132.36 142.09 43.67 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.01 135.98 66.38 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.474 2.116 . . . . 0.0 112.328 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 t -105.37 130.91 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.863 -175.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 28.6 tt0 -60.11 121.39 11.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.0 tp -60.9 -21.46 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -171.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.61 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.945 -0.472 . . . . 0.0 111.421 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 62.9 mttp -105.7 1.23 26.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.565 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -59.64 -31.25 69.35 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.37 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -78.04 -30.05 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 40' ' ' VAL . 26.0 t0 -78.41 -43.33 27.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 30.2 m-85 -56.52 -47.26 79.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.6 p -65.71 -37.26 85.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -60.7 -43.07 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.75 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 36' ' ' ASP . 58.0 t -63.26 -44.11 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.591 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.75 -21.48 66.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.3 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.3 m -81.79 -11.59 58.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.048 0.451 . . . . 0.0 110.704 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -105.89 -26.14 11.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.726 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 46' ' ' VAL . 40.2 tp -81.84 94.83 7.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.739 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -97.35 90.3 5.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.174 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.508 HG22 ' HG ' ' A' ' 44' ' ' LEU . 22.2 m -142.06 173.49 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.67 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.74 173.1 25.73 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.548 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.599 HG13 HG23 ' A' ' 50' ' ' THR . 13.6 p 177.23 141.25 0.24 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -42.06 105.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.918 2.412 . . . . 0.0 112.374 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.599 HG23 HG13 ' A' ' 48' ' ' VAL . 1.7 p -130.23 167.03 19.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.069 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -127.07 62.75 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.66 -174.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.581 ' HB2' HD21 ' A' ' 72' ' ' ASN . 23.2 t 69.2 150.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.728 174.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.17 24.49 70.48 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.958 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 7.7 p30 -96.46 128.53 43.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.025 0.441 . . . . 0.0 110.506 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 58' ' ' LYS . 49.1 t -79.21 113.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.195 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.04 -50.18 17.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.965 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 36.7 t -130.75 123.07 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.647 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.692 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 50.3 tttp -106.25 135.4 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.784 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.582 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 6.6 t-20 64.32 31.99 12.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.72 0.638 . . . . 0.0 110.712 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.547 HG12 ' HG3' ' A' ' 61' ' ' MET . 10.8 tt -60.65 134.83 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.547 ' HG3' HG12 ' A' ' 60' ' ' ILE . 76.2 mtp 62.6 18.45 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.942 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 70.67 -2.87 2.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 65' ' ' VAL . 9.6 t -79.69 -8.59 59.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.57 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 59' ' ' ASN . . . 83.16 3.41 90.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.897 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 27' ' ' LYS . 7.9 t -67.05 129.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.899 0.381 . . . . 0.0 110.237 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.692 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 3.1 m-20 -99.35 122.34 42.35 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -87.09 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.3 pt -108.83 134.96 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.411 0.624 . . . . 0.0 111.954 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.531 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 7.5 t -81.12 135.06 35.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.231 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -111.69 -6.32 14.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.991 0.424 . . . . 0.0 111.233 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 62.5 tttp -96.8 138.64 34.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.612 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -85.76 128.26 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.84 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 18' ' ' TYR . 94.2 mt -109.32 102.18 48.35 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.973 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo . . . . . 0 N--CA 1.455 -0.753 0 C-N-CA 122.706 2.27 . . . . 0.0 112.382 176.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 54.4 mmtt . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -131.98 134.59 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.706 0.288 . . . . 0.0 110.856 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 28' ' ' PRO . 36.3 mm -57.75 127.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 111.116 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -102.66 115.58 30.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.544 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 139.42 53.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.833 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.8 m -158.67 179.26 9.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.652 0.263 . . . . 0.0 110.615 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.48 130.19 71.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.158 0.504 . . . . 0.0 110.231 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.76 155.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.76 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 9.5 mmt180 -69.37 123.88 22.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.585 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.788 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.7 p -107.43 136.94 40.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.178 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 49.2 mtp180 -125.87 -179.32 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.656 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.94 -160.24 13.52 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.323 -0.942 . . . . 0.0 113.088 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -85.44 15.95 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.775 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.788 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -80.98 179.0 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -125.69 69.33 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.713 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.45 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 40.5 m-85 -153.11 178.86 9.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.299 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.91 -23.68 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 0.0 111.116 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.67 149.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 14.6 p -131.98 131.49 22.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.033 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 14.2 Cg_exo -68.9 131.77 23.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.132 2.555 . . . . 0.0 112.63 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.53 152.63 37.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.956 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HG3' HG13 ' A' ' 68' ' ' ILE . 21.5 ptmt -141.13 173.55 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 0.0 111.034 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -109.67 131.75 54.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.129 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -72.72 -26.05 61.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.806 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.6 mttt -122.33 132.83 24.2 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HA ' HD13 ' A' ' 5' ' ' ILE . 77.7 Cg_exo -50.31 132.96 35.65 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.082 2.521 . . . . 0.0 112.49 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.2 124.53 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.784 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 43.8 tt0 -63.2 134.86 56.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pt -72.54 67.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.326 1.06 . . . . 0.0 112.247 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.0 p -155.71 -30.96 0.1 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.88 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -94.01 3.54 55.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -51.93 -52.73 48.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.438 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.68 -38.21 57.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.128 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 4.8 t0 -62.03 -37.63 85.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 63' ' ' THR . 4.5 m-30 -60.23 -50.22 74.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.827 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 p -62.9 -25.54 68.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.209 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 36' ' ' ASP . 94.1 m-20 -65.99 -50.04 65.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 36' ' ' ASP . 42.1 t -63.55 -41.7 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.806 HD23 HD12 ' A' ' 44' ' ' LEU . 47.4 mt -63.12 -29.31 70.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.7 m -72.72 -11.68 60.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HD3' HH11 ' A' ' 43' ' ' ARG . 56.4 mtt-85 -108.41 3.81 23.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.311 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.806 HD12 HD23 ' A' ' 41' ' ' LEU . 27.5 mt -99.56 119.8 38.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.514 0.674 . . . . 0.0 111.387 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.5 100.89 7.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.626 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 m -90.8 -177.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.728 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -167.71 -168.62 30.11 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.059 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t 68.22 101.27 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 C-N-CA 122.946 0.498 . . . . 0.0 111.178 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 12.3 Cg_endo -58.33 108.45 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.808 2.338 . . . . 0.0 111.939 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.84 -165.27 1.01 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.93 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 44.0 mmtm -128.05 169.87 13.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.024 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.9 p -58.94 136.31 57.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 23.53 34.6 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.732 -0.746 . . . . 0.0 111.877 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.671 HD21 ' HB3' ' A' ' 69' ' ' CYS . 8.5 p30 -97.24 131.34 44.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 68' ' ' ILE . 63.1 t -82.73 108.42 15.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.06 -57.59 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.268 0.556 . . . . 0.0 109.609 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 62.7 m -115.25 94.16 4.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.95 114.16 17.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.733 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t30 65.25 79.71 0.25 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.691 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 tt -71.66 122.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.277 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ttt 68.77 -76.33 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.868 0.73 . . . . 0.0 110.75 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -178.9 82.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.515 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 39.0 p -141.83 -44.02 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.176 -169.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.74 8.01 57.39 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -170.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 27' ' ' LYS . 73.9 t -98.46 131.68 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.184 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.39 116.21 28.68 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 57' ' ' CYS . 48.2 mm -81.78 100.21 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.128 0.49 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.45 HG13 ' HG3' ' A' ' 24' ' ' LYS . 22.1 pt -96.8 145.51 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.301 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.671 ' HB3' HD21 ' A' ' 54' ' ' ASN . 43.6 t -100.39 142.73 31.46 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -115.84 7.19 14.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.326 0.584 . . . . 0.0 110.625 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -96.71 142.24 28.98 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.598 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -93.93 111.79 23.54 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.21 120.37 56.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.448 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 C-N-CA 122.891 2.394 . . . . 0.0 111.628 175.96 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 94.4 mttt . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -140.65 153.91 46.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.756 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.98 114.26 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 110.988 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.4 ' HB3' HG21 ' A' ' 29' ' ' VAL . 64.7 t80 -79.94 140.69 36.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.39 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -150.94 133.47 15.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.946 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -150.18 -172.83 4.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.2 138.18 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.714 0.292 . . . . 0.0 110.39 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 44' ' ' LEU . 14.2 p -119.1 149.65 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.473 ' HA ' HG12 ' A' ' 20' ' ' VAL . 53.1 mtt180 -82.87 116.75 22.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.191 0.52 . . . . 0.0 110.808 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG12 ' HE3' ' A' ' 16' ' ' LYS . 21.3 t -88.37 137.51 20.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.959 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.561 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.6 ttp85 -98.52 150.23 21.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.365 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.82 169.71 13.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.332 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.07 27.3 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.242 0.544 . . . . 0.0 111.709 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.589 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -70.93 173.08 7.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.489 176.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -86.18 26.31 1.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -145.21 -179.69 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.718 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -131.31 -34.69 1.39 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 11' ' ' ARG . 22.7 m -134.75 149.34 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.672 0.272 . . . . 0.0 111.129 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -125.68 133.54 25.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.68 120.76 6.88 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.418 2.079 . . . . 0.0 112.171 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.1 140.42 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.926 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.08 168.86 15.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.127 0.489 . . . . 0.0 110.875 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -108.93 130.9 55.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.607 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 7.5 p30 -80.98 -10.0 59.77 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.632 -172.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.607 ' HE2' ' OD1' ' A' ' 26' ' ' ASN . 26.9 mtmt -130.99 144.53 53.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.532 176.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 50.9 Cg_exo -54.85 138.05 76.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.209 2.606 . . . . 0.0 113.541 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 6' ' ' PHE . 28.1 t -106.39 143.29 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.691 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.93 139.86 55.1 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.0 pt -76.34 12.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.6 p -128.9 -3.27 5.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.069 0.462 . . . . 0.0 110.468 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -99.48 -15.35 18.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -65.12 -21.05 66.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.026 0.441 . . . . 0.0 110.632 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.88 -44.31 99.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.092 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.6 m-20 -58.66 -50.23 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.891 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.4 m-85 -63.06 -43.22 99.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.11 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -62.81 -36.95 84.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.862 0.363 . . . . 0.0 111.006 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -66.69 -36.35 82.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.783 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 36' ' ' ASP . 96.0 t -69.35 -43.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.394 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 99.7 mt -61.97 -24.2 66.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -65.63 -18.14 65.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.944 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -104.03 -2.05 26.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 56' ' ' VAL . 24.1 tp -84.17 53.65 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.238 0.542 . . . . 0.0 111.292 -171.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -78.31 76.66 4.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.22 149.44 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.99 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -119.08 48.99 0.9 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.53 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.17 114.67 16.2 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.613 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 26.0 Cg_exo -62.07 103.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.562 2.174 . . . . 0.0 111.095 171.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.675 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 22.9 p -95.97 173.57 7.37 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' HD21 ' A' ' 54' ' ' ASN . 75.6 mmtt -97.31 -146.94 0.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.337 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.543 ' HB2' HD21 ' A' ' 72' ' ' ASN . 26.6 t -102.3 131.17 49.06 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.3 26.98 19.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.596 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.675 ' ND2' ' HB ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -86.83 112.45 21.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 68' ' ' ILE . 47.5 t -73.37 106.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.534 HG11 HD21 ' A' ' 44' ' ' LEU . 24.4 t -79.37 -46.37 23.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.169 0.509 . . . . 0.0 109.745 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 59.7 m -130.65 109.67 10.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 28.0 ttmt -85.12 129.33 34.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 53.72 69.37 0.72 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 123.812 0.695 . . . . 0.0 109.823 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.458 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.0 tt -78.76 125.53 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.317 -173.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.422 ' HG2' HG12 ' A' ' 60' ' ' ILE . 96.4 mmm 64.31 19.22 11.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.94 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 65.02 98.7 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.468 0.48 . . . . 0.0 111.298 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 65' ' ' VAL . 8.4 t -171.46 -34.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.478 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.22 -17.96 5.87 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.156 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.534 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 33.1 m -82.38 142.57 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.306 0.574 . . . . 0.0 112.014 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -108.23 131.62 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -91.5 114.11 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 55' ' ' VAL . 37.7 pt -117.35 134.06 62.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.887 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 54' ' ' ASN . 2.0 p -87.82 134.17 33.74 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -118.71 17.25 13.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 112.147 -168.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HB3' HG23 ' A' ' 21' ' ' VAL . 60.4 tttp -117.08 131.05 57.01 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.551 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -82.73 109.36 16.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.71 132.09 39.66 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.62 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo . . . . . 0 C--O 1.237 0.456 0 C-N-CA 122.447 2.098 . . . . 0.0 111.264 172.486 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.564 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.2 mttt . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.307 0.575 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.66 179.74 5.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.554 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.67 116.12 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.25 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.597 ' HB2' HG21 ' A' ' 29' ' ' VAL . 77.0 t80 -59.36 128.09 35.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -153.52 135.43 14.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.007 0.432 . . . . 0.0 110.097 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -153.2 169.34 23.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.36 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 59.8 t -114.32 118.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 41' ' ' LEU . 34.2 m -117.58 173.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.245 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.465 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 1.9 mmt85 -72.8 126.63 30.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.762 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.579 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.4 p -104.77 129.14 57.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.503 0.668 . . . . 0.0 111.239 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.504 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 41.9 ttt85 -104.65 142.32 34.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.974 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 168.15 12.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.0 m -83.26 102.21 11.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.98 -174.66 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.928 -179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.24 -0.9 56.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.49 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 47.9 m-85 -110.04 143.26 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.732 -0.387 . . . . 0.0 112.021 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -104.64 -10.59 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.756 0.789 . . . . 0.0 109.079 175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.2 m -142.33 148.41 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.414 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 12' ' ' VAL . 7.2 p -134.44 125.89 17.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.195 0.522 . . . . 0.0 111.749 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 5.8 Cg_exo -77.54 113.41 3.51 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.396 2.73 . . . . 0.0 112.306 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 ' SG ' ' A' ' 69' ' ' CYS . 31.5 m -104.82 161.04 4.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.544 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -153.24 178.77 9.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.487 0.66 . . . . 0.0 111.213 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.27 147.2 33.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.13 -3.71 56.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.506 0.669 . . . . 0.0 109.258 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB3' HG22 ' A' ' 65' ' ' VAL . 34.4 ttmt -128.72 129.84 23.49 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.417 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 38.3 Cg_exo -58.04 132.24 48.25 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 112.429 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' A' ' 6' ' ' PHE . 18.5 m -117.65 -178.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.564 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -97.96 135.26 39.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 pt -77.01 -19.49 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.307 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 37' ' ' PHE . 56.3 mtpt -93.99 0.79 56.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -53.82 -42.93 68.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.895 0.378 . . . . 0.0 110.676 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.55 -45.04 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.04 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 40' ' ' VAL . 8.9 t70 -67.46 -43.72 80.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.32 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.438 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 47.4 m-85 -61.48 -43.59 98.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.236 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.32 -35.97 80.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.753 0.311 . . . . 0.0 110.715 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 60' ' ' ILE . 61.7 t -67.05 -40.99 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.563 ' HB3' HG11 ' A' ' 10' ' ' VAL . 49.8 mt -62.49 -39.11 92.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.555 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -68.07 -12.91 61.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.417 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.8 ttt85 -95.13 -9.16 34.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.277 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.65 132.85 55.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.588 . . . . 0.0 111.431 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 11' ' ' ARG . 3.3 m-85 -106.99 102.83 12.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.797 173.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.93 157.89 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.258 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . 172.99 -148.91 10.79 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.751 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 85.1 t 72.49 126.13 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.345 0 O-C-N 124.099 0.529 . . . . 0.0 110.789 -175.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.682 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 82.6 Cg_exo -42.92 110.7 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.488 2.792 . . . . 0.0 113.074 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -139.65 169.48 17.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.622 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -95.93 173.57 7.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 110.707 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -68.54 119.83 13.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.439 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 30.47 5.78 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.693 HD21 ' HB2' ' A' ' 69' ' ' CYS . 10.6 p30 -89.1 131.67 35.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 68' ' ' ILE . 57.8 t -85.74 127.31 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.856 -175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.42 -75.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.228 0.537 . . . . 0.0 110.228 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -115.65 98.79 6.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.177 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 87.7 tttt -78.69 128.37 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 8.7 t-20 63.65 41.86 6.82 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.439 HD11 HG11 ' A' ' 40' ' ' VAL . 6.2 tt -53.27 -50.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.146 -172.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.435 ' HB2' HG23 ' A' ' 63' ' ' THR . 82.1 mtp -114.61 30.93 6.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.653 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 15.6 m120 63.4 23.84 13.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.391 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 61' ' ' MET . 67.6 p -86.93 -21.08 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.706 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.27 79.24 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.494 -174.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 27' ' ' LYS . 41.8 t -90.04 130.44 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.604 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' OD2' ' HE3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -95.92 107.92 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.5 mm -75.9 120.42 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 35.1 pt -126.43 137.57 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.221 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.693 ' HB2' HD21 ' A' ' 54' ' ' ASN . 3.8 m -86.73 132.88 33.74 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -102.29 6.42 40.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.351 0.596 . . . . 0.0 110.901 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.49 ' HD3' ' CZ ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -96.75 134.66 39.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.767 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.599 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -86.69 126.97 34.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.682 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.3 mp -95.35 109.09 43.31 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 91.6 Cg_endo . . . . . 0 N--CA 1.453 -0.883 0 C-N-CA 123.059 2.506 . . . . 0.0 112.567 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.07 151.7 48.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.656 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -72.5 109.46 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 83.7 t80 -59.31 98.77 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.477 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -112.84 120.42 41.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m -152.78 -159.39 1.0 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.599 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 8.9 p -128.9 138.5 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 120.768 0.318 . . . . 0.0 110.629 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -108.61 143.96 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 42' ' ' SER . 91.3 mtt180 -81.16 134.03 35.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.551 0.691 . . . . 0.0 110.261 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.639 HG11 ' HE2' ' A' ' 16' ' ' LYS . 42.5 t -116.17 150.67 18.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.231 -168.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -106.13 145.93 30.85 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 63.46 0.9 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.665 -175.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -85.27 4.23 35.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.757 ' HG2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -160.89 -178.35 6.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.121 -1.854 . . . . 0.0 107.705 179.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -93.6 75.69 4.38 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.367 -174.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -174.09 143.84 0.94 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 15.7 m120 -98.75 -33.48 10.9 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.14 163.79 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' HB ' HD11 ' A' ' 73' ' ' LEU . 9.8 p -153.84 140.15 12.66 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 120.668 0.271 . . . . 0.0 110.67 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 72.7 Cg_endo -79.14 145.54 19.38 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.568 2.179 . . . . 0.0 112.863 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.61 168.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.109 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.3 ptpt -141.07 173.78 11.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.39 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 90.7 p -109.17 138.88 44.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.87 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -68.04 -33.23 74.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.993 0.425 . . . . 0.0 110.85 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -115.78 147.17 38.45 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.056 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.51 120.37 7.76 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.771 2.314 . . . . 0.0 111.071 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.45 151.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -51.35 130.38 26.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.172 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 pt -61.12 -18.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -63.38 -35.68 81.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -95.81 10.87 35.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 111.555 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -61.86 -39.75 92.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.45 -40.93 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.386 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.21 -55.04 39.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.566 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.5 m-30 -67.36 -38.94 85.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.588 -174.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 p -69.05 -31.06 69.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.401 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -62.8 -32.39 73.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -79.94 -45.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.689 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 93.4 mt -63.18 -24.89 68.09 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' A' ' 11' ' ' ARG . 8.7 p -80.99 -18.84 45.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 110.971 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -99.09 -11.28 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.74 140.86 29.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.998 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -130.52 102.63 6.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.506 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 19.4 m -109.81 141.53 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.136 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.13 -3.01 29.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.584 -176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.478 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 14.5 m -58.8 125.81 78.48 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.757 ' HB3' ' HG2' ' A' ' 16' ' ' LYS . 33.7 Cg_endo -97.75 68.7 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.703 2.935 . . . . 0.0 112.732 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -179.27 5.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.407 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 13.8 mptt -99.94 -173.24 2.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.711 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.429 ' HB2' HD21 ' A' ' 72' ' ' ASN . 23.1 t -66.12 146.01 55.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 0.0 111.06 -177.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.71 31.7 35.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.344 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 69' ' ' CYS . 9.5 p30 -101.43 133.92 45.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.728 0.299 . . . . 0.0 110.281 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 58' ' ' LYS . 50.8 t -79.4 115.13 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 110.699 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.21 -51.56 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.004 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.9 m -127.41 110.18 12.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.897 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' HG11 ' A' ' 55' ' ' VAL . 65.3 tttp -99.04 123.82 43.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.679 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.2 t-20 62.94 60.26 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.519 HG12 ' HG3' ' A' ' 61' ' ' MET . 14.9 tt -76.39 123.0 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.285 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.519 ' HG3' HG12 ' A' ' 60' ' ' ILE . 86.7 mtp 65.73 23.11 11.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.927 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.679 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 11.2 m120 60.14 76.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.114 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -127.85 -44.06 1.5 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.047 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.26 16.24 12.63 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -109.98 136.31 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.52 107.82 18.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.491 0.662 . . . . 0.0 110.055 175.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.69 113.54 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.509 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.3 pt -110.88 141.45 26.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.211 0.529 . . . . 0.0 111.774 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.55 ' HB3' HD21 ' A' ' 54' ' ' ASN . 50.2 t -89.65 141.86 28.21 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -116.78 -2.24 11.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.156 0.503 . . . . 0.0 110.96 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -98.05 146.82 25.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.646 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -92.71 123.5 36.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.736 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.6 mm? -81.58 127.11 74.19 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.5 -175.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 13.6 Cg_exo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 122.739 2.293 . . . . 0.0 113.433 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 88.2 mttt . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.917 0.389 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -119.64 141.73 49.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.149 -172.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -67.34 106.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.969 0.414 . . . . 0.0 110.235 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.42 121.43 17.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 t -141.93 144.98 34.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.982 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.6 m -158.85 170.43 22.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.02 118.7 57.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -105.63 152.24 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -74.97 116.28 15.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.075 0.464 . . . . 0.0 110.515 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.748 HG13 ' HE2' ' A' ' 16' ' ' LYS . 9.0 p -88.98 144.55 8.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.552 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 8.3 ttp180 -122.38 -178.91 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.418 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -171.57 23.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.881 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.5 m -80.53 91.8 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 0.0 110.894 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.748 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -157.71 -167.7 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.166 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.18 18.56 7.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.357 0.598 . . . . 0.0 110.373 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.543 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 90.5 m-85 -118.43 165.5 13.81 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -125.35 -1.4 7.57 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.232 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 m -149.82 151.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.0 p -144.86 121.37 6.16 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.89 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 24.5 Cg_exo -62.84 114.9 2.61 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.761 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.55 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -108.57 151.4 10.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.31 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.2 171.95 15.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.176 0.512 . . . . 0.0 111.353 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -109.0 130.13 55.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.875 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -77.96 -9.73 59.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.0 110.206 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 65' ' ' VAL . 90.0 mttt -122.22 143.72 39.88 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.499 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 37.2 Cg_endo -66.54 131.06 25.1 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.415 2.077 . . . . 0.0 112.394 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.58 136.8 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.658 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 4.7 pt-20 -84.15 146.18 28.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.875 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.705 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . 11.6 pt -72.92 2.86 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 p -83.66 -32.89 25.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.355 0.598 . . . . 0.0 109.966 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -92.9 -7.22 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.969 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.705 ' HB2' ' HA ' ' A' ' 31' ' ' ILE . 68.2 t90 -57.68 -40.88 80.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.017 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -66.19 -42.18 90.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.759 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.2 m-20 -60.62 -45.1 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -60.22 -39.99 88.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 m -63.41 -38.8 92.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.85 -38.44 91.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.621 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 36' ' ' ASP . 59.9 t -67.75 -41.44 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.96 -20.45 64.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.062 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.2 t -82.84 5.07 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 110.097 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -125.7 -31.89 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.349 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.6 tp -77.61 111.9 13.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.634 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -117.27 107.42 14.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 56' ' ' VAL . 15.7 m -92.77 121.36 43.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -106.76 24.52 25.24 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.169 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.52 104.42 55.94 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.72 95.9 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.518 2.146 . . . . 0.0 111.345 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.23 156.52 20.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 35.2 mtmm -101.9 78.22 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.83 ' HB2' ' ND2' ' A' ' 72' ' ' ASN . 15.8 t 68.43 159.72 0.17 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.619 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 30.91 63.84 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.558 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -109.66 119.6 39.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.402 0.62 . . . . 0.0 111.245 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG22 HG22 ' A' ' 68' ' ' ILE . 21.3 t -81.35 109.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.25 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 46' ' ' VAL . 4.1 m -85.66 -40.32 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.689 0.28 . . . . 0.0 111.027 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.7 m -130.42 100.98 5.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.418 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -85.32 119.94 26.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.9 t30 62.46 75.69 0.39 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.686 0.755 . . . . 0.0 109.358 -170.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tt -72.92 127.9 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.946 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 93.3 mmm 66.38 -80.37 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.835 0.71 . . . . 0.0 110.355 -175.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' MET . 59.2 t30 172.47 80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.103 0.561 . . . . 0.0 109.851 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 t -158.48 15.11 0.19 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.872 0.367 . . . . 0.0 111.367 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.22 -22.37 7.22 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.934 -0.651 . . . . 0.0 114.011 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 27' ' ' LYS . 65.9 t -66.95 121.43 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 117.313 0.556 . . . . 0.0 111.873 -174.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.49 121.97 37.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.904 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.57 122.87 41.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.809 0.338 . . . . 0.0 110.446 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 55' ' ' VAL . 20.1 pt -121.44 140.0 46.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.366 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.55 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.7 m -90.43 122.36 33.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -101.3 8.18 42.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 49.1 tttp -96.19 145.07 25.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.83 ' ND2' ' HB2' ' A' ' 52' ' ' SER . 0.8 OUTLIER -92.68 103.62 15.98 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.929 -177.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 12' ' ' VAL . 75.2 mt -96.32 111.59 57.16 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.411 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.459 -0.546 0 C-N-CA 122.676 2.251 . . . . 0.0 111.35 176.479 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 45.5 mmtt . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.6 139.77 50.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.883 0.373 . . . . 0.0 110.622 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.82 121.94 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.582 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -75.58 102.02 5.14 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -125.8 127.65 46.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.414 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -154.51 172.13 18.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 110.83 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.488 HG12 ' HB ' ' A' ' 20' ' ' VAL . 48.1 t -113.1 117.17 54.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.53 156.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.75 0.31 . . . . 0.0 110.649 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -72.96 102.97 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.587 HG13 ' HE2' ' A' ' 16' ' ' LYS . 10.2 p -85.05 134.33 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.699 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 68.8 mtp180 -126.54 -179.07 4.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.5 -172.86 33.42 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.14 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 p -74.84 99.26 3.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.169 0.509 . . . . 0.0 111.991 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -166.6 178.3 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.496 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -87.56 -27.54 22.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.469 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.595 ' HE2' ' HA ' ' A' ' 73' ' ' LEU . 82.3 m-85 -79.73 171.16 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -126.15 -15.1 5.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 171.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 9' ' ' VAL . 11.8 m -148.29 147.47 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.07 132.67 14.86 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.922 0.392 . . . . 0.0 111.204 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 138.96 21.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.643 2.229 . . . . 0.0 112.669 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.19 156.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.417 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -142.63 165.81 26.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.828 0.346 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 p -109.46 142.3 40.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -78.89 -8.29 58.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.242 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.19 134.43 16.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.127 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 52.6 Cg_exo -56.95 136.12 74.78 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.817 2.345 . . . . 0.0 112.183 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.26 145.65 20.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.3 135.01 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 pt -66.33 -9.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.293 . . . . 0.0 111.549 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 m -67.58 -30.73 70.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 87.9 mttt -86.83 -17.4 33.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.649 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -51.78 -45.44 63.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.148 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.5 -44.98 99.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 111.46 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 40' ' ' VAL . 14.8 t70 -79.46 -32.27 42.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 1.7 m-85 -56.18 -48.7 75.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.122 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -60.99 -44.37 97.51 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.277 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -57.56 -47.19 82.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.731 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 36' ' ' ASP . 87.6 t -64.78 -46.02 93.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.669 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 tp -65.71 -31.93 73.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.857 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -66.8 -20.9 66.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 110.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 43' ' ' ARG . 55.0 mtm180 -104.85 8.91 34.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.4 tp -110.47 84.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.591 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 79.6 m-85 -92.78 101.02 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -122.04 159.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.348 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -145.58 -134.4 2.69 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.517 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.46 115.57 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.024 0.53 . . . . 0.0 110.711 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 65.2 Cg_exo -53.54 111.07 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.08 2.52 . . . . 0.0 112.825 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -109.27 -170.91 1.74 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.042 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -127.13 166.75 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.004 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.918 ' HB2' HD21 ' A' ' 72' ' ' ASN . 22.5 t -61.86 131.3 49.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.693 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.54 21.16 32.5 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.634 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.621 HD21 ' HB3' ' A' ' 69' ' ' CYS . 9.7 p30 -89.19 131.73 35.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.75 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 68' ' ' ILE . 38.7 t -87.27 106.16 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.119 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.4 -55.76 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.143 0.496 . . . . 0.0 109.809 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 t -130.7 121.11 24.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.403 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 31.8 ttmt -92.34 112.48 24.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.223 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 62' ' ' ASN . 62.9 t30 58.86 54.93 4.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.619 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.527 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 10.4 tt -46.27 -43.18 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.822 -171.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.501 ' HG3' HG12 ' A' ' 60' ' ' ILE . 84.4 mtp -128.98 29.03 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.491 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.424 ' HA ' ' ND2' ' A' ' 59' ' ' ASN . 40.7 t-20 53.81 72.51 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.406 0.622 . . . . 0.0 110.626 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -153.89 13.67 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.0 37.57 83.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.589 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 27' ' ' LYS . 52.0 t -127.08 120.95 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.014 0.435 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.592 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 15.9 m-20 -96.05 121.69 38.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.39 101.98 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.449 HG22 HG22 ' A' ' 55' ' ' VAL . 13.4 pt -109.15 139.92 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.368 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.621 ' HB3' HD21 ' A' ' 54' ' ' ASN . 43.9 t -95.25 145.24 25.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.258 174.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -121.05 8.91 10.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 110.495 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 24.9 tptp -96.68 131.37 43.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.918 HD21 ' HB2' ' A' ' 52' ' ' SER . 11.0 m-80 -91.15 116.4 28.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.887 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.595 ' HA ' ' HE2' ' A' ' 18' ' ' TYR . 6.1 mp -96.73 119.59 63.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 122.245 1.963 . . . . 0.0 110.709 172.14 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 10.4 mmmm . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.719 ' HB3' ' HZ2' ' A' ' 34' ' ' TRP . 6.4 t70 -130.11 171.01 13.3 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.3 112.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.102 -0.374 . . . . 0.0 111.309 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.477 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 29.4 t80 -66.34 115.22 6.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.493 . . . . 0.0 110.357 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -123.39 133.42 54.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.777 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.3 t -152.98 -163.55 1.73 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 20' ' ' VAL . 8.8 p -141.07 136.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.84 148.75 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.21 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -73.56 143.06 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 111.03 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 18' ' ' TYR . 57.4 t -105.76 146.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.692 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.75 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 19.4 ttp180 -140.38 -179.31 5.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.479 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' N ' ' HG2' ' A' ' 13' ' ' ARG . . . 111.7 -154.27 16.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.166 165.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -77.93 20.43 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.322 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -156.4 142.45 18.09 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.24 87.43 7.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.256 0.551 . . . . 0.0 110.285 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' HB3' HG11 ' A' ' 12' ' ' VAL . 2.2 t80 -117.59 141.71 48.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.53 -69.88 0.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.4 ' HB ' ' CG2' ' A' ' 9' ' ' VAL . 17.6 m -136.74 148.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.073 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.9 p -127.44 127.42 24.15 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.659 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 55.6 Cg_endo -71.4 133.83 23.38 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.685 2.257 . . . . 0.0 112.424 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 69' ' ' CYS . 27.1 m -119.44 166.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.031 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -147.09 176.35 10.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.383 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 16.3 m -109.15 131.21 55.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.31 -11.32 59.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.964 0.411 . . . . 0.0 110.428 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HB3' HG22 ' A' ' 65' ' ' VAL . 39.5 ttpt -135.78 135.15 21.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 14.4 Cg_endo -56.28 141.47 88.56 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 65' ' ' VAL . 4.2 m -122.18 174.21 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.131 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . 25.3 mt-10 -71.36 140.25 50.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 33' ' ' LYS . 36.0 pt -67.54 151.71 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 m 72.69 -32.77 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.116 0.566 . . . . 0.0 111.112 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 30' ' ' GLU . 19.2 tptm -64.26 -16.92 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 174.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.719 ' HZ2' ' HB3' ' A' ' 4' ' ' ASP . 52.0 m0 -54.27 -39.07 66.54 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.589 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.15 -36.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.15 -44.54 79.51 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.165 0.507 . . . . 0.0 110.263 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -66.45 -37.26 84.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 t -65.78 -32.27 73.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.291 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.48 -42.6 99.59 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.076 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.63 -47.8 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.869 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.851 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -64.1 -20.59 66.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 110.543 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -104.13 14.8 29.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.857 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 56' ' ' VAL . 32.0 tp -112.52 139.09 48.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -127.16 97.66 5.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.78 124.64 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.228 0.537 . . . . 0.0 111.055 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.75 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -109.62 175.19 18.61 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.182 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 99.2 t 73.53 134.29 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 123.05 0.54 . . . . 0.0 111.544 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.61 116.7 3.38 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.859 2.373 . . . . 0.0 111.78 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 p -118.79 169.52 9.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -120.3 169.36 10.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -52.58 118.64 3.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 24.95 9.84 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.115 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.677 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.8 p30 -88.47 132.34 34.52 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 68' ' ' ILE . 34.4 t -88.25 125.47 41.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.07 -175.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.471 ' HB ' HD21 ' A' ' 44' ' ' LEU . 30.5 m -97.85 -38.15 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.092 0.472 . . . . 0.0 110.258 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.6 m -130.9 105.14 7.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.791 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -95.19 127.48 41.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.12 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 1.6 t-20 54.56 40.37 31.79 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.842 0.713 . . . . 0.0 109.748 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.597 HG12 ' HG2' ' A' ' 61' ' ' MET . 10.4 tt -41.96 -50.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.622 -169.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.597 ' HG2' HG12 ' A' ' 60' ' ' ILE . 25.7 mmt -134.71 49.04 2.25 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.35 -0.219 . . . . 0.0 110.628 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 8.5 p30 56.71 5.86 0.25 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.841 1.256 . . . . 0.0 113.753 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.592 HG23 ' H ' ' A' ' 65' ' ' VAL . 5.0 t -78.56 -11.68 59.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.311 0.577 . . . . 0.0 110.71 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -6.35 83.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.268 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.592 ' H ' HG23 ' A' ' 63' ' ' THR . 66.5 t -81.33 126.9 39.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.817 0.341 . . . . 0.0 110.512 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -108.77 123.85 49.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mm -81.68 117.35 27.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' VAL . 33.6 pt -121.99 139.85 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.612 -173.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.677 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.8 m -89.32 137.32 32.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -105.38 13.12 30.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.128 0.49 . . . . 0.0 111.454 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 21' ' ' VAL . 31.9 mmtt -96.76 142.64 28.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.547 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -96.47 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 mt -99.8 112.71 64.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.581 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.457 -0.642 0 C-N-CA 122.994 2.463 . . . . 0.0 112.007 177.07 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 93.2 mttt . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 154.51 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 28' ' ' PRO . 46.7 mm -73.97 112.79 11.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.431 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.528 ' HB2' HG21 ' A' ' 29' ' ' VAL . 87.0 t80 -64.01 104.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.592 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -111.02 120.56 42.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -141.47 -166.86 2.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 60.5 t -133.63 129.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.39 152.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -91.96 133.26 35.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 110.307 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 HG23 ' A' ' 46' ' ' VAL . 2.5 t -118.76 133.31 66.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 112.025 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.566 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 92.4 mtt-85 -108.29 -179.11 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.353 173.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -161.6 21.59 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.453 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.2 m -78.77 74.87 5.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 111.393 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -147.96 166.66 27.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.581 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -89.32 -46.42 8.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.855 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.422 ' O ' ' HD2' ' A' ' 16' ' ' LYS . 85.4 m-85 -83.67 156.8 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -103.35 -3.03 26.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.865 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 6.5 m -143.51 145.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -134.18 129.13 19.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.436 174.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HG2' ' HB2' ' A' ' 71' ' ' LYS . 36.0 Cg_endo -67.89 128.89 18.57 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.494 2.129 . . . . 0.0 112.342 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 69' ' ' CYS . 27.1 m -115.94 161.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.343 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -139.76 178.33 7.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.13 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.21 134.45 51.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.768 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -72.87 -22.25 60.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HB2' HG22 ' A' ' 65' ' ' VAL . 37.7 mtmm -132.42 146.29 60.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' HD13 ' A' ' 5' ' ' ILE . 23.9 Cg_exo -63.15 137.62 62.5 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.969 2.446 . . . . 0.0 112.818 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 6' ' ' PHE . 33.4 m -114.99 160.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.411 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.608 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 59.4 mt-10 -68.65 139.7 55.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 29.7 pt -60.22 -26.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.375 . . . . 0.0 111.675 -177.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 m -74.74 -17.41 60.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.082 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.608 ' HE2' ' OE1' ' A' ' 30' ' ' GLU . 63.8 mttm -90.48 -5.29 56.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.612 0.244 . . . . 0.0 111.334 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.442 ' CD1' ' HA ' ' A' ' 31' ' ' ILE . 10.5 m95 -59.05 -31.26 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.02 -48.3 75.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.462 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 40' ' ' VAL . 7.1 m-20 -56.5 -50.63 71.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.49 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.434 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 32.4 m-85 -63.07 -37.05 85.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.371 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -63.4 -41.83 98.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.832 -0.167 . . . . 0.0 111.095 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -62.78 -35.27 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.958 0.409 . . . . 0.0 110.679 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 36' ' ' ASP . 59.1 t -70.02 -48.58 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.61 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.938 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.3 m -66.18 -12.14 54.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.644 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -105.15 -9.29 17.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 109.918 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.11 124.0 43.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.605 -172.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -125.3 117.1 23.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.641 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.514 HG11 HG13 ' A' ' 56' ' ' VAL . 24.9 m -106.02 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -151.3 47.04 0.59 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.426 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.33 119.73 17.69 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-O 120.562 0.22 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.66 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 55.8 Cg_endo -73.49 97.59 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.581 2.188 . . . . 0.0 111.473 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 p -96.77 170.22 9.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 64.1 mttp -98.27 -149.76 0.35 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.695 171.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 2.0 p -92.36 119.59 32.06 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.62 58.16 1.21 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.177 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.511 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 21.1 m-80 -127.91 129.24 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.17 110.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.167 0.508 . . . . 0.0 111.322 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 HG11 ' A' ' 46' ' ' VAL . 45.1 t -83.98 -42.61 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.684 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.1 m -130.53 103.6 6.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.443 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -84.23 128.19 34.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.528 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 54.79 52.66 11.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.348 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.554 HG21 HG12 ' A' ' 67' ' ' ILE . 12.7 tt -75.32 135.7 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.403 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.7 mmt 65.07 13.85 8.97 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.477 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.4 13.15 5.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.568 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 65' ' ' VAL . 8.9 t -87.51 -7.49 57.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.449 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.46 66.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.629 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.516 ' H ' HG23 ' A' ' 63' ' ' THR . 77.1 t -73.07 137.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.113 0.483 . . . . 0.0 110.283 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.94 120.2 38.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.554 HG12 HG21 ' A' ' 60' ' ' ILE . 44.0 mm -80.04 115.97 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.77 0.319 . . . . 0.0 110.397 -175.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 26.3 pt -116.13 131.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.649 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.52 ' HB3' HG12 ' A' ' 23' ' ' VAL . 1.8 p -81.13 139.32 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 11.7 t -126.13 6.99 7.18 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.395 -173.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.532 ' HB3' HG23 ' A' ' 21' ' ' VAL . 64.2 tttp -99.67 131.12 45.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -76.19 107.17 8.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.506 HD11 ' HB ' ' A' ' 21' ' ' VAL . 95.8 mt -81.58 112.62 35.68 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.279 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 N--CA 1.459 -0.548 0 C-N-CA 122.487 2.125 . . . . 0.0 112.067 -179.062 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 28' ' ' PRO . 68.2 mttm . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.62 157.13 32.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.575 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.3 mm -82.74 101.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 81.9 t80 -58.8 106.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.339 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -122.26 128.69 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.068 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -149.54 -168.98 3.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.9 m -121.75 137.53 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.705 0.288 . . . . 0.0 110.34 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.86 152.27 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -89.45 111.18 22.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.576 0.703 . . . . 0.0 110.117 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.608 ' HB ' ' HZ1' ' A' ' 16' ' ' LYS . 3.0 t -98.28 140.01 19.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.608 -173.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 45' ' ' TYR . 67.6 mtm180 -79.75 144.37 33.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.54 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -70.58 95.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 115.124 -169.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 p -117.37 12.33 14.23 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 165.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HZ1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -169.96 -168.92 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.359 -171.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.43 -41.36 14.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.602 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 78.2 m-85 -82.4 97.32 8.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 111.498 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 95.8 m-20 -98.63 10.72 40.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.52 122.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 73' ' ' LEU . 4.4 p -130.91 139.73 36.49 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.719 -173.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.43 124.39 10.33 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.923 2.415 . . . . 0.0 112.966 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.4 154.61 16.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.516 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -143.98 178.97 7.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB2' HG11 ' A' ' 65' ' ' VAL . 67.8 p -108.93 127.67 54.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.758 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -63.9 -24.32 67.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.863 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB2' HG22 ' A' ' 65' ' ' VAL . 82.8 mttt -122.68 142.71 38.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HB2' ' CB ' ' A' ' 3' ' ' LYS . 32.5 Cg_endo -64.81 128.29 20.58 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.232 1.955 . . . . 0.0 112.117 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.04 150.26 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.201 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.07 120.75 14.8 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.19 84.12 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.725 1.25 . . . . 0.0 111.914 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.1 m -138.04 -10.45 1.52 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.081 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -103.46 17.77 23.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -173.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -62.99 -26.84 69.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 110.494 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 64.2 mt -73.02 -47.91 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.429 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 40' ' ' VAL . 5.8 m-20 -68.29 -39.71 82.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.546 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.8 m-30 -64.21 -48.41 75.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -66.43 -30.75 71.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.182 0.515 . . . . 0.0 110.064 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 14.5 t-20 -56.72 -49.66 74.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.028 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 36' ' ' ASP . 47.1 t -70.99 -38.03 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.736 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 81.2 mt -62.01 -25.35 67.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.245 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -77.86 4.3 12.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.004 0.43 . . . . 0.0 111.396 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -141.64 16.75 2.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 0.0 109.963 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.9 tp -115.1 59.43 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.725 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 78.7 m-85 -83.83 92.05 7.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.738 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 48' ' ' VAL . 14.9 p -92.18 147.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.99 49.19 0.93 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.1 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 22.3 m -130.23 128.96 22.81 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 48' ' ' VAL . 23.2 Cg_exo -67.39 133.26 29.74 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.136 2.558 . . . . 0.0 111.589 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.509 ' H ' HD13 ' A' ' 73' ' ' LEU . 2.0 p -133.41 179.68 6.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.961 -174.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -118.92 169.5 9.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.53 ' HB2' HD21 ' A' ' 72' ' ' ASN . 11.0 t -59.56 128.71 38.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 0.0 111.805 -173.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.97 26.71 12.1 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.554 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.591 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.0 p30 -96.42 137.53 35.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' A' ' 58' ' ' LYS . 62.4 t -77.6 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.69 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.87 -57.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.2 t -130.49 109.25 10.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.915 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' HG11 ' A' ' 55' ' ' VAL . 9.3 tmtm? -84.12 119.82 25.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.623 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 57.46 50.86 10.56 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 110.221 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.651 HG12 ' HG2' ' A' ' 61' ' ' MET . 8.0 tt -49.15 -50.46 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.666 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.651 ' HG2' HG12 ' A' ' 60' ' ' ILE . 95.8 mmm -130.12 45.41 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.791 0.329 . . . . 0.0 110.585 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.04 29.63 19.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.194 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -86.31 -20.05 28.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.689 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.79 87.52 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 27' ' ' LYS . 69.0 t -104.47 138.75 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.212 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 58' ' ' LYS . 4.3 m-20 -97.41 106.94 19.35 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.07 107.12 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 55' ' ' VAL . 33.4 pt -114.69 144.87 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.977 -171.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.591 ' HB3' HD21 ' A' ' 54' ' ' ASN . 10.3 t -89.65 141.97 28.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.046 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -120.07 6.74 10.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 56.7 tttp -101.74 147.55 26.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -98.01 110.88 23.37 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 21' ' ' VAL . 5.7 mp -87.45 116.1 65.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.988 -176.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 2.9 Cg_exo . . . . . 0 C--O 1.236 0.377 0 C-N-CA 123.013 2.475 . . . . 0.0 111.519 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.3 mttt . . . . . 0 C--O 1.233 0.188 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -140.57 164.4 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.022 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -74.85 113.19 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 72.8 t80 -59.35 108.5 0.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.842 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -126.26 120.98 31.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.381 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -155.79 -156.79 0.67 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.2 m -132.08 147.03 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.784 0.326 . . . . 0.0 110.465 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.51 150.42 18.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.017 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.463 ' HD3' HG12 ' A' ' 20' ' ' VAL . 12.0 mmt180 -84.38 121.31 27.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 6.5 t -100.66 118.27 47.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.389 -173.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' C ' ' HA3' ' A' ' 47' ' ' GLY . 62.5 ttt180 -133.1 104.2 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 47' ' ' GLY . . . 174.42 -171.83 44.88 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -78.3 99.31 6.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -171.78 -166.63 0.44 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.36 -179.372 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -128.35 71.68 1.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -161.28 176.12 11.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.425 HD22 HG13 ' A' ' 20' ' ' VAL . 4.0 t30 -136.12 -50.07 0.69 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 110.551 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.463 HG12 ' HD3' ' A' ' 11' ' ' ARG . 15.9 m -131.11 133.45 62.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.19 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 73' ' ' LEU . 4.4 p -127.59 140.79 39.01 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.225 -177.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 47.2 Cg_endo -70.08 137.63 34.98 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.243 1.962 . . . . 0.0 112.199 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -135.25 146.79 29.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.558 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -145.22 178.93 7.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.914 0.388 . . . . 0.0 111.288 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.515 ' HB2' HG11 ' A' ' 65' ' ' VAL . 91.3 p -108.86 129.56 55.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.03 -39.77 72.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.516 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 65' ' ' VAL . 32.3 ttmt -119.52 140.25 29.0 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.462 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.91 126.22 20.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.533 2.155 . . . . 0.0 111.924 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.54 156.92 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.646 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 25.8 mt-10 -67.09 127.29 32.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.9 pt -74.31 -6.8 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 110.877 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.9 t -60.6 -31.96 71.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.331 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.447 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 33.2 mtmm -107.1 14.86 25.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.719 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -57.52 -36.21 71.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.698 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.19 -39.69 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.04 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 40' ' ' VAL . 25.7 t0 -71.96 -42.16 66.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 22.3 m-85 -58.08 -46.22 85.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.272 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.0 p -68.98 -28.6 66.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.309 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -72.69 -24.66 61.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.918 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 57.6 t -71.67 -44.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.18 -42.86 91.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.407 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -77.91 2.85 16.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 111.227 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -111.49 -15.89 13.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.537 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 93.3 mt -74.07 -71.66 0.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.861 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 58.5 79.92 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.465 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.3 p -125.22 143.36 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.614 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' C ' ' A' ' 13' ' ' ARG . . . -139.17 88.98 0.2 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.086 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 60.0 t -128.82 120.61 20.58 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' VAL . 14.2 Cg_endo -57.71 111.13 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 111.779 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 171.66 14.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.548 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -100.55 178.32 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.341 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -68.9 129.17 39.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.57 28.56 10.25 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.285 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.8 p30 -88.32 131.32 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 66' ' ' ASP . 37.0 t -88.97 110.71 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.794 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.99 -64.74 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.131 0.491 . . . . 0.0 109.789 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.412 ' HB3' ' HB ' ' A' ' 60' ' ' ILE . 70.3 m -100.47 116.69 33.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.311 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HD3' HG12 ' A' ' 55' ' ' VAL . 25.3 mmtt -83.4 104.01 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.6 t30 54.77 66.31 1.27 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.703 0.763 . . . . 0.0 109.595 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.48 HD11 HG11 ' A' ' 40' ' ' VAL . 12.3 tt -61.69 111.25 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.539 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm 63.76 26.17 14.35 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.63 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 m120 62.75 82.68 0.17 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.284 0.564 . . . . 0.0 111.372 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.2 p -133.14 -20.83 2.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.203 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.22 7.45 73.2 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.35 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 27' ' ' LYS . 60.1 t -116.72 129.44 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.049 0.452 . . . . 0.0 110.442 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.492 ' HB2' HG13 ' A' ' 55' ' ' VAL . 5.4 p-10 -95.55 126.08 40.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 169.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 mm -83.15 110.89 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.018 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.7 pt -117.4 138.53 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.451 0.643 . . . . 0.0 112.273 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.555 ' HB3' HD21 ' A' ' 54' ' ' ASN . 40.7 t -92.11 145.7 24.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -114.92 -2.74 12.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HD3' HG23 ' A' ' 21' ' ' VAL . 55.9 tttp -97.04 149.88 21.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.593 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -96.76 132.62 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -175.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.493 HD11 HG21 ' A' ' 21' ' ' VAL . 5.1 mp -111.79 93.98 22.5 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 N--CA 1.452 -0.967 0 C-N-CA 122.776 2.317 . . . . 0.0 113.024 -177.558 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 94.2 mttt . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -124.19 148.17 47.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.487 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.468 HG22 HG23 ' A' ' 7' ' ' THR . 42.0 mm -64.6 119.74 9.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.083 0.468 . . . . 0.0 110.959 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 91.6 t80 -78.13 96.01 5.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.034 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 5' ' ' ILE . 16.6 p -105.72 125.19 50.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 60.0 m -149.94 -169.0 3.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 138.83 52.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.3 157.85 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.459 ' HD2' HG12 ' A' ' 20' ' ' VAL . 33.6 mmm-85 -79.74 133.1 36.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.802 0.334 . . . . 0.0 110.797 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 46' ' ' VAL . 2.8 t -120.63 139.1 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.284 0.564 . . . . 0.0 110.669 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 64.6 ttt-85 -119.43 170.49 9.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.074 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.09 174.35 18.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.634 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.6 p -72.52 86.35 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.549 ' HG2' ' HG3' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -178.15 164.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.044 171.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -91.71 34.14 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.374 -0.376 . . . . 0.0 112.011 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.418 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 97.5 m-85 -130.55 102.91 6.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 110.31 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.39 -7.06 55.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.546 -176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.459 HG12 ' HD2' ' A' ' 11' ' ' ARG . 15.5 m -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.511 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.512 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.1 p -140.78 138.25 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.435 177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' SER . 55.2 Cg_endo -72.98 129.57 14.42 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.558 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 69' ' ' CYS . 30.1 m -115.58 161.55 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.569 ' HG3' HG13 ' A' ' 68' ' ' ILE . 18.3 ptpt -131.34 174.94 9.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.481 ' HB2' HG11 ' A' ' 65' ' ' VAL . 79.8 p -108.93 130.95 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.262 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.78 -44.71 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HG3' ' HD2' ' A' ' 28' ' ' PRO . 37.5 ttpt -121.09 140.88 31.76 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.538 ' HD2' ' HG3' ' A' ' 27' ' ' LYS . 84.6 Cg_exo -46.92 130.76 16.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.088 2.526 . . . . 0.0 112.835 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.81 127.09 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.667 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 40.9 mt-10 -52.5 135.3 34.12 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.301 176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 tp -68.26 81.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 122.051 0.929 . . . . 0.0 110.881 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t 179.9 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.217 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.12 -5.69 52.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.295 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -57.56 -34.25 68.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.27 -54.99 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.658 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 7.5 m-20 -62.44 -38.16 88.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.02 -51.42 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.242 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -64.9 -32.01 73.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.632 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 24.9 t-20 -55.56 -54.34 45.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.901 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 36' ' ' ASP . 67.3 t -60.42 -42.93 92.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.98 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.4 mt -60.99 -27.2 68.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -68.28 -10.63 56.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.58 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -130.2 20.07 5.34 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 174.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.3 tp -109.89 115.23 29.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.43 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -117.29 112.69 21.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.369 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.551 HG23 HG13 ' A' ' 12' ' ' VAL . 27.3 m -96.67 178.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -143.98 176.04 23.51 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.089 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.7 t 71.97 139.75 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 122.797 0.439 . . . . 0.0 111.216 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HG3' ' HG2' ' A' ' 16' ' ' LYS . 25.1 Cg_exo -64.8 119.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.447 2.098 . . . . 0.0 111.401 170.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.587 ' HB ' ' CG ' ' A' ' 54' ' ' ASN . 40.6 p -101.6 166.34 10.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.826 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.59 -148.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.82 ' HB2' HD21 ' A' ' 72' ' ' ASN . 11.4 t -101.95 120.81 41.0 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.31 49.77 1.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.026 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.587 ' CG ' ' HB ' ' A' ' 50' ' ' THR . 1.5 m-80 -108.69 109.11 20.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 68' ' ' ILE . 94.7 t -69.55 111.38 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 -62.55 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.71 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -130.81 115.3 16.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.032 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 20.6 ptmt -98.18 141.97 30.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.824 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.497 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 11.8 t-20 58.34 41.7 22.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.716 0.77 . . . . 0.0 109.028 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.773 HG12 ' HG2' ' A' ' 61' ' ' MET . 14.4 tt -64.51 133.67 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.41 -173.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.773 ' HG2' HG12 ' A' ' 60' ' ' ILE . 83.7 mmm 63.39 21.85 12.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 65.65 10.91 7.11 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.13 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -69.87 -43.82 71.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.96 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.497 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 117.43 -27.14 7.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 25' ' ' SER . 85.8 t -66.95 140.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.67 0.271 . . . . 0.0 110.766 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 4.2 m-20 -95.63 123.0 38.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.76 106.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.569 HG13 ' HG3' ' A' ' 24' ' ' LYS . 25.7 pt -115.53 132.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.857 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.578 ' HB3' HD22 ' A' ' 54' ' ' ASN . 18.2 t -72.09 142.1 49.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.1 t -126.35 1.83 7.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 64.7 tttp -102.58 129.08 49.03 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.481 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.82 HD21 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -86.23 106.39 17.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.974 -174.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 62.9 mt -95.73 126.03 46.76 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.079 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 73' ' ' LEU . 15.6 Cg_endo . . . . . 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.175 . . . . 0.0 111.532 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.03 -71.48 0.73 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -134.75 163.23 30.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.64 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.3 145.43 42.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.746 0.308 . . . . 0.0 110.563 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.38 119.73 12.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.923 0.392 . . . . 0.0 110.277 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 77.0 t80 -60.11 125.71 24.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.155 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.8 m -145.15 120.39 10.19 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -148.28 178.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.58 120.97 66.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.3 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -112.74 150.58 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.805 0.336 . . . . 0.0 110.333 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.538 ' HA ' HG12 ' A' ' 20' ' ' VAL . 91.0 mtt180 -77.22 134.45 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.597 ' CG1' ' HE3' ' A' ' 16' ' ' LYS . 12.0 t -112.85 111.6 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -90.84 100.91 13.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.448 -174.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.11 162.5 14.0 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.2 t -85.03 99.84 11.28 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -149.58 39.77 0.81 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.356 -175.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.6 tttm 70.74 -66.07 0.31 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.568 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -73.79 -179.06 3.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.401 . . . . 0.0 111.363 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.0 -36.43 1.98 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.653 0.263 . . . . 0.0 111.245 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 11' ' ' ARG . 17.0 m -129.03 158.99 41.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.218 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.2 p -128.67 133.4 25.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.923 0.392 . . . . 0.0 111.092 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.93 118.8 5.72 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.529 2.152 . . . . 0.0 111.717 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 69' ' ' CYS . 28.9 m -112.5 150.54 14.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.547 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.51 ' HE3' HG21 ' A' ' 70' ' ' THR . 18.3 ptpt -136.66 170.56 15.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.969 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 17.0 t -109.45 155.71 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.279 0.561 . . . . 0.0 110.72 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.468 HD21 ' HE2' ' A' ' 27' ' ' LYS . 21.1 p-10 -78.04 -32.86 51.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.176 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' HD21 ' A' ' 26' ' ' ASN . 51.1 mtmt -122.58 150.86 58.97 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.975 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 23.3 Cg_exo -64.38 136.9 53.06 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.137 2.558 . . . . 0.0 112.971 -176.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -124.57 150.19 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.824 -177.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -69.52 145.7 52.45 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.866 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tt -60.35 -27.27 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.987 0.422 . . . . 0.0 111.546 -174.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.45 -28.0 68.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.923 0.392 . . . . 0.0 111.059 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -90.13 -20.73 22.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.711 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -57.55 -43.33 84.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -67.37 -45.59 85.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.135 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.96 -45.8 89.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.449 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CE2' HG11 ' A' ' 29' ' ' VAL . 22.1 m-30 -67.51 -37.44 82.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.602 0.239 . . . . 0.0 110.877 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.8 m -64.44 -33.7 76.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -62.21 -40.2 95.32 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.22 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 50.7 t -64.98 -44.3 96.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.338 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.91 -21.92 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.443 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -73.5 -13.59 61.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.381 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 40' ' ' VAL . 10.3 ptt180 -111.65 1.26 16.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.366 0.603 . . . . 0.0 109.43 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 tt -108.73 133.02 53.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.683 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.96 110.24 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.642 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 43.2 t -78.01 126.72 38.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.96 5.49 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.773 -1.203 . . . . 0.0 112.589 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.8 112.14 20.52 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.535 0.207 . . . . 0.0 110.913 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 6.1 Cg_exo -75.44 102.95 1.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.774 2.316 . . . . 0.0 110.786 170.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.61 -178.57 4.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.302 0.572 . . . . 0.0 112.352 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -87.91 -178.23 5.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.367 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 p -74.85 140.13 43.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.462 . . . . 0.0 111.181 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 32.16 16.95 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.712 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.719 HD21 ' HB2' ' A' ' 69' ' ' CYS . 10.4 p30 -96.58 128.4 43.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.313 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG22 HG22 ' A' ' 68' ' ' ILE . 47.7 t -83.15 120.53 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.917 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.99 -61.26 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.509 0.671 . . . . 0.0 109.798 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.69 121.38 25.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.286 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -91.81 136.5 33.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.26 56.52 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.452 0.47 . . . . 0.0 110.236 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.6 tt -69.37 125.57 27.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.254 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 96.9 mmm 64.46 23.85 13.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.564 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.5 t30 51.26 69.5 0.64 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.793 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.8 p -114.49 -35.01 5.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.845 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.67 9.95 34.13 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.454 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 27' ' ' LYS . 1.7 p -104.04 157.28 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -109.29 137.97 46.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mm -111.52 117.19 54.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 34.3 pt -123.78 136.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 111.793 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.719 ' HB2' HD21 ' A' ' 54' ' ' ASN . 2.7 m -82.72 134.59 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.51 HG21 ' HE3' ' A' ' 24' ' ' LYS . 12.7 t -109.77 3.9 21.27 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.246 -176.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' HB3' HG23 ' A' ' 21' ' ' VAL . 55.7 tptt -96.68 143.6 27.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -90.93 121.12 32.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.8 mm? -98.35 112.27 61.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.91 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 8.6 Cg_endo -87.39 96.36 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.145 2.564 . . . . 0.0 111.719 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 42.7 tttm -69.78 -58.44 3.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.411 0.624 . . . . 0.0 110.685 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -106.95 113.71 27.36 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.632 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.5 m -85.42 80.01 9.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.155 0.502 . . . . 0.0 110.629 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.1 mt -102.06 88.9 3.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.319 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.92 118.18 36.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -112.06 47.6 1.04 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.129 0.49 . . . . 0.0 110.634 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -100.59 -41.64 6.87 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -101.37 150.67 22.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.693 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -79.04 -91.73 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 176.3 142.37 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 39.0 m170 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.952 175.081 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mtt . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.583 0.23 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -133.21 126.41 31.53 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.587 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.529 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 99.4 mttt -105.17 146.59 29.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.536 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.42 148.65 50.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.03 0.443 . . . . 0.0 111.377 -176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 25' ' ' SER . 47.2 mm -61.77 110.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.309 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -66.93 110.9 3.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -123.89 127.93 48.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.878 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.4 m -154.72 173.85 15.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.2 t -117.26 125.04 73.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 m -105.6 156.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.808 0.337 . . . . 0.0 110.664 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 11' ' ' ARG . 21.7 mtp85 -90.24 116.9 28.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.124 0.488 . . . . 0.0 109.788 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 t -108.45 140.76 25.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.875 -172.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 65.9 mtt-85 -97.53 158.41 15.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.62 157.74 9.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.05 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 77' ' ' SER . 5.0 p -81.55 45.37 0.87 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.461 0.648 . . . . 0.0 111.013 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 33.58 2.32 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.087 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.8 tptt 69.74 -59.27 0.5 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.717 0.807 . . . . 0.0 112.056 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -80.91 -177.46 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -143.5 11.4 1.68 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.294 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.521 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.5 m -146.31 147.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.024 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 71' ' ' LYS . 9.5 p -137.66 133.71 18.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.562 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -70.47 116.0 4.44 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.804 2.336 . . . . 0.0 112.269 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.9 m -105.44 151.33 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.954 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.28 163.27 30.8 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.363 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 5' ' ' ILE . 19.5 m -109.27 131.82 54.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -75.61 -12.68 60.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 110.924 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 65' ' ' VAL . 75.0 mmtt -115.98 143.16 30.33 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 17.1 Cg_exo -67.59 120.25 7.27 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.316 2.011 . . . . 0.0 110.923 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 t -99.73 148.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.677 -172.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.529 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 54.1 mt-10 -64.0 119.53 10.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 172.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -61.32 -22.31 27.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 m -70.03 -16.54 63.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.996 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -98.8 11.7 37.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.216 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -62.95 -35.07 78.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.685 0.279 . . . . 0.0 110.8 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 pt -66.58 -39.94 85.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.519 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 40' ' ' VAL . 37.2 t70 -61.77 -48.03 82.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.75 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.43 -40.77 89.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 64.9 m -60.91 -38.94 87.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.934 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -62.27 -43.47 98.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 36' ' ' ASP . 47.8 t -65.38 -45.1 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.533 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.19 -27.34 69.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.567 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.6 m -73.73 -5.01 38.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.29 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -113.6 5.08 16.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.239 0.543 . . . . 0.0 109.679 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.8 tp -109.05 42.14 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.022 -172.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -70.19 94.61 0.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.397 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.59 154.23 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.26 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -124.59 98.42 0.56 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.299 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 7.3 p -168.5 126.14 0.89 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.783 0.325 . . . . 0.0 110.763 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.638 ' HB2' ' HD3' ' A' ' 75' ' ' LYS . 8.5 Cg_exo -72.49 120.99 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.743 2.295 . . . . 0.0 111.373 174.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -122.11 -179.23 4.09 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.82 173.13 6.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.23 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.424 ' CB ' HD21 ' A' ' 72' ' ' ASN . 2.1 p -69.84 126.13 28.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.119 0.485 . . . . 0.0 110.83 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.14 30.05 13.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.759 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.852 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -88.85 128.04 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 68' ' ' ILE . 22.1 t -88.19 112.83 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.376 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -76.46 -62.28 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 44.3 t -130.64 108.81 10.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.253 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.9 138.76 32.33 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.55 43.23 16.26 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 6.2 tt -50.44 -39.11 16.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.339 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.86 39.48 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 62.87 18.82 11.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 122.11 0.957 . . . . 0.0 109.71 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 65' ' ' VAL . 20.5 p -82.51 -25.4 33.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.164 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.19 15.28 69.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.281 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 27' ' ' LYS . 48.7 t -92.26 139.08 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.85 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.61 101.01 12.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.81 102.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.8 pt -115.35 136.58 51.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.573 -172.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.852 ' HB2' HD21 ' A' ' 54' ' ' ASN . 2.3 m -87.77 135.9 33.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -108.39 0.26 21.01 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.126 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HB3' HG23 ' A' ' 21' ' ' VAL . 66.4 tttp -102.47 140.12 37.17 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.593 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -89.28 132.31 34.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.4 mm? -95.64 122.98 57.64 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.257 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 37.6 Cg_exo -60.74 125.56 17.55 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.007 2.472 . . . . 0.0 112.484 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HD3' ' HB2' ' A' ' 49' ' ' PRO . 34.1 mmtp -73.43 -24.99 60.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.204 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -85.17 113.65 21.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.728 -173.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 15' ' ' SER . 17.1 p -99.31 48.8 0.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.323 0.582 . . . . 0.0 109.607 174.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.6 pt? -69.01 -5.01 19.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.105 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -78.48 79.22 4.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.631 0.729 . . . . 0.0 110.943 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -118.97 -67.9 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 170.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 67.45 -75.86 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.908 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -130.15 126.38 37.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.508 0.194 . . . . 0.0 110.52 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -96.15 71.52 2.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.429 0.633 . . . . 0.0 110.658 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -143.03 -77.36 0.24 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 . . . . . 0 C--O 1.242 0.68 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.445 175.059 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.801 0.334 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -104.42 114.5 28.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.786 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 60.0 mttm -82.32 126.22 31.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.333 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -140.6 179.64 6.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.0 mm -89.61 101.93 12.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.452 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 75.7 t80 -59.56 107.39 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.503 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -118.71 127.41 53.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 t -152.99 -171.89 4.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 m -126.08 140.74 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.0 p -120.72 154.19 24.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.897 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 11' ' ' ARG . 18.7 mtp-105 -82.4 128.73 34.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.402 0.62 . . . . 0.0 110.698 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.534 HG11 ' NZ ' ' A' ' 16' ' ' LYS . 15.6 t -97.25 141.95 14.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.326 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -137.29 100.68 4.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.374 0.607 . . . . 0.0 110.679 -176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.55 -175.47 47.25 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.8 t -86.45 78.99 9.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.458 0.646 . . . . 0.0 110.309 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.534 ' NZ ' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -160.9 148.68 15.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.432 177.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -83.74 37.7 0.6 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -165.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.496 ' HB2' HD12 ' A' ' 73' ' ' LEU . 29.4 m-85 -151.75 109.06 3.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.531 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -89.52 7.99 33.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.64 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 m -141.57 132.29 26.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 71' ' ' LYS . 13.1 p -133.29 131.56 21.67 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.959 0.409 . . . . 0.0 110.896 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.33 124.64 10.09 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.718 2.279 . . . . 0.0 112.396 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.472 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -115.79 155.36 17.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.475 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -138.71 171.29 14.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.499 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 18.6 m -109.29 129.28 55.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.257 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -72.92 -21.99 60.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.072 0.463 . . . . 0.0 110.636 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -116.04 135.82 22.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 37.0 Cg_endo -66.13 116.54 4.07 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.449 2.1 . . . . 0.0 112.56 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 6' ' ' PHE . 3.8 m -105.82 148.49 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.983 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 2.0 mp0 -64.93 141.63 58.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 111.086 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -77.05 22.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.424 0.631 . . . . 0.0 111.279 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.6 m -114.4 4.15 15.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.347 0.594 . . . . 0.0 109.703 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -106.33 16.3 24.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.414 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -52.44 -49.07 65.3 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.967 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 tt -53.99 -50.77 51.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.071 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 40' ' ' VAL . 45.0 m-20 -65.05 -48.08 75.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.246 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -67.38 -36.46 81.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.294 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -62.86 -41.14 99.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.572 0.225 . . . . 0.0 110.738 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.4 -42.49 98.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.817 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 36' ' ' ASP . 58.7 t -67.51 -49.21 73.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.137 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -66.54 -29.68 69.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 111.178 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -72.56 -20.51 61.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 110.481 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 43' ' ' ARG . 12.8 mtp180 -103.51 -1.75 27.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.184 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.6 tp -107.2 93.46 4.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.124 0.488 . . . . 0.0 110.704 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -96.25 91.29 5.81 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.19 139.26 23.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.65 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.24 -130.78 5.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.128 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.428 HG13 ' HD2' ' A' ' 49' ' ' PRO . 94.0 t 70.41 140.01 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 112.081 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' HG13 ' A' ' 48' ' ' VAL . 61.0 Cg_endo -74.74 98.11 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.478 2.119 . . . . 0.0 111.764 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 p -108.49 163.78 12.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.67 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.9 mtmt -115.93 177.08 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.596 ' HB2' HD21 ' A' ' 72' ' ' ASN . 34.3 t -61.86 131.84 51.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.914 0.387 . . . . 0.0 111.149 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.18 25.28 19.81 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.054 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.731 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.3 p30 -95.0 125.19 39.5 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.413 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.537 HG22 HG22 ' A' ' 68' ' ' ILE . 17.0 t -86.44 109.25 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.0 m -78.69 -40.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.915 0.388 . . . . 0.0 110.169 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.2 t -130.48 105.37 7.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HG2' ' OD1' ' A' ' 66' ' ' ASP . 9.5 tmtm? -90.7 129.56 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 60.71 47.93 7.62 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.392 0.433 . . . . 0.0 111.078 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 65' ' ' VAL . 12.7 tt -60.98 135.8 25.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.197 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.5 mmt 64.33 11.5 6.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.226 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 57.94 28.72 16.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.802 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 65' ' ' VAL . 9.0 t -101.95 -7.69 22.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.341 0.591 . . . . 0.0 110.345 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.46 5.53 57.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.903 176.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.552 ' O ' HG22 ' A' ' 60' ' ' ILE . 94.8 t -85.01 130.99 35.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.007 0.432 . . . . 0.0 109.958 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 66.4 m-20 -107.08 110.48 22.6 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.287 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -76.97 108.6 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.537 HG22 HG22 ' A' ' 55' ' ' VAL . 25.8 pt -114.7 136.59 50.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.249 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.731 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.7 m -92.02 136.15 33.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -108.86 8.54 26.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.065 0.46 . . . . 0.0 111.641 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HB3' HG23 ' A' ' 21' ' ' VAL . 45.1 tttp -102.2 148.31 25.59 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.76 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.596 HD21 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -99.87 124.04 44.76 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 18' ' ' TYR . 2.5 mm? -108.09 120.3 47.28 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.528 -174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.42 143.48 27.82 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.942 2.428 . . . . 0.0 111.943 175.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HG2' ' N ' ' A' ' 76' ' ' ASP . 53.6 tttm -94.89 165.85 12.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.385 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 6.2 p-10 -72.18 172.86 9.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.609 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.2 t -110.71 125.85 53.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.033 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.69 -13.1 58.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 111.277 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -88.4 12.06 15.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.828 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -58.04 -35.78 71.81 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.008 0.432 . . . . 0.0 109.938 173.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -106.95 107.73 18.9 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -103.8 104.52 14.54 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -78.51 101.31 7.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.941 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -71.94 131.23 42.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.628 178.108 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -73.35 111.07 8.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.037 0.446 . . . . 0.0 111.126 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -109.28 158.82 17.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.1 136.6 54.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.566 HG12 ' HA ' ' A' ' 28' ' ' PRO . 4.6 mt -74.05 126.15 34.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.611 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -63.88 117.01 6.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.62 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 m -134.62 120.54 19.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -149.96 -169.55 3.41 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 20' ' ' VAL . 7.2 p -132.44 127.72 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.25 153.33 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.678 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 11' ' ' ARG . 57.6 mtt180 -75.32 128.9 36.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.546 HG13 ' HA3' ' A' ' 47' ' ' GLY . 19.5 t -86.56 125.36 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -110.27 123.0 48.99 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.826 0.346 . . . . 0.0 110.539 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . 144.04 -174.61 24.31 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.704 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.0 m -72.09 95.39 1.62 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -139.02 176.97 8.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.392 -175.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 74' ' ' PRO . 51.7 tptt -110.66 -30.6 7.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.252 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.416 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -96.29 138.3 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 16' ' ' LYS . 56.3 t30 -77.83 -45.42 24.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.767 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 9' ' ' VAL . 18.4 m -128.17 147.63 32.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.397 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 12' ' ' VAL . 9.5 p -128.27 121.4 21.53 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 121.246 0.546 . . . . 0.0 111.406 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 32.4 Cg_exo -59.9 125.45 17.74 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.86 2.373 . . . . 0.0 112.636 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.553 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -117.86 155.48 19.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.839 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -143.64 177.33 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.038 0.447 . . . . 0.0 111.092 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.54 ' HB3' HG23 ' A' ' 5' ' ' ILE . 40.4 t -109.2 147.08 33.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.734 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -84.04 -8.34 59.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 110.716 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' HG22 ' A' ' 65' ' ' VAL . 37.2 mtmm -139.3 144.48 40.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HA ' HG12 ' A' ' 5' ' ' ILE . 23.1 Cg_exo -63.61 129.92 26.53 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.71 2.273 . . . . 0.0 112.155 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 175.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.029 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 124.02 21.94 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.22 -24.11 35.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.107 0.48 . . . . 0.0 110.993 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 p -83.69 1.79 40.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.596 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -95.05 7.28 46.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.8 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -59.07 -30.57 68.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.615 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 9.1 pt -66.49 -38.65 82.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.554 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -76.8 -40.12 49.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.561 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -66.03 -51.41 58.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.745 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.6 m -63.56 -25.75 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.419 . . . . 0.0 110.565 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.601 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 9.3 t-20 -59.57 -50.78 72.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.783 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.22 -40.71 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.26 -32.02 71.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.358 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.6 t -64.96 -21.14 66.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.828 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 43' ' ' ARG . 21.2 tpt180 -109.59 1.98 20.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.335 0.588 . . . . 0.0 109.883 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 46' ' ' VAL . 44.5 tp -108.26 92.01 3.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.597 -176.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.54 95.71 7.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.304 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 44' ' ' LEU . 15.7 m -141.75 -157.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.916 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . 137.44 -88.08 0.22 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.297 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.5 t 68.28 117.86 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.215 0 O-C-N 123.919 0.423 . . . . 0.0 110.552 -175.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.886 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 80.6 Cg_exo -43.29 105.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.519 2.813 . . . . 0.0 113.455 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.93 -163.89 1.39 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.195 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -120.88 -175.91 3.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.685 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.46 129.64 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.772 -175.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.32 22.41 24.73 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.408 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.79 HD21 ' HB2' ' A' ' 69' ' ' CYS . 11.0 p30 -85.32 133.45 34.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.195 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 66' ' ' ASP . 61.4 t -90.92 120.48 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.656 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.26 -52.56 9.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.581 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 77.4 m -130.9 117.3 19.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.481 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 1.005 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 49.9 tttp -99.49 132.81 44.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.787 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.7 t30 67.11 39.2 3.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.431 0.634 . . . . 0.0 110.161 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.39 128.46 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.916 177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 57.1 mtt 66.14 16.36 10.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 0.0 111.444 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.34 36.59 20.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.287 0.565 . . . . 0.0 110.848 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.6 p -82.58 -26.06 32.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.415 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.93 10.19 65.0 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.298 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG22 ' HE2' ' A' ' 27' ' ' LYS . 68.8 t -108.59 131.67 58.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.51 0.195 . . . . 0.0 111.022 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 1.005 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.0 p-10 -99.79 124.89 45.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.221 0.534 . . . . 0.0 109.849 170.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.38 121.34 34.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.403 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.5 pt -121.11 138.3 51.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.0 111.687 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.79 ' HB2' HD21 ' A' ' 54' ' ' ASN . 2.9 m -91.09 141.93 28.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -111.68 2.17 17.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.222 0.534 . . . . 0.0 111.072 -174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.505 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.1 tmtt? -96.19 131.91 42.18 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -83.78 113.38 20.87 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.886 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 73.8 mt -97.4 125.93 43.49 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.06 -173.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.654 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 33.2 Cg_exo -60.46 141.0 94.38 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.956 2.438 . . . . 0.0 111.677 176.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -122.39 33.02 5.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.338 -170.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.43 105.4 0.42 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.662 -177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 p -146.8 52.28 1.1 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.84 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.478 ' H ' HD22 ' A' ' 78' ' ' LEU . 3.2 mm? -56.89 -38.55 72.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.655 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.48 111.39 23.04 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -72.29 149.27 44.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.016 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -69.39 108.52 3.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.344 -173.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.7 m80 65.86 95.35 0.06 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.41 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -100.66 155.83 17.67 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -116.49 173.31 6.68 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.358 0.599 . . . . 0.0 111.309 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 13.4 p80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.536 173.537 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.417 ' O ' ' HG2' ' A' ' 1' ' ' MET . 23.0 m170 -70.57 163.75 26.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.176 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 82.2 mttt -74.26 156.98 36.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.654 -175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -123.23 158.63 30.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.82 0.343 . . . . 0.0 110.726 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.9 mm -76.31 112.39 14.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.801 0.334 . . . . 0.0 110.735 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 86.2 t80 -63.66 104.21 0.64 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.5 m -115.81 122.67 46.11 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.2 m -148.42 -169.8 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.606 0.241 . . . . 0.0 110.515 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 46.8 t -123.19 132.03 72.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.4 155.72 11.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -91.63 129.47 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.062 0.458 . . . . 0.0 110.648 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.719 HG22 HG22 ' A' ' 21' ' ' VAL . 2.6 t -97.67 146.99 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -169.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 68.9 ttt180 -119.95 147.28 44.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.585 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.16 -168.55 21.16 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.828 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 p -75.3 99.9 4.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -157.87 168.82 26.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.233 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.77 -54.28 4.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.83 0.348 . . . . 0.0 111.561 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 70.1 m-85 -86.69 127.12 34.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.873 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.575 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 16.6 m120 -79.69 -13.72 59.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.173 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.6 m -135.47 139.48 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.719 HG22 HG22 ' A' ' 12' ' ' VAL . 17.7 m -134.48 134.65 22.63 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.612 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.19 132.47 22.7 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.672 2.248 . . . . 0.0 112.908 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 69' ' ' CYS . 30.7 m -121.66 165.74 17.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.233 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.2 ptpt -148.18 178.99 8.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.086 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.479 ' HB2' HG11 ' A' ' 65' ' ' VAL . 78.9 p -108.97 131.13 55.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.036 0.446 . . . . 0.0 111.131 -176.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -53.4 -41.44 65.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.524 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HB2' HG22 ' A' ' 65' ' ' VAL . 7.1 mtmp? -126.28 151.49 72.34 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 18.0 Cg_endo -58.0 126.6 22.14 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.767 2.311 . . . . 0.0 111.969 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -119.92 157.18 22.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.114 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -73.8 141.72 46.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.717 0.294 . . . . 0.0 110.208 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.6 pt -69.87 -8.1 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 111.16 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.7 p -66.06 -25.81 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.454 . . . . 0.0 110.403 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -99.11 2.48 46.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.914 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -56.01 -52.79 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.1 pt -68.93 -26.66 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.711 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.24 -46.88 19.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.394 . . . . 0.0 110.642 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -61.2 -41.38 96.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.763 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 p -66.89 -35.97 81.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.068 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -56.57 -45.55 81.26 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.966 0.413 . . . . 0.0 110.508 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.94 -48.03 87.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.17 -28.78 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.761 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.1 m -73.87 -8.82 57.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.004 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 43' ' ' ARG . 60.9 mtt180 -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.215 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.43 99.78 8.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.847 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 17.3 m-85 -88.95 109.48 20.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.636 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.3 120.77 36.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -120.82 41.23 1.96 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.566 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.5 t -125.42 86.66 56.83 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 71.5 Cg_exo -50.79 118.12 3.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.707 2.271 . . . . 0.0 111.967 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.37 -171.05 2.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.235 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 9.4 mmpt? -95.11 -172.46 2.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.268 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -72.55 136.59 45.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.892 0.377 . . . . 0.0 111.282 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.84 30.14 8.64 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.132 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.466 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.9 p30 -93.15 133.44 36.34 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 66' ' ' ASP . 44.7 t -89.27 105.95 16.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.999 0.428 . . . . 0.0 110.692 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.0 t -74.3 -48.19 37.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.153 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.33 99.83 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.228 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HG2' HG11 ' A' ' 55' ' ' VAL . 57.0 mttp -76.24 102.73 5.95 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.3 m120 55.04 77.68 0.2 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.3 tt -47.26 -51.83 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 123.695 0.622 . . . . 0.0 112.326 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtm -141.99 54.59 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.856 0.36 . . . . 0.0 110.445 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 59.83 28.33 17.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.453 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.7 p -83.62 -20.19 34.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.742 -175.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.93 80.46 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.34 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 27' ' ' LYS . 71.2 t -112.73 129.55 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.839 0.352 . . . . 0.0 110.302 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB3' HG13 ' A' ' 55' ' ' VAL . 28.6 m-20 -95.63 134.04 38.98 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.9 mm -93.2 108.25 20.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.411 HG22 HG22 ' A' ' 55' ' ' VAL . 22.0 pt -109.43 142.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.733 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.466 ' HB3' HD21 ' A' ' 54' ' ' ASN . 53.3 t -92.5 142.0 27.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -113.47 4.74 16.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.909 0.385 . . . . 0.0 111.047 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.59 141.51 29.76 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.895 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -94.09 112.97 24.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.747 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 HG11 ' A' ' 21' ' ' VAL . 5.9 mp -88.07 127.24 58.24 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.403 . . . . 0.0 111.524 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -86.97 101.45 0.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.895 2.397 . . . . 0.0 111.154 171.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 49' ' ' PRO . 14.5 ptmm? -93.47 -36.65 12.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.506 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -75.74 121.22 22.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m -138.22 83.4 1.97 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.97 0.414 . . . . 0.0 111.413 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 74.3 mt -86.56 73.7 10.03 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -88.41 136.27 33.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.013 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -115.88 88.88 2.98 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.439 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -83.31 117.82 23.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -69.62 106.36 3.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.452 0.644 . . . . 0.0 111.208 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -169.1 125.07 0.9 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.038 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -80.35 106.49 12.41 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.665 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.3 t60 . . . . . 0 C--O 1.255 1.348 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.178 -177.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -82.08 112.25 18.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.563 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 49.0 mttp -88.08 132.54 34.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.332 174.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -109.35 -179.94 3.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.48 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 28' ' ' PRO . 29.6 mm -101.84 115.28 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.005 0.431 . . . . 0.0 110.19 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -78.11 122.75 26.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.196 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -141.41 137.44 32.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.962 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -153.44 178.51 9.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 20' ' ' VAL . 10.4 p -110.91 130.31 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.874 0.369 . . . . 0.0 110.121 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.37 157.57 19.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.149 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -81.23 127.54 32.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.324 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.474 ' HB ' ' HE2' ' A' ' 16' ' ' LYS . 3.7 t -84.28 130.73 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.96 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 61.8 ttp85 -107.0 155.33 19.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.445 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.15 175.7 22.74 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.87 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 p -79.79 105.17 10.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.448 0.642 . . . . 0.0 111.007 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HD3' ' H ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -162.68 -175.37 4.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.808 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -119.07 40.12 3.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.428 0.633 . . . . 0.0 110.824 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.59 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 4.2 m-85 -129.72 154.02 47.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.448 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -114.92 -46.45 2.92 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.435 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 9' ' ' VAL . 17.8 m -134.26 142.24 41.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.009 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 12' ' ' VAL . 15.0 p -129.54 136.66 29.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.428 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.72 124.99 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.62 2.214 . . . . 0.0 112.69 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -113.99 164.5 10.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.977 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -145.36 179.06 7.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.306 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -109.16 134.66 51.43 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.67 -37.73 73.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.275 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -118.43 150.76 48.54 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.252 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 48.6 Cg_endo -67.3 139.6 50.43 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.499 2.132 . . . . 0.0 113.048 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.445 HG11 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -113.56 173.5 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.405 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.563 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 79.9 mt-10 -98.67 135.8 39.65 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.101 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.856 ' HA ' ' HD1' ' A' ' 34' ' ' TRP . 14.6 tt -55.67 -21.52 10.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.781 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.2 m -57.15 -31.81 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.374 . . . . 0.0 111.562 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 33' ' ' LYS . 28.2 mtpp -102.87 14.79 31.09 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -177.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.856 ' HD1' ' HA ' ' A' ' 31' ' ' ILE . 1.2 m95 -60.05 -44.5 94.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 110.75 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -67.95 -35.08 70.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 40' ' ' VAL . 34.8 t70 -67.78 -43.68 79.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.9 m-30 -69.86 -39.95 76.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.975 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.43 -35.85 78.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.481 . . . . 0.0 109.821 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -58.47 -45.44 88.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.861 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 36' ' ' ASP . 43.7 t -69.09 -48.2 70.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.417 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.0 mt -66.63 -33.2 75.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.5 p -71.55 -11.77 61.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.772 0.32 . . . . 0.0 111.559 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -119.08 10.1 12.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.996 0.427 . . . . 0.0 110.499 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.507 ' HG ' HG23 ' A' ' 46' ' ' VAL . 31.5 tp -104.71 127.2 52.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB3' ' HB2' ' A' ' 13' ' ' ARG . 43.9 m-85 -119.45 97.12 5.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.355 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.507 HG23 ' HG ' ' A' ' 44' ' ' LEU . 61.4 t -111.29 140.41 30.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -124.08 -134.75 4.33 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.992 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t 60.08 79.95 0.28 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.205 0.526 . . . . 0.0 109.994 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.47 118.41 5.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.652 2.235 . . . . 0.0 111.691 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -174.27 3.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.884 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -87.79 -177.19 5.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.571 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.446 ' HB2' HD21 ' A' ' 72' ' ' ASN . 32.0 t -67.45 134.1 50.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.761 -177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.32 25.78 11.96 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.987 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 11.0 p30 -94.03 143.06 26.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.38 115.99 28.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.266 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.29 -56.56 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.972 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 46.0 t -130.72 118.01 20.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 31.0 tttm -97.71 129.88 44.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.736 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.417 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 14.1 m120 54.98 47.21 22.65 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 123.501 0.501 . . . . 0.0 109.955 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.0 tt -53.95 110.04 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.6 mmt 66.68 31.45 7.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.246 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 71.34 4.22 4.97 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -57.59 -42.53 83.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 111.21 -9.37 28.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.646 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.96 137.46 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.998 0.428 . . . . 0.0 110.231 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 7.0 m-20 -102.18 107.31 18.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -75.3 103.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.3 pt -108.05 146.07 14.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.296 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' A' ' 21' ' ' VAL . 2.4 t -90.51 142.32 27.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.475 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -119.22 13.97 12.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.399 0.618 . . . . 0.0 110.63 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -96.58 142.05 29.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 52' ' ' SER . 5.9 m120 -89.97 98.14 11.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 96.6 mt -99.56 117.41 63.81 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.873 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 5.0 Cg_exo -78.67 103.35 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.661 2.24 . . . . 0.0 112.699 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -61.45 -73.9 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.503 0.668 . . . . 0.0 109.438 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -149.0 8.63 0.75 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.777 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 m -85.4 32.17 0.57 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.958 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.7 tp -76.99 100.6 5.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.093 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -109.74 171.58 7.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.492 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -89.08 32.34 0.83 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.28 0.562 . . . . 0.0 109.586 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -115.24 97.53 6.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.873 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 83' ' ' HIS . 40.4 t-80 -157.12 -66.14 0.1 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 173.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER 158.78 179.79 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.168 176.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -83.86 16.25 2.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.95 0.881 . . . . 0.0 108.767 171.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' H ' ' C ' ' A' ' 83' ' ' HIS . 22.2 t-80 . . . . . 0 C--O 1.249 1.068 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.598 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.729 0.776 . . . . 0.0 111.216 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.8 88.62 0.1 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -111.71 144.29 41.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.232 -167.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -140.65 154.44 46.42 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.97 117.13 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.96 0.41 . . . . 0.0 110.741 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 78.2 t80 -78.53 109.67 12.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.199 0.523 . . . . 0.0 109.827 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 t -123.53 132.21 53.84 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.564 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 m -152.77 -165.1 2.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.123 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.626 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 42.7 t -128.31 134.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.541 0.21 . . . . 0.0 110.453 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -119.0 148.64 21.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.39 135.23 40.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.275 0.559 . . . . 0.0 111.53 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.34 141.54 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.577 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -127.13 173.87 9.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.278 . . . . 0.0 110.325 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.36 -177.48 31.0 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.864 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.2 m -76.12 96.47 3.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.254 0.549 . . . . 0.0 110.674 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.9 -173.44 4.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.649 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -100.73 -52.43 3.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.833 0.349 . . . . 0.0 110.742 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -75.2 124.3 26.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.975 0.417 . . . . 0.0 111.956 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -79.84 -15.92 56.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.626 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 15.3 m -142.03 146.02 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.644 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 73' ' ' LEU . 13.0 p -124.38 134.28 25.39 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 120.852 0.358 . . . . 0.0 110.807 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.92 126.02 13.33 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.656 2.237 . . . . 0.0 112.367 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.525 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.8 m -114.33 162.34 12.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.576 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -144.73 178.93 7.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.914 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 69.1 m -109.12 133.55 52.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.202 0.525 . . . . 0.0 111.306 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -59.52 -44.65 93.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.591 174.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 65' ' ' VAL . 67.1 mttm -121.0 152.45 56.5 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.49 139.52 82.37 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.653 2.236 . . . . 0.0 111.88 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 65' ' ' VAL . 5.8 t -112.57 136.11 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.97 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.31 118.8 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.5 tt -55.16 -28.1 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 m -65.33 -18.39 65.27 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 33' ' ' LYS . 23.5 mtpp -100.72 17.51 21.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.487 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -57.39 -40.66 78.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.325 0.583 . . . . 0.0 109.942 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -62.33 -45.43 98.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.981 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HB3' ' HG3' ' A' ' 61' ' ' MET . 1.8 m-20 -53.48 -54.61 34.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.592 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -63.07 -41.1 99.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.092 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -61.23 -47.25 86.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.022 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -67.06 -27.26 67.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.572 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 36' ' ' ASP . 99.1 t -77.35 -46.53 28.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.636 0.255 . . . . 0.0 110.937 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.32 -30.36 66.12 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 p -69.69 -22.31 63.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.805 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -107.19 10.87 29.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.166 0.507 . . . . 0.0 110.283 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 tp -114.11 143.33 44.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.912 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -130.96 142.12 50.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.145 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 p -119.49 143.83 29.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 48' ' ' VAL . . . -121.7 163.82 15.02 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.055 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 92.1 t 75.82 128.27 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.325 0 C-N-CA 123.179 0.592 . . . . 0.0 111.262 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HG3' ' HG2' ' A' ' 75' ' ' LYS . 11.2 Cg_endo -54.13 110.76 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.155 2.57 . . . . 0.0 111.499 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.45 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 p -99.17 -164.16 1.1 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.713 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' H ' ' HB ' ' A' ' 50' ' ' THR . 19.6 ptmt -127.16 -152.88 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.434 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 32.6 m -98.96 135.63 40.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 169.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.73 24.04 11.29 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.877 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.847 HD22 ' HB2' ' A' ' 69' ' ' CYS . 40.8 m-20 -78.97 99.1 6.69 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 68' ' ' ILE . 17.9 t -77.79 92.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 m -74.09 -45.52 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.559 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 8.5 t -130.96 120.16 23.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -104.33 144.06 32.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 44.72 39.82 3.71 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.671 0.748 . . . . 0.0 110.847 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.559 ' HB ' ' SG ' ' A' ' 57' ' ' CYS . 5.3 tt -56.0 127.18 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.277 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.603 ' HG3' ' HB3' ' A' ' 36' ' ' ASP . 93.8 mmm 63.59 29.89 15.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 70.2 17.76 7.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.906 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.3 p -78.44 -61.58 1.96 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.86 0.362 . . . . 0.0 111.777 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.31 1.31 9.35 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 27' ' ' LYS . 96.8 t -88.15 139.88 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.944 0.402 . . . . 0.0 110.664 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -95.68 114.65 26.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.231 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.9 mm -83.13 106.55 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.8 pt -119.4 133.5 66.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.259 0.552 . . . . 0.0 112.297 -172.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.847 ' HB2' HD22 ' A' ' 54' ' ' ASN . 1.9 m -78.4 147.64 33.99 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 10.9 t -132.38 13.82 4.58 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -112.93 122.34 47.35 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.481 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -67.8 109.96 3.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 21' ' ' VAL . 90.9 mt -87.73 117.16 68.16 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.448 -173.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.76 160.88 14.23 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.691 2.261 . . . . 0.0 111.92 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HG2' ' HG3' ' A' ' 49' ' ' PRO . 49.8 mtpt -104.4 -34.65 8.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.161 0.505 . . . . 0.0 109.761 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -109.71 132.09 54.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.02 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 69.0 m -83.16 99.36 9.87 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 170.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.06 106.78 0.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -62.23 111.86 2.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.138 0.494 . . . . 0.0 111.039 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -77.69 76.44 4.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.327 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 147.48 25.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.697 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -139.64 27.25 2.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.022 0.439 . . . . 0.0 111.124 -171.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -131.35 101.91 5.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 68.17 26.65 7.02 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.881 0.848 . . . . 0.0 109.127 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 68.9 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.189 -177.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 tpt . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.729 0.3 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -70.77 106.39 3.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.96 0.41 . . . . 0.0 110.591 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 96.3 mttt -97.72 129.72 44.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -123.63 169.92 10.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.99 0.424 . . . . 0.0 110.76 -169.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.06 102.68 12.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 29' ' ' VAL . 87.7 t80 -59.26 117.95 5.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.666 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -124.06 130.26 52.26 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.797 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 t -143.23 -172.11 3.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -131.33 124.87 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 41' ' ' LEU . 29.6 m -112.46 162.04 10.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.41 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -91.88 130.97 37.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.216 0.532 . . . . 0.0 111.35 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -108.43 121.49 61.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.739 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.445 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.4 mtm105 -99.58 154.3 18.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.12 166.58 12.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.355 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 p -82.61 84.9 7.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 111.759 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 -174.23 4.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.888 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -86.84 -59.58 2.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.713 0.292 . . . . 0.0 110.988 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.48 6.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.205 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.44 -15.43 30.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.529 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.9 m -136.74 129.79 45.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.1 p -119.17 129.93 25.12 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.164 0.506 . . . . 0.0 111.758 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 37.5 Cg_endo -69.1 125.81 12.95 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 111.59 170.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 69' ' ' CYS . 30.6 m -113.9 158.25 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.084 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -141.06 174.17 10.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.751 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 14.9 m -109.11 127.5 54.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.05 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -65.24 -30.89 71.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.922 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB2' HG22 ' A' ' 65' ' ' VAL . 64.3 mttm -111.2 138.73 21.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 21.1 Cg_exo -65.38 116.88 4.14 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.369 2.046 . . . . 0.0 111.485 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 6' ' ' PHE . 29.3 m -93.37 162.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.997 -174.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 46.1 mt-10 -79.71 145.8 32.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.153 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 33' ' ' LYS . 16.9 pt -71.53 177.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.013 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 74.6 m 70.98 -25.48 0.17 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.039 0.536 . . . . 0.0 112.028 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.457 ' HD3' ' CZ ' ' A' ' 37' ' ' PHE . 13.9 tttm -84.63 7.53 19.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.173 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -62.07 -34.94 77.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.3 tt -70.48 -31.52 46.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.301 0.572 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 25.3 t70 -65.94 -57.03 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.989 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CZ ' ' HD3' ' A' ' 33' ' ' LYS . 27.5 m-85 -64.63 -36.24 83.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.519 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.1 p -67.24 -37.12 83.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -54.85 -49.64 70.62 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 110.346 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.46 -48.71 85.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.234 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 10' ' ' VAL . 69.0 mt -70.06 -41.08 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -68.05 -19.86 64.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.917 0.389 . . . . 0.0 111.049 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -101.27 10.75 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.164 0.507 . . . . 0.0 110.041 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 tp -116.86 118.75 33.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.318 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -108.98 129.27 55.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.958 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.6 140.23 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.148 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -127.2 71.94 0.47 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.888 -178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.4 p -166.0 123.25 1.04 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-O 120.811 0.339 . . . . 0.0 110.776 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.49 113.13 3.39 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.839 2.36 . . . . 0.0 111.614 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.13 170.31 9.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.389 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 53.8 mtmt -103.55 176.33 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.354 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.706 ' HB2' HD21 ' A' ' 72' ' ' ASN . 19.0 t -61.25 135.47 57.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 111.473 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.64 26.79 21.75 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.967 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.702 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.7 p30 -97.5 133.26 42.31 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.253 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 68' ' ' ILE . 8.6 t -93.07 124.59 45.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.471 -176.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 m -96.99 -39.51 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.802 0.334 . . . . 0.0 111.215 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 28.3 t -127.74 121.2 29.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' HG11 ' A' ' 55' ' ' VAL . 59.6 mttm -106.06 128.85 54.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.857 -177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.747 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.7 t-20 58.91 48.84 10.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.65 0.738 . . . . 0.0 109.169 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.491 HG12 ' HG2' ' A' ' 61' ' ' MET . 11.6 tt -60.16 127.09 19.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.108 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.491 ' HG2' HG12 ' A' ' 60' ' ' ILE . 98.2 mmm 63.51 21.78 12.91 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.159 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.747 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 3.4 t-20 57.8 79.4 0.2 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.452 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.0 p -138.65 -55.72 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.068 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.0 -9.4 6.32 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 27' ' ' LYS . 95.4 t -79.89 132.01 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.048 0.451 . . . . 0.0 110.579 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.99 114.57 28.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.1 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.89 114.03 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.656 HG22 HG22 ' A' ' 55' ' ' VAL . 20.6 pt -118.37 140.75 40.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.0 -173.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.702 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.9 m -92.2 146.34 23.79 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -119.38 11.15 12.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 0.0 112.223 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.589 ' HB2' HG23 ' A' ' 21' ' ' VAL . 68.5 mmtt -96.41 155.24 16.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.953 -0.467 . . . . 0.0 109.919 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.706 HD21 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -106.55 104.89 14.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.78 132.08 43.31 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.773 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.7 106.58 1.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.462 2.108 . . . . 0.0 112.044 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HG3' ' OD2' ' A' ' 76' ' ' ASP . 0.2 OUTLIER -71.99 -75.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.521 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.417 ' OD2' ' HG3' ' A' ' 75' ' ' LYS . 28.6 m-20 -132.9 2.28 3.66 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.268 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 76' ' ' ASP . 80.3 p 56.54 -85.59 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.062 0.945 . . . . 0.0 112.261 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -140.69 146.12 37.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.745 0.307 . . . . 0.0 110.504 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -123.29 146.88 47.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -56.66 -72.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -169.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.8 m170 63.46 -74.85 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.963 0.505 . . . . 0.0 110.998 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -166.93 -72.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -170.74 142.7 2.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -64.97 113.4 3.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.975 0.417 . . . . 0.0 110.691 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.413 177.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -77.35 161.92 27.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.398 . . . . 0.0 110.906 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 52.0 mttp -124.39 120.3 31.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.18 156.27 49.27 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.965 -173.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.1 mm -63.4 110.47 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.028 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -76.55 106.84 8.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 24' ' ' LYS . 74.3 p -110.41 134.21 52.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.624 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -153.75 -167.1 2.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.37 132.31 71.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.91 149.15 16.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -87.8 114.08 24.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.712 ' HB ' ' HE3' ' A' ' 16' ' ' LYS . 6.6 t -84.85 139.35 17.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.189 -168.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpt85 -105.8 137.77 43.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.376 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.91 -178.3 16.38 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.412 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.8 t -81.4 110.28 16.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.084 0.468 . . . . 0.0 110.564 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.948 ' HE2' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -163.07 168.48 20.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.179 -179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.726 ' HD2' ' HB2' ' A' ' 76' ' ' ASP . 80.9 tttt -95.79 -20.67 18.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' HD22 ' A' ' 73' ' ' LEU . 78.9 m-85 -107.46 111.36 23.62 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.948 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 86.7 m-20 -76.67 -19.6 57.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.09 138.89 52.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.585 0.231 . . . . 0.0 110.422 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 71' ' ' LYS . 5.8 p -135.34 139.83 32.63 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.831 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 53.6 Cg_endo -72.81 130.68 16.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.572 2.181 . . . . 0.0 112.505 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.22 162.42 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.557 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HB3' HG22 ' A' ' 7' ' ' THR . 22.2 ptmt -143.53 170.75 15.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.159 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -109.23 128.27 54.92 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 66' ' ' ASP . 2.0 p-10 -75.72 -0.91 22.5 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 111.141 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HB2' HG22 ' A' ' 65' ' ' VAL . 43.3 mtmt -132.36 142.09 43.67 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.01 135.98 66.38 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.474 2.116 . . . . 0.0 112.328 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 t -105.37 130.91 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.863 -175.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 28.6 tt0 -60.11 121.39 11.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.0 tp -60.9 -21.46 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -171.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.61 61.05 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.945 -0.472 . . . . 0.0 111.421 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 62.9 mttp -105.7 1.23 26.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.565 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -59.64 -31.25 69.35 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.37 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -78.04 -30.05 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 40' ' ' VAL . 26.0 t0 -78.41 -43.33 27.68 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 30.2 m-85 -56.52 -47.26 79.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.6 p -65.71 -37.26 85.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -60.7 -43.07 98.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.75 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 36' ' ' ASP . 58.0 t -63.26 -44.11 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.591 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.75 -21.48 66.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.3 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.3 m -81.79 -11.59 58.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.048 0.451 . . . . 0.0 110.704 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -105.89 -26.14 11.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.726 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 46' ' ' VAL . 40.2 tp -81.84 94.83 7.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.739 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -97.35 90.3 5.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.174 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.508 HG22 ' HG ' ' A' ' 44' ' ' LEU . 22.2 m -142.06 173.49 7.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.67 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.74 173.1 25.73 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.548 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.599 HG13 HG23 ' A' ' 50' ' ' THR . 13.6 p 177.23 141.25 0.24 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -42.06 105.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.918 2.412 . . . . 0.0 112.374 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.599 HG23 HG13 ' A' ' 48' ' ' VAL . 1.7 p -130.23 167.03 19.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.069 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -127.07 62.75 1.33 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.66 -174.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.581 ' HB2' HD21 ' A' ' 72' ' ' ASN . 23.2 t 69.2 150.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.728 174.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.17 24.49 70.48 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.958 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 69' ' ' CYS . 7.7 p30 -96.46 128.53 43.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.025 0.441 . . . . 0.0 110.506 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 58' ' ' LYS . 49.1 t -79.21 113.75 18.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.195 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.04 -50.18 17.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.965 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 60' ' ' ILE . 36.7 t -130.75 123.07 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.647 176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.692 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 50.3 tttp -106.25 135.4 47.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.784 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.582 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 6.6 t-20 64.32 31.99 12.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.72 0.638 . . . . 0.0 110.712 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.547 HG12 ' HG3' ' A' ' 61' ' ' MET . 10.8 tt -60.65 134.83 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.714 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.547 ' HG3' HG12 ' A' ' 60' ' ' ILE . 76.2 mtp 62.6 18.45 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.942 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.4 m120 70.67 -2.87 2.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 65' ' ' VAL . 9.6 t -79.69 -8.59 59.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.57 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 59' ' ' ASN . . . 83.16 3.41 90.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.897 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 27' ' ' LYS . 7.9 t -67.05 129.43 31.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.899 0.381 . . . . 0.0 110.237 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.692 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 3.1 m-20 -99.35 122.34 42.35 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -87.09 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 31.3 pt -108.83 134.96 49.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.411 0.624 . . . . 0.0 111.954 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.531 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 7.5 t -81.12 135.06 35.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.231 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -111.69 -6.32 14.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.991 0.424 . . . . 0.0 111.233 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 62.5 tttp -96.8 138.64 34.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.612 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -85.76 128.26 34.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.84 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 18' ' ' TYR . 94.2 mt -109.32 102.18 48.35 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.973 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -89.8 177.25 2.64 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.706 2.27 . . . . 0.0 112.382 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 8.2 mtpm? -120.1 159.63 24.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.939 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.726 ' HB2' ' HD2' ' A' ' 17' ' ' LYS . 7.3 t70 -108.37 -157.83 0.63 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 m 68.68 20.39 8.23 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 122.945 0.498 . . . . 0.0 111.319 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -88.03 138.69 31.23 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.1 pm0 -81.89 40.49 0.61 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.39 -27.8 59.22 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.435 ' CE1' ' HB2' ' A' ' 83' ' ' HIS . 15.5 t-80 -103.59 110.6 22.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.857 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -94.1 96.94 9.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.491 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.435 ' HB2' ' CE1' ' A' ' 81' ' ' HIS . 66.3 t60 -96.24 -67.48 0.85 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -129.59 30.99 4.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.194 0.997 . . . . 0.0 108.507 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 C--O 1.243 0.726 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.329 178.116 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.559 0.219 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 61.17 94.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.544 0.688 . . . . 0.0 112.69 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 54.4 mmtt -100.17 127.07 46.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.195 174.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -131.98 134.59 45.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.706 0.288 . . . . 0.0 110.856 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 28' ' ' PRO . 36.3 mm -57.75 127.4 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.019 0.438 . . . . 0.0 111.116 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -102.66 115.58 30.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.544 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 139.42 53.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.833 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.8 m -158.67 179.26 9.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.652 0.263 . . . . 0.0 110.615 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.48 130.19 71.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.158 0.504 . . . . 0.0 110.231 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.76 155.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.76 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 9.5 mmt180 -69.37 123.88 22.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 110.585 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.788 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.7 p -107.43 136.94 40.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.178 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 49.2 mtp180 -125.87 -179.32 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.656 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.94 -160.24 13.52 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.323 -0.942 . . . . 0.0 113.088 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -85.44 15.95 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.775 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.788 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -80.98 179.0 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 -179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 75' ' ' LYS . 97.2 mttt -125.69 69.33 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.713 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.45 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 40.5 m-85 -153.11 178.86 9.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.299 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.91 -23.68 3.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.03 0.443 . . . . 0.0 111.116 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.67 149.31 18.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 14.6 p -131.98 131.49 22.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.033 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 14.2 Cg_exo -68.9 131.77 23.22 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.132 2.555 . . . . 0.0 112.63 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.53 152.63 37.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.956 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HG3' HG13 ' A' ' 68' ' ' ILE . 21.5 ptmt -141.13 173.55 11.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.093 0.473 . . . . 0.0 111.034 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -109.67 131.75 54.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.129 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -72.72 -26.05 61.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.806 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.6 mttt -122.33 132.83 24.2 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HA ' HD13 ' A' ' 5' ' ' ILE . 77.7 Cg_exo -50.31 132.96 35.65 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.082 2.521 . . . . 0.0 112.49 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.2 124.53 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.784 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 3' ' ' LYS . 43.8 tt0 -63.2 134.86 56.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pt -72.54 67.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 122.326 1.06 . . . . 0.0 112.247 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.0 p -155.71 -30.96 0.1 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.88 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -94.01 3.54 55.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -51.93 -52.73 48.08 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.438 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.1 mt -72.68 -38.21 57.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.128 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 4.8 t0 -62.03 -37.63 85.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.301 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 63' ' ' THR . 4.5 m-30 -60.23 -50.22 74.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.827 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 p -62.9 -25.54 68.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.209 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 36' ' ' ASP . 94.1 m-20 -65.99 -50.04 65.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 36' ' ' ASP . 42.1 t -63.55 -41.7 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.806 HD23 HD12 ' A' ' 44' ' ' LEU . 47.4 mt -63.12 -29.31 70.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.883 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.7 m -72.72 -11.68 60.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.962 0.41 . . . . 0.0 110.929 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HD3' HH11 ' A' ' 43' ' ' ARG . 56.4 mtt-85 -108.41 3.81 23.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.311 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.806 HD12 HD23 ' A' ' 41' ' ' LEU . 27.5 mt -99.56 119.8 38.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.514 0.674 . . . . 0.0 111.387 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -119.5 100.89 7.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.626 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 m -90.8 -177.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.728 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -167.71 -168.62 30.11 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.059 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t 68.22 101.27 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.277 0 C-N-CA 122.946 0.498 . . . . 0.0 111.178 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.581 ' CG ' ' HG2' ' A' ' 75' ' ' LYS . 12.3 Cg_endo -58.33 108.45 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.808 2.338 . . . . 0.0 111.939 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.84 -165.27 1.01 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.93 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 44.0 mmtm -128.05 169.87 13.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.024 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.9 p -58.94 136.31 57.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 0.0 111.787 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 23.53 34.6 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.732 -0.746 . . . . 0.0 111.877 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.671 HD21 ' HB3' ' A' ' 69' ' ' CYS . 8.5 p30 -97.24 131.34 44.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 68' ' ' ILE . 63.1 t -82.73 108.42 15.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.06 -57.59 4.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.268 0.556 . . . . 0.0 109.609 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 62.7 m -115.25 94.16 4.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.95 114.16 17.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.733 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t30 65.25 79.71 0.25 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.691 -171.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.5 tt -71.66 122.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.277 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ttt 68.77 -76.33 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.868 0.73 . . . . 0.0 110.75 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -178.9 82.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.515 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 39.0 p -141.83 -44.02 0.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.176 -169.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.74 8.01 57.39 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -170.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 27' ' ' LYS . 73.9 t -98.46 131.68 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.184 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.39 116.21 28.68 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 57' ' ' CYS . 48.2 mm -81.78 100.21 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.128 0.49 . . . . 0.0 109.705 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.45 HG13 ' HG3' ' A' ' 24' ' ' LYS . 22.1 pt -96.8 145.51 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.301 -177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.671 ' HB3' HD21 ' A' ' 54' ' ' ASN . 43.6 t -100.39 142.73 31.46 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -115.84 7.19 14.47 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.326 0.584 . . . . 0.0 110.625 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -96.71 142.24 28.98 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.598 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -93.93 111.79 23.54 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.21 120.37 56.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.448 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -85.13 158.9 11.41 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.891 2.394 . . . . 0.0 111.628 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.581 ' HG2' ' CG ' ' A' ' 49' ' ' PRO . 86.9 mttt -100.0 -58.61 1.88 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.628 0.728 . . . . 0.0 109.327 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.09 -177.38 6.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.604 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.1 t -72.64 -27.08 61.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.714 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 80' ' ' HIS . 42.8 tp -136.19 138.68 42.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.558 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 3.45 9.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.449 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -94.9 140.78 29.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.205 -171.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -126.26 131.69 51.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.089 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -65.14 -41.63 94.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.012 0.434 . . . . 0.0 110.492 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -111.9 98.41 7.36 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -79.18 157.54 27.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.925 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.25 1.127 0 O-C-N 123.84 0.712 . . . . 0.0 110.877 -178.462 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -153.93 -66.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.936 175.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 94.4 mttt -124.43 141.75 51.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.229 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -140.65 153.91 46.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.756 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.98 114.26 2.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.114 0.483 . . . . 0.0 110.988 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.4 ' HB3' HG21 ' A' ' 29' ' ' VAL . 64.7 t80 -79.94 140.69 36.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.39 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -150.94 133.47 15.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.946 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -150.18 -172.83 4.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.2 138.18 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.714 0.292 . . . . 0.0 110.39 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 44' ' ' LEU . 14.2 p -119.1 149.65 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.473 ' HA ' HG12 ' A' ' 20' ' ' VAL . 53.1 mtt180 -82.87 116.75 22.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.191 0.52 . . . . 0.0 110.808 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG12 ' HE3' ' A' ' 16' ' ' LYS . 21.3 t -88.37 137.51 20.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.959 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.561 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 43.6 ttp85 -98.52 150.23 21.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.365 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.82 169.71 13.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.332 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.07 27.3 2.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.242 0.544 . . . . 0.0 111.709 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.589 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -70.93 173.08 7.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.489 176.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -86.18 26.31 1.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -145.21 -179.69 6.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.718 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -131.31 -34.69 1.39 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.368 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 11' ' ' ARG . 22.7 m -134.75 149.34 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.672 0.272 . . . . 0.0 111.129 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -125.68 133.54 25.0 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.68 120.76 6.88 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.418 2.079 . . . . 0.0 112.171 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.1 140.42 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.926 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.08 168.86 15.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.127 0.489 . . . . 0.0 110.875 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.9 m -108.93 130.9 55.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.607 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 7.5 p30 -80.98 -10.0 59.77 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.632 -172.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.607 ' HE2' ' OD1' ' A' ' 26' ' ' ASN . 26.9 mtmt -130.99 144.53 53.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.532 176.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 50.9 Cg_exo -54.85 138.05 76.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.209 2.606 . . . . 0.0 113.541 -173.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 6' ' ' PHE . 28.1 t -106.39 143.29 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.691 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . 0.8 OUTLIER -68.93 139.86 55.1 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.0 pt -76.34 12.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 93.6 p -128.9 -3.27 5.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.069 0.462 . . . . 0.0 110.468 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -99.48 -15.35 18.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.959 0.409 . . . . 0.0 110.731 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -65.12 -21.05 66.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.026 0.441 . . . . 0.0 110.632 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.8 mt -62.88 -44.31 99.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.092 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.6 m-20 -58.66 -50.23 74.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.891 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.4 m-85 -63.06 -43.22 99.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.11 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -62.81 -36.95 84.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.862 0.363 . . . . 0.0 111.006 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -66.69 -36.35 82.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.783 177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 36' ' ' ASP . 96.0 t -69.35 -43.25 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.394 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 99.7 mt -61.97 -24.2 66.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -65.63 -18.14 65.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.944 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -104.03 -2.05 26.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 56' ' ' VAL . 24.1 tp -84.17 53.65 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.238 0.542 . . . . 0.0 111.292 -171.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -78.31 76.66 4.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.791 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.22 149.44 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.99 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -119.08 48.99 0.9 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.53 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.17 114.67 16.2 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.613 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 26.0 Cg_exo -62.07 103.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.562 2.174 . . . . 0.0 111.095 171.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.675 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 22.9 p -95.97 173.57 7.37 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' HD21 ' A' ' 54' ' ' ASN . 75.6 mmtt -97.31 -146.94 0.31 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.337 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.543 ' HB2' HD21 ' A' ' 72' ' ' ASN . 26.6 t -102.3 131.17 49.06 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 170.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.3 26.98 19.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.596 175.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.675 ' ND2' ' HB ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -86.83 112.45 21.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 68' ' ' ILE . 47.5 t -73.37 106.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.534 HG11 HD21 ' A' ' 44' ' ' LEU . 24.4 t -79.37 -46.37 23.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.169 0.509 . . . . 0.0 109.745 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 59.7 m -130.65 109.67 10.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.641 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 28.0 ttmt -85.12 129.33 34.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.8 t30 53.72 69.37 0.72 Allowed 'General case' 0 C--O 1.236 0.377 0 O-C-N 123.812 0.695 . . . . 0.0 109.823 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.458 HG23 ' CE1' ' A' ' 37' ' ' PHE . 13.0 tt -78.76 125.53 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.317 -173.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.422 ' HG2' HG12 ' A' ' 60' ' ' ILE . 96.4 mmm 64.31 19.22 11.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.94 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 65.02 98.7 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.468 0.48 . . . . 0.0 111.298 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 65' ' ' VAL . 8.4 t -171.46 -34.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.478 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.22 -17.96 5.87 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.156 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.534 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 33.1 m -82.38 142.57 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.306 0.574 . . . . 0.0 112.014 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -108.23 131.62 54.5 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -91.5 114.11 28.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.444 HG22 ' HA ' ' A' ' 55' ' ' VAL . 37.7 pt -117.35 134.06 62.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.887 -175.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 54' ' ' ASN . 2.0 p -87.82 134.17 33.74 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -118.71 17.25 13.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.056 0.455 . . . . 0.0 112.147 -168.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HB3' HG23 ' A' ' 21' ' ' VAL . 60.4 tttp -117.08 131.05 57.01 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.551 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -82.73 109.36 16.82 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.71 132.09 39.66 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.62 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.36 128.05 19.51 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.447 2.098 . . . . 0.0 111.264 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 75' ' ' LYS . 3.1 mtpt -60.37 156.01 16.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.225 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.19 175.84 9.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.435 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.0 p -117.85 133.34 56.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.617 0.246 . . . . 0.0 110.632 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.7 tp -76.64 83.28 3.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.348 0.594 . . . . 0.0 110.065 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.535 ' HA ' ' CD2' ' A' ' 85' ' ' HIS . 41.6 mt-10 -116.3 -59.21 2.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.692 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.5 t60 55.18 88.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 O-C-N 124.01 0.819 . . . . 0.0 111.172 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -67.72 99.37 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.582 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -158.2 -66.97 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -161.95 159.19 26.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.44 0.162 . . . . 0.0 110.672 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.7 t60 55.95 79.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 124.03 0.831 . . . . 0.0 112.007 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.535 ' CD2' ' HA ' ' A' ' 79' ' ' GLU . 18.2 t-80 . . . . . 0 C--O 1.245 0.822 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.435 173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.754 0.312 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -150.83 138.78 19.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.564 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.2 mttt -75.13 114.83 14.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.307 0.575 . . . . 0.0 110.149 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.66 179.74 5.2 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.554 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.8 mm -78.67 116.12 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.25 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.597 ' HB2' HG21 ' A' ' 29' ' ' VAL . 77.0 t80 -59.36 128.09 35.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -153.52 135.43 14.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.007 0.432 . . . . 0.0 110.097 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -153.2 169.34 23.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.36 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 59.8 t -114.32 118.7 59.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 41' ' ' LEU . 34.2 m -117.58 173.43 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.245 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.465 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 1.9 mmt85 -72.8 126.63 30.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.762 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.579 HG13 ' HE2' ' A' ' 16' ' ' LYS . 7.4 p -104.77 129.14 57.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.503 0.668 . . . . 0.0 111.239 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.504 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 41.9 ttt85 -104.65 142.32 34.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.974 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.61 168.15 12.65 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.802 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.0 m -83.26 102.21 11.79 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -158.98 -174.66 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.928 -179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -93.24 -0.9 56.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.49 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 47.9 m-85 -110.04 143.26 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.732 -0.387 . . . . 0.0 112.021 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -104.64 -10.59 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.756 0.789 . . . . 0.0 109.079 175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 16.2 m -142.33 148.41 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.414 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 12' ' ' VAL . 7.2 p -134.44 125.89 17.96 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.195 0.522 . . . . 0.0 111.749 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 5.8 Cg_exo -77.54 113.41 3.51 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 123.396 2.73 . . . . 0.0 112.306 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 ' SG ' ' A' ' 69' ' ' CYS . 31.5 m -104.82 161.04 4.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.544 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -153.24 178.77 9.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.487 0.66 . . . . 0.0 111.213 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.27 147.2 33.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.13 -3.71 56.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.506 0.669 . . . . 0.0 109.258 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB3' HG22 ' A' ' 65' ' ' VAL . 34.4 ttmt -128.72 129.84 23.49 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.417 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 38.3 Cg_exo -58.04 132.24 48.25 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 112.429 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.597 HG21 ' HB2' ' A' ' 6' ' ' PHE . 18.5 m -117.65 -178.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 -178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.564 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -97.96 135.26 39.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.6 pt -77.01 -19.49 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 t -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.307 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 37' ' ' PHE . 56.3 mtpt -93.99 0.79 56.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -53.82 -42.93 68.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.895 0.378 . . . . 0.0 110.676 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.55 -45.04 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.04 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 40' ' ' VAL . 8.9 t70 -67.46 -43.72 80.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.32 -175.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.438 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 47.4 m-85 -61.48 -43.59 98.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.1 m -62.83 -36.49 83.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.236 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.32 -35.97 80.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.753 0.311 . . . . 0.0 110.715 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 60' ' ' ILE . 61.7 t -67.05 -40.99 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 175.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.563 ' HB3' HG11 ' A' ' 10' ' ' VAL . 49.8 mt -62.49 -39.11 92.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.555 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -68.07 -12.91 61.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.417 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.8 ttt85 -95.13 -9.16 34.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.277 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.65 132.85 55.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.588 . . . . 0.0 111.431 -176.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 11' ' ' ARG . 3.3 m-85 -106.99 102.83 12.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.797 173.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.9 m -98.93 157.89 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.258 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . 172.99 -148.91 10.79 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.751 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 85.1 t 72.49 126.13 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.345 0 O-C-N 124.099 0.529 . . . . 0.0 110.789 -175.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.682 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 82.6 Cg_exo -42.92 110.7 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.488 2.792 . . . . 0.0 113.074 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -139.65 169.48 17.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.622 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -95.93 173.57 7.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 110.707 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -68.54 119.83 13.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.439 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 30.47 5.78 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.693 HD21 ' HB2' ' A' ' 69' ' ' CYS . 10.6 p30 -89.1 131.67 35.15 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 68' ' ' ILE . 57.8 t -85.74 127.31 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.856 -175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.42 -75.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.228 0.537 . . . . 0.0 110.228 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -115.65 98.79 6.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.177 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 87.7 tttt -78.69 128.37 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.653 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 8.7 t-20 63.65 41.86 6.82 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.439 HD11 HG11 ' A' ' 40' ' ' VAL . 6.2 tt -53.27 -50.68 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.146 -172.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.435 ' HB2' HG23 ' A' ' 63' ' ' THR . 82.1 mtp -114.61 30.93 6.98 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.653 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 15.6 m120 63.4 23.84 13.9 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.391 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 61' ' ' MET . 67.6 p -86.93 -21.08 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.706 -174.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.27 79.24 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.494 -174.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 27' ' ' LYS . 41.8 t -90.04 130.44 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.604 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' OD2' ' HE3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -95.92 107.92 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.5 mm -75.9 120.42 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 35.1 pt -126.43 137.57 57.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.221 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.693 ' HB2' HD21 ' A' ' 54' ' ' ASN . 3.8 m -86.73 132.88 33.74 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -102.29 6.42 40.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.351 0.596 . . . . 0.0 110.901 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.49 ' HD3' ' CZ ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -96.75 134.66 39.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.767 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.599 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -86.69 126.97 34.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.682 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.3 mp -95.35 109.09 43.31 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.734 0.302 . . . . 0.0 110.884 -177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 72' ' ' ASN . 91.6 Cg_endo -88.82 138.71 3.65 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.059 2.506 . . . . 0.0 112.567 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -117.67 156.25 28.53 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.29 108.15 0.39 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.855 0.36 . . . . 0.0 110.77 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.5 m -127.72 95.34 4.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.726 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.1 tp 65.33 112.75 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.998 0.811 . . . . 0.0 112.661 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -76.57 56.55 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.13 174.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -115.43 -41.59 3.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.217 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 65.63 167.62 0.2 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.987 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -153.22 99.72 2.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.259 172.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -121.14 110.37 16.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.988 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -133.95 88.91 2.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.19 0.519 . . . . 0.0 110.552 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.3 t60 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.49 -0.766 . . . . 0.0 109.641 176.923 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 52.02 81.7 0.08 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.073 -174.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.28 160.69 30.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.057 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.07 151.7 48.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.656 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -72.5 109.46 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 83.7 t80 -59.31 98.77 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.477 -177.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -112.84 120.42 41.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m -152.78 -159.39 1.0 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.599 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 8.9 p -128.9 138.5 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 120.768 0.318 . . . . 0.0 110.629 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 p -108.61 143.96 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 42' ' ' SER . 91.3 mtt180 -81.16 134.03 35.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.551 0.691 . . . . 0.0 110.261 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.639 HG11 ' HE2' ' A' ' 16' ' ' LYS . 42.5 t -116.17 150.67 18.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.231 -168.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -106.13 145.93 30.85 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 63.46 0.9 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.665 -175.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -85.27 4.23 35.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.757 ' HG2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -160.89 -178.35 6.76 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.121 -1.854 . . . . 0.0 107.705 179.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -93.6 75.69 4.38 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.367 -174.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -174.09 143.84 0.94 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 12' ' ' VAL . 15.7 m120 -98.75 -33.48 10.9 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -173.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.14 163.79 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' HB ' HD11 ' A' ' 73' ' ' LEU . 9.8 p -153.84 140.15 12.66 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 120.668 0.271 . . . . 0.0 110.67 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 72.7 Cg_endo -79.14 145.54 19.38 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.568 2.179 . . . . 0.0 112.863 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.61 168.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.109 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 17.3 ptpt -141.07 173.78 11.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.39 178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 90.7 p -109.17 138.88 44.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.87 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -68.04 -33.23 74.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.993 0.425 . . . . 0.0 110.85 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -115.78 147.17 38.45 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.056 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.51 120.37 7.76 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.771 2.314 . . . . 0.0 111.071 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.45 151.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -51.35 130.38 26.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.172 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 pt -61.12 -18.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -63.38 -35.68 81.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.095 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -95.81 10.87 35.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.879 0.371 . . . . 0.0 111.555 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.0 t90 -61.86 -39.75 92.97 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -70.45 -40.93 78.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.386 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.21 -55.04 39.92 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.566 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.5 m-30 -67.36 -38.94 85.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.588 -174.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 p -69.05 -31.06 69.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.401 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -62.8 -32.39 73.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.19 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -79.94 -45.82 22.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.689 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 93.4 mt -63.18 -24.89 68.09 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' A' ' 11' ' ' ARG . 8.7 p -80.99 -18.84 45.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.984 0.421 . . . . 0.0 110.971 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -99.09 -11.28 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.74 140.86 29.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.998 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -130.52 102.63 6.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.506 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 19.4 m -109.81 141.53 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.136 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.13 -3.01 29.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.584 -176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.478 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 14.5 m -58.8 125.81 78.48 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.919 ' HG2' ' HD2' ' A' ' 75' ' ' LYS . 33.7 Cg_endo -97.75 68.7 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.703 2.935 . . . . 0.0 112.732 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -179.27 5.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.407 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HG3' ' OD1' ' A' ' 72' ' ' ASN . 13.8 mptt -99.94 -173.24 2.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.711 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.429 ' HB2' HD21 ' A' ' 72' ' ' ASN . 23.1 t -66.12 146.01 55.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 0.0 111.06 -177.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.71 31.7 35.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.344 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.55 HD21 ' HB3' ' A' ' 69' ' ' CYS . 9.5 p30 -101.43 133.92 45.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.728 0.299 . . . . 0.0 110.281 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 58' ' ' LYS . 50.8 t -79.4 115.13 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 110.699 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.21 -51.56 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.004 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.9 m -127.41 110.18 12.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.897 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' HG11 ' A' ' 55' ' ' VAL . 65.3 tttp -99.04 123.82 43.61 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.679 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 11.2 t-20 62.94 60.26 1.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.519 HG12 ' HG3' ' A' ' 61' ' ' MET . 14.9 tt -76.39 123.0 31.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.285 -174.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.519 ' HG3' HG12 ' A' ' 60' ' ' ILE . 86.7 mtp 65.73 23.11 11.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.927 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.679 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 11.2 m120 60.14 76.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.114 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -127.85 -44.06 1.5 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.047 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.26 16.24 12.63 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -109.98 136.31 46.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.52 107.82 18.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.491 0.662 . . . . 0.0 110.055 175.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.69 113.54 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.509 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.3 pt -110.88 141.45 26.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.211 0.529 . . . . 0.0 111.774 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.55 ' HB3' HD21 ' A' ' 54' ' ' ASN . 50.2 t -89.65 141.86 28.21 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -116.78 -2.24 11.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.156 0.503 . . . . 0.0 110.96 -175.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -98.05 146.82 25.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.646 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -92.71 123.5 36.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.736 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 3.6 mm? -81.58 127.11 74.19 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.5 -175.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 13.6 Cg_exo -68.84 100.0 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.739 2.293 . . . . 0.0 113.433 -178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.919 ' HD2' ' HG2' ' A' ' 49' ' ' PRO . 65.6 tttt -130.7 -59.81 1.0 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 169.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -69.61 100.53 1.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.311 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.2 m -94.64 123.55 38.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.246 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.0 mt -84.81 -7.52 59.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.648 -174.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -85.8 105.66 16.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.1 0.476 . . . . 0.0 110.865 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -76.83 95.17 4.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.375 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.75 136.24 38.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.653 -175.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -81.94 111.38 18.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.568 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -157.78 -47.65 0.06 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.426 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -179.82 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.678 174.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 82.8 t60 . . . . . 0 C--O 1.245 0.823 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.103 172.797 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 121.022 0.439 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -129.89 154.62 47.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 28' ' ' PRO . 88.2 mttt -74.49 154.24 38.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.917 0.389 . . . . 0.0 110.854 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -119.64 141.73 49.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.149 -172.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -67.34 106.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.969 0.414 . . . . 0.0 110.235 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.42 121.43 17.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 t -141.93 144.98 34.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.982 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.6 m -158.85 170.43 22.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.02 118.7 57.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -105.63 152.24 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -74.97 116.28 15.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.075 0.464 . . . . 0.0 110.515 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.748 HG13 ' HE2' ' A' ' 16' ' ' LYS . 9.0 p -88.98 144.55 8.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.552 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 8.3 ttp180 -122.38 -178.91 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.418 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -171.57 23.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.881 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 76' ' ' ASP . 42.5 m -80.53 91.8 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 0.0 110.894 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.748 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -157.71 -167.7 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.166 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.18 18.56 7.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.357 0.598 . . . . 0.0 110.373 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.543 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 90.5 m-85 -118.43 165.5 13.81 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.781 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -125.35 -1.4 7.57 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.232 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 m -149.82 151.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 71' ' ' LYS . 7.0 p -144.86 121.37 6.16 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.89 176.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 71' ' ' LYS . 24.5 Cg_exo -62.84 114.9 2.61 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.203 2.602 . . . . 0.0 112.761 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.55 HG12 ' SG ' ' A' ' 69' ' ' CYS . 34.7 m -108.57 151.4 10.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.31 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.2 171.95 15.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.176 0.512 . . . . 0.0 111.353 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -109.0 130.13 55.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.875 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -77.96 -9.73 59.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.57 . . . . 0.0 110.206 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 65' ' ' VAL . 90.0 mttt -122.22 143.72 39.88 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.499 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 37.2 Cg_endo -66.54 131.06 25.1 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.415 2.077 . . . . 0.0 112.394 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.58 136.8 41.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.658 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 4.7 pt-20 -84.15 146.18 28.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.875 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.705 ' HA ' ' HB2' ' A' ' 34' ' ' TRP . 11.6 pt -72.92 2.86 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 p -83.66 -32.89 25.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.355 0.598 . . . . 0.0 109.966 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -92.9 -7.22 46.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.969 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' HB2' ' HA ' ' A' ' 31' ' ' ILE . 68.2 t90 -57.68 -40.88 80.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.017 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -66.19 -42.18 90.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.759 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.2 m-20 -60.62 -45.1 95.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -60.22 -39.99 88.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.3 m -63.41 -38.8 92.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.85 -38.44 91.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.621 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 36' ' ' ASP . 59.9 t -67.75 -41.44 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.96 -20.45 64.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.062 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.2 t -82.84 5.07 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 110.097 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -125.7 -31.89 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.349 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.6 tp -77.61 111.9 13.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.634 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -117.27 107.42 14.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 56' ' ' VAL . 15.7 m -92.77 121.36 43.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -106.76 24.52 25.24 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.169 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.52 104.42 55.94 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.72 95.9 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.518 2.146 . . . . 0.0 111.345 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.23 156.52 20.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 35.2 mtmm -101.9 78.22 1.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.83 ' HB2' ' ND2' ' A' ' 72' ' ' ASN . 15.8 t 68.43 159.72 0.17 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.619 174.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 30.91 63.84 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.558 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -109.66 119.6 39.91 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.402 0.62 . . . . 0.0 111.245 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG22 HG22 ' A' ' 68' ' ' ILE . 21.3 t -81.35 109.9 16.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.25 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 46' ' ' VAL . 4.1 m -85.66 -40.32 14.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.689 0.28 . . . . 0.0 111.027 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 74.7 m -130.42 100.98 5.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.418 176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -85.32 119.94 26.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.9 t30 62.46 75.69 0.39 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.686 0.755 . . . . 0.0 109.358 -170.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tt -72.92 127.9 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.946 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' A' ' 62' ' ' ASN . 93.3 mmm 66.38 -80.37 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.835 0.71 . . . . 0.0 110.355 -175.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' MET . 59.2 t30 172.47 80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.103 0.561 . . . . 0.0 109.851 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 t -158.48 15.11 0.19 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.872 0.367 . . . . 0.0 111.367 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.22 -22.37 7.22 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.934 -0.651 . . . . 0.0 114.011 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 27' ' ' LYS . 65.9 t -66.95 121.43 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 117.313 0.556 . . . . 0.0 111.873 -174.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.49 121.97 37.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.904 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.57 122.87 41.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.809 0.338 . . . . 0.0 110.446 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.45 HG22 HG22 ' A' ' 55' ' ' VAL . 20.1 pt -121.44 140.0 46.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.366 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.55 ' SG ' HG12 ' A' ' 23' ' ' VAL . 2.7 m -90.43 122.36 33.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -101.3 8.18 42.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 -172.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 49.1 tttp -96.19 145.07 25.85 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.83 ' ND2' ' HB2' ' A' ' 52' ' ' SER . 0.8 OUTLIER -92.68 103.62 15.98 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.929 -177.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 12' ' ' VAL . 75.2 mt -96.32 111.59 57.16 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.411 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -75.01 115.65 4.35 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.676 2.251 . . . . 0.0 111.35 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HE2' ' OG ' ' A' ' 77' ' ' SER . 87.0 tttt -75.77 126.1 30.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.351 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 15' ' ' SER . 23.0 t70 -111.59 90.26 3.29 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.45 ' OG ' ' HE2' ' A' ' 75' ' ' LYS . 48.2 m -77.84 99.67 6.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.26 -173.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.4 mt -110.66 -26.24 9.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.021 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.14 37.5 0.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.43 0.634 . . . . 0.0 110.471 -173.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 81' ' ' HIS . 0.6 OUTLIER -151.24 164.86 35.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.545 -178.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 80' ' ' HIS . 24.3 m170 75.75 -58.39 0.55 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -47.78 -66.25 0.43 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -169.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 84' ' ' HIS . 6.3 p80 -140.68 11.27 2.27 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.653 -175.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.518 ' HB3' ' O ' ' A' ' 83' ' ' HIS . 22.6 t60 72.19 144.15 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.559 0.537 . . . . 0.0 110.759 -175.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.538 176.828 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.68 30.82 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.867 0.841 . . . . 0.0 110.103 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 45.5 mmtt -83.5 110.04 17.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.462 172.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.6 139.77 50.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.883 0.373 . . . . 0.0 110.622 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.82 121.94 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.582 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -75.58 102.02 5.14 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -125.8 127.65 46.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.414 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -154.51 172.13 18.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 110.83 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.488 HG12 ' HB ' ' A' ' 20' ' ' VAL . 48.1 t -113.1 117.17 54.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -105.53 156.68 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.75 0.31 . . . . 0.0 110.649 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -72.96 102.97 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.587 HG13 ' HE2' ' A' ' 16' ' ' LYS . 10.2 p -85.05 134.33 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.699 ' O ' ' HA3' ' A' ' 47' ' ' GLY . 68.8 mtp180 -126.54 -179.07 4.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.5 -172.86 33.42 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.14 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 p -74.84 99.26 3.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.169 0.509 . . . . 0.0 111.991 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -166.6 178.3 6.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.496 175.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -87.56 -27.54 22.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.469 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.595 ' HE2' ' HA ' ' A' ' 73' ' ' LEU . 82.3 m-85 -79.73 171.16 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -126.15 -15.1 5.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.172 171.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 9' ' ' VAL . 11.8 m -148.29 147.47 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.07 132.67 14.86 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.922 0.392 . . . . 0.0 111.204 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 138.96 21.88 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.643 2.229 . . . . 0.0 112.669 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.19 156.28 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.417 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -142.63 165.81 26.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.828 0.346 . . . . 0.0 110.764 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 p -109.46 142.3 40.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -78.89 -8.29 58.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.242 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -139.19 134.43 16.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.127 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 52.6 Cg_exo -56.95 136.12 74.78 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.817 2.345 . . . . 0.0 112.183 178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.26 145.65 20.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.3 135.01 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 pt -66.33 -9.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.714 0.293 . . . . 0.0 111.549 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 m -67.58 -30.73 70.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 37' ' ' PHE . 87.9 mttt -86.83 -17.4 33.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.649 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -51.78 -45.44 63.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.148 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.2 tt -61.5 -44.98 99.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.627 0.251 . . . . 0.0 111.46 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 40' ' ' VAL . 14.8 t70 -79.46 -32.27 42.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 33' ' ' LYS . 1.7 m-85 -56.18 -48.7 75.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.122 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -60.99 -44.37 97.51 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.277 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -57.56 -47.19 82.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.731 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 36' ' ' ASP . 87.6 t -64.78 -46.02 93.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.669 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 tp -65.71 -31.93 73.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.857 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.0 m -66.8 -20.9 66.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 110.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 43' ' ' ARG . 55.0 mtm180 -104.85 8.91 34.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.4 tp -110.47 84.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.591 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 79.6 m-85 -92.78 101.02 13.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -122.04 159.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.348 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.699 ' HA3' ' O ' ' A' ' 13' ' ' ARG . . . -145.58 -134.4 2.69 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.517 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.46 115.57 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.024 0.53 . . . . 0.0 110.711 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HG3' ' HB3' ' A' ' 16' ' ' LYS . 65.2 Cg_exo -53.54 111.07 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.08 2.52 . . . . 0.0 112.825 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -109.27 -170.91 1.74 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.042 -176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -127.13 166.75 17.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.004 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.918 ' HB2' HD21 ' A' ' 72' ' ' ASN . 22.5 t -61.86 131.3 49.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 0.0 110.693 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.54 21.16 32.5 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.634 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.621 HD21 ' HB3' ' A' ' 69' ' ' CYS . 9.7 p30 -89.19 131.73 35.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.75 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 68' ' ' ILE . 38.7 t -87.27 106.16 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.119 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.4 -55.76 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.143 0.496 . . . . 0.0 109.809 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 t -130.7 121.11 24.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.403 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HG3' ' OD1' ' A' ' 66' ' ' ASP . 31.8 ttmt -92.34 112.48 24.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.223 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 62' ' ' ASN . 62.9 t30 58.86 54.93 4.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.619 -173.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.527 ' HA ' ' SG ' ' A' ' 57' ' ' CYS . 10.4 tt -46.27 -43.18 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.822 -171.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.501 ' HG3' HG12 ' A' ' 60' ' ' ILE . 84.4 mtp -128.98 29.03 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.491 -175.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.424 ' HA ' ' ND2' ' A' ' 59' ' ' ASN . 40.7 t-20 53.81 72.51 0.44 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.406 0.622 . . . . 0.0 110.626 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -153.89 13.67 0.46 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.0 37.57 83.41 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.589 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 27' ' ' LYS . 52.0 t -127.08 120.95 56.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.014 0.435 . . . . 0.0 110.895 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.592 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 15.9 m-20 -96.05 121.69 38.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.39 101.98 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.449 HG22 HG22 ' A' ' 55' ' ' VAL . 13.4 pt -109.15 139.92 29.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.368 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.621 ' HB3' HD21 ' A' ' 54' ' ' ASN . 43.9 t -95.25 145.24 25.21 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.258 174.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -121.05 8.91 10.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 110.495 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 24.9 tptp -96.68 131.37 43.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.918 HD21 ' HB2' ' A' ' 52' ' ' SER . 11.0 m-80 -91.15 116.4 28.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.887 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.595 ' HA ' ' HE2' ' A' ' 18' ' ' TYR . 6.1 mp -96.73 119.59 63.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.577 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.21 123.1 13.03 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.245 1.963 . . . . 0.0 110.709 172.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HA ' ' CB ' ' A' ' 49' ' ' PRO . 13.2 tptm -69.95 -71.23 0.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.114 -171.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.414 ' OD2' ' HG3' ' A' ' 75' ' ' LYS . 35.6 m-20 -118.17 101.28 8.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.251 -173.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.3 t -69.34 99.73 1.24 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.62 90.37 3.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.383 0.611 . . . . 0.0 111.292 -174.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.91 97.98 4.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.83 176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -110.6 11.12 22.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.372 0.606 . . . . 0.0 110.583 -175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -90.05 164.08 14.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.14 0.495 . . . . 0.0 110.117 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -97.57 178.65 5.11 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -57.5 -50.71 72.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.726 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -166.24 -58.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 173.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.101 171.7 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -166.21 121.53 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.214 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 28' ' ' PRO . 10.4 mmmm -91.69 113.07 25.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.449 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.719 ' HB3' ' HZ2' ' A' ' 34' ' ' TRP . 6.4 t70 -130.11 171.01 13.3 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.3 112.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 122.102 -0.374 . . . . 0.0 111.309 -174.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.477 ' HB3' ' OG ' ' A' ' 25' ' ' SER . 29.4 t80 -66.34 115.22 6.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.134 0.493 . . . . 0.0 110.357 174.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -123.39 133.42 54.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.777 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.3 t -152.98 -163.55 1.73 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 20' ' ' VAL . 8.8 p -141.07 136.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.84 148.75 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.21 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -73.56 143.06 46.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.031 0.443 . . . . 0.0 111.03 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 18' ' ' TYR . 57.4 t -105.76 146.3 12.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.692 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.75 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 19.4 ttp180 -140.38 -179.31 5.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.479 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' N ' ' HG2' ' A' ' 13' ' ' ARG . . . 111.7 -154.27 16.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.956 -1.116 . . . . 0.0 114.166 165.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.3 m -77.93 20.43 0.36 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.322 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -156.4 142.45 18.09 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.24 87.43 7.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.256 0.551 . . . . 0.0 110.285 -175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' HB3' HG11 ' A' ' 12' ' ' VAL . 2.2 t80 -117.59 141.71 48.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.53 -69.88 0.51 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.4 ' HB ' ' CG2' ' A' ' 9' ' ' VAL . 17.6 m -136.74 148.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.073 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 71' ' ' LYS . 13.9 p -127.44 127.42 24.15 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 110.659 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD2' ' HG3' ' A' ' 71' ' ' LYS . 55.6 Cg_endo -71.4 133.83 23.38 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.685 2.257 . . . . 0.0 112.424 176.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 69' ' ' CYS . 27.1 m -119.44 166.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.031 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -147.09 176.35 10.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.383 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 16.3 m -109.15 131.21 55.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -78.31 -11.32 59.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.964 0.411 . . . . 0.0 110.428 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HB3' HG22 ' A' ' 65' ' ' VAL . 39.5 ttpt -135.78 135.15 21.3 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HB2' ' HB3' ' A' ' 3' ' ' LYS . 14.4 Cg_endo -56.28 141.47 88.56 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 65' ' ' VAL . 4.2 m -122.18 174.21 6.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.131 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HB2' ' CB ' ' A' ' 33' ' ' LYS . 25.3 mt-10 -71.36 140.25 50.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 33' ' ' LYS . 36.0 pt -67.54 151.71 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 m 72.69 -32.77 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.116 0.566 . . . . 0.0 111.112 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 30' ' ' GLU . 19.2 tptm -64.26 -16.92 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 174.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.719 ' HZ2' ' HB3' ' A' ' 4' ' ' ASP . 52.0 m0 -54.27 -39.07 66.54 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.589 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.15 -36.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.011 -176.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.15 -44.54 79.51 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.165 0.507 . . . . 0.0 110.263 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -66.45 -37.26 84.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 t -65.78 -32.27 73.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.291 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.48 -42.6 99.59 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.076 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.63 -47.8 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.869 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.851 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.1 t -64.1 -20.59 66.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.192 0.52 . . . . 0.0 110.543 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -104.13 14.8 29.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.857 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 56' ' ' VAL . 32.0 tp -112.52 139.09 48.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -127.16 97.66 5.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.78 124.64 37.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.228 0.537 . . . . 0.0 111.055 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.75 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -109.62 175.19 18.61 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.182 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 47' ' ' GLY . 99.2 t 73.53 134.29 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 123.05 0.54 . . . . 0.0 111.544 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.61 116.7 3.38 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.859 2.373 . . . . 0.0 111.78 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 p -118.79 169.52 9.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -120.3 169.36 10.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -52.58 118.64 3.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.2 24.95 9.84 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.115 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.677 HD21 ' HB2' ' A' ' 69' ' ' CYS . 9.8 p30 -88.47 132.34 34.52 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 68' ' ' ILE . 34.4 t -88.25 125.47 41.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.07 -175.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.471 ' HB ' HD21 ' A' ' 44' ' ' LEU . 30.5 m -97.85 -38.15 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.092 0.472 . . . . 0.0 110.258 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 70.6 m -130.9 105.14 7.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.791 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -95.19 127.48 41.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.12 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 62' ' ' ASN . 1.6 t-20 54.56 40.37 31.79 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.842 0.713 . . . . 0.0 109.748 -177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.597 HG12 ' HG2' ' A' ' 61' ' ' MET . 10.4 tt -41.96 -50.18 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.622 -169.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.597 ' HG2' HG12 ' A' ' 60' ' ' ILE . 25.7 mmt -134.71 49.04 2.25 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.35 -0.219 . . . . 0.0 110.628 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' OD1' ' A' ' 59' ' ' ASN . 8.5 p30 56.71 5.86 0.25 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.841 1.256 . . . . 0.0 113.753 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.592 HG23 ' H ' ' A' ' 65' ' ' VAL . 5.0 t -78.56 -11.68 59.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.311 0.577 . . . . 0.0 110.71 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.26 -6.35 83.5 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.268 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.592 ' H ' HG23 ' A' ' 63' ' ' THR . 66.5 t -81.33 126.9 39.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.817 0.341 . . . . 0.0 110.512 178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -108.77 123.85 49.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 mm -81.68 117.35 27.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.531 HG22 HG22 ' A' ' 55' ' ' VAL . 33.6 pt -121.99 139.85 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.612 -173.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.677 ' HB2' HD21 ' A' ' 54' ' ' ASN . 1.8 m -89.32 137.32 32.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -105.38 13.12 30.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.128 0.49 . . . . 0.0 111.454 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 21' ' ' VAL . 31.9 mmtt -96.76 142.64 28.53 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.915 0.388 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.547 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -96.47 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.6 mt -99.8 112.71 64.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.581 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -91.58 -171.87 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.994 2.463 . . . . 0.0 112.007 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 8.5 mtpm? -108.03 101.4 10.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.64 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 63.13 -169.64 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.931 0.77 . . . . 0.0 111.302 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 p -99.84 87.66 3.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.065 0.46 . . . . 0.0 110.546 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.2 mt -97.36 -26.94 14.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.428 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -166.31 153.55 9.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -73.2 -17.8 61.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 0.0 110.729 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.6 m80 70.3 167.92 0.3 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.323 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -144.35 125.87 14.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.897 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -94.75 -15.43 23.85 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.3 m170 -105.05 -173.52 2.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.158 173.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.311 179.621 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -140.24 82.58 1.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 0.0 110.203 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 93.2 mttt -130.43 130.58 44.46 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.512 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 154.51 26.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -171.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 28' ' ' PRO . 46.7 mm -73.97 112.79 11.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.431 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.528 ' HB2' HG21 ' A' ' 29' ' ' VAL . 87.0 t80 -64.01 104.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 110.592 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.1 p -111.02 120.56 42.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.108 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -141.47 -166.86 2.28 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 20' ' ' VAL . 60.5 t -133.63 129.79 55.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.39 152.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -91.96 133.26 35.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 110.307 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 HG23 ' A' ' 46' ' ' VAL . 2.5 t -118.76 133.31 66.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.435 0.636 . . . . 0.0 112.025 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.566 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 92.4 mtt-85 -108.29 -179.11 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.353 173.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -161.6 21.59 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.453 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.2 m -78.77 74.87 5.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 111.393 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -147.96 166.66 27.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.581 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -89.32 -46.42 8.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.855 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.422 ' O ' ' HD2' ' A' ' 16' ' ' LYS . 85.4 m-85 -83.67 156.8 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.916 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -103.35 -3.03 26.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.865 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 9' ' ' VAL . 6.5 m -143.51 145.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.103 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 71' ' ' LYS . 14.5 p -134.18 129.13 19.76 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.436 174.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HG2' ' HB2' ' A' ' 71' ' ' LYS . 36.0 Cg_endo -67.89 128.89 18.57 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.494 2.129 . . . . 0.0 112.342 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 69' ' ' CYS . 27.1 m -115.94 161.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.343 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -139.76 178.33 7.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.13 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 6' ' ' PHE . 17.4 m -109.21 134.45 51.73 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.768 177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -72.87 -22.25 60.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.993 0.425 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HB2' HG22 ' A' ' 65' ' ' VAL . 37.7 mtmm -132.42 146.29 60.89 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.59 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' HD13 ' A' ' 5' ' ' ILE . 23.9 Cg_exo -63.15 137.62 62.5 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.969 2.446 . . . . 0.0 112.818 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 6' ' ' PHE . 33.4 m -114.99 160.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.411 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.608 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 59.4 mt-10 -68.65 139.7 55.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.442 ' HA ' ' CD1' ' A' ' 34' ' ' TRP . 29.7 pt -60.22 -26.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.889 0.375 . . . . 0.0 111.675 -177.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 m -74.74 -17.41 60.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.082 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.608 ' HE2' ' OE1' ' A' ' 30' ' ' GLU . 63.8 mttm -90.48 -5.29 56.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.612 0.244 . . . . 0.0 111.334 -177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.442 ' CD1' ' HA ' ' A' ' 31' ' ' ILE . 10.5 m95 -59.05 -31.26 68.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.02 -48.3 75.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.462 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 40' ' ' VAL . 7.1 m-20 -56.5 -50.63 71.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.49 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.434 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 32.4 m-85 -63.07 -37.05 85.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.371 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -63.4 -41.83 98.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.832 -0.167 . . . . 0.0 111.095 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -62.78 -35.27 79.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.958 0.409 . . . . 0.0 110.679 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 36' ' ' ASP . 59.1 t -70.02 -48.58 61.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.7 mp -64.61 -39.81 94.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.938 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.3 m -66.18 -12.14 54.06 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.644 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -105.15 -9.29 17.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.222 0.534 . . . . 0.0 109.918 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.11 124.0 43.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.605 -172.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -125.3 117.1 23.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.641 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.514 HG11 HG13 ' A' ' 56' ' ' VAL . 24.9 m -106.02 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -151.3 47.04 0.59 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.426 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.33 119.73 17.69 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-O 120.562 0.22 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.66 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . 55.8 Cg_endo -73.49 97.59 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.581 2.188 . . . . 0.0 111.473 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.0 p -96.77 170.22 9.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' ASN . 64.1 mttp -98.27 -149.76 0.35 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.695 171.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 2.0 p -92.36 119.59 32.06 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.62 58.16 1.21 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.177 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.511 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 21.1 m-80 -127.91 129.24 46.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -79.17 110.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.167 0.508 . . . . 0.0 111.322 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 HG11 ' A' ' 46' ' ' VAL . 45.1 t -83.98 -42.61 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.684 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.1 m -130.53 103.6 6.74 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.443 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -84.23 128.19 34.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.528 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 54.79 52.66 11.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.348 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.554 HG21 HG12 ' A' ' 67' ' ' ILE . 12.7 tt -75.32 135.7 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.403 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.7 mmt 65.07 13.85 8.97 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.477 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.4 13.15 5.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.568 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 65' ' ' VAL . 8.9 t -87.51 -7.49 57.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.166 0.508 . . . . 0.0 110.449 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -12.46 66.3 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.629 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.516 ' H ' HG23 ' A' ' 63' ' ' THR . 77.1 t -73.07 137.93 22.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.113 0.483 . . . . 0.0 110.283 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.94 120.2 38.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.554 HG12 HG21 ' A' ' 60' ' ' ILE . 44.0 mm -80.04 115.97 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.77 0.319 . . . . 0.0 110.397 -175.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 26.3 pt -116.13 131.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.649 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.52 ' HB3' HG12 ' A' ' 23' ' ' VAL . 1.8 p -81.13 139.32 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 11.7 t -126.13 6.99 7.18 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.395 -173.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' HB3' HG23 ' A' ' 21' ' ' VAL . 64.2 tttp -99.67 131.12 45.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -76.19 107.17 8.24 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.506 HD11 ' HB ' ' A' ' 21' ' ' VAL . 95.8 mt -81.58 112.62 35.68 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.279 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.94 117.79 4.77 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.487 2.125 . . . . 0.0 112.067 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -69.67 107.99 3.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.013 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.24 65.72 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.658 0.742 . . . . 0.0 110.611 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.6 t -174.48 127.33 0.33 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.407 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.3 mt -105.51 158.21 16.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.226 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -74.17 95.14 2.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -104.19 110.37 22.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.729 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -143.43 121.03 11.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.895 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -91.58 131.12 37.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.091 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -162.5 40.76 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.267 0.556 . . . . 0.0 109.815 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -79.03 47.75 0.8 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.48 0.657 . . . . 0.0 110.512 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 . . . . . 0 C--O 1.249 1.075 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.269 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.628 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 6.4 mmt . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 62.1 -94.86 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.669 0.605 . . . . 0.0 110.01 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 28' ' ' PRO . 68.2 mttm -107.93 140.52 40.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.62 157.13 32.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.575 -175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 47.3 mm -82.74 101.48 7.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 81.9 t80 -58.8 106.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.339 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -122.26 128.69 51.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.068 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -149.54 -168.98 3.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.9 m -121.75 137.53 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.705 0.288 . . . . 0.0 110.34 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.86 152.27 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -89.45 111.18 22.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.576 0.703 . . . . 0.0 110.117 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.608 ' HB ' ' HZ1' ' A' ' 16' ' ' LYS . 3.0 t -98.28 140.01 19.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.608 -173.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 45' ' ' TYR . 67.6 mtm180 -79.75 144.37 33.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.54 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -70.58 95.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.077 -0.965 . . . . 0.0 115.124 -169.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 p -117.37 12.33 14.23 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 165.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HZ1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -169.96 -168.92 0.8 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.359 -171.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.43 -41.36 14.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.602 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 78.2 m-85 -82.4 97.32 8.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 111.498 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 95.8 m-20 -98.63 10.72 40.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.52 122.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 73' ' ' LEU . 4.4 p -130.91 139.73 36.49 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.719 -173.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.43 124.39 10.33 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.923 2.415 . . . . 0.0 112.966 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.4 154.61 16.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.516 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -143.98 178.97 7.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.503 ' HB2' HG11 ' A' ' 65' ' ' VAL . 67.8 p -108.93 127.67 54.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.758 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -63.9 -24.32 67.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.863 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HB2' HG22 ' A' ' 65' ' ' VAL . 82.8 mttt -122.68 142.71 38.25 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HB2' ' CB ' ' A' ' 3' ' ' LYS . 32.5 Cg_endo -64.81 128.29 20.58 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.232 1.955 . . . . 0.0 112.117 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.04 150.26 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.201 -176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.07 120.75 14.8 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.19 84.12 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.725 1.25 . . . . 0.0 111.914 -174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.1 m -138.04 -10.45 1.52 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.081 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -103.46 17.77 23.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -173.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -62.99 -26.84 69.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 0.0 110.494 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 39' ' ' ASN . 64.2 mt -73.02 -47.91 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.429 176.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 40' ' ' VAL . 5.8 m-20 -68.29 -39.71 82.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.546 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.8 m-30 -64.21 -48.41 75.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.756 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -66.43 -30.75 71.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.182 0.515 . . . . 0.0 110.064 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 14.5 t-20 -56.72 -49.66 74.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.028 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 36' ' ' ASP . 47.1 t -70.99 -38.03 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.736 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 37' ' ' PHE . 81.2 mt -62.01 -25.35 67.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.245 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -77.86 4.3 12.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.004 0.43 . . . . 0.0 111.396 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -141.64 16.75 2.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 0.0 109.963 174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.9 tp -115.1 59.43 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.725 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 78.7 m-85 -83.83 92.05 7.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.738 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 48' ' ' VAL . 14.9 p -92.18 147.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.99 49.19 0.93 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.1 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 22.3 m -130.23 128.96 22.81 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.724 ' HG2' ' HD2' ' A' ' 75' ' ' LYS . 23.2 Cg_exo -67.39 133.26 29.74 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.136 2.558 . . . . 0.0 111.589 173.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.509 ' H ' HD13 ' A' ' 73' ' ' LEU . 2.0 p -133.41 179.68 6.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.961 -174.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -118.92 169.5 9.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.751 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.53 ' HB2' HD21 ' A' ' 72' ' ' ASN . 11.0 t -59.56 128.71 38.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 0.0 111.805 -173.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.97 26.71 12.1 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.554 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.591 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.0 p30 -96.42 137.53 35.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' A' ' 58' ' ' LYS . 62.4 t -77.6 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.69 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.2 t -86.87 -57.79 3.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.2 t -130.49 109.25 10.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.915 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB2' HG11 ' A' ' 55' ' ' VAL . 9.3 tmtm? -84.12 119.82 25.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.623 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 57.46 50.86 10.56 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 110.221 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.651 HG12 ' HG2' ' A' ' 61' ' ' MET . 8.0 tt -49.15 -50.46 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.666 -173.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.651 ' HG2' HG12 ' A' ' 60' ' ' ILE . 95.8 mmm -130.12 45.41 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.791 0.329 . . . . 0.0 110.585 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 m120 60.04 29.63 19.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.194 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -86.31 -20.05 28.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.689 -176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.63 8.79 87.52 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 27' ' ' LYS . 69.0 t -104.47 138.75 27.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.212 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 58' ' ' LYS . 4.3 m-20 -97.41 106.94 19.35 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.8 mm -72.07 107.12 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 55' ' ' VAL . 33.4 pt -114.69 144.87 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.977 -171.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.591 ' HB3' HD21 ' A' ' 54' ' ' ASN . 10.3 t -89.65 141.97 28.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.046 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -120.07 6.74 10.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 56.7 tttp -101.74 147.55 26.33 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -98.01 110.88 23.37 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 21' ' ' VAL . 5.7 mp -87.45 116.1 65.0 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.988 -176.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 73' ' ' LEU . 2.9 Cg_exo -77.27 148.45 26.99 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 123.013 2.475 . . . . 0.0 111.519 175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.724 ' HD2' ' HG2' ' A' ' 49' ' ' PRO . 56.2 tttm -145.34 158.23 43.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.544 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 79.2 -177.09 0.09 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.07 0.948 . . . . 0.0 110.75 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.5 m -110.53 18.28 19.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.46 -171.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.12 136.37 52.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -70.66 145.11 50.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.787 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -147.83 97.06 2.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.539 0.685 . . . . 0.0 110.17 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -123.13 116.64 23.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.848 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -80.5 104.88 11.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 110.767 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -144.16 121.1 11.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.167 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -67.96 107.15 2.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 111.125 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 13.5 p80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.867 177.479 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -142.62 17.94 2.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.917 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HE2' ' HG2' ' A' ' 30' ' ' GLU . 97.3 mttt -103.53 142.0 35.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.915 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -140.57 164.4 30.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.022 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -74.85 113.19 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 72.8 t80 -59.35 108.5 0.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.842 177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -126.26 120.98 31.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.381 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 t -155.79 -156.79 0.67 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.2 m -132.08 147.03 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.784 0.326 . . . . 0.0 110.465 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.8 p -116.51 150.42 18.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.017 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.463 ' HD3' HG12 ' A' ' 20' ' ' VAL . 12.0 mmt180 -84.38 121.31 27.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.023 -177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 6.5 t -100.66 118.27 47.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.389 -173.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' C ' ' HA3' ' A' ' 47' ' ' GLY . 62.5 ttt180 -133.1 104.2 6.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 47' ' ' GLY . . . 174.42 -171.83 44.88 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t -78.3 99.31 6.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.921 0.391 . . . . 0.0 110.702 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -171.78 -166.63 0.44 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.36 -179.372 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -128.35 71.68 1.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -161.28 176.12 11.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.425 HD22 HG13 ' A' ' 20' ' ' VAL . 4.0 t30 -136.12 -50.07 0.69 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 110.551 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.463 HG12 ' HD3' ' A' ' 11' ' ' ARG . 15.9 m -131.11 133.45 62.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.19 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 73' ' ' LEU . 4.4 p -127.59 140.79 39.01 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.225 -177.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 21' ' ' VAL . 47.2 Cg_endo -70.08 137.63 34.98 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.243 1.962 . . . . 0.0 112.199 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 p -135.25 146.79 29.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.558 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -145.22 178.93 7.71 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.914 0.388 . . . . 0.0 111.288 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.515 ' HB2' HG11 ' A' ' 65' ' ' VAL . 91.3 p -108.86 129.56 55.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.254 0.55 . . . . 0.0 109.61 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.03 -39.77 72.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.516 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB3' HG22 ' A' ' 65' ' ' VAL . 32.3 ttmt -119.52 140.25 29.0 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.462 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.91 126.22 20.5 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.533 2.155 . . . . 0.0 111.924 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.54 156.92 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.646 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 3' ' ' LYS . 25.8 mt-10 -67.09 127.29 32.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.963 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.9 pt -74.31 -6.8 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.109 0.481 . . . . 0.0 110.877 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.9 t -60.6 -31.96 71.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.331 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.447 ' O ' ' HD1' ' A' ' 37' ' ' PHE . 33.2 mtmm -107.1 14.86 25.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.719 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -57.52 -36.21 71.28 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.698 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.4 mt -65.19 -39.69 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.04 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 40' ' ' VAL . 25.7 t0 -71.96 -42.16 66.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.286 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' A' ' 33' ' ' LYS . 22.3 m-85 -58.08 -46.22 85.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.272 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.0 p -68.98 -28.6 66.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.309 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -72.69 -24.66 61.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.918 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 57.6 t -71.67 -44.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.18 -42.86 91.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.407 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -77.91 2.85 16.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 111.227 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -111.49 -15.89 13.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.537 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 93.3 mt -74.07 -71.66 0.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.861 -175.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 58.5 79.92 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.465 -173.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.3 p -125.22 143.36 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.614 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' C ' ' A' ' 13' ' ' ARG . . . -139.17 88.98 0.2 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.086 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 60.0 t -128.82 120.61 20.58 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' VAL . 14.2 Cg_endo -57.71 111.13 0.74 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.674 2.249 . . . . 0.0 111.779 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 171.66 14.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.548 -174.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -100.55 178.32 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.341 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -68.9 129.17 39.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.57 28.56 10.25 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.285 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 69' ' ' CYS . 10.8 p30 -88.32 131.32 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 66' ' ' ASP . 37.0 t -88.97 110.71 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.794 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.99 -64.74 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.131 0.491 . . . . 0.0 109.789 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.412 ' HB3' ' HB ' ' A' ' 60' ' ' ILE . 70.3 m -100.47 116.69 33.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.311 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HD3' HG12 ' A' ' 55' ' ' VAL . 25.3 mmtt -83.4 104.01 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 57.6 t30 54.77 66.31 1.27 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.703 0.763 . . . . 0.0 109.595 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.48 HD11 HG11 ' A' ' 40' ' ' VAL . 12.3 tt -61.69 111.25 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.539 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm 63.76 26.17 14.35 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.63 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 m120 62.75 82.68 0.17 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.284 0.564 . . . . 0.0 111.372 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.2 p -133.14 -20.83 2.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.203 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.22 7.45 73.2 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.35 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 27' ' ' LYS . 60.1 t -116.72 129.44 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.049 0.452 . . . . 0.0 110.442 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' HB2' HG13 ' A' ' 55' ' ' VAL . 5.4 p-10 -95.55 126.08 40.59 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 169.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 mm -83.15 110.89 18.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.018 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 29.7 pt -117.4 138.53 47.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.451 0.643 . . . . 0.0 112.273 -172.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.555 ' HB3' HD21 ' A' ' 54' ' ' ASN . 40.7 t -92.11 145.7 24.31 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -114.92 -2.74 12.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.056 0.455 . . . . 0.0 111.331 -173.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HD3' HG23 ' A' ' 21' ' ' VAL . 55.9 tttp -97.04 149.88 21.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.593 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -96.76 132.62 42.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -175.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.493 HD11 HG21 ' A' ' 21' ' ' VAL . 5.1 mp -111.79 93.98 22.5 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.909 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -92.24 137.9 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.776 2.317 . . . . 0.0 113.024 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -142.47 112.16 6.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.09 120.89 32.7 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.7 p -146.98 114.91 6.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.985 0.421 . . . . 0.0 112.085 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 78' ' ' LEU . 6.4 mp -77.2 105.11 8.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -85.36 80.95 8.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -164.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 58.04 26.63 13.79 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 168.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -88.47 28.72 1.07 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.47 0.652 . . . . 0.0 110.343 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -161.72 96.73 1.04 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.086 0.469 . . . . 0.0 110.105 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -171.36 -55.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -87.9 55.58 3.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 . . . . . 0 C--O 1.249 1.07 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.764 -172.687 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mmm . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.686 0.279 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -88.92 -18.72 26.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.342 0.591 . . . . 0.0 109.854 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 94.2 mttt -115.59 122.2 44.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.561 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -124.19 148.17 47.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.487 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.468 HG22 HG23 ' A' ' 7' ' ' THR . 42.0 mm -64.6 119.74 9.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.083 0.468 . . . . 0.0 110.959 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 91.6 t80 -78.13 96.01 5.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.034 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 5' ' ' ILE . 16.6 p -105.72 125.19 50.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 174.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 60.0 m -149.94 -169.0 3.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.52 138.83 52.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.3 157.85 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.459 ' HD2' HG12 ' A' ' 20' ' ' VAL . 33.6 mmm-85 -79.74 133.1 36.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.802 0.334 . . . . 0.0 110.797 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 46' ' ' VAL . 2.8 t -120.63 139.1 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.284 0.564 . . . . 0.0 110.669 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 64.6 ttt-85 -119.43 170.49 9.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.074 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.09 174.35 18.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.634 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.6 p -72.52 86.35 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.549 ' HG2' ' HG3' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -178.15 164.09 1.76 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.044 171.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -91.71 34.14 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.374 -0.376 . . . . 0.0 112.011 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 97.5 m-85 -130.55 102.91 6.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.814 0.34 . . . . 0.0 110.31 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.39 -7.06 55.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.546 -176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.459 HG12 ' HD2' ' A' ' 11' ' ' ARG . 15.5 m -140.99 143.59 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.511 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.512 ' HB ' HG21 ' A' ' 12' ' ' VAL . 3.1 p -140.78 138.25 18.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.435 177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' SER . 55.2 Cg_endo -72.98 129.57 14.42 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.558 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 69' ' ' CYS . 30.1 m -115.58 161.55 14.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.569 ' HG3' HG13 ' A' ' 68' ' ' ILE . 18.3 ptpt -131.34 174.94 9.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.481 ' HB2' HG11 ' A' ' 65' ' ' VAL . 79.8 p -108.93 130.95 55.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.262 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -55.78 -44.71 77.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HG3' ' HD2' ' A' ' 28' ' ' PRO . 37.5 ttpt -121.09 140.88 31.76 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.538 ' HD2' ' HG3' ' A' ' 27' ' ' LYS . 84.6 Cg_exo -46.92 130.76 16.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.088 2.526 . . . . 0.0 112.835 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.81 127.09 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.667 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.558 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 40.9 mt-10 -52.5 135.3 34.12 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.301 176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.5 tp -68.26 81.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 122.051 0.929 . . . . 0.0 110.881 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t 179.9 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.217 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.12 -5.69 52.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.295 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -57.56 -34.25 68.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.228 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.27 -54.99 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.658 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 7.5 m-20 -62.44 -38.16 88.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.972 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.02 -51.42 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.242 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 t -64.9 -32.01 73.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.632 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 24.9 t-20 -55.56 -54.34 45.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.901 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 36' ' ' ASP . 67.3 t -60.42 -42.93 92.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.98 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.4 mt -60.99 -27.2 68.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.2 t -68.28 -10.63 56.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.58 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -130.2 20.07 5.34 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 174.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.3 tp -109.89 115.23 29.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.43 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -117.29 112.69 21.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.369 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.551 HG23 HG13 ' A' ' 12' ' ' VAL . 27.3 m -96.67 178.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.346 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 13' ' ' ARG . . . -143.98 176.04 23.51 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.089 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.7 t 71.97 139.75 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 122.797 0.439 . . . . 0.0 111.216 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HG2' ' HA ' ' A' ' 75' ' ' LYS . 25.1 Cg_exo -64.8 119.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.447 2.098 . . . . 0.0 111.401 170.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.587 ' HB ' ' CG ' ' A' ' 54' ' ' ASN . 40.6 p -101.6 166.34 10.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.826 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.59 -148.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.82 ' HB2' HD21 ' A' ' 72' ' ' ASN . 11.4 t -101.95 120.81 41.0 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.31 49.77 1.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.026 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.587 ' CG ' ' HB ' ' A' ' 50' ' ' THR . 1.5 m-80 -108.69 109.11 20.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 68' ' ' ILE . 94.7 t -69.55 111.38 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.98 -62.55 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.71 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 75.7 m -130.81 115.3 16.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.032 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 20.6 ptmt -98.18 141.97 30.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.824 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.497 ' ND2' ' HA2' ' A' ' 64' ' ' GLY . 11.8 t-20 58.34 41.7 22.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.716 0.77 . . . . 0.0 109.028 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.773 HG12 ' HG2' ' A' ' 61' ' ' MET . 14.4 tt -64.51 133.67 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.41 -173.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.773 ' HG2' HG12 ' A' ' 60' ' ' ILE . 83.7 mmm 63.39 21.85 12.98 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 65.65 10.91 7.11 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.689 0.757 . . . . 0.0 110.13 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -69.87 -43.82 71.09 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.96 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.497 ' HA2' ' ND2' ' A' ' 59' ' ' ASN . . . 117.43 -27.14 7.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.351 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 25' ' ' SER . 85.8 t -66.95 140.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.67 0.271 . . . . 0.0 110.766 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 4.2 m-20 -95.63 123.0 38.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.76 106.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.569 HG13 ' HG3' ' A' ' 24' ' ' LYS . 25.7 pt -115.53 132.9 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.857 -172.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.578 ' HB3' HD22 ' A' ' 54' ' ' ASN . 18.2 t -72.09 142.1 49.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.1 t -126.35 1.83 7.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -173.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 64.7 tttp -102.58 129.08 49.03 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.481 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.82 HD21 ' HB2' ' A' ' 52' ' ' SER . 0.7 OUTLIER -86.23 106.39 17.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.974 -174.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 62.9 mt -95.73 126.03 46.76 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.079 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 73' ' ' LEU . 15.6 Cg_endo -58.34 132.19 47.34 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.563 2.175 . . . . 0.0 111.532 176.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 49' ' ' PRO . 51.8 tttm -95.38 -82.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.53 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.89 93.18 6.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.969 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.3 t -86.89 93.27 9.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.466 0.651 . . . . 0.0 110.215 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.7 mt -92.42 61.12 3.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.648 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.51 133.98 43.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.625 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -79.65 119.82 23.13 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -58.25 -48.95 78.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.343 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -145.54 -76.05 0.21 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.616 173.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -151.22 116.22 5.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.492 -174.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -151.55 129.32 11.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.285 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.6 p80 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.251 175.404 . . . . . . . . 0 0 . 1 stop_ save_